{"disclaimer":"Transcripts available through this tool are created by using automatic speech recognition and are not official records nor official documents of the United Nations. Official records and official documents are available on the Official Document System of the United Nations.","url":"https://transcripts.un.org/en/asset/k1j/k1jrujg19l","llms":{"note":"Plain-text sibling of this page, compact for LLM context. For the full API guide (search, listing, URL grammar) see /llms.txt.","textUrl":"/en/asset/k1j/k1jrujg19l.txt","guide":"/llms.txt"},"video":{"id":"k1j/k1jrujg19l","kaltura_id":"1_jrujg19l","title":"Evidence and Science-Based Approaches in Drug Policy, HIV and Health: Good Practices and Windows of Opportunity (HLPF 2025 Side Event)","clean_title":"Evidence and Science-Based Approaches in Drug Policy, HIV and Health: Good Practices and Windows of Opportunity (HLPF 2025 Side Event)","url":"https://webtv.un.org/en/asset/k1j/k1jrujg19l","date":"2025-07-17T00:00:00.000Z","scheduled_time":"2025-07-17T17:15:00.000Z","status":"finished","duration":"01:37:01","category":"Side Events","body":null,"event_code":null,"event_type":null,"session_number":null,"pv_symbol":null,"pv_part":null,"slug":"asset/k1j/k1jrujg19l"},"metadata":{"summary":null,"description":null,"categories":[],"geographic_subject":[],"subject_topical":[],"corporate_name":[],"speaker_affiliation":[],"related_documents":[]},"transcript":{"transcript_id":"azure-llm-speech-7f6a3732-60e3-425d-9674-0bae48dbe06d","language":"en","data":[{"statement_number":1,"start":1.71,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=0:02","paragraphs":[{"sentences":[{"text":"Thank you all for being here this afternoon.","start":1.71,"end":4.11,"topics":[],"words":[{"text":"Thank","start":1.71,"end":2.03},{"text":"you","start":2.03,"end":2.23},{"text":"all","start":2.23,"end":2.43},{"text":"for","start":2.43,"end":2.59},{"text":"being","start":2.59,"end":2.83},{"text":"here","start":2.83,"end":3.23},{"text":"this","start":3.23,"end":3.47},{"text":"afternoon.","start":3.47,"end":4.11}]},{"text":"I am Ambassador Alicia Buenrostro Massieu.","start":4.35,"end":7.47,"topics":[],"words":[{"text":"I","start":4.35,"end":4.51},{"text":"am","start":4.59,"end":4.83},{"text":"Ambassador","start":4.83,"end":5.55},{"text":"Alicia","start":5.55,"end":6.19},{"text":"Buenrostro","start":6.19,"end":6.91},{"text":"Massieu.","start":6.91,"end":7.47}]},{"text":"I am Deputy Permanent Representative of Mexico at the Permanent Mission of my country here, who is a very proud co-organizer of this event.","start":7.55,"end":18.99,"topics":[],"words":[{"text":"I","start":7.55,"end":7.71},{"text":"am","start":7.71,"end":7.87},{"text":"Deputy","start":7.87,"end":8.27},{"text":"Permanent","start":8.27,"end":8.71},{"text":"Representative","start":8.71,"end":9.47},{"text":"of","start":9.47,"end":9.63},{"text":"Mexico","start":9.63,"end":10.43},{"text":"at","start":12.11,"end":12.27},{"text":"the","start":12.27,"end":12.35},{"text":"Permanent","start":12.35,"end":12.95},{"text":"Mission","start":12.95,"end":13.35},{"text":"of","start":13.35,"end":13.47},{"text":"my","start":13.47,"end":13.63},{"text":"country","start":13.63,"end":14.07},{"text":"here,","start":14.07,"end":14.59},{"text":"who","start":14.91,"end":15.39},{"text":"is","start":15.39,"end":15.79},{"text":"a","start":15.87,"end":15.95},{"text":"very","start":15.95,"end":16.31},{"text":"proud","start":16.31,"end":16.71},{"text":"co-organizer","start":16.75,"end":18.03},{"text":"of","start":18.03,"end":18.27},{"text":"this","start":18.27,"end":18.51},{"text":"event.","start":18.51,"end":18.99}]},{"text":"Today, we will discuss evidence and science-based approaches to drug policy, HIV, and health.","start":19.39,"end":27.63,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"Today,","start":19.39,"end":20.03},{"text":"we","start":20.19,"end":20.35},{"text":"will","start":20.39,"end":20.55},{"text":"discuss","start":20.55,"end":21.23},{"text":"evidence","start":21.31,"end":22.03},{"text":"and","start":22.19,"end":22.51},{"text":"science-based","start":22.51,"end":23.55},{"text":"approaches","start":23.63,"end":24.43},{"text":"to","start":24.43,"end":24.63},{"text":"drug","start":24.67,"end":24.95},{"text":"policy,","start":24.95,"end":25.71},{"text":"HIV,","start":26.11,"end":26.99},{"text":"and","start":26.99,"end":27.23},{"text":"health.","start":27.23,"end":27.63}]},{"text":"Through our discussions and dialogue, we will seek to identify windows of opportunity and good practices towards more humane and effective drug policies.","start":28.27,"end":39.55,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Through","start":28.27,"end":28.59},{"text":"our","start":28.59,"end":28.91},{"text":"discussions","start":28.91,"end":29.67},{"text":"and","start":29.67,"end":29.83},{"text":"dialogue,","start":29.83,"end":30.43},{"text":"we","start":30.59,"end":30.83},{"text":"will","start":30.83,"end":30.99},{"text":"seek","start":30.99,"end":31.39},{"text":"to","start":31.39,"end":31.55},{"text":"identify","start":31.55,"end":32.51},{"text":"windows","start":32.75,"end":33.43},{"text":"of","start":33.43,"end":33.55},{"text":"opportunity","start":33.55,"end":34.47},{"text":"and","start":34.47,"end":34.63},{"text":"good","start":34.63,"end":34.79},{"text":"practices","start":34.83,"end":35.55},{"text":"towards","start":35.55,"end":36.03},{"text":"more","start":36.03,"end":36.35},{"text":"humane","start":36.35,"end":37.07},{"text":"and","start":37.31,"end":37.63},{"text":"effective","start":37.63,"end":38.35},{"text":"drug","start":38.35,"end":38.75},{"text":"policies.","start":38.75,"end":39.55}]},{"text":"I will now deliver some opening remarks on behalf of my country, Mexico.","start":39.87,"end":45.63,"topics":[],"words":[{"text":"I","start":39.87,"end":40.03},{"text":"will","start":40.03,"end":40.27},{"text":"now","start":40.27,"end":40.59},{"text":"deliver","start":40.59,"end":41.23},{"text":"some","start":41.23,"end":41.55},{"text":"opening","start":41.55,"end":42.11},{"text":"remarks","start":42.11,"end":42.75},{"text":"on","start":42.75,"end":42.87},{"text":"behalf","start":42.91,"end":43.39},{"text":"of","start":43.47,"end":43.79},{"text":"my","start":43.87,"end":44.19},{"text":"country,","start":44.19,"end":44.91},{"text":"Mexico.","start":44.99,"end":45.63}]},{"text":"So, Excellencies, colleagues, dear friends, thank you to all co-organizers for making this discussion possible.","start":46.35,"end":54.75,"topics":[],"words":[{"text":"So,","start":46.35,"end":46.75},{"text":"Excellencies,","start":46.91,"end":47.87},{"text":"colleagues,","start":47.87,"end":48.59},{"text":"dear","start":48.71,"end":48.83},{"text":"friends,","start":48.83,"end":49.55},{"text":"thank","start":49.95,"end":50.35},{"text":"you","start":50.35,"end":50.67},{"text":"to","start":50.99,"end":51.19},{"text":"all","start":51.19,"end":51.27},{"text":"co-organizers","start":51.27,"end":52.59},{"text":"for","start":52.59,"end":52.75},{"text":"making","start":52.75,"end":53.23},{"text":"this","start":53.23,"end":53.51},{"text":"discussion","start":53.51,"end":54.11},{"text":"possible.","start":54.11,"end":54.75}]},{"text":"Mexico is honored to join you in advancing a conversation that remains urgent, that is also complex, and deeply relevant.","start":55.15,"end":64.11,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Mexico","start":55.15,"end":55.59},{"text":"is","start":55.59,"end":55.79},{"text":"honored","start":55.79,"end":56.15},{"text":"to","start":56.15,"end":56.27},{"text":"join","start":56.35,"end":56.75},{"text":"you","start":56.75,"end":56.99},{"text":"in","start":56.99,"end":57.23},{"text":"advancing","start":57.23,"end":57.95},{"text":"a","start":57.95,"end":58.03},{"text":"conversation","start":58.03,"end":58.99},{"text":"that","start":58.99,"end":59.23},{"text":"remains","start":59.23,"end":59.87},{"text":"urgent,","start":59.95,"end":60.59},{"text":"that","start":60.91,"end":61.15},{"text":"is","start":61.15,"end":61.31},{"text":"also","start":61.31,"end":61.63},{"text":"complex,","start":61.63,"end":62.43},{"text":"and","start":62.67,"end":62.95},{"text":"deeply","start":62.95,"end":63.39},{"text":"relevant.","start":63.39,"end":64.11}]},{"text":"We often speak of the world drug problem as if it is a single issue with a single solution.","start":64.67,"end":72.19,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"We","start":64.67,"end":64.99},{"text":"often","start":64.99,"end":65.31},{"text":"speak","start":65.31,"end":65.79},{"text":"of","start":65.87,"end":66.11},{"text":"the","start":66.11,"end":66.19},{"text":"world","start":66.19,"end":66.71},{"text":"drug","start":66.71,"end":66.99},{"text":"problem","start":66.99,"end":67.71},{"text":"as","start":67.79,"end":68.27},{"text":"if","start":68.75,"end":68.99},{"text":"it","start":69.07,"end":69.31},{"text":"is","start":69.31,"end":69.55},{"text":"a","start":69.55,"end":69.63},{"text":"single","start":69.63,"end":70.11},{"text":"issue","start":70.11,"end":70.67},{"text":"with","start":70.67,"end":70.91},{"text":"a","start":70.91,"end":70.99},{"text":"single","start":70.99,"end":71.47},{"text":"solution.","start":71.47,"end":72.19}]},{"text":"But in truth, what we are dealing with are overlapping realities that involve human rights, health justice, gender inequality, and public trust.","start":72.67,"end":83.95,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."}],"words":[{"text":"But","start":72.67,"end":72.87},{"text":"in","start":72.87,"end":72.99},{"text":"truth,","start":72.99,"end":73.47},{"text":"what","start":73.71,"end":74.03},{"text":"we","start":74.03,"end":74.23},{"text":"are","start":74.23,"end":74.35},{"text":"dealing","start":74.35,"end":74.83},{"text":"with","start":74.83,"end":75.15},{"text":"are","start":75.23,"end":75.71},{"text":"overlapping","start":75.71,"end":76.59},{"text":"realities","start":76.59,"end":77.39},{"text":"that","start":77.39,"end":77.71},{"text":"involve","start":77.71,"end":78.11},{"text":"human","start":78.11,"end":78.55},{"text":"rights,","start":78.55,"end":79.15},{"text":"health","start":79.55,"end":79.99},{"text":"justice,","start":80.15,"end":80.83},{"text":"gender","start":81.15,"end":81.79},{"text":"inequality,","start":81.87,"end":82.91},{"text":"and","start":82.91,"end":83.15},{"text":"public","start":83.15,"end":83.55},{"text":"trust.","start":83.55,"end":83.95}]},{"text":"For too long, responses have relied on simplistic, punitive paradigms that overlook these complexities.","start":84.87,"end":93.03,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"For","start":84.87,"end":85.11},{"text":"too","start":85.11,"end":85.35},{"text":"long,","start":85.35,"end":85.75},{"text":"responses","start":85.91,"end":86.79},{"text":"have","start":86.79,"end":87.03},{"text":"relied","start":87.03,"end":87.59},{"text":"on","start":87.59,"end":87.75},{"text":"simplistic,","start":87.75,"end":88.63},{"text":"punitive","start":88.63,"end":89.19},{"text":"paradigms","start":89.19,"end":90.07},{"text":"that","start":90.31,"end":90.79},{"text":"overlook","start":90.79,"end":91.51},{"text":"these","start":91.59,"end":91.99},{"text":"complexities.","start":91.99,"end":93.03}]},{"text":"These approaches have proven ineffective and, in many cases, counterproductive.","start":93.67,"end":98.63,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"These","start":93.67,"end":93.91},{"text":"approaches","start":93.91,"end":94.63},{"text":"have","start":94.63,"end":94.75},{"text":"proven","start":94.75,"end":95.35},{"text":"ineffective","start":95.35,"end":96.23},{"text":"and,","start":96.39,"end":96.63},{"text":"in","start":96.63,"end":96.79},{"text":"many","start":96.79,"end":97.03},{"text":"cases,","start":97.03,"end":97.51},{"text":"counterproductive.","start":97.51,"end":98.63}]},{"text":"Serious efforts must begin with honest reflection, acknowledging the need to rethink past policies to design more effective responses.","start":99.03,"end":109.03,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Serious","start":99.03,"end":99.67},{"text":"efforts","start":99.67,"end":100.23},{"text":"must","start":100.23,"end":100.51},{"text":"begin","start":100.51,"end":101.03},{"text":"with","start":101.03,"end":101.35},{"text":"honest","start":101.43,"end":101.99},{"text":"reflection,","start":101.99,"end":102.71},{"text":"acknowledging","start":102.95,"end":103.75},{"text":"the","start":103.75,"end":103.91},{"text":"need","start":103.91,"end":104.15},{"text":"to","start":104.15,"end":104.35},{"text":"rethink","start":104.35,"end":104.95},{"text":"past","start":104.95,"end":105.23},{"text":"policies","start":105.23,"end":105.91},{"text":"to","start":106.15,"end":106.31},{"text":"design","start":106.31,"end":106.95},{"text":"more","start":106.95,"end":107.43},{"text":"effective","start":107.43,"end":108.07},{"text":"responses.","start":108.07,"end":109.03}]},{"text":"This rethinking includes listening more carefully to those whose needs have been systematically ignored.","start":110.03,"end":117.75,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"This","start":110.03,"end":110.43},{"text":"rethinking","start":110.43,"end":111.31},{"text":"includes","start":111.31,"end":112.11},{"text":"listening","start":112.19,"end":112.83},{"text":"more","start":112.83,"end":113.07},{"text":"carefully","start":113.07,"end":113.63},{"text":"to","start":113.63,"end":113.75},{"text":"those","start":113.79,"end":114.27},{"text":"whose","start":114.59,"end":114.91},{"text":"needs","start":114.91,"end":115.31},{"text":"have","start":115.31,"end":115.59},{"text":"been","start":115.59,"end":115.95},{"text":"systematically","start":115.95,"end":117.15},{"text":"ignored.","start":117.15,"end":117.75}]},{"text":"People who use drugs continue to face barriers to basic services, especially those in vulnerable situations.","start":118.51,"end":126.11,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"People","start":118.51,"end":118.91},{"text":"who","start":118.91,"end":119.07},{"text":"use","start":119.07,"end":119.35},{"text":"drugs","start":119.35,"end":119.79},{"text":"continue","start":119.79,"end":120.43},{"text":"to","start":120.43,"end":120.59},{"text":"face","start":120.59,"end":120.91},{"text":"barriers","start":120.91,"end":121.47},{"text":"to","start":121.47,"end":121.63},{"text":"basic","start":121.63,"end":122.03},{"text":"services,","start":122.03,"end":122.83},{"text":"especially","start":123.15,"end":123.87},{"text":"those","start":123.87,"end":124.27},{"text":"in","start":124.35,"end":124.51},{"text":"vulnerable","start":124.51,"end":125.23},{"text":"situations.","start":125.23,"end":126.11}]},{"text":"Women, for example, experience intersecting forms of inequality shaped by gender norms, discrimination, and unequal access to services.","start":126.59,"end":137.15,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Women,","start":126.59,"end":127.07},{"text":"for","start":127.07,"end":127.27},{"text":"example,","start":127.27,"end":127.95},{"text":"experience","start":128.03,"end":128.75},{"text":"intersecting","start":128.75,"end":129.55},{"text":"forms","start":129.55,"end":129.99},{"text":"of","start":129.99,"end":130.11},{"text":"inequality","start":130.11,"end":131.07},{"text":"shaped","start":131.39,"end":131.87},{"text":"by","start":131.87,"end":132.11},{"text":"gender","start":132.11,"end":132.51},{"text":"norms,","start":132.51,"end":133.15},{"text":"discrimination,","start":133.31,"end":134.59},{"text":"and","start":134.75,"end":134.99},{"text":"unequal","start":134.99,"end":135.55},{"text":"access","start":135.55,"end":136.11},{"text":"to","start":136.11,"end":136.27},{"text":"services.","start":136.27,"end":137.15}]},{"text":"These are not consequences of drug use.","start":138.35,"end":141.47,"topics":[],"words":[{"text":"These","start":138.35,"end":138.99},{"text":"are","start":138.99,"end":139.15},{"text":"not","start":139.15,"end":139.47},{"text":"consequences","start":139.47,"end":140.43},{"text":"of","start":140.43,"end":140.59},{"text":"drug","start":140.59,"end":140.91},{"text":"use.","start":140.91,"end":141.47}]},{"text":"They are flaws within the systems we have created.","start":141.71,"end":145.63,"topics":[],"words":[{"text":"They","start":141.71,"end":141.95},{"text":"are","start":141.95,"end":142.11},{"text":"flaws","start":142.11,"end":142.75},{"text":"within","start":142.75,"end":143.15},{"text":"the","start":143.15,"end":143.23},{"text":"systems","start":143.23,"end":144.03},{"text":"we","start":144.43,"end":144.67},{"text":"have","start":144.67,"end":144.99},{"text":"created.","start":144.99,"end":145.63}]},{"text":"And precisely for that same reason, these are the deficiencies we have the power and responsibility to correct.","start":146.11,"end":153.95,"topics":[],"words":[{"text":"And","start":146.11,"end":146.27},{"text":"precisely","start":146.27,"end":146.91},{"text":"for","start":146.91,"end":147.15},{"text":"that","start":147.15,"end":147.39},{"text":"same","start":147.39,"end":147.63},{"text":"reason,","start":147.63,"end":148.19},{"text":"these","start":148.35,"end":148.75},{"text":"are","start":148.75,"end":148.91},{"text":"the","start":148.91,"end":149.15},{"text":"deficiencies","start":149.15,"end":149.95},{"text":"we","start":149.95,"end":150.15},{"text":"have","start":150.15,"end":150.51},{"text":"the","start":150.59,"end":150.75},{"text":"power","start":150.75,"end":151.31},{"text":"and","start":151.55,"end":151.75},{"text":"responsibility","start":151.75,"end":152.91},{"text":"to","start":153.15,"end":153.31},{"text":"correct.","start":153.31,"end":153.95}]},{"text":"Everything changes and everything evolves.","start":154.35,"end":156.99,"topics":[],"words":[{"text":"Everything","start":154.35,"end":154.83},{"text":"changes","start":154.91,"end":155.63},{"text":"and","start":155.63,"end":155.91},{"text":"everything","start":155.91,"end":156.35},{"text":"evolves.","start":156.43,"end":156.99}]},{"text":"The numbers are telling.","start":157.55,"end":158.99,"topics":[],"words":[{"text":"The","start":157.55,"end":157.71},{"text":"numbers","start":157.71,"end":158.27},{"text":"are","start":158.27,"end":158.43},{"text":"telling.","start":158.43,"end":158.99}]},{"text":"High rates of HIV and hepatitis C among people who inject drugs.","start":159.07,"end":164.35,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"High","start":159.07,"end":159.39},{"text":"rates","start":159.39,"end":159.87},{"text":"of","start":159.91,"end":160.03},{"text":"HIV","start":160.03,"end":160.83},{"text":"and","start":160.83,"end":160.99},{"text":"hepatitis","start":160.99,"end":161.83},{"text":"C","start":161.83,"end":162.27},{"text":"among","start":162.27,"end":162.67},{"text":"people","start":162.67,"end":163.19},{"text":"who","start":163.19,"end":163.31},{"text":"inject","start":163.31,"end":163.83},{"text":"drugs.","start":163.83,"end":164.35}]},{"text":"rising overdose deaths despite proven interventions, underinvestment in harm reduction services, and the persistent overcriminalization of drug use, often at the expense of public health and human dignity.","start":164.79,"end":182.47,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"rising","start":164.79,"end":165.51},{"text":"overdose","start":165.51,"end":166.31},{"text":"deaths","start":166.31,"end":166.87},{"text":"despite","start":166.87,"end":167.51},{"text":"proven","start":167.51,"end":168.15},{"text":"interventions,","start":168.15,"end":169.19},{"text":"underinvestment","start":170.47,"end":171.59},{"text":"in","start":171.59,"end":171.75},{"text":"harm","start":171.75,"end":172.15},{"text":"reduction","start":172.15,"end":172.71},{"text":"services,","start":172.71,"end":173.51},{"text":"and","start":173.75,"end":173.95},{"text":"the","start":173.95,"end":174.07},{"text":"persistent","start":174.07,"end":174.87},{"text":"overcriminalization","start":175.03,"end":176.79},{"text":"of","start":176.79,"end":177.03},{"text":"drug","start":177.03,"end":177.43},{"text":"use,","start":177.43,"end":177.91},{"text":"often","start":178.39,"end":178.95},{"text":"at","start":178.95,"end":179.15},{"text":"the","start":179.15,"end":179.31},{"text":"expense","start":179.35,"end":180.15},{"text":"of","start":180.15,"end":180.23},{"text":"public","start":180.23,"end":180.79},{"text":"health","start":180.79,"end":181.19},{"text":"and","start":181.35,"end":181.55},{"text":"human","start":181.59,"end":181.99},{"text":"dignity.","start":181.99,"end":182.47}]},{"text":"We have seen that punitive approaches can reinforce cycles of marginalization, erode public confidence, and divert resources away from care and prevention.","start":183.35,"end":195.91,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"We","start":183.35,"end":183.59},{"text":"have","start":183.59,"end":183.83},{"text":"seen","start":183.83,"end":184.23},{"text":"that","start":184.23,"end":184.39},{"text":"punitive","start":184.39,"end":184.95},{"text":"approaches","start":184.95,"end":185.75},{"text":"can","start":185.75,"end":186.15},{"text":"reinforce","start":186.15,"end":186.95},{"text":"cycles","start":187.19,"end":188.03},{"text":"of","start":188.03,"end":188.23},{"text":"marginalization,","start":188.23,"end":189.67},{"text":"erode","start":189.99,"end":190.43},{"text":"public","start":190.47,"end":190.91},{"text":"confidence,","start":190.91,"end":191.67},{"text":"and","start":191.75,"end":192.03},{"text":"divert","start":192.03,"end":192.47},{"text":"resources","start":192.47,"end":193.27},{"text":"away","start":193.35,"end":193.75},{"text":"from","start":193.75,"end":194.07},{"text":"care","start":194.15,"end":194.55},{"text":"and","start":194.79,"end":195.19},{"text":"prevention.","start":195.19,"end":195.91}]},{"text":"But behind those figures are people, and how we treat them, whether with support or suspicion, says a great deal about the kind of societies we are striving to shape.","start":196.71,"end":209.51,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"But","start":196.71,"end":196.95},{"text":"behind","start":196.95,"end":197.47},{"text":"those","start":197.47,"end":197.67},{"text":"figures","start":197.67,"end":198.39},{"text":"are","start":198.39,"end":198.63},{"text":"people,","start":198.63,"end":199.19},{"text":"and","start":199.95,"end":200.07},{"text":"how","start":200.07,"end":200.39},{"text":"we","start":200.39,"end":200.55},{"text":"treat","start":200.55,"end":200.91},{"text":"them,","start":200.91,"end":201.27},{"text":"whether","start":202.07,"end":202.55},{"text":"with","start":202.55,"end":202.75},{"text":"support","start":202.75,"end":203.35},{"text":"or","start":203.35,"end":203.51},{"text":"suspicion,","start":203.51,"end":204.31},{"text":"says","start":204.55,"end":204.95},{"text":"a","start":204.95,"end":205.03},{"text":"great","start":205.03,"end":205.35},{"text":"deal","start":205.35,"end":205.75},{"text":"about","start":205.75,"end":206.03},{"text":"the","start":206.03,"end":206.19},{"text":"kind","start":206.23,"end":206.71},{"text":"of","start":206.75,"end":206.87},{"text":"societies","start":206.87,"end":207.67},{"text":"we","start":207.83,"end":208.03},{"text":"are","start":208.03,"end":208.15},{"text":"striving","start":208.15,"end":208.87},{"text":"to","start":208.87,"end":208.99},{"text":"shape.","start":209.03,"end":209.51}]},{"text":"For all these reasons, my country, Mexico, underscores that health and human rights are not optional considerations.","start":210.47,"end":218.79,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"For","start":210.47,"end":210.79},{"text":"all","start":210.79,"end":210.95},{"text":"these","start":210.95,"end":211.19},{"text":"reasons,","start":211.19,"end":211.83},{"text":"my","start":211.83,"end":212.07},{"text":"country,","start":212.07,"end":212.71},{"text":"Mexico,","start":212.71,"end":213.43},{"text":"underscores","start":213.75,"end":214.55},{"text":"that","start":214.55,"end":214.67},{"text":"health","start":214.71,"end":215.19},{"text":"and","start":215.27,"end":215.47},{"text":"human","start":215.47,"end":215.91},{"text":"rights","start":215.91,"end":216.47},{"text":"are","start":216.47,"end":216.63},{"text":"not","start":216.63,"end":217.03},{"text":"optional","start":217.11,"end":217.75},{"text":"considerations.","start":217.75,"end":218.79}]},{"text":"They are essential, simply essential pillars of effective drug policies.","start":219.19,"end":224.55,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"They","start":219.19,"end":219.43},{"text":"are","start":219.43,"end":219.59},{"text":"essential,","start":219.59,"end":220.39},{"text":"simply","start":220.39,"end":221.11},{"text":"essential","start":221.11,"end":221.67},{"text":"pillars","start":221.67,"end":222.31},{"text":"of","start":222.55,"end":222.79},{"text":"effective","start":222.79,"end":223.35},{"text":"drug","start":223.35,"end":223.67},{"text":"policies.","start":223.67,"end":224.55}]},{"text":"Drug-related challenges are not merely a matter of security, but also issues of social justice that require coordinated public health and development responses.","start":224.95,"end":237.27,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Drug-related","start":224.95,"end":225.83},{"text":"challenges","start":225.83,"end":226.63},{"text":"are","start":226.63,"end":226.87},{"text":"not","start":226.87,"end":227.11},{"text":"merely","start":227.11,"end":227.71},{"text":"a","start":227.71,"end":227.75},{"text":"matter","start":227.75,"end":228.27},{"text":"of","start":228.27,"end":228.39},{"text":"security,","start":228.39,"end":229.11},{"text":"but","start":229.43,"end":229.67},{"text":"also","start":229.67,"end":230.07},{"text":"issues","start":230.07,"end":230.63},{"text":"of","start":230.63,"end":230.79},{"text":"social","start":230.79,"end":231.27},{"text":"justice","start":231.27,"end":231.91},{"text":"that","start":232.15,"end":232.39},{"text":"require","start":232.39,"end":232.99},{"text":"coordinated","start":232.99,"end":234.71},{"text":"public","start":234.71,"end":235.07},{"text":"health","start":235.07,"end":235.51},{"text":"and","start":235.67,"end":235.87},{"text":"development","start":235.87,"end":236.47},{"text":"responses.","start":236.47,"end":237.27}]},{"text":"At the national level, we have sought to respond with broader, more comprehensive strategies, national programs like Sembrando Vida and Jovenes Construyendo el Futuro, which are part of a broader effort to transform the structural conditions that foster vulnerability by expanding opportunities in communities historically marginalized.","start":238.03,"end":260.99,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"At","start":238.03,"end":238.11},{"text":"the","start":238.11,"end":238.27},{"text":"national","start":238.27,"end":238.83},{"text":"level,","start":238.83,"end":239.15},{"text":"we","start":239.15,"end":239.35},{"text":"have","start":239.35,"end":239.55},{"text":"sought","start":239.55,"end":239.91},{"text":"to","start":239.91,"end":239.99},{"text":"respond","start":239.99,"end":240.67},{"text":"with","start":240.67,"end":240.87},{"text":"broader,","start":240.91,"end":241.55},{"text":"more","start":241.79,"end":242.11},{"text":"comprehensive","start":242.11,"end":242.91},{"text":"strategies,","start":242.91,"end":243.71},{"text":"national","start":243.71,"end":244.19},{"text":"programs","start":244.19,"end":244.91},{"text":"like","start":245.23,"end":245.63},{"text":"Sembrando","start":245.63,"end":246.35},{"text":"Vida","start":246.35,"end":246.71},{"text":"and","start":246.71,"end":247.15},{"text":"Jovenes","start":247.23,"end":247.71},{"text":"Construyendo","start":247.71,"end":248.35},{"text":"el","start":248.35,"end":248.43},{"text":"Futuro,","start":248.43,"end":248.99},{"text":"which","start":249.31,"end":249.63},{"text":"are","start":249.63,"end":249.79},{"text":"part","start":249.79,"end":250.15},{"text":"of","start":250.15,"end":250.23},{"text":"a","start":250.23,"end":250.43},{"text":"broader","start":250.43,"end":250.91},{"text":"effort","start":250.91,"end":251.35},{"text":"to","start":251.35,"end":251.43},{"text":"transform","start":251.43,"end":252.11},{"text":"the","start":252.11,"end":252.27},{"text":"structural","start":252.27,"end":252.91},{"text":"conditions","start":252.91,"end":253.63},{"text":"that","start":253.95,"end":254.19},{"text":"foster","start":254.19,"end":254.67},{"text":"vulnerability","start":254.67,"end":255.79},{"text":"by","start":255.95,"end":256.15},{"text":"expanding","start":256.15,"end":256.75},{"text":"opportunities","start":256.75,"end":257.71},{"text":"in","start":257.71,"end":257.95},{"text":"communities","start":257.95,"end":258.83},{"text":"historically","start":258.99,"end":259.95},{"text":"marginalized.","start":260.03,"end":260.99}]},{"text":"These policies reflect a deliberate shift towards addressing root causes, as a prerequisite for building humane, equitable and sustainable responses to drug-related challenges.","start":261.63,"end":274.23,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"These","start":261.63,"end":261.95},{"text":"policies","start":261.95,"end":262.51},{"text":"reflect","start":262.51,"end":263.23},{"text":"a","start":263.31,"end":263.39},{"text":"deliberate","start":263.39,"end":264.19},{"text":"shift","start":264.19,"end":264.67},{"text":"towards","start":264.83,"end":265.31},{"text":"addressing","start":265.31,"end":265.95},{"text":"root","start":266.03,"end":266.27},{"text":"causes,","start":266.27,"end":266.83},{"text":"as","start":267.19,"end":267.43},{"text":"a","start":267.43,"end":267.51},{"text":"prerequisite","start":267.51,"end":268.47},{"text":"for","start":268.47,"end":268.79},{"text":"building","start":268.79,"end":269.11},{"text":"humane,","start":269.11,"end":269.75},{"text":"equitable","start":269.99,"end":270.79},{"text":"and","start":270.95,"end":271.15},{"text":"sustainable","start":271.15,"end":271.79},{"text":"responses","start":271.79,"end":272.47},{"text":"to","start":272.47,"end":272.63},{"text":"drug-related","start":272.63,"end":273.51},{"text":"challenges.","start":273.51,"end":274.23}]},{"text":"Mexico also believes that international cooperation is one of the most effective means, probably the only one, real one that we have to address drug-related challenges.","start":274.79,"end":286.15,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Mexico","start":274.79,"end":275.31},{"text":"also","start":275.31,"end":275.75},{"text":"believes","start":275.75,"end":276.23},{"text":"that","start":276.23,"end":276.47},{"text":"international","start":276.47,"end":277.23},{"text":"cooperation","start":277.23,"end":278.07},{"text":"is","start":278.23,"end":278.47},{"text":"one","start":278.47,"end":278.63},{"text":"of","start":278.63,"end":278.71},{"text":"the","start":278.71,"end":278.87},{"text":"most","start":278.87,"end":279.35},{"text":"effective","start":279.35,"end":279.99},{"text":"means,","start":279.99,"end":280.39},{"text":"probably","start":280.55,"end":281.23},{"text":"the","start":281.23,"end":281.31},{"text":"only","start":281.31,"end":281.51},{"text":"one,","start":281.51,"end":281.83},{"text":"real","start":281.91,"end":282.39},{"text":"one","start":282.39,"end":282.79},{"text":"that","start":282.87,"end":283.11},{"text":"we","start":283.11,"end":283.27},{"text":"have","start":283.27,"end":283.59},{"text":"to","start":283.91,"end":284.11},{"text":"address","start":284.11,"end":284.71},{"text":"drug-related","start":284.79,"end":285.59},{"text":"challenges.","start":285.59,"end":286.15}]},{"text":"As a testament to that commitment, Mexico has presented the main resolution in the General Assembly related to this matter over 30 years, which was most recently adopted earlier this session by consensus and with 71 co-sponsors.","start":286.87,"end":303.71,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"As","start":286.87,"end":286.99},{"text":"a","start":286.99,"end":287.07},{"text":"testament","start":287.07,"end":287.67},{"text":"to","start":287.67,"end":287.75},{"text":"that","start":287.75,"end":287.95},{"text":"commitment,","start":287.95,"end":288.67},{"text":"Mexico","start":288.91,"end":289.47},{"text":"has","start":289.47,"end":289.71},{"text":"presented","start":289.71,"end":290.23},{"text":"the","start":290.23,"end":290.39},{"text":"main","start":290.39,"end":290.75},{"text":"resolution","start":290.75,"end":291.55},{"text":"in","start":291.55,"end":291.71},{"text":"the","start":291.71,"end":291.83},{"text":"General","start":291.87,"end":292.35},{"text":"Assembly","start":292.35,"end":292.99},{"text":"related","start":292.99,"end":293.59},{"text":"to","start":293.59,"end":293.75},{"text":"this","start":293.95,"end":294.27},{"text":"matter","start":294.27,"end":294.75},{"text":"over","start":294.91,"end":295.39},{"text":"30","start":295.39,"end":295.87},{"text":"years,","start":295.87,"end":296.43},{"text":"which","start":296.59,"end":296.83},{"text":"was","start":296.83,"end":297.15},{"text":"most","start":297.15,"end":297.55},{"text":"recently","start":297.55,"end":298.11},{"text":"adopted","start":298.11,"end":298.67},{"text":"earlier","start":298.67,"end":299.15},{"text":"this","start":299.15,"end":299.43},{"text":"session","start":299.43,"end":300.03},{"text":"by","start":300.03,"end":300.27},{"text":"consensus","start":300.27,"end":301.07},{"text":"and","start":301.39,"end":301.63},{"text":"with","start":301.63,"end":301.79},{"text":"71","start":301.79,"end":302.75},{"text":"co-sponsors.","start":302.75,"end":303.71}]},{"text":"Over the past three decades, we have witnessed a shift beyond narrow interpretations of control to a more comprehensive approach, which acknowledges the importance of public health and human rights in crafting more effective international drug policy responses.","start":304.55,"end":322.95,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Over","start":304.55,"end":304.87},{"text":"the","start":304.87,"end":305.03},{"text":"past","start":305.03,"end":305.43},{"text":"three","start":305.43,"end":305.63},{"text":"decades,","start":305.63,"end":306.31},{"text":"we","start":306.31,"end":306.47},{"text":"have","start":306.47,"end":306.71},{"text":"witnessed","start":306.71,"end":307.43},{"text":"a","start":307.43,"end":307.51},{"text":"shift","start":307.51,"end":307.99},{"text":"beyond","start":308.07,"end":308.71},{"text":"narrow","start":308.71,"end":309.35},{"text":"interpretations","start":309.35,"end":310.31},{"text":"of","start":310.31,"end":310.47},{"text":"control","start":310.47,"end":311.19},{"text":"to","start":311.51,"end":311.67},{"text":"a","start":311.67,"end":311.75},{"text":"more","start":311.75,"end":311.99},{"text":"comprehensive","start":311.99,"end":312.79},{"text":"approach,","start":312.79,"end":313.43},{"text":"which","start":313.67,"end":313.99},{"text":"acknowledges","start":313.99,"end":314.95},{"text":"the","start":314.95,"end":315.15},{"text":"importance","start":315.15,"end":315.95},{"text":"of","start":315.95,"end":316.07},{"text":"public","start":316.07,"end":316.79},{"text":"health","start":316.79,"end":317.19},{"text":"and","start":317.35,"end":317.59},{"text":"human","start":317.59,"end":317.99},{"text":"rights","start":317.99,"end":318.39},{"text":"in","start":318.39,"end":318.63},{"text":"crafting","start":318.63,"end":319.35},{"text":"more","start":319.51,"end":319.87},{"text":"effective","start":319.87,"end":320.47},{"text":"international","start":320.47,"end":321.27},{"text":"drug","start":321.27,"end":321.55},{"text":"policy","start":321.55,"end":322.07},{"text":"responses.","start":322.07,"end":322.95}]},{"text":"These are recognized as essential dimensions that must also ground our work within the UN system, meaning that entities in New York, Vienna, and Geneva must work together to achieve better results.","start":323.59,"end":339.43,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"These","start":323.59,"end":323.99},{"text":"are","start":323.99,"end":324.27},{"text":"recognized","start":324.27,"end":325.19},{"text":"as","start":325.83,"end":325.99},{"text":"essential","start":325.99,"end":326.67},{"text":"dimensions","start":326.67,"end":327.51},{"text":"that","start":328.07,"end":328.31},{"text":"must","start":328.31,"end":328.59},{"text":"also","start":328.59,"end":328.99},{"text":"ground","start":328.99,"end":329.43},{"text":"our","start":329.43,"end":329.75},{"text":"work","start":329.75,"end":330.15},{"text":"within","start":330.15,"end":330.55},{"text":"the","start":330.55,"end":330.67},{"text":"UN","start":330.71,"end":331.03},{"text":"system,","start":331.03,"end":331.59},{"text":"meaning","start":331.91,"end":332.55},{"text":"that","start":332.55,"end":332.87},{"text":"entities","start":333.35,"end":334.07},{"text":"in","start":334.07,"end":334.35},{"text":"New","start":334.35,"end":334.55},{"text":"York,","start":334.55,"end":335.03},{"text":"Vienna,","start":335.15,"end":335.59},{"text":"and","start":335.59,"end":335.87},{"text":"Geneva","start":335.87,"end":336.39},{"text":"must","start":336.71,"end":336.99},{"text":"work","start":336.99,"end":337.23},{"text":"together","start":337.23,"end":337.67},{"text":"to","start":337.67,"end":337.87},{"text":"achieve","start":337.87,"end":338.31},{"text":"better","start":338.31,"end":338.75},{"text":"results.","start":338.75,"end":339.43}]},{"text":"It also means giving civil society and especially communities with lived experience a seat at the table that allows for their meaningful participation.","start":340.15,"end":351.03,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"It","start":340.15,"end":340.35},{"text":"also","start":340.35,"end":340.63},{"text":"means","start":340.63,"end":341.11},{"text":"giving","start":341.11,"end":341.47},{"text":"civil","start":341.47,"end":342.71},{"text":"society","start":342.71,"end":343.51},{"text":"and","start":343.51,"end":343.71},{"text":"especially","start":343.71,"end":344.31},{"text":"communities","start":344.31,"end":345.03},{"text":"with","start":345.03,"end":345.35},{"text":"lived","start":345.59,"end":345.99},{"text":"experience","start":345.99,"end":346.71},{"text":"a","start":347.11,"end":347.19},{"text":"seat","start":347.19,"end":347.51},{"text":"at","start":347.51,"end":347.59},{"text":"the","start":347.59,"end":347.75},{"text":"table","start":347.75,"end":348.23},{"text":"that","start":348.23,"end":348.39},{"text":"allows","start":348.39,"end":348.95},{"text":"for","start":348.95,"end":349.19},{"text":"their","start":349.19,"end":349.35},{"text":"meaningful","start":349.35,"end":349.91},{"text":"participation.","start":349.91,"end":351.03}]},{"text":"We welcome the progress made in recent years within multilateral forums, including the recognition of harm reduction in UN resolutions.","start":352.55,"end":361.79,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"We","start":352.55,"end":352.79},{"text":"welcome","start":352.79,"end":353.23},{"text":"the","start":353.23,"end":353.35},{"text":"progress","start":353.35,"end":353.91},{"text":"made","start":353.91,"end":354.23},{"text":"in","start":354.23,"end":354.47},{"text":"recent","start":354.47,"end":354.91},{"text":"years","start":354.91,"end":355.35},{"text":"within","start":355.35,"end":355.75},{"text":"multilateral","start":355.75,"end":356.55},{"text":"forums,","start":356.55,"end":357.11},{"text":"including","start":357.43,"end":358.03},{"text":"the","start":358.03,"end":358.15},{"text":"recognition","start":358.15,"end":359.11},{"text":"of","start":359.11,"end":359.35},{"text":"harm","start":359.35,"end":359.67},{"text":"reduction","start":359.67,"end":360.39},{"text":"in","start":360.39,"end":360.63},{"text":"UN","start":360.63,"end":360.95},{"text":"resolutions.","start":360.95,"end":361.79}]},{"text":"the multiplicity of factors that contribute to addressing drug-related challenges, including UN Women, UNDP, the OHCHR, and UNAIDS, and landmark reports like those of the OHCHR and the Special Rapporteur on the Right to Health that reflect our evolving collective understanding.","start":362.47,"end":386.79,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"the","start":362.47,"end":362.63},{"text":"multiplicity","start":362.63,"end":363.51},{"text":"of","start":363.51,"end":363.59},{"text":"factors","start":363.59,"end":364.15},{"text":"that","start":364.15,"end":364.31},{"text":"contribute","start":364.31,"end":365.03},{"text":"to","start":365.03,"end":365.19},{"text":"addressing","start":365.19,"end":365.75},{"text":"drug-related","start":366.47,"end":367.27},{"text":"challenges,","start":367.27,"end":367.99},{"text":"including","start":368.23,"end":368.95},{"text":"UN","start":368.95,"end":369.27},{"text":"Women,","start":369.27,"end":369.83},{"text":"UNDP,","start":369.83,"end":370.71},{"text":"the","start":370.71,"end":370.91},{"text":"OHCHR,","start":371.03,"end":372.63},{"text":"and","start":372.87,"end":373.11},{"text":"UNAIDS,","start":373.11,"end":374.19},{"text":"and","start":374.19,"end":375.51},{"text":"landmark","start":375.67,"end":376.23},{"text":"reports","start":376.23,"end":376.79},{"text":"like","start":376.87,"end":377.11},{"text":"those","start":377.11,"end":377.51},{"text":"of","start":377.51,"end":377.75},{"text":"the","start":377.75,"end":377.87},{"text":"OHCHR","start":377.99,"end":379.51},{"text":"and","start":379.91,"end":380.11},{"text":"the","start":380.11,"end":380.19},{"text":"Special","start":380.19,"end":380.63},{"text":"Rapporteur","start":380.63,"end":381.51},{"text":"on","start":381.75,"end":381.99},{"text":"the","start":381.99,"end":382.07},{"text":"Right","start":382.07,"end":382.51},{"text":"to","start":382.51,"end":382.63},{"text":"Health","start":382.63,"end":383.03},{"text":"that","start":383.27,"end":383.59},{"text":"reflect","start":383.59,"end":384.27},{"text":"our","start":384.27,"end":384.55},{"text":"evolving","start":384.59,"end":385.11},{"text":"collective","start":385.11,"end":385.83},{"text":"understanding.","start":385.91,"end":386.79}]},{"text":"We celebrate these achievements and must continue to build on them.","start":387.27,"end":391.35,"topics":[],"words":[{"text":"We","start":387.27,"end":387.51},{"text":"celebrate","start":387.51,"end":388.15},{"text":"these","start":388.15,"end":388.39},{"text":"achievements","start":388.39,"end":389.19},{"text":"and","start":389.19,"end":389.43},{"text":"must","start":389.43,"end":389.59},{"text":"continue","start":389.59,"end":390.23},{"text":"to","start":390.23,"end":390.39},{"text":"build","start":390.39,"end":390.79},{"text":"on","start":390.79,"end":391.03},{"text":"them.","start":391.03,"end":391.35}]},{"text":"At the same time, we recognize that there are different contexts that shape diverse responses.","start":392.51,"end":398.67,"topics":[],"words":[{"text":"At","start":392.51,"end":392.67},{"text":"the","start":392.67,"end":392.75},{"text":"same","start":392.75,"end":393.07},{"text":"time,","start":393.07,"end":393.55},{"text":"we","start":393.63,"end":393.91},{"text":"recognize","start":393.91,"end":394.67},{"text":"that","start":394.67,"end":394.83},{"text":"there","start":394.83,"end":395.03},{"text":"are","start":395.03,"end":395.15},{"text":"different","start":395.15,"end":395.71},{"text":"contexts","start":395.71,"end":396.35},{"text":"that","start":396.59,"end":396.91},{"text":"shape","start":396.91,"end":397.23},{"text":"diverse","start":397.23,"end":397.79},{"text":"responses.","start":397.79,"end":398.67}]},{"text":"We understand and approach this issue from different angles shaped by our histories, legal systems and social contexts.","start":399.07,"end":408.75,"topics":[],"words":[{"text":"We","start":399.07,"end":399.31},{"text":"understand","start":399.31,"end":400.15},{"text":"and","start":400.43,"end":400.75},{"text":"approach","start":400.91,"end":401.55},{"text":"this","start":401.55,"end":401.87},{"text":"issue","start":401.87,"end":402.35},{"text":"from","start":402.59,"end":402.99},{"text":"different","start":402.99,"end":403.55},{"text":"angles","start":403.55,"end":404.11},{"text":"shaped","start":404.27,"end":404.75},{"text":"by","start":404.75,"end":405.07},{"text":"our","start":405.07,"end":405.23},{"text":"histories,","start":405.23,"end":406.03},{"text":"legal","start":406.27,"end":406.67},{"text":"systems","start":406.67,"end":407.39},{"text":"and","start":407.39,"end":407.59},{"text":"social","start":407.59,"end":408.03},{"text":"contexts.","start":408.03,"end":408.75}]},{"text":"Rather than viewing these differences as obstacles, we should see them as an invitation to learn from one another, identifying where practices align, where they diverge, and how they can evolve.","start":409.35,"end":423.27,"topics":[],"words":[{"text":"Rather","start":409.35,"end":409.75},{"text":"than","start":409.75,"end":409.95},{"text":"viewing","start":409.99,"end":410.39},{"text":"these","start":410.39,"end":410.71},{"text":"differences","start":410.71,"end":411.51},{"text":"as","start":411.59,"end":411.91},{"text":"obstacles,","start":411.91,"end":412.63},{"text":"we","start":412.87,"end":413.07},{"text":"should","start":413.07,"end":413.23},{"text":"see","start":413.27,"end":413.67},{"text":"them","start":413.67,"end":414.15},{"text":"as","start":414.15,"end":414.39},{"text":"an","start":414.39,"end":414.55},{"text":"invitation","start":414.55,"end":415.35},{"text":"to","start":415.35,"end":415.51},{"text":"learn","start":415.51,"end":415.99},{"text":"from","start":416.23,"end":416.55},{"text":"one","start":416.55,"end":416.95},{"text":"another,","start":416.95,"end":417.43},{"text":"identifying","start":417.59,"end":418.67},{"text":"where","start":418.67,"end":418.95},{"text":"practices","start":418.95,"end":419.75},{"text":"align,","start":419.75,"end":420.31},{"text":"where","start":420.47,"end":420.79},{"text":"they","start":420.79,"end":421.03},{"text":"diverge,","start":421.03,"end":421.83},{"text":"and","start":421.83,"end":422.07},{"text":"how","start":422.07,"end":422.39},{"text":"they","start":422.39,"end":422.55},{"text":"can","start":422.55,"end":422.83},{"text":"evolve.","start":422.83,"end":423.27}]},{"text":"There simply is no one-size-fits-all approach.","start":423.83,"end":427.51,"topics":[],"words":[{"text":"There","start":423.83,"end":424.23},{"text":"simply","start":424.23,"end":424.87},{"text":"is","start":424.87,"end":425.11},{"text":"no","start":425.11,"end":425.35},{"text":"one-size-fits-all","start":425.35,"end":426.95},{"text":"approach.","start":426.95,"end":427.51}]},{"text":"Similarly, today's discussion is not about prescribing a single model, but about learning from diverse experiences.","start":428.23,"end":436.07,"topics":[],"words":[{"text":"Similarly,","start":428.23,"end":429.03},{"text":"today's","start":429.03,"end":429.55},{"text":"discussion","start":429.55,"end":430.31},{"text":"is","start":430.31,"end":430.55},{"text":"not","start":430.55,"end":430.79},{"text":"about","start":430.79,"end":431.11},{"text":"prescribing","start":431.11,"end":431.99},{"text":"a","start":431.99,"end":432.07},{"text":"single","start":432.07,"end":432.55},{"text":"model,","start":432.55,"end":433.03},{"text":"but","start":433.35,"end":433.55},{"text":"about","start":433.55,"end":433.79},{"text":"learning","start":433.79,"end":434.39},{"text":"from","start":434.39,"end":434.63},{"text":"diverse","start":434.63,"end":435.11},{"text":"experiences.","start":435.11,"end":436.07}]},{"text":"We will hear from member states, from UN agencies, as well as from civil society, including communities with lived experience.","start":436.31,"end":444.55,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"We","start":436.31,"end":436.55},{"text":"will","start":436.55,"end":436.71},{"text":"hear","start":436.71,"end":437.15},{"text":"from","start":437.15,"end":437.39},{"text":"member","start":437.39,"end":437.75},{"text":"states,","start":437.75,"end":438.31},{"text":"from","start":438.31,"end":438.55},{"text":"UN","start":438.63,"end":438.95},{"text":"agencies,","start":438.95,"end":439.59},{"text":"as","start":439.59,"end":439.83},{"text":"well","start":439.83,"end":440.03},{"text":"as","start":440.03,"end":440.15},{"text":"from","start":440.15,"end":440.31},{"text":"civil","start":440.31,"end":440.63},{"text":"society,","start":440.63,"end":441.43},{"text":"including","start":441.75,"end":442.31},{"text":"communities","start":442.31,"end":443.03},{"text":"with","start":443.03,"end":443.31},{"text":"lived","start":443.31,"end":443.67},{"text":"experience.","start":443.67,"end":444.55}]},{"text":"Their contributions will highlight good practices and opportunities for scaling up responses that are grounded in science on human rights and public health.","start":445.91,"end":455.99,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Their","start":445.91,"end":446.15},{"text":"contributions","start":446.15,"end":447.19},{"text":"will","start":447.19,"end":447.43},{"text":"highlight","start":447.43,"end":447.99},{"text":"good","start":447.99,"end":448.31},{"text":"practices","start":448.31,"end":449.03},{"text":"and","start":449.03,"end":449.31},{"text":"opportunities","start":449.35,"end":449.99},{"text":"for","start":449.99,"end":450.23},{"text":"scaling","start":450.23,"end":450.79},{"text":"up","start":450.79,"end":451.03},{"text":"responses","start":451.35,"end":452.07},{"text":"that","start":452.07,"end":452.23},{"text":"are","start":452.23,"end":452.55},{"text":"grounded","start":452.55,"end":452.95},{"text":"in","start":452.95,"end":453.11},{"text":"science","start":453.11,"end":453.67},{"text":"on","start":454.03,"end":454.15},{"text":"human","start":454.23,"end":454.55},{"text":"rights","start":454.55,"end":455.03},{"text":"and","start":455.03,"end":455.23},{"text":"public","start":455.23,"end":455.67},{"text":"health.","start":455.67,"end":455.99}]},{"text":"We hope these examples inspire broader cooperation and support, particularly as we look to further align our drug policies with efforts to achieve the sustainable development goals.","start":456.51,"end":468.67,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"We","start":456.51,"end":456.71},{"text":"hope","start":456.71,"end":456.99},{"text":"these","start":456.99,"end":457.23},{"text":"examples","start":457.23,"end":457.95},{"text":"inspire","start":457.95,"end":458.67},{"text":"broader","start":458.67,"end":459.07},{"text":"cooperation","start":459.07,"end":459.75},{"text":"and","start":459.75,"end":459.87},{"text":"support,","start":459.87,"end":460.43},{"text":"particularly","start":460.67,"end":461.71},{"text":"as","start":461.71,"end":461.95},{"text":"we","start":461.95,"end":462.11},{"text":"look","start":462.11,"end":462.39},{"text":"to","start":462.51,"end":462.67},{"text":"further","start":462.67,"end":463.31},{"text":"align","start":463.31,"end":463.79},{"text":"our","start":464.07,"end":464.35},{"text":"drug","start":464.35,"end":464.59},{"text":"policies","start":464.59,"end":465.23},{"text":"with","start":465.23,"end":465.47},{"text":"efforts","start":465.47,"end":465.95},{"text":"to","start":465.95,"end":466.07},{"text":"achieve","start":466.07,"end":466.51},{"text":"the","start":466.75,"end":466.91},{"text":"sustainable","start":466.91,"end":467.55},{"text":"development","start":467.55,"end":468.15},{"text":"goals.","start":468.15,"end":468.67}]},{"text":"As we look ahead, we encourage all partners to continue building on this momentum.","start":468.99,"end":473.79,"topics":[],"words":[{"text":"As","start":468.99,"end":469.23},{"text":"we","start":469.23,"end":469.35},{"text":"look","start":469.39,"end":469.79},{"text":"ahead,","start":469.79,"end":470.03},{"text":"we","start":470.11,"end":470.31},{"text":"encourage","start":470.31,"end":470.87},{"text":"all","start":470.87,"end":470.99},{"text":"partners","start":470.99,"end":471.55},{"text":"to","start":471.55,"end":471.71},{"text":"continue","start":471.71,"end":472.27},{"text":"building","start":472.27,"end":472.75},{"text":"on","start":472.75,"end":472.95},{"text":"this","start":472.95,"end":473.15},{"text":"momentum.","start":473.15,"end":473.79}]},{"text":"Please note that in doing so, you can always count on Mexico as a partner and friend, and we look forward to our discussion.","start":474.31,"end":482.87,"topics":[],"words":[{"text":"Please","start":474.31,"end":474.63},{"text":"note","start":474.63,"end":474.99},{"text":"that","start":474.99,"end":475.19},{"text":"in","start":475.19,"end":475.35},{"text":"doing","start":475.35,"end":475.75},{"text":"so,","start":475.75,"end":476.23},{"text":"you","start":476.39,"end":476.55},{"text":"can","start":476.55,"end":476.79},{"text":"always","start":476.79,"end":477.35},{"text":"count","start":477.35,"end":477.75},{"text":"on","start":477.75,"end":477.91},{"text":"Mexico","start":477.91,"end":478.55},{"text":"as","start":478.79,"end":479.03},{"text":"a","start":479.03,"end":479.11},{"text":"partner","start":479.11,"end":479.67},{"text":"and","start":479.67,"end":479.83},{"text":"friend,","start":479.83,"end":480.31},{"text":"and","start":480.39,"end":480.63},{"text":"we","start":480.63,"end":480.79},{"text":"look","start":480.79,"end":480.99},{"text":"forward","start":480.99,"end":481.47},{"text":"to","start":481.47,"end":481.75},{"text":"our","start":481.75,"end":482.07},{"text":"discussion.","start":482.07,"end":482.87}]},{"text":"And I thank you all for being here.","start":483.11,"end":486.07,"topics":[],"words":[{"text":"And","start":483.11,"end":483.39},{"text":"I","start":483.39,"end":483.43},{"text":"thank","start":483.43,"end":483.83},{"text":"you","start":483.83,"end":484.07},{"text":"all","start":484.19,"end":484.55},{"text":"for","start":484.71,"end":485.03},{"text":"being","start":485.19,"end":485.59},{"text":"here.","start":485.67,"end":486.07}]},{"text":"I thank you.","start":486.23,"end":486.79,"topics":[],"words":[{"text":"I","start":486.23,"end":486.39},{"text":"thank","start":486.39,"end":486.71},{"text":"you.","start":486.71,"end":486.79}]}]}],"speaker":{"affiliation":"MEX","group":null,"function":"Deputy Permanent Representative","affiliation_full":"Mexico"}},{"statement_number":2,"start":494.43,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=8:15","paragraphs":[{"sentences":[{"text":"Thank you, Ambassador, for your wise words and for setting the setting the scene for our discussion today.","start":494.43,"end":501.75,"topics":[],"words":[{"text":"Thank","start":494.43,"end":494.71},{"text":"you,","start":494.71,"end":494.79},{"text":"Ambassador,","start":494.79,"end":495.67},{"text":"for","start":495.67,"end":495.83},{"text":"your","start":495.83,"end":496.07},{"text":"wise","start":496.07,"end":496.39},{"text":"words","start":496.39,"end":496.87},{"text":"and","start":496.87,"end":497.03},{"text":"for","start":497.03,"end":497.59},{"text":"setting","start":498.23,"end":498.71},{"text":"the","start":498.71,"end":498.87},{"text":"setting","start":499.19,"end":499.59},{"text":"the","start":499.59,"end":499.67},{"text":"scene","start":499.67,"end":500.07},{"text":"for","start":500.07,"end":500.47},{"text":"our","start":500.51,"end":500.71},{"text":"discussion","start":500.71,"end":501.27},{"text":"today.","start":501.27,"end":501.75}]},{"text":"Excellencies, distinguished colleagues, and dear friends, it's our pleasure on behalf of UNDP to welcome you.","start":502.15,"end":508.31,"topics":[],"words":[{"text":"Excellencies,","start":502.15,"end":503.19},{"text":"distinguished","start":503.35,"end":503.95},{"text":"colleagues,","start":503.95,"end":504.55},{"text":"and","start":504.55,"end":504.67},{"text":"dear","start":504.67,"end":504.87},{"text":"friends,","start":504.87,"end":505.35},{"text":"it's","start":505.59,"end":505.83},{"text":"our","start":505.83,"end":506.07},{"text":"pleasure","start":506.15,"end":506.55},{"text":"on","start":506.55,"end":506.63},{"text":"behalf","start":506.63,"end":506.91},{"text":"of","start":506.91,"end":507.03},{"text":"UNDP","start":507.03,"end":507.51},{"text":"to","start":507.51,"end":507.63},{"text":"welcome","start":507.63,"end":508.07},{"text":"you.","start":508.07,"end":508.31}]},{"text":"And let me begin by thanking the governments of Colombia, the Czech Republic, Mexico, and Switzerland, our close partners from the Office of the High Commissioner for Human Rights, the Joint Programme on AIDS, WHO, and the Global Commission on Drug Policy, and the Open Society Foundations.","start":509.15,"end":526.79,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"And","start":509.15,"end":509.27},{"text":"let","start":509.27,"end":509.43},{"text":"me","start":509.43,"end":509.59},{"text":"begin","start":509.59,"end":509.91},{"text":"by","start":509.91,"end":510.07},{"text":"thanking","start":510.07,"end":510.55},{"text":"the","start":510.55,"end":510.63},{"text":"governments","start":510.63,"end":511.15},{"text":"of","start":511.15,"end":511.27},{"text":"Colombia,","start":511.27,"end":511.83},{"text":"the","start":511.83,"end":511.91},{"text":"Czech","start":511.91,"end":512.23},{"text":"Republic,","start":512.23,"end":512.87},{"text":"Mexico,","start":512.87,"end":513.47},{"text":"and","start":513.47,"end":513.59},{"text":"Switzerland,","start":513.59,"end":514.31},{"text":"our","start":514.71,"end":514.87},{"text":"close","start":514.87,"end":515.35},{"text":"partners","start":515.35,"end":515.99},{"text":"from","start":515.99,"end":516.39},{"text":"the","start":516.71,"end":516.83},{"text":"Office","start":516.83,"end":517.15},{"text":"of","start":517.15,"end":517.23},{"text":"the","start":517.23,"end":517.31},{"text":"High","start":517.31,"end":517.51},{"text":"Commissioner","start":517.51,"end":517.95},{"text":"for","start":517.95,"end":518.07},{"text":"Human","start":518.07,"end":518.31},{"text":"Rights,","start":518.31,"end":518.87},{"text":"the","start":519.19,"end":519.31},{"text":"Joint","start":519.31,"end":519.59},{"text":"Programme","start":519.59,"end":520.15},{"text":"on","start":520.15,"end":520.55},{"text":"AIDS,","start":521.35,"end":521.75},{"text":"WHO,","start":522.15,"end":522.39},{"text":"and","start":522.39,"end":522.55},{"text":"the","start":522.55,"end":522.63},{"text":"Global","start":522.63,"end":523.43},{"text":"Commission","start":523.43,"end":523.91},{"text":"on","start":523.91,"end":524.07},{"text":"Drug","start":524.07,"end":524.23},{"text":"Policy,","start":524.23,"end":524.95},{"text":"and","start":524.95,"end":525.23},{"text":"the","start":525.23,"end":525.31},{"text":"Open","start":525.31,"end":525.55},{"text":"Society","start":525.55,"end":525.99},{"text":"Foundations.","start":525.99,"end":526.79}]},{"text":"and all of you, communities, civil society, and multilateral partners for your leadership and engagement in this important development issue.","start":527.11,"end":534.63,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"and","start":527.11,"end":527.31},{"text":"all","start":527.31,"end":527.51},{"text":"of","start":527.51,"end":527.59},{"text":"you,","start":527.59,"end":527.91},{"text":"communities,","start":528.31,"end":528.91},{"text":"civil","start":528.91,"end":529.23},{"text":"society,","start":529.23,"end":529.71},{"text":"and","start":529.71,"end":529.83},{"text":"multilateral","start":529.83,"end":530.47},{"text":"partners","start":530.47,"end":531.03},{"text":"for","start":531.03,"end":531.15},{"text":"your","start":531.15,"end":531.27},{"text":"leadership","start":531.27,"end":531.83},{"text":"and","start":531.83,"end":531.99},{"text":"engagement","start":531.99,"end":532.63},{"text":"in","start":532.79,"end":532.99},{"text":"this","start":532.99,"end":533.11},{"text":"important","start":533.11,"end":533.67},{"text":"development","start":533.67,"end":534.23},{"text":"issue.","start":534.23,"end":534.63}]},{"text":"We live in challenging times marked by increasing risk, turbulence, and uncertainty, and this is certainly taking a toll on the HIV health and development responses.","start":535.59,"end":545.91,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"We","start":535.59,"end":535.75},{"text":"live","start":535.75,"end":535.95},{"text":"in","start":535.95,"end":536.07},{"text":"challenging","start":536.07,"end":536.63},{"text":"times","start":536.63,"end":537.27},{"text":"marked","start":537.59,"end":537.91},{"text":"by","start":537.91,"end":538.07},{"text":"increasing","start":538.07,"end":538.63},{"text":"risk,","start":538.63,"end":539.11},{"text":"turbulence,","start":539.19,"end":539.99},{"text":"and","start":539.99,"end":540.11},{"text":"uncertainty,","start":540.11,"end":541.03},{"text":"and","start":541.51,"end":541.67},{"text":"this","start":541.67,"end":541.83},{"text":"is","start":541.83,"end":541.91},{"text":"certainly","start":541.91,"end":542.39},{"text":"taking","start":542.39,"end":542.79},{"text":"a","start":542.79,"end":542.83},{"text":"toll","start":542.83,"end":543.31},{"text":"on","start":543.31,"end":543.43},{"text":"the","start":543.43,"end":543.51},{"text":"HIV","start":543.51,"end":544.15},{"text":"health","start":544.15,"end":544.51},{"text":"and","start":544.51,"end":544.63},{"text":"development","start":544.63,"end":545.11},{"text":"responses.","start":545.11,"end":545.91}]},{"text":"The 2025 Global AIDS Update reminds us that while there has been progress in HIV, this progress is not guaranteed.","start":546.23,"end":554.07,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"The","start":546.23,"end":546.35},{"text":"2025","start":546.35,"end":547.27},{"text":"Global","start":547.27,"end":547.67},{"text":"AIDS","start":547.67,"end":547.91},{"text":"Update","start":547.91,"end":548.47},{"text":"reminds","start":548.79,"end":549.27},{"text":"us","start":549.27,"end":549.59},{"text":"that","start":549.59,"end":549.71},{"text":"while","start":549.71,"end":549.99},{"text":"there","start":549.99,"end":550.19},{"text":"has","start":550.19,"end":550.31},{"text":"been","start":550.31,"end":550.47},{"text":"progress","start":550.47,"end":550.95},{"text":"in","start":550.95,"end":551.07},{"text":"HIV,","start":551.07,"end":551.75},{"text":"this","start":551.99,"end":552.15},{"text":"progress","start":552.15,"end":552.71},{"text":"is","start":552.71,"end":552.87},{"text":"not","start":552.87,"end":553.19},{"text":"guaranteed.","start":553.35,"end":554.07}]},{"text":"New infections continue to rise in key populations, including people who use drugs.","start":554.51,"end":559.47,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"New","start":554.51,"end":554.75},{"text":"infections","start":554.75,"end":555.35},{"text":"continue","start":555.35,"end":555.79},{"text":"to","start":555.79,"end":555.91},{"text":"rise","start":555.91,"end":556.27},{"text":"in","start":556.27,"end":556.43},{"text":"key","start":556.43,"end":556.59},{"text":"populations,","start":556.59,"end":557.55},{"text":"including","start":557.71,"end":558.19},{"text":"people","start":558.19,"end":558.51},{"text":"who","start":558.51,"end":558.67},{"text":"use","start":558.67,"end":558.91},{"text":"drugs.","start":558.91,"end":559.47}]},{"text":"We cannot afford to let the HIV response stall or reverse.","start":559.95,"end":563.79,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"We","start":559.95,"end":560.19},{"text":"cannot","start":560.19,"end":560.59},{"text":"afford","start":560.59,"end":560.91},{"text":"to","start":560.91,"end":561.03},{"text":"let","start":561.03,"end":561.47},{"text":"the","start":561.47,"end":561.55},{"text":"HIV","start":561.55,"end":562.03},{"text":"response","start":562.03,"end":562.63},{"text":"stall","start":562.63,"end":562.95},{"text":"or","start":562.95,"end":563.19},{"text":"reverse.","start":563.19,"end":563.79}]},{"text":"Losing hard-won gains, especially for the most marginalized people, would be a collective failure.","start":564.11,"end":570.19,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Losing","start":564.11,"end":564.59},{"text":"hard-won","start":564.59,"end":565.15},{"text":"gains,","start":565.15,"end":565.63},{"text":"especially","start":565.63,"end":566.27},{"text":"for","start":566.27,"end":566.75},{"text":"the","start":566.91,"end":567.11},{"text":"most","start":567.11,"end":567.43},{"text":"marginalized","start":567.43,"end":568.07},{"text":"people,","start":568.07,"end":568.43},{"text":"would","start":568.43,"end":568.59},{"text":"be","start":568.59,"end":568.91},{"text":"a","start":568.91,"end":568.95},{"text":"collective","start":568.99,"end":569.59},{"text":"failure.","start":569.59,"end":570.19}]},{"text":"The 2025 World Drug Report confirms yet again that drug use continues to rise.","start":570.83,"end":576.51,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"The","start":570.83,"end":570.91},{"text":"2025","start":570.91,"end":571.79},{"text":"World","start":571.79,"end":572.07},{"text":"Drug","start":572.07,"end":572.35},{"text":"Report","start":572.35,"end":572.91},{"text":"confirms","start":573.07,"end":573.71},{"text":"yet","start":573.71,"end":573.95},{"text":"again","start":573.95,"end":574.43},{"text":"that","start":574.59,"end":574.79},{"text":"drug","start":574.79,"end":574.99},{"text":"use","start":574.99,"end":575.23},{"text":"continues","start":575.23,"end":575.79},{"text":"to","start":575.79,"end":575.91},{"text":"rise.","start":575.91,"end":576.51}]},{"text":"Around 14 million people globally inject drugs.","start":576.83,"end":581.31,"topics":[],"words":[{"text":"Around","start":576.83,"end":577.23},{"text":"14","start":577.23,"end":577.71},{"text":"million","start":577.71,"end":578.11},{"text":"people","start":578.11,"end":578.67},{"text":"globally","start":579.95,"end":580.39},{"text":"inject","start":580.39,"end":580.79},{"text":"drugs.","start":580.79,"end":581.31}]},{"text":"People who inject drugs are 14 times more likely to acquire HIV, and they account for 12% of all people living with HIV, and nearly half are also contending with hepatitis C. We heard about the impact on women.","start":581.71,"end":595.71,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."}],"words":[{"text":"People","start":581.71,"end":581.99},{"text":"who","start":581.99,"end":582.11},{"text":"inject","start":582.11,"end":582.51},{"text":"drugs","start":582.51,"end":582.83},{"text":"are","start":582.83,"end":582.99},{"text":"14","start":582.99,"end":583.63},{"text":"times","start":583.63,"end":583.95},{"text":"more","start":583.95,"end":584.19},{"text":"likely","start":584.19,"end":584.59},{"text":"to","start":584.59,"end":584.75},{"text":"acquire","start":584.75,"end":585.23},{"text":"HIV,","start":585.23,"end":585.87},{"text":"and","start":586.19,"end":586.47},{"text":"they","start":586.47,"end":586.55},{"text":"account","start":586.55,"end":587.39},{"text":"for","start":587.39,"end":587.63},{"text":"12%","start":587.63,"end":587.67},{"text":"of","start":587.71,"end":587.95},{"text":"all","start":587.95,"end":588.11},{"text":"people","start":588.11,"end":588.43},{"text":"living","start":588.43,"end":588.67},{"text":"with","start":588.67,"end":588.83},{"text":"HIV,","start":588.83,"end":589.47},{"text":"and","start":589.79,"end":589.95},{"text":"nearly","start":589.95,"end":590.27},{"text":"half","start":590.27,"end":590.67},{"text":"are","start":590.67,"end":590.83},{"text":"also","start":590.83,"end":591.39},{"text":"contending","start":591.55,"end":592.11},{"text":"with","start":592.11,"end":592.23},{"text":"hepatitis","start":592.23,"end":592.87},{"text":"C.","start":592.87,"end":593.23},{"text":"We","start":593.95,"end":594.15},{"text":"heard","start":594.15,"end":594.35},{"text":"about","start":594.35,"end":594.63},{"text":"the","start":594.63,"end":594.71},{"text":"impact","start":594.71,"end":595.15},{"text":"on","start":595.15,"end":595.31},{"text":"women.","start":595.31,"end":595.71}]},{"text":"Criminalization of drug use and possession exists in more than 150 countries and pushes people away from services, deepens stigma, and erodes public trust.","start":596.43,"end":607.55,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Criminalization","start":596.43,"end":597.63},{"text":"of","start":598.03,"end":598.27},{"text":"drug","start":598.27,"end":598.51},{"text":"use","start":598.51,"end":598.79},{"text":"and","start":598.79,"end":598.91},{"text":"possession","start":598.91,"end":599.63},{"text":"exists","start":599.71,"end":600.59},{"text":"in","start":600.59,"end":600.67},{"text":"more","start":600.67,"end":600.99},{"text":"than","start":600.99,"end":601.19},{"text":"150","start":601.19,"end":601.87},{"text":"countries","start":601.87,"end":602.51},{"text":"and","start":602.91,"end":603.07},{"text":"pushes","start":603.07,"end":603.47},{"text":"people","start":603.47,"end":603.79},{"text":"away","start":603.79,"end":604.11},{"text":"from","start":604.11,"end":604.27},{"text":"services,","start":604.27,"end":604.99},{"text":"deepens","start":604.99,"end":605.43},{"text":"stigma,","start":605.43,"end":605.83},{"text":"and","start":605.83,"end":606.15},{"text":"erodes","start":606.15,"end":606.59},{"text":"public","start":606.59,"end":606.95},{"text":"trust.","start":606.95,"end":607.55}]},{"text":"We clearly need to do things differently.","start":608.03,"end":610.35,"topics":[],"words":[{"text":"We","start":608.03,"end":608.27},{"text":"clearly","start":608.27,"end":608.75},{"text":"need","start":608.75,"end":608.99},{"text":"to","start":608.99,"end":609.11},{"text":"do","start":609.11,"end":609.31},{"text":"things","start":609.31,"end":609.67},{"text":"differently.","start":609.67,"end":610.35}]},{"text":"And we need to do more of them, do them better and faster.","start":610.83,"end":613.95,"topics":[],"words":[{"text":"And","start":610.83,"end":610.99},{"text":"we","start":610.99,"end":611.15},{"text":"need","start":611.15,"end":611.35},{"text":"to","start":611.35,"end":611.47},{"text":"do","start":611.47,"end":611.63},{"text":"more","start":611.63,"end":611.91},{"text":"of","start":611.91,"end":612.03},{"text":"them,","start":612.03,"end":612.35},{"text":"do","start":612.35,"end":612.55},{"text":"them","start":612.55,"end":612.75},{"text":"better","start":612.75,"end":613.15},{"text":"and","start":613.15,"end":613.39},{"text":"faster.","start":613.39,"end":613.95}]},{"text":"While the global drug policy framework is under review in line with the 2025 CND resolutions from Vienna this year, let me emphasize that even now we have the tools.","start":614.39,"end":626.11,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"While","start":614.39,"end":614.59},{"text":"the","start":614.59,"end":614.71},{"text":"global","start":614.71,"end":615.11},{"text":"drug","start":615.11,"end":615.31},{"text":"policy","start":615.31,"end":615.87},{"text":"framework","start":615.87,"end":616.39},{"text":"is","start":616.39,"end":616.51},{"text":"under","start":616.51,"end":616.79},{"text":"review","start":616.79,"end":617.47},{"text":"in","start":617.55,"end":617.79},{"text":"line","start":617.79,"end":618.07},{"text":"with","start":618.07,"end":618.31},{"text":"the","start":618.31,"end":618.43},{"text":"2025","start":618.43,"end":619.35},{"text":"CND","start":619.35,"end":619.91},{"text":"resolutions","start":619.91,"end":620.75},{"text":"from","start":621.15,"end":621.35},{"text":"Vienna","start":621.35,"end":621.71},{"text":"this","start":621.71,"end":621.95},{"text":"year,","start":621.95,"end":622.27},{"text":"let","start":622.67,"end":622.83},{"text":"me","start":622.83,"end":623.03},{"text":"emphasize","start":623.03,"end":623.71},{"text":"that","start":623.71,"end":623.87},{"text":"even","start":623.87,"end":624.31},{"text":"now","start":624.31,"end":624.59},{"text":"we","start":624.59,"end":624.91},{"text":"have","start":624.91,"end":625.31},{"text":"the","start":625.31,"end":625.47},{"text":"tools.","start":625.47,"end":626.11}]},{"text":"We have the science-based, evidence-based and rights-based tools.","start":626.43,"end":630.83,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"We","start":626.43,"end":626.59},{"text":"have","start":626.59,"end":626.91},{"text":"the","start":626.91,"end":627.07},{"text":"science-based,","start":627.07,"end":628.27},{"text":"evidence-based","start":628.35,"end":629.31},{"text":"and","start":629.31,"end":629.47},{"text":"rights-based","start":629.47,"end":630.31},{"text":"tools.","start":630.31,"end":630.83}]},{"text":"What we need is the political will and ambition to apply them.","start":631.11,"end":634.67,"topics":[],"words":[{"text":"What","start":631.11,"end":631.39},{"text":"we","start":631.39,"end":631.47},{"text":"need","start":631.47,"end":631.87},{"text":"is","start":631.87,"end":632.11},{"text":"the","start":632.11,"end":632.27},{"text":"political","start":632.27,"end":632.83},{"text":"will","start":632.83,"end":633.15},{"text":"and","start":633.15,"end":633.31},{"text":"ambition","start":633.31,"end":633.87},{"text":"to","start":633.87,"end":633.99},{"text":"apply","start":633.99,"end":634.43},{"text":"them.","start":634.43,"end":634.67}]},{"text":"The UN system common position on drugs commits us to work together to scale health, human rights and evidence-based approaches.","start":635.47,"end":643.15,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"The","start":635.47,"end":635.59},{"text":"UN","start":635.59,"end":636.03},{"text":"system","start":636.11,"end":636.67},{"text":"common","start":636.67,"end":637.03},{"text":"position","start":637.03,"end":637.55},{"text":"on","start":637.55,"end":637.67},{"text":"drugs","start":637.67,"end":638.19},{"text":"commits","start":638.19,"end":638.59},{"text":"us","start":638.59,"end":638.67},{"text":"to","start":638.67,"end":638.83},{"text":"work","start":638.83,"end":639.15},{"text":"together","start":639.15,"end":639.71},{"text":"to","start":639.87,"end":640.03},{"text":"scale","start":640.03,"end":640.51},{"text":"health,","start":640.51,"end":640.91},{"text":"human","start":640.91,"end":641.23},{"text":"rights","start":641.23,"end":641.59},{"text":"and","start":641.59,"end":641.75},{"text":"evidence-based","start":641.75,"end":642.43},{"text":"approaches.","start":642.43,"end":643.15}]},{"text":"The international guidelines on human rights and drug policy, developed by UNDP, OHCHR, UNAIDS and the University of Essex, provide a practical roadmap for supporting the kind of reform that is needed.","start":643.71,"end":656.35,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"The","start":643.71,"end":643.83},{"text":"international","start":643.83,"end":644.59},{"text":"guidelines","start":644.59,"end":645.23},{"text":"on","start":645.23,"end":645.31},{"text":"human","start":645.31,"end":645.63},{"text":"rights","start":645.63,"end":645.95},{"text":"and","start":645.95,"end":646.07},{"text":"drug","start":646.07,"end":646.23},{"text":"policy,","start":646.23,"end":646.91},{"text":"developed","start":647.15,"end":647.63},{"text":"by","start":647.63,"end":647.79},{"text":"UNDP,","start":647.79,"end":648.59},{"text":"OHCHR,","start":648.83,"end":649.79},{"text":"UNAIDS","start":649.79,"end":650.67},{"text":"and","start":650.67,"end":650.79},{"text":"the","start":650.79,"end":650.87},{"text":"University","start":650.87,"end":651.43},{"text":"of","start":651.43,"end":651.55},{"text":"Essex,","start":651.55,"end":652.11},{"text":"provide","start":652.35,"end":652.75},{"text":"a","start":652.75,"end":652.83},{"text":"practical","start":652.83,"end":653.39},{"text":"roadmap","start":653.39,"end":653.95},{"text":"for","start":653.95,"end":654.11},{"text":"supporting","start":654.11,"end":654.67},{"text":"the","start":654.67,"end":654.75},{"text":"kind","start":654.75,"end":654.99},{"text":"of","start":654.99,"end":655.07},{"text":"reform","start":655.07,"end":655.55},{"text":"that","start":655.55,"end":655.71},{"text":"is","start":655.71,"end":655.87},{"text":"needed.","start":655.87,"end":656.35}]},{"text":"Action is already happening.","start":657.07,"end":658.59,"topics":[],"words":[{"text":"Action","start":657.07,"end":657.55},{"text":"is","start":657.55,"end":657.63},{"text":"already","start":657.63,"end":658.03},{"text":"happening.","start":658.03,"end":658.59}]},{"text":"Member states are leading the way.","start":658.75,"end":660.35,"topics":[],"words":[{"text":"Member","start":658.75,"end":659.07},{"text":"states","start":659.07,"end":659.43},{"text":"are","start":659.43,"end":659.55},{"text":"leading","start":659.55,"end":659.87},{"text":"the","start":659.87,"end":659.95},{"text":"way.","start":659.95,"end":660.35}]},{"text":"Colombia has embedded the guidelines in their national drug strategy.","start":660.67,"end":664.35,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Colombia","start":660.67,"end":661.19},{"text":"has","start":661.19,"end":661.39},{"text":"embedded","start":661.39,"end":661.83},{"text":"the","start":661.83,"end":661.91},{"text":"guidelines","start":661.91,"end":662.59},{"text":"in","start":662.59,"end":662.75},{"text":"their","start":662.75,"end":662.91},{"text":"national","start":662.91,"end":663.31},{"text":"drug","start":663.31,"end":663.55},{"text":"strategy.","start":663.55,"end":664.35}]},{"text":"Brazil is using them to review punitive laws and scale up intersectional community-led services.","start":664.83,"end":671.39,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Brazil","start":664.83,"end":665.31},{"text":"is","start":665.31,"end":665.47},{"text":"using","start":665.47,"end":665.79},{"text":"them","start":665.79,"end":666.51},{"text":"to","start":666.67,"end":666.79},{"text":"review","start":666.79,"end":667.23},{"text":"punitive","start":667.23,"end":667.71},{"text":"laws","start":667.71,"end":668.19},{"text":"and","start":668.43,"end":668.59},{"text":"scale","start":668.59,"end":668.99},{"text":"up","start":668.99,"end":669.15},{"text":"intersectional","start":669.15,"end":669.95},{"text":"community-led","start":669.95,"end":670.59},{"text":"services.","start":670.59,"end":671.39}]},{"text":"These are important examples of progress.","start":671.87,"end":674.35,"topics":[],"words":[{"text":"These","start":671.87,"end":672.07},{"text":"are","start":672.07,"end":672.19},{"text":"important","start":672.19,"end":672.83},{"text":"examples","start":672.83,"end":673.51},{"text":"of","start":673.51,"end":673.63},{"text":"progress.","start":673.63,"end":674.35}]},{"text":"Momentum is building elsewhere, too.","start":674.83,"end":676.91,"topics":[],"words":[{"text":"Momentum","start":674.83,"end":675.31},{"text":"is","start":675.31,"end":675.47},{"text":"building","start":675.47,"end":675.95},{"text":"elsewhere,","start":675.95,"end":676.43},{"text":"too.","start":676.43,"end":676.91}]},{"text":"In Ghana, legal reforms are advancing alternatives to incarceration and strengthening harm reduction strategies.","start":677.47,"end":684.11,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"In","start":677.47,"end":677.63},{"text":"Ghana,","start":677.63,"end":678.11},{"text":"legal","start":678.11,"end":678.51},{"text":"reforms","start":678.51,"end":679.07},{"text":"are","start":679.07,"end":679.19},{"text":"advancing","start":679.19,"end":679.79},{"text":"alternatives","start":679.79,"end":680.59},{"text":"to","start":680.59,"end":680.71},{"text":"incarceration","start":680.71,"end":681.79},{"text":"and","start":681.95,"end":682.11},{"text":"strengthening","start":682.11,"end":682.67},{"text":"harm","start":682.67,"end":682.91},{"text":"reduction","start":682.91,"end":683.39},{"text":"strategies.","start":683.39,"end":684.11}]},{"text":"In Eastern Europe and Central Asia, punitive environments persist.","start":684.51,"end":688.27,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"In","start":684.51,"end":684.75},{"text":"Eastern","start":684.75,"end":685.03},{"text":"Europe","start":685.03,"end":685.31},{"text":"and","start":685.31,"end":685.47},{"text":"Central","start":685.47,"end":685.79},{"text":"Asia,","start":685.79,"end":686.27},{"text":"punitive","start":686.51,"end":686.91},{"text":"environments","start":686.91,"end":687.55},{"text":"persist.","start":687.55,"end":688.27}]},{"text":"But countries like Albania are fostering promising judicial practices that could inspire others in the region.","start":688.63,"end":694.79,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"But","start":688.63,"end":688.79},{"text":"countries","start":688.79,"end":689.19},{"text":"like","start":689.19,"end":689.39},{"text":"Albania","start":689.39,"end":689.95},{"text":"are","start":689.95,"end":690.15},{"text":"fostering","start":690.15,"end":690.79},{"text":"promising","start":690.79,"end":691.43},{"text":"judicial","start":691.43,"end":691.83},{"text":"practices","start":691.83,"end":692.63},{"text":"that","start":692.83,"end":692.95},{"text":"could","start":692.95,"end":693.15},{"text":"inspire","start":693.15,"end":693.75},{"text":"others","start":693.75,"end":694.07},{"text":"in","start":694.07,"end":694.15},{"text":"the","start":694.15,"end":694.27},{"text":"region.","start":694.27,"end":694.79}]},{"text":"Ukraine is in the process of reforming its drug policy.","start":695.43,"end":698.71,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Ukraine","start":695.43,"end":696.07},{"text":"is","start":696.07,"end":696.15},{"text":"in","start":696.15,"end":696.31},{"text":"the","start":696.31,"end":696.39},{"text":"process","start":696.39,"end":696.91},{"text":"of","start":696.91,"end":697.03},{"text":"reforming","start":697.03,"end":697.59},{"text":"its","start":697.59,"end":697.79},{"text":"drug","start":697.79,"end":697.99},{"text":"policy.","start":697.99,"end":698.71}]},{"text":"We see evidence and science-based developments in many countries and regions, from Pakistan to Scotland in the United Kingdom.","start":699.27,"end":706.47,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"We","start":699.27,"end":699.51},{"text":"see","start":699.51,"end":699.83},{"text":"evidence","start":699.83,"end":700.27},{"text":"and","start":700.27,"end":700.39},{"text":"science-based","start":700.39,"end":701.07},{"text":"developments","start":701.07,"end":701.67},{"text":"in","start":701.67,"end":701.79},{"text":"many","start":701.79,"end":702.07},{"text":"countries","start":702.07,"end":702.47},{"text":"and","start":702.47,"end":702.63},{"text":"regions,","start":702.63,"end":703.27},{"text":"from","start":703.43,"end":703.67},{"text":"Pakistan","start":703.67,"end":704.39},{"text":"to","start":704.63,"end":704.75},{"text":"Scotland","start":704.75,"end":705.43},{"text":"in","start":705.43,"end":705.59},{"text":"the","start":705.59,"end":705.67},{"text":"United","start":705.67,"end":706.03},{"text":"Kingdom.","start":706.03,"end":706.47}]},{"text":"At UNDP, we are committed to working alongside governments, communities, and all stakeholders to advance the kind of legal and policy reform for better HIV health and development outcomes.","start":707.19,"end":718.15,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"At","start":707.19,"end":707.31},{"text":"UNDP,","start":707.35,"end":707.99},{"text":"we","start":707.99,"end":708.15},{"text":"are","start":708.15,"end":708.23},{"text":"committed","start":708.23,"end":708.67},{"text":"to","start":708.67,"end":708.79},{"text":"working","start":708.79,"end":709.27},{"text":"alongside","start":709.27,"end":709.95},{"text":"governments,","start":709.95,"end":710.63},{"text":"communities,","start":710.63,"end":711.43},{"text":"and","start":711.67,"end":711.87},{"text":"all","start":711.87,"end":711.99},{"text":"stakeholders","start":711.99,"end":712.63},{"text":"to","start":712.63,"end":712.79},{"text":"advance","start":712.79,"end":713.23},{"text":"the","start":713.23,"end":713.31},{"text":"kind","start":713.31,"end":713.47},{"text":"of","start":713.47,"end":713.59},{"text":"legal","start":713.59,"end":713.95},{"text":"and","start":713.95,"end":714.07},{"text":"policy","start":714.07,"end":714.55},{"text":"reform","start":714.55,"end":715.03},{"text":"for","start":715.35,"end":715.59},{"text":"better","start":715.59,"end":715.91},{"text":"HIV","start":715.91,"end":716.55},{"text":"health","start":716.55,"end":716.87},{"text":"and","start":716.87,"end":716.99},{"text":"development","start":716.99,"end":717.51},{"text":"outcomes.","start":717.51,"end":718.15}]},{"text":"It's not just about drug policy.","start":718.67,"end":720.71,"topics":[],"words":[{"text":"It's","start":718.67,"end":718.95},{"text":"not","start":718.95,"end":719.19},{"text":"just","start":719.19,"end":719.59},{"text":"about","start":719.59,"end":719.87},{"text":"drug","start":719.87,"end":720.07},{"text":"policy.","start":720.07,"end":720.71}]},{"text":"It's about inclusive and sustainable development.","start":721.07,"end":723.67,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"It's","start":721.07,"end":721.31},{"text":"about","start":721.31,"end":721.55},{"text":"inclusive","start":721.55,"end":722.11},{"text":"and","start":722.11,"end":722.23},{"text":"sustainable","start":722.23,"end":722.87},{"text":"development.","start":722.87,"end":723.67}]},{"text":"It's about realizing the right to life, the right to health, and building the institutions and unleashing the local capacity.","start":724.31,"end":731.75,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"It's","start":724.31,"end":724.55},{"text":"about","start":724.55,"end":724.79},{"text":"realizing","start":724.79,"end":725.43},{"text":"the","start":725.43,"end":725.51},{"text":"right","start":725.51,"end":725.79},{"text":"to","start":725.79,"end":725.87},{"text":"life,","start":725.87,"end":726.11},{"text":"the","start":726.55,"end":726.67},{"text":"right","start":726.67,"end":726.91},{"text":"to","start":726.91,"end":726.99},{"text":"health,","start":726.99,"end":727.43},{"text":"and","start":727.67,"end":727.91},{"text":"building","start":727.91,"end":728.31},{"text":"the","start":728.31,"end":728.43},{"text":"institutions","start":728.43,"end":729.51},{"text":"and","start":729.67,"end":729.95},{"text":"unleashing","start":729.95,"end":730.55},{"text":"the","start":730.55,"end":730.63},{"text":"local","start":730.63,"end":730.95},{"text":"capacity.","start":730.95,"end":731.75}]},{"text":"Oops.","start":733.35,"end":733.55,"topics":[],"words":[{"text":"Oops.","start":733.35,"end":733.55}]},{"text":"Sorry.","start":736.91,"end":737.35,"topics":[],"words":[{"text":"Sorry.","start":736.91,"end":737.35}]},{"text":"And unleashing, sorry, some kind of an issue.","start":740.67,"end":744.51,"topics":[],"words":[{"text":"And","start":740.67,"end":740.87},{"text":"unleashing,","start":740.87,"end":741.43},{"text":"sorry,","start":742.07,"end":742.55},{"text":"some","start":742.55,"end":742.79},{"text":"kind","start":743.83,"end":744.07},{"text":"of","start":744.07,"end":744.15},{"text":"an","start":744.15,"end":744.27},{"text":"issue.","start":744.27,"end":744.51}]},{"text":"Today's dialogue.","start":757.27,"end":758.23,"topics":[],"words":[{"text":"Today's","start":757.27,"end":757.71},{"text":"dialogue.","start":757.71,"end":758.23}]}]}],"speaker":{"affiliation":"UNDP","group":null,"function":null,"affiliation_full":"UNDP"}},{"statement_number":3,"start":795.91,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=13:16","paragraphs":[{"sentences":[{"text":"Helen Clark.","start":795.91,"end":796.75,"topics":[],"words":[{"text":"Helen","start":795.91,"end":796.47},{"text":"Clark.","start":796.47,"end":796.75}]},{"text":"Let's see what's happening next.","start":796.75,"end":810.94,"topics":[],"words":[{"text":"Let's","start":796.75,"end":797.03},{"text":"see","start":797.03,"end":797.11},{"text":"what's","start":797.11,"end":797.43},{"text":"happening","start":799.23,"end":799.51},{"text":"next.","start":810.74,"end":810.94}]}]}],"speaker":{"affiliation":null,"group":null,"function":null,"affiliation_full":null}},{"statement_number":4,"start":810.94,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=13:31","paragraphs":[{"sentences":[{"text":"Excellencies, distinguished guests, ladies and gentlemen, on behalf of the Global Commission on Drug Policy, let me thank the organizers and co-sponsors of this event, Columbia, WHO and the Open Society Foundations.","start":810.94,"end":840.19,"topics":[],"words":[{"text":"Excellencies,","start":810.94,"end":811.54},{"text":"distinguished","start":811.54,"end":812.02},{"text":"guests,","start":812.02,"end":812.22},{"text":"ladies","start":812.38,"end":812.58},{"text":"and","start":812.94,"end":813.06},{"text":"gentlemen,","start":819.44,"end":819.8},{"text":"on","start":822.8,"end":822.88},{"text":"behalf","start":823.12,"end":823.36},{"text":"of","start":823.48,"end":823.56},{"text":"the","start":823.68,"end":823.76},{"text":"Global","start":823.76,"end":824},{"text":"Commission","start":824.2,"end":824.52},{"text":"on","start":824.72,"end":824.8},{"text":"Drug","start":824.88,"end":825.04},{"text":"Policy,","start":825.12,"end":825.4},{"text":"let","start":825.8,"end":825.92},{"text":"me","start":826.36,"end":826.48},{"text":"thank","start":826.48,"end":826.64},{"text":"the","start":826.64,"end":826.72},{"text":"organizers","start":827,"end":827.48},{"text":"and","start":827.68,"end":827.8},{"text":"co-sponsors","start":827.84,"end":828.52},{"text":"of","start":828.6,"end":828.68},{"text":"this","start":828.68,"end":828.8},{"text":"event,","start":829.08,"end":829.28},{"text":"Columbia,","start":829.68,"end":830.16},{"text":"WHO","start":836.87,"end":837.55},{"text":"and","start":837.87,"end":838.07},{"text":"the","start":838.07,"end":838.15},{"text":"Open","start":838.27,"end":838.59},{"text":"Society","start":838.59,"end":839.31},{"text":"Foundations.","start":839.31,"end":840.19}]},{"text":"Today's topic, evidence and science-based approaches in drug policy, HIV and health, is timely for a number of reasons, both positive and negative.","start":841.15,"end":852.19,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"Today's","start":841.15,"end":841.71},{"text":"topic,","start":841.71,"end":842.19},{"text":"evidence","start":842.91,"end":843.47},{"text":"and","start":843.47,"end":843.59},{"text":"science-based","start":843.59,"end":844.35},{"text":"approaches","start":844.35,"end":844.99},{"text":"in","start":844.99,"end":845.07},{"text":"drug","start":845.07,"end":845.39},{"text":"policy,","start":845.39,"end":846.03},{"text":"HIV","start":846.19,"end":846.99},{"text":"and","start":846.99,"end":847.23},{"text":"health,","start":847.23,"end":847.59},{"text":"is","start":848.03,"end":848.35},{"text":"timely","start":848.35,"end":849.07},{"text":"for","start":849.07,"end":849.31},{"text":"a","start":849.31,"end":849.35},{"text":"number","start":849.35,"end":849.63},{"text":"of","start":849.63,"end":849.71},{"text":"reasons,","start":849.71,"end":850.35},{"text":"both","start":850.83,"end":851.07},{"text":"positive","start":851.07,"end":851.63},{"text":"and","start":851.63,"end":851.83},{"text":"negative.","start":851.83,"end":852.19}]},{"text":"On the positive side, We see the number of jurisdictions acting to decriminalise possession of drugs for personal consumption growing.","start":853.23,"end":862.31,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"On","start":853.23,"end":853.39},{"text":"the","start":853.39,"end":853.47},{"text":"positive","start":853.47,"end":853.95},{"text":"side,","start":853.95,"end":854.51},{"text":"We","start":854.87,"end":855.03},{"text":"see","start":855.03,"end":855.19},{"text":"the","start":855.19,"end":855.35},{"text":"number","start":855.35,"end":855.83},{"text":"of","start":855.83,"end":855.91},{"text":"jurisdictions","start":855.91,"end":856.79},{"text":"acting","start":856.79,"end":857.35},{"text":"to","start":857.35,"end":857.51},{"text":"decriminalise","start":857.51,"end":858.63},{"text":"possession","start":858.63,"end":859.19},{"text":"of","start":859.19,"end":859.35},{"text":"drugs","start":859.35,"end":859.83},{"text":"for","start":859.83,"end":859.99},{"text":"personal","start":859.99,"end":860.55},{"text":"consumption","start":860.55,"end":861.43},{"text":"growing.","start":861.83,"end":862.31}]},{"text":"And particularly in the case of cannabis, there is movement to legal supply as well.","start":862.87,"end":868.07,"topics":[],"words":[{"text":"And","start":862.87,"end":863.07},{"text":"particularly","start":863.07,"end":863.63},{"text":"in","start":863.63,"end":863.71},{"text":"the","start":863.71,"end":863.79},{"text":"case","start":863.79,"end":864.15},{"text":"of","start":864.15,"end":864.31},{"text":"cannabis,","start":864.31,"end":865.03},{"text":"there","start":865.35,"end":865.59},{"text":"is","start":865.59,"end":865.67},{"text":"movement","start":865.67,"end":866.27},{"text":"to","start":866.27,"end":866.35},{"text":"legal","start":866.35,"end":866.79},{"text":"supply","start":866.79,"end":867.43},{"text":"as","start":867.55,"end":867.75},{"text":"well.","start":867.75,"end":868.07}]},{"text":"We see Scotland establishing the first ever safer consumption room in the United Kingdom for people who inject drugs.","start":869.19,"end":878.39,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"We","start":869.19,"end":869.43},{"text":"see","start":869.43,"end":869.59},{"text":"Scotland","start":869.59,"end":870.47},{"text":"establishing","start":870.79,"end":871.75},{"text":"the","start":871.91,"end":872.03},{"text":"first","start":872.03,"end":872.63},{"text":"ever","start":872.63,"end":873.03},{"text":"safer","start":873.03,"end":873.67},{"text":"consumption","start":873.67,"end":874.39},{"text":"room","start":874.39,"end":874.79},{"text":"in","start":874.87,"end":875.03},{"text":"the","start":875.03,"end":875.11},{"text":"United","start":875.11,"end":875.51},{"text":"Kingdom","start":875.51,"end":875.99},{"text":"for","start":876.71,"end":876.87},{"text":"people","start":876.87,"end":877.27},{"text":"who","start":877.27,"end":877.43},{"text":"inject","start":877.43,"end":877.87},{"text":"drugs.","start":877.87,"end":878.39}]},{"text":"I visited it in Glasgow earlier this month, and I was very impressed.","start":879.51,"end":884.07,"topics":[],"words":[{"text":"I","start":879.51,"end":879.67},{"text":"visited","start":879.67,"end":880.35},{"text":"it","start":880.35,"end":880.55},{"text":"in","start":880.63,"end":880.79},{"text":"Glasgow","start":880.83,"end":881.43},{"text":"earlier","start":881.59,"end":881.91},{"text":"this","start":881.91,"end":882.15},{"text":"month,","start":882.15,"end":882.47},{"text":"and","start":882.51,"end":882.63},{"text":"I","start":882.63,"end":882.79},{"text":"was","start":882.79,"end":882.95},{"text":"very","start":882.95,"end":883.39},{"text":"impressed.","start":883.39,"end":884.07}]},{"text":"by the firm commitment of the Scottish Government, Glasgow City Council and the National Health Service in Scotland to the service.","start":884.71,"end":892.71,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"by","start":884.71,"end":884.75},{"text":"the","start":884.79,"end":884.91},{"text":"firm","start":884.91,"end":885.35},{"text":"commitment","start":885.35,"end":885.95},{"text":"of","start":885.95,"end":886.03},{"text":"the","start":886.03,"end":886.11},{"text":"Scottish","start":886.15,"end":886.71},{"text":"Government,","start":886.71,"end":887.19},{"text":"Glasgow","start":887.71,"end":888.15},{"text":"City","start":888.15,"end":888.47},{"text":"Council","start":888.47,"end":889.11},{"text":"and","start":889.51,"end":889.67},{"text":"the","start":889.67,"end":889.75},{"text":"National","start":889.75,"end":890.15},{"text":"Health","start":890.15,"end":890.39},{"text":"Service","start":890.39,"end":890.87},{"text":"in","start":890.87,"end":890.99},{"text":"Scotland","start":890.99,"end":891.67},{"text":"to","start":891.67,"end":891.95},{"text":"the","start":891.99,"end":892.07},{"text":"service.","start":892.07,"end":892.71}]},{"text":"They are owning the challenge that they have of being ranked highest in western Europe for drug-related deaths by overdose, and they are acting within the legal parameters that they have to do what they can to reduce that number of deaths.","start":893.75,"end":909.83,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"They","start":893.75,"end":894.15},{"text":"are","start":894.55,"end":894.63},{"text":"owning","start":894.63,"end":895.03},{"text":"the","start":895.03,"end":895.19},{"text":"challenge","start":895.19,"end":895.75},{"text":"that","start":895.75,"end":895.87},{"text":"they","start":895.87,"end":895.95},{"text":"have","start":895.95,"end":896.47},{"text":"of","start":897.15,"end":897.31},{"text":"being","start":897.31,"end":897.59},{"text":"ranked","start":897.59,"end":897.99},{"text":"highest","start":897.99,"end":898.67},{"text":"in","start":898.67,"end":898.79},{"text":"western","start":898.79,"end":899.27},{"text":"Europe","start":899.27,"end":899.59},{"text":"for","start":899.59,"end":899.75},{"text":"drug-related","start":899.75,"end":900.67},{"text":"deaths","start":900.67,"end":900.95},{"text":"by","start":900.95,"end":901.19},{"text":"overdose,","start":901.23,"end":901.99},{"text":"and","start":902.55,"end":902.75},{"text":"they","start":902.75,"end":902.95},{"text":"are","start":902.95,"end":903.11},{"text":"acting","start":903.11,"end":903.59},{"text":"within","start":903.59,"end":904.07},{"text":"the","start":904.07,"end":904.15},{"text":"legal","start":904.15,"end":904.55},{"text":"parameters","start":904.55,"end":905.19},{"text":"that","start":905.19,"end":905.31},{"text":"they","start":905.31,"end":905.43},{"text":"have","start":905.43,"end":905.91},{"text":"to","start":906.47,"end":906.59},{"text":"do","start":906.63,"end":906.79},{"text":"what","start":906.79,"end":907.03},{"text":"they","start":907.03,"end":907.19},{"text":"can","start":907.19,"end":907.75},{"text":"to","start":907.75,"end":907.83},{"text":"reduce","start":907.83,"end":908.47},{"text":"that","start":908.71,"end":908.87},{"text":"number","start":908.87,"end":909.19},{"text":"of","start":909.19,"end":909.27},{"text":"deaths.","start":909.27,"end":909.83}]},{"text":"The Glasgow service currently awaits approval from authorities in London to be able to test the drugs that people bring to the centre to consume.","start":911.03,"end":919.99,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"The","start":911.03,"end":911.19},{"text":"Glasgow","start":911.19,"end":911.67},{"text":"service","start":911.67,"end":912.23},{"text":"currently","start":912.23,"end":912.63},{"text":"awaits","start":912.63,"end":913.03},{"text":"approval","start":913.03,"end":913.59},{"text":"from","start":913.59,"end":913.83},{"text":"authorities","start":913.83,"end":914.55},{"text":"in","start":914.55,"end":914.63},{"text":"London","start":914.63,"end":915.19},{"text":"to","start":915.51,"end":915.63},{"text":"be","start":915.67,"end":915.83},{"text":"able","start":915.83,"end":916.07},{"text":"to","start":916.07,"end":916.15},{"text":"test","start":916.23,"end":916.67},{"text":"the","start":916.67,"end":916.79},{"text":"drugs","start":916.79,"end":917.27},{"text":"that","start":917.27,"end":917.51},{"text":"people","start":917.51,"end":917.91},{"text":"bring","start":917.91,"end":918.31},{"text":"to","start":918.31,"end":918.47},{"text":"the","start":918.47,"end":918.59},{"text":"centre","start":918.59,"end":919.03},{"text":"to","start":919.03,"end":919.19},{"text":"consume.","start":919.19,"end":919.99}]},{"text":"One hopes that approval can be speedily given, because, if such a service were available, one could anticipate that fewer medical emergencies would arise.","start":921.03,"end":934.55,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"One","start":921.03,"end":921.27},{"text":"hopes","start":921.51,"end":921.91},{"text":"that","start":922.39,"end":922.71},{"text":"approval","start":922.71,"end":923.35},{"text":"can","start":923.35,"end":923.51},{"text":"be","start":923.51,"end":923.67},{"text":"speedily","start":923.67,"end":924.31},{"text":"given,","start":924.31,"end":924.79},{"text":"because,","start":925.79,"end":926.31},{"text":"if","start":926.55,"end":926.71},{"text":"such","start":926.71,"end":927.11},{"text":"a","start":927.11,"end":927.15},{"text":"service","start":927.15,"end":927.91},{"text":"were","start":928.15,"end":928.47},{"text":"available,","start":928.47,"end":928.95},{"text":"one","start":929.67,"end":929.99},{"text":"could","start":929.99,"end":930.23},{"text":"anticipate","start":930.23,"end":931.11},{"text":"that","start":931.27,"end":931.51},{"text":"fewer","start":931.51,"end":932.07},{"text":"medical","start":932.23,"end":932.87},{"text":"emergencies","start":932.95,"end":933.67},{"text":"would","start":933.67,"end":933.87},{"text":"arise.","start":933.87,"end":934.55}]},{"text":"Also positive is the agreement at the Commission on Narcotic Drugs to commission an independent expert review of the UN-mandated global drug control policy.","start":935.83,"end":947.35,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Also","start":935.83,"end":936.23},{"text":"positive","start":936.23,"end":936.75},{"text":"is","start":937.35,"end":937.59},{"text":"the","start":937.59,"end":937.71},{"text":"agreement","start":937.71,"end":938.23},{"text":"at","start":938.23,"end":938.39},{"text":"the","start":938.39,"end":938.47},{"text":"Commission","start":938.47,"end":938.95},{"text":"on","start":938.95,"end":939.15},{"text":"Narcotic","start":939.15,"end":939.67},{"text":"Drugs","start":939.67,"end":940.23},{"text":"to","start":940.71,"end":940.83},{"text":"commission","start":940.83,"end":941.43},{"text":"an","start":941.43,"end":941.51},{"text":"independent","start":941.59,"end":942.47},{"text":"expert","start":942.47,"end":943.03},{"text":"review","start":943.03,"end":943.67},{"text":"of","start":943.67,"end":943.83},{"text":"the","start":943.83,"end":943.99},{"text":"UN-mandated","start":943.99,"end":945.19},{"text":"global","start":945.39,"end":945.91},{"text":"drug","start":945.95,"end":946.19},{"text":"control","start":946.19,"end":946.71},{"text":"policy.","start":946.71,"end":947.35}]},{"text":"And I congratulate Colombia on their successful leadership of this initiative.","start":947.91,"end":952.91,"topics":[],"words":[{"text":"And","start":947.91,"end":948.15},{"text":"I","start":948.15,"end":948.23},{"text":"congratulate","start":948.23,"end":949.11},{"text":"Colombia","start":949.11,"end":949.91},{"text":"on","start":950.27,"end":950.39},{"text":"their","start":950.39,"end":950.55},{"text":"successful","start":950.55,"end":951.31},{"text":"leadership","start":951.31,"end":951.83},{"text":"of","start":951.91,"end":952.07},{"text":"this","start":952.07,"end":952.31},{"text":"initiative.","start":952.31,"end":952.91}]},{"text":"At the same time, we see some jurisdictions which are stubbornly refusing to move on community-based harm reduction, even in the face of a move away from consumption of plant-based substances to synthetics.","start":954.27,"end":969.43,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"At","start":954.27,"end":954.35},{"text":"the","start":954.35,"end":954.51},{"text":"same","start":954.51,"end":954.87},{"text":"time,","start":954.87,"end":955.43},{"text":"we","start":955.99,"end":956.15},{"text":"see","start":956.15,"end":956.39},{"text":"some","start":956.39,"end":956.79},{"text":"jurisdictions","start":956.79,"end":957.67},{"text":"which","start":957.67,"end":957.99},{"text":"are","start":957.99,"end":958.07},{"text":"stubbornly","start":958.07,"end":959.11},{"text":"refusing","start":959.11,"end":959.83},{"text":"to","start":959.83,"end":959.95},{"text":"move","start":959.95,"end":960.47},{"text":"on","start":960.51,"end":960.63},{"text":"community-based","start":960.63,"end":961.63},{"text":"harm","start":961.63,"end":961.91},{"text":"reduction,","start":961.91,"end":962.55},{"text":"even","start":963.43,"end":963.83},{"text":"in","start":963.83,"end":963.91},{"text":"the","start":963.91,"end":964.07},{"text":"face","start":964.07,"end":964.55},{"text":"of","start":964.55,"end":964.63},{"text":"a","start":964.63,"end":964.71},{"text":"move","start":964.71,"end":965.11},{"text":"away","start":965.11,"end":965.43},{"text":"from","start":965.43,"end":965.67},{"text":"consumption","start":965.67,"end":966.47},{"text":"of","start":966.47,"end":966.55},{"text":"plant-based","start":966.55,"end":967.31},{"text":"substances","start":967.31,"end":968.07},{"text":"to","start":968.47,"end":968.63},{"text":"synthetics.","start":968.63,"end":969.43}]},{"text":"and in the face of the growing presence of potent synthetics in the mix of drugs being consumed in a number of places.","start":970.23,"end":978.79,"topics":[],"words":[{"text":"and","start":970.23,"end":970.47},{"text":"in","start":970.47,"end":970.55},{"text":"the","start":970.55,"end":970.67},{"text":"face","start":970.67,"end":971.11},{"text":"of","start":971.11,"end":971.19},{"text":"the","start":971.19,"end":971.27},{"text":"growing","start":971.27,"end":971.83},{"text":"presence","start":971.83,"end":972.47},{"text":"of","start":972.83,"end":972.95},{"text":"potent","start":972.95,"end":973.55},{"text":"synthetics","start":973.55,"end":974.39},{"text":"in","start":974.79,"end":974.95},{"text":"the","start":974.95,"end":975.03},{"text":"mix","start":975.03,"end":975.39},{"text":"of","start":975.39,"end":975.51},{"text":"drugs","start":975.51,"end":976.07},{"text":"being","start":976.39,"end":976.67},{"text":"consumed","start":976.67,"end":977.51},{"text":"in","start":977.55,"end":977.63},{"text":"a","start":977.63,"end":977.67},{"text":"number","start":977.67,"end":978.07},{"text":"of","start":978.07,"end":978.15},{"text":"places.","start":978.15,"end":978.79}]},{"text":"It's vital for harm reduction to encompass the right of people who use drugs to have their drugs tested, for there to be easily accessible, no questions asked, walk-in services available for safer consumption.","start":979.75,"end":995.59,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"It's","start":979.75,"end":980.07},{"text":"vital","start":980.07,"end":980.63},{"text":"for","start":980.63,"end":980.79},{"text":"harm","start":980.79,"end":981.11},{"text":"reduction","start":981.11,"end":981.83},{"text":"to","start":982.31,"end":982.47},{"text":"encompass","start":982.47,"end":983.19},{"text":"the","start":983.19,"end":983.27},{"text":"right","start":983.27,"end":983.67},{"text":"of","start":983.67,"end":983.75},{"text":"people","start":983.75,"end":984.23},{"text":"who","start":984.23,"end":984.35},{"text":"use","start":984.35,"end":984.71},{"text":"drugs","start":984.71,"end":985.03},{"text":"to","start":985.03,"end":985.23},{"text":"have","start":985.23,"end":985.51},{"text":"their","start":985.51,"end":985.67},{"text":"drugs","start":985.67,"end":986.07},{"text":"tested,","start":986.07,"end":986.63},{"text":"for","start":987.67,"end":987.95},{"text":"there","start":987.95,"end":988.15},{"text":"to","start":988.15,"end":988.27},{"text":"be","start":988.27,"end":988.83},{"text":"easily","start":988.83,"end":989.19},{"text":"accessible,","start":989.19,"end":989.91},{"text":"no","start":990.31,"end":990.63},{"text":"questions","start":990.63,"end":991.27},{"text":"asked,","start":991.27,"end":991.75},{"text":"walk-in","start":991.75,"end":992.31},{"text":"services","start":992.31,"end":993.19},{"text":"available","start":993.67,"end":994.31},{"text":"for","start":994.31,"end":994.43},{"text":"safer","start":994.43,"end":994.83},{"text":"consumption.","start":994.83,"end":995.59}]},{"text":"for there to be naloxone, which reverses opioid overdoses, to be widely available, and for more research to be done on the most effective treatments for overdoses from synthetics.","start":996.83,"end":1009.39,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"for","start":996.83,"end":996.95},{"text":"there","start":996.95,"end":997.15},{"text":"to","start":997.15,"end":997.23},{"text":"be","start":997.23,"end":997.47},{"text":"naloxone,","start":997.47,"end":998.43},{"text":"which","start":998.55,"end":998.91},{"text":"reverses","start":998.91,"end":999.63},{"text":"opioid","start":999.71,"end":1000.27},{"text":"overdoses,","start":1000.27,"end":1000.99},{"text":"to","start":1000.99,"end":1001.07},{"text":"be","start":1001.07,"end":1001.23},{"text":"widely","start":1001.23,"end":1001.71},{"text":"available,","start":1001.71,"end":1002.27},{"text":"and","start":1003.15,"end":1003.39},{"text":"for","start":1003.39,"end":1003.55},{"text":"more","start":1003.55,"end":1003.91},{"text":"research","start":1003.91,"end":1004.23},{"text":"to","start":1004.23,"end":1004.47},{"text":"be","start":1004.47,"end":1004.67},{"text":"done","start":1004.67,"end":1004.99},{"text":"on","start":1004.99,"end":1005.07},{"text":"the","start":1005.07,"end":1005.15},{"text":"most","start":1005.15,"end":1005.63},{"text":"effective","start":1005.63,"end":1006.11},{"text":"treatments","start":1006.11,"end":1006.75},{"text":"for","start":1006.75,"end":1006.99},{"text":"overdoses","start":1006.99,"end":1007.87},{"text":"from","start":1008.27,"end":1008.59},{"text":"synthetics.","start":1008.59,"end":1009.39}]},{"text":"The evidence is that comprehensive harm reduction services do save lives.","start":1010.27,"end":1015.95,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"The","start":1010.27,"end":1010.43},{"text":"evidence","start":1010.43,"end":1011.23},{"text":"is","start":1011.23,"end":1011.55},{"text":"that","start":1011.55,"end":1011.79},{"text":"comprehensive","start":1011.79,"end":1012.67},{"text":"harm","start":1012.67,"end":1012.99},{"text":"reduction","start":1012.99,"end":1013.47},{"text":"services","start":1013.47,"end":1014.19},{"text":"do","start":1014.51,"end":1014.83},{"text":"save","start":1014.83,"end":1015.31},{"text":"lives.","start":1015.31,"end":1015.95}]},{"text":"Also highly negative, sadly, is the cloud hanging over our global efforts to end HIV/AIDS as a public health threat.","start":1017.23,"end":1026.11,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"Also","start":1017.23,"end":1017.75},{"text":"highly","start":1017.79,"end":1018.27},{"text":"negative,","start":1018.27,"end":1018.75},{"text":"sadly,","start":1018.75,"end":1019.31},{"text":"is","start":1019.87,"end":1020.11},{"text":"the","start":1020.11,"end":1020.19},{"text":"cloud","start":1020.19,"end":1020.75},{"text":"hanging","start":1020.75,"end":1021.23},{"text":"over","start":1021.31,"end":1021.67},{"text":"our","start":1021.95,"end":1022.11},{"text":"global","start":1022.11,"end":1022.67},{"text":"efforts","start":1022.67,"end":1023.07},{"text":"to","start":1023.07,"end":1023.23},{"text":"end","start":1023.23,"end":1023.63},{"text":"HIV/AIDS","start":1023.71,"end":1024.83},{"text":"as","start":1024.83,"end":1024.91},{"text":"a","start":1024.91,"end":1024.95},{"text":"public","start":1024.95,"end":1025.39},{"text":"health","start":1025.39,"end":1025.75},{"text":"threat.","start":1025.75,"end":1026.11}]},{"text":"The United States PEPFAR program, established by President George W. Bush, has been a major actor in the fight against the AIDS pandemic, and it has literally saved millions of lives.","start":1026.35,"end":1041.43,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"The","start":1026.35,"end":1026.39},{"text":"United","start":1027.43,"end":1027.75},{"text":"States","start":1027.75,"end":1027.95},{"text":"PEPFAR","start":1027.95,"end":1028.91},{"text":"program,","start":1028.91,"end":1029.43},{"text":"established","start":1029.55,"end":1030.15},{"text":"by","start":1030.23,"end":1030.47},{"text":"President","start":1030.47,"end":1031.07},{"text":"George","start":1031.19,"end":1031.59},{"text":"W.","start":1031.59,"end":1031.91},{"text":"Bush,","start":1031.91,"end":1032.31},{"text":"has","start":1032.95,"end":1033.19},{"text":"been","start":1033.19,"end":1033.47},{"text":"a","start":1033.47,"end":1033.51},{"text":"major","start":1033.51,"end":1034.23},{"text":"actor","start":1034.23,"end":1034.83},{"text":"in","start":1035.03,"end":1035.19},{"text":"the","start":1035.19,"end":1035.27},{"text":"fight","start":1035.27,"end":1035.75},{"text":"against","start":1035.75,"end":1036.27},{"text":"the","start":1036.27,"end":1036.35},{"text":"AIDS","start":1036.39,"end":1036.63},{"text":"pandemic,","start":1036.63,"end":1037.27},{"text":"and","start":1037.83,"end":1038.07},{"text":"it","start":1038.07,"end":1038.23},{"text":"has","start":1038.23,"end":1038.55},{"text":"literally","start":1038.55,"end":1039.35},{"text":"saved","start":1039.51,"end":1040.07},{"text":"millions","start":1040.07,"end":1040.63},{"text":"of","start":1040.63,"end":1040.71},{"text":"lives.","start":1040.71,"end":1041.43}]},{"text":"Its fate hangs in the balance, even this very week, as the Senate debates the administration's budget bill.","start":1042.15,"end":1049.35,"topics":[],"words":[{"text":"Its","start":1042.15,"end":1042.39},{"text":"fate","start":1042.39,"end":1042.87},{"text":"hangs","start":1042.87,"end":1043.31},{"text":"in","start":1043.31,"end":1043.39},{"text":"the","start":1043.39,"end":1043.51},{"text":"balance,","start":1043.51,"end":1044.23},{"text":"even","start":1044.31,"end":1044.63},{"text":"this","start":1044.63,"end":1044.87},{"text":"very","start":1044.87,"end":1045.19},{"text":"week,","start":1045.19,"end":1045.59},{"text":"as","start":1046.15,"end":1046.31},{"text":"the","start":1046.31,"end":1046.43},{"text":"Senate","start":1046.43,"end":1046.99},{"text":"debates","start":1046.99,"end":1047.51},{"text":"the","start":1047.51,"end":1047.59},{"text":"administration's","start":1047.59,"end":1048.47},{"text":"budget","start":1048.47,"end":1048.91},{"text":"bill.","start":1048.95,"end":1049.35}]},{"text":"It is to be hoped that enough bipartisan support for PEPFAR can be mustered for it to continue its work.","start":1050.79,"end":1057.79,"topics":[],"words":[{"text":"It","start":1050.79,"end":1050.91},{"text":"is","start":1050.95,"end":1051.19},{"text":"to","start":1051.19,"end":1051.31},{"text":"be","start":1051.31,"end":1051.43},{"text":"hoped","start":1051.43,"end":1051.83},{"text":"that","start":1051.83,"end":1051.99},{"text":"enough","start":1051.99,"end":1052.31},{"text":"bipartisan","start":1052.31,"end":1053.35},{"text":"support","start":1053.35,"end":1053.67},{"text":"for","start":1053.67,"end":1053.79},{"text":"PEPFAR","start":1053.79,"end":1054.75},{"text":"can","start":1054.75,"end":1054.87},{"text":"be","start":1054.87,"end":1055.03},{"text":"mustered","start":1055.03,"end":1055.59},{"text":"for","start":1056.27,"end":1056.39},{"text":"it","start":1056.39,"end":1056.55},{"text":"to","start":1056.55,"end":1056.63},{"text":"continue","start":1056.63,"end":1057.15},{"text":"its","start":1057.15,"end":1057.39},{"text":"work.","start":1057.39,"end":1057.79}]},{"text":"But sadly, the disruption in funding has already resulted in lives lost.","start":1058.75,"end":1064.11,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"But","start":1058.75,"end":1058.99},{"text":"sadly,","start":1058.99,"end":1059.79},{"text":"the","start":1060.19,"end":1060.35},{"text":"disruption","start":1060.39,"end":1061.03},{"text":"in","start":1061.03,"end":1061.15},{"text":"funding","start":1061.15,"end":1061.79},{"text":"has","start":1061.79,"end":1062.03},{"text":"already","start":1062.03,"end":1062.47},{"text":"resulted","start":1062.47,"end":1062.95},{"text":"in","start":1062.95,"end":1063.15},{"text":"lives","start":1063.15,"end":1063.55},{"text":"lost.","start":1063.55,"end":1064.11}]},{"text":"And if the funding does go, millions more cases of HIV infections and deaths are forecast.","start":1065.23,"end":1072.59,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"And","start":1065.23,"end":1065.55},{"text":"if","start":1065.55,"end":1065.79},{"text":"the","start":1065.79,"end":1065.95},{"text":"funding","start":1065.95,"end":1066.43},{"text":"does","start":1066.43,"end":1066.75},{"text":"go,","start":1066.75,"end":1067.07},{"text":"millions","start":1068.19,"end":1068.67},{"text":"more","start":1068.67,"end":1068.87},{"text":"cases","start":1068.87,"end":1069.43},{"text":"of","start":1069.43,"end":1069.55},{"text":"HIV","start":1069.55,"end":1070.11},{"text":"infections","start":1070.11,"end":1070.87},{"text":"and","start":1070.87,"end":1071.03},{"text":"deaths","start":1071.03,"end":1071.55},{"text":"are","start":1071.63,"end":1071.75},{"text":"forecast.","start":1071.75,"end":1072.59}]},{"text":"Harm reduction in the form of needle exchange schemes is so vital for ending HIV/AIDS and for prevention of HIV transmission to people who inject drugs.","start":1073.87,"end":1085.55,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"Harm","start":1073.87,"end":1074.19},{"text":"reduction","start":1074.19,"end":1074.91},{"text":"in","start":1074.91,"end":1075.07},{"text":"the","start":1075.07,"end":1075.19},{"text":"form","start":1075.19,"end":1075.55},{"text":"of","start":1075.55,"end":1075.63},{"text":"needle","start":1075.63,"end":1076.03},{"text":"exchange","start":1076.03,"end":1076.63},{"text":"schemes","start":1076.63,"end":1077.07},{"text":"is","start":1077.07,"end":1077.23},{"text":"so","start":1077.23,"end":1077.55},{"text":"vital","start":1077.55,"end":1078.11},{"text":"for","start":1078.35,"end":1078.63},{"text":"ending","start":1078.63,"end":1078.91},{"text":"HIV/AIDS","start":1078.91,"end":1080.03},{"text":"and","start":1080.75,"end":1080.99},{"text":"for","start":1080.99,"end":1081.15},{"text":"prevention","start":1081.15,"end":1081.91},{"text":"of","start":1081.91,"end":1082.03},{"text":"HIV","start":1082.03,"end":1082.51},{"text":"transmission","start":1082.51,"end":1083.39},{"text":"to","start":1083.87,"end":1083.99},{"text":"people","start":1083.99,"end":1084.43},{"text":"who","start":1084.43,"end":1084.55},{"text":"inject","start":1084.55,"end":1084.95},{"text":"drugs.","start":1084.95,"end":1085.55}]},{"text":"Those people were estimated by UNAIDS in 2022 to be 14 times more likely to have HIV than is the general population.","start":1086.47,"end":1097.11,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"Those","start":1086.47,"end":1086.87},{"text":"people","start":1086.87,"end":1087.35},{"text":"were","start":1087.35,"end":1087.59},{"text":"estimated","start":1087.59,"end":1088.31},{"text":"by","start":1088.31,"end":1088.55},{"text":"UNAIDS","start":1088.55,"end":1089.59},{"text":"in","start":1089.59,"end":1089.75},{"text":"2022","start":1089.75,"end":1090.63},{"text":"to","start":1091.11,"end":1091.27},{"text":"be","start":1091.27,"end":1091.51},{"text":"14","start":1091.51,"end":1092.31},{"text":"times","start":1092.31,"end":1093.03},{"text":"more","start":1093.03,"end":1093.19},{"text":"likely","start":1093.19,"end":1093.67},{"text":"to","start":1093.67,"end":1093.79},{"text":"have","start":1093.79,"end":1093.99},{"text":"HIV","start":1093.99,"end":1094.87},{"text":"than","start":1095.27,"end":1095.51},{"text":"is","start":1095.55,"end":1095.75},{"text":"the","start":1095.75,"end":1095.83},{"text":"general","start":1095.83,"end":1096.27},{"text":"population.","start":1096.27,"end":1097.11}]},{"text":"Figures cited by the International Association of Providers of AIDS Care suggest that one in 10 new HIV infections is caused by the sharing of needles.","start":1098.23,"end":1110.47,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"Figures","start":1098.23,"end":1098.67},{"text":"cited","start":1098.67,"end":1099.15},{"text":"by","start":1099.15,"end":1099.35},{"text":"the","start":1099.35,"end":1099.47},{"text":"International","start":1099.47,"end":1100.11},{"text":"Association","start":1100.11,"end":1100.95},{"text":"of","start":1100.95,"end":1101.03},{"text":"Providers","start":1101.03,"end":1101.67},{"text":"of","start":1101.67,"end":1101.75},{"text":"AIDS","start":1101.75,"end":1102.07},{"text":"Care","start":1102.07,"end":1102.63},{"text":"suggest","start":1103.03,"end":1103.75},{"text":"that","start":1104.15,"end":1104.39},{"text":"one","start":1104.39,"end":1104.87},{"text":"in","start":1104.87,"end":1104.95},{"text":"10","start":1104.95,"end":1105.59},{"text":"new","start":1106.07,"end":1106.39},{"text":"HIV","start":1106.47,"end":1107.07},{"text":"infections","start":1107.07,"end":1107.91},{"text":"is","start":1108.23,"end":1108.47},{"text":"caused","start":1108.47,"end":1108.99},{"text":"by","start":1108.99,"end":1109.11},{"text":"the","start":1109.11,"end":1109.19},{"text":"sharing","start":1109.27,"end":1109.71},{"text":"of","start":1109.71,"end":1109.83},{"text":"needles.","start":1109.83,"end":1110.47}]},{"text":"So the evidence is strong.","start":1111.75,"end":1113.27,"topics":[],"words":[{"text":"So","start":1111.75,"end":1111.95},{"text":"the","start":1111.99,"end":1112.11},{"text":"evidence","start":1112.15,"end":1112.55},{"text":"is","start":1112.55,"end":1112.67},{"text":"strong.","start":1112.67,"end":1113.27}]},{"text":"Harm reduction will and does save lives.","start":1113.75,"end":1117.27,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"Harm","start":1113.75,"end":1114.11},{"text":"reduction","start":1114.11,"end":1114.71},{"text":"will","start":1114.71,"end":1115.19},{"text":"and","start":1115.51,"end":1115.79},{"text":"does","start":1115.79,"end":1116.15},{"text":"save","start":1116.15,"end":1116.67},{"text":"lives.","start":1116.67,"end":1117.27}]},{"text":"The prohibitionist approach to drugs, driven by the UN conventions, has failed on every level.","start":1118.23,"end":1125.59,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"The","start":1118.23,"end":1118.39},{"text":"prohibitionist","start":1118.39,"end":1119.31},{"text":"approach","start":1119.31,"end":1119.75},{"text":"to","start":1119.75,"end":1119.91},{"text":"drugs,","start":1119.91,"end":1120.55},{"text":"driven","start":1120.79,"end":1121.19},{"text":"by","start":1121.19,"end":1121.31},{"text":"the","start":1121.31,"end":1121.51},{"text":"UN","start":1121.51,"end":1121.83},{"text":"conventions,","start":1121.83,"end":1122.71},{"text":"has","start":1123.51,"end":1123.83},{"text":"failed","start":1123.83,"end":1124.39},{"text":"on","start":1124.55,"end":1124.79},{"text":"every","start":1124.79,"end":1125.11},{"text":"level.","start":1125.11,"end":1125.59}]},{"text":"Under its rubric, we see impediments to harm reduction and to access to essential medication.","start":1126.71,"end":1133.43,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"Under","start":1126.71,"end":1127.03},{"text":"its","start":1127.03,"end":1127.19},{"text":"rubric,","start":1127.19,"end":1127.71},{"text":"we","start":1128.31,"end":1128.47},{"text":"see","start":1128.47,"end":1128.71},{"text":"impediments","start":1128.71,"end":1129.51},{"text":"to","start":1129.51,"end":1129.63},{"text":"harm","start":1129.63,"end":1129.91},{"text":"reduction","start":1129.91,"end":1130.63},{"text":"and","start":1131.19,"end":1131.39},{"text":"to","start":1131.39,"end":1131.51},{"text":"access","start":1131.51,"end":1131.99},{"text":"to","start":1131.99,"end":1132.11},{"text":"essential","start":1132.11,"end":1132.63},{"text":"medication.","start":1132.63,"end":1133.43}]},{"text":"We see criminalisation of people who use drugs.","start":1134.39,"end":1137.27,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"We","start":1134.39,"end":1134.55},{"text":"see","start":1134.55,"end":1134.79},{"text":"criminalisation","start":1134.79,"end":1135.83},{"text":"of","start":1135.83,"end":1135.91},{"text":"people","start":1135.91,"end":1136.31},{"text":"who","start":1136.31,"end":1136.39},{"text":"use","start":1136.39,"end":1136.63},{"text":"drugs.","start":1136.63,"end":1137.27}]},{"text":"We see over-incarceration.","start":1137.83,"end":1139.51,"topics":[],"words":[{"text":"We","start":1137.83,"end":1137.99},{"text":"see","start":1137.99,"end":1138.23},{"text":"over-incarceration.","start":1138.23,"end":1139.51}]},{"text":"We see human rights abuses.","start":1139.51,"end":1141.27,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"We","start":1139.51,"end":1139.63},{"text":"see","start":1139.63,"end":1139.83},{"text":"human","start":1139.83,"end":1140.23},{"text":"rights","start":1140.23,"end":1140.55},{"text":"abuses.","start":1140.55,"end":1141.27}]},{"text":"The so-called war on drugs is responsible for countless lives lost, people disappeared and forced displacement.","start":1142.07,"end":1150.27,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"The","start":1142.07,"end":1142.19},{"text":"so-called","start":1142.19,"end":1142.87},{"text":"war","start":1142.87,"end":1143.15},{"text":"on","start":1143.15,"end":1143.27},{"text":"drugs","start":1143.27,"end":1143.83},{"text":"is","start":1144.59,"end":1144.75},{"text":"responsible","start":1144.75,"end":1145.55},{"text":"for","start":1145.55,"end":1145.79},{"text":"countless","start":1145.79,"end":1146.43},{"text":"lives","start":1146.43,"end":1146.83},{"text":"lost,","start":1146.83,"end":1147.31},{"text":"people","start":1147.71,"end":1148.11},{"text":"disappeared","start":1148.11,"end":1148.83},{"text":"and","start":1148.83,"end":1149.07},{"text":"forced","start":1149.07,"end":1149.51},{"text":"displacement.","start":1149.51,"end":1150.27}]},{"text":"It is so important that the UN review panel to be appointed is truly independent and expert.","start":1151.39,"end":1160.19,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"It","start":1151.39,"end":1151.59},{"text":"is","start":1151.63,"end":1151.75},{"text":"so","start":1151.75,"end":1152.23},{"text":"important","start":1152.23,"end":1152.99},{"text":"that","start":1153.71,"end":1153.95},{"text":"the","start":1153.95,"end":1154.07},{"text":"UN","start":1154.11,"end":1154.75},{"text":"review","start":1154.83,"end":1155.31},{"text":"panel","start":1155.31,"end":1155.87},{"text":"to","start":1155.87,"end":1156.03},{"text":"be","start":1156.03,"end":1156.23},{"text":"appointed","start":1156.23,"end":1156.91},{"text":"is","start":1157.47,"end":1157.71},{"text":"truly","start":1157.71,"end":1158.43},{"text":"independent","start":1158.43,"end":1159.31},{"text":"and","start":1159.31,"end":1159.55},{"text":"expert.","start":1159.55,"end":1160.19}]},{"text":"If it looks at the global policy settings objectively, it cannot fail to recommend substantial change which enables evidence and science-based approaches to drug policy.","start":1160.91,"end":1174.19,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"If","start":1160.91,"end":1161.11},{"text":"it","start":1161.11,"end":1161.23},{"text":"looks","start":1161.23,"end":1161.63},{"text":"at","start":1161.63,"end":1161.71},{"text":"the","start":1161.71,"end":1161.83},{"text":"global","start":1161.83,"end":1162.27},{"text":"policy","start":1162.27,"end":1162.75},{"text":"settings","start":1162.75,"end":1163.19},{"text":"objectively,","start":1163.19,"end":1163.95},{"text":"it","start":1164.51,"end":1164.67},{"text":"cannot","start":1164.75,"end":1165.31},{"text":"fail","start":1165.31,"end":1166.03},{"text":"to","start":1166.59,"end":1166.71},{"text":"recommend","start":1166.71,"end":1167.43},{"text":"substantial","start":1167.43,"end":1168.27},{"text":"change","start":1168.27,"end":1168.91},{"text":"which","start":1169.35,"end":1169.71},{"text":"enables","start":1169.71,"end":1170.59},{"text":"evidence","start":1170.75,"end":1171.39},{"text":"and","start":1171.39,"end":1171.63},{"text":"science-based","start":1171.63,"end":1172.59},{"text":"approaches","start":1172.59,"end":1173.15},{"text":"to","start":1173.15,"end":1173.31},{"text":"drug","start":1173.31,"end":1173.55},{"text":"policy.","start":1173.55,"end":1174.19}]},{"text":"If the panel can achieve that, it will be doing humanity a great service.","start":1175.23,"end":1180.99,"topics":[],"words":[{"text":"If","start":1175.23,"end":1175.35},{"text":"the","start":1175.35,"end":1175.47},{"text":"panel","start":1175.47,"end":1175.87},{"text":"can","start":1175.87,"end":1176.15},{"text":"achieve","start":1176.15,"end":1176.47},{"text":"that,","start":1176.47,"end":1176.91},{"text":"it","start":1177.63,"end":1177.87},{"text":"will","start":1177.87,"end":1178.19},{"text":"be","start":1178.19,"end":1178.35},{"text":"doing","start":1178.35,"end":1178.83},{"text":"humanity","start":1178.99,"end":1179.87},{"text":"a","start":1179.95,"end":1179.99},{"text":"great","start":1179.99,"end":1180.27},{"text":"service.","start":1180.27,"end":1180.99}]},{"text":"Thank you for the opportunity to speak to this topic today.","start":1181.79,"end":1185.55,"topics":[],"words":[{"text":"Thank","start":1181.79,"end":1182.11},{"text":"you","start":1182.11,"end":1182.23},{"text":"for","start":1182.23,"end":1182.43},{"text":"the","start":1182.43,"end":1182.55},{"text":"opportunity","start":1182.55,"end":1183.31},{"text":"to","start":1183.47,"end":1183.59},{"text":"speak","start":1183.63,"end":1183.95},{"text":"to","start":1183.95,"end":1184.07},{"text":"this","start":1184.07,"end":1184.35},{"text":"topic","start":1184.35,"end":1184.75},{"text":"today.","start":1185.07,"end":1185.55}]}]}],"speaker":{"affiliation":"GCDP","group":null,"function":null,"affiliation_full":"GCDP"}},{"statement_number":5,"start":1189.63,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=19:50","paragraphs":[{"sentences":[{"text":"Wonderful.","start":1189.63,"end":1190.27,"topics":[],"words":[{"text":"Wonderful.","start":1189.63,"end":1190.27}]},{"text":"And we'll convey your appreciation to Helen for the video statement.","start":1190.35,"end":1200.91,"topics":[],"words":[{"text":"And","start":1190.35,"end":1190.55},{"text":"we'll","start":1190.59,"end":1190.99},{"text":"convey","start":1195.39,"end":1195.87},{"text":"your","start":1195.87,"end":1196.15},{"text":"appreciation","start":1196.15,"end":1196.99},{"text":"to","start":1196.99,"end":1197.47},{"text":"Helen","start":1198.27,"end":1198.75},{"text":"for","start":1198.75,"end":1199.31},{"text":"the","start":1199.71,"end":1199.91},{"text":"video","start":1199.91,"end":1200.27},{"text":"statement.","start":1200.27,"end":1200.91}]},{"text":"We'd now like to begin the panel discussion moderated by the ambassador, followed by inputs from the floor from member states and UN partners.","start":1201.39,"end":1209.31,"topics":[],"words":[{"text":"We'd","start":1201.39,"end":1201.71},{"text":"now","start":1201.71,"end":1201.79},{"text":"like","start":1201.79,"end":1202.03},{"text":"to","start":1202.03,"end":1202.15},{"text":"begin","start":1202.15,"end":1202.59},{"text":"the","start":1202.59,"end":1202.75},{"text":"panel","start":1202.75,"end":1203.03},{"text":"discussion","start":1203.03,"end":1203.63},{"text":"moderated","start":1203.63,"end":1204.19},{"text":"by","start":1204.19,"end":1204.35},{"text":"the","start":1204.39,"end":1204.47},{"text":"ambassador,","start":1204.99,"end":1205.63},{"text":"followed","start":1205.63,"end":1205.95},{"text":"by","start":1205.95,"end":1206.27},{"text":"inputs","start":1206.27,"end":1206.75},{"text":"from","start":1206.75,"end":1207.15},{"text":"the","start":1207.15,"end":1207.27},{"text":"floor","start":1207.27,"end":1207.63},{"text":"from","start":1207.63,"end":1207.83},{"text":"member","start":1207.83,"end":1208.07},{"text":"states","start":1208.07,"end":1208.43},{"text":"and","start":1208.43,"end":1208.55},{"text":"UN","start":1208.55,"end":1208.75},{"text":"partners.","start":1208.75,"end":1209.31}]},{"text":"And then we'll close with a few reflections going forward.","start":1209.63,"end":1212.51,"topics":[],"words":[{"text":"And","start":1209.63,"end":1209.87},{"text":"then","start":1209.87,"end":1209.99},{"text":"we'll","start":1209.99,"end":1210.23},{"text":"close","start":1210.23,"end":1210.51},{"text":"with","start":1210.51,"end":1210.71},{"text":"a","start":1210.71,"end":1210.75},{"text":"few","start":1210.75,"end":1211.07},{"text":"reflections","start":1211.07,"end":1211.79},{"text":"going","start":1211.79,"end":1212.03},{"text":"forward.","start":1212.03,"end":1212.51}]},{"text":"Ambassador, over to you.","start":1213.23,"end":1214.43,"topics":[],"words":[{"text":"Ambassador,","start":1213.23,"end":1213.79},{"text":"over","start":1213.95,"end":1214.19},{"text":"to","start":1214.19,"end":1214.31},{"text":"you.","start":1214.31,"end":1214.43}]}]}],"speaker":{"affiliation":"UNDP","group":null,"function":null,"affiliation_full":"UNDP"}},{"statement_number":6,"start":1219.15,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=20:20","paragraphs":[{"sentences":[{"text":"Thank you.","start":1219.15,"end":1219.63,"topics":[],"words":[{"text":"Thank","start":1219.15,"end":1219.39},{"text":"you.","start":1219.39,"end":1219.63}]},{"text":"Thank you very much.","start":1219.79,"end":1220.99,"topics":[],"words":[{"text":"Thank","start":1219.79,"end":1220.07},{"text":"you","start":1220.07,"end":1220.15},{"text":"very","start":1220.15,"end":1220.51},{"text":"much.","start":1220.51,"end":1220.99}]},{"text":"Mandeep, and we're going to open the session.","start":1222.15,"end":1226.15,"topics":[],"words":[{"text":"Mandeep,","start":1222.15,"end":1222.71},{"text":"and","start":1223.11,"end":1223.59},{"text":"we're","start":1224.07,"end":1224.39},{"text":"going","start":1224.39,"end":1224.71},{"text":"to","start":1224.71,"end":1225.07},{"text":"open","start":1225.07,"end":1225.35},{"text":"the","start":1225.35,"end":1225.51},{"text":"session.","start":1225.51,"end":1226.15}]},{"text":"We turn to our panel discussion.","start":1227.11,"end":1229.19,"topics":[],"words":[{"text":"We","start":1227.11,"end":1227.35},{"text":"turn","start":1227.35,"end":1227.67},{"text":"to","start":1227.67,"end":1227.79},{"text":"our","start":1227.79,"end":1228.07},{"text":"panel","start":1228.07,"end":1228.47},{"text":"discussion.","start":1228.47,"end":1229.19}]},{"text":"Each speaker will provide a brief narrative reflection on how their country or organization is advancing rights-based, evidence-informed drug policy and harm reduction.","start":1229.51,"end":1242.23,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"Each","start":1229.51,"end":1229.83},{"text":"speaker","start":1229.83,"end":1230.47},{"text":"will","start":1230.47,"end":1230.67},{"text":"provide","start":1230.67,"end":1231.27},{"text":"a","start":1231.27,"end":1231.35},{"text":"brief","start":1231.35,"end":1231.99},{"text":"narrative","start":1231.99,"end":1232.55},{"text":"reflection","start":1232.55,"end":1233.35},{"text":"on","start":1233.59,"end":1233.75},{"text":"how","start":1233.75,"end":1234.07},{"text":"their","start":1234.07,"end":1234.23},{"text":"country","start":1234.23,"end":1235.03},{"text":"or","start":1235.03,"end":1235.15},{"text":"organization","start":1235.15,"end":1236.31},{"text":"is","start":1236.55,"end":1236.79},{"text":"advancing","start":1236.79,"end":1237.59},{"text":"rights-based,","start":1237.59,"end":1238.67},{"text":"evidence-informed","start":1239.03,"end":1240.19},{"text":"drug","start":1240.19,"end":1240.39},{"text":"policy","start":1240.39,"end":1241.03},{"text":"and","start":1241.03,"end":1241.19},{"text":"harm","start":1241.19,"end":1241.59},{"text":"reduction.","start":1241.59,"end":1242.23}]},{"text":"So I will introduce each speaker with their title and the topic they will be addressing today.","start":1242.55,"end":1248.15,"topics":[],"words":[{"text":"So","start":1242.55,"end":1242.95},{"text":"I","start":1242.95,"end":1243.11},{"text":"will","start":1243.11,"end":1243.27},{"text":"introduce","start":1243.27,"end":1243.91},{"text":"each","start":1243.91,"end":1244.07},{"text":"speaker","start":1244.07,"end":1244.63},{"text":"with","start":1244.63,"end":1244.87},{"text":"their","start":1244.87,"end":1245.03},{"text":"title","start":1245.03,"end":1245.67},{"text":"and","start":1245.67,"end":1245.87},{"text":"the","start":1245.87,"end":1245.95},{"text":"topic","start":1245.95,"end":1246.55},{"text":"they","start":1246.55,"end":1246.79},{"text":"will","start":1246.79,"end":1246.95},{"text":"be","start":1246.95,"end":1247.19},{"text":"addressing","start":1247.19,"end":1247.75},{"text":"today.","start":1247.75,"end":1248.15}]},{"text":"So our first speaker is Jindrich Bohusl, who is advisor to the Prime Minister in the Czech Republic.","start":1248.87,"end":1258.67,"topics":[],"words":[{"text":"So","start":1248.87,"end":1249.15},{"text":"our","start":1249.15,"end":1249.43},{"text":"first","start":1249.43,"end":1249.75},{"text":"speaker","start":1249.75,"end":1250.39},{"text":"is","start":1250.39,"end":1250.79},{"text":"Jindrich","start":1250.87,"end":1251.47},{"text":"Bohusl,","start":1253.31,"end":1254.43},{"text":"who","start":1254.91,"end":1255.07},{"text":"is","start":1255.07,"end":1255.31},{"text":"advisor","start":1255.31,"end":1255.95},{"text":"to","start":1255.95,"end":1256.03},{"text":"the","start":1256.03,"end":1256.19},{"text":"Prime","start":1256.19,"end":1256.47},{"text":"Minister","start":1256.47,"end":1257.23},{"text":"in","start":1257.31,"end":1257.51},{"text":"the","start":1257.51,"end":1257.63},{"text":"Czech","start":1257.63,"end":1257.95},{"text":"Republic.","start":1257.95,"end":1258.67}]},{"text":"He will be speaking to us about the role of harm reduction and decriminalization in Czech drug policy.","start":1258.91,"end":1266.03,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"He","start":1258.91,"end":1259.11},{"text":"will","start":1259.11,"end":1259.31},{"text":"be","start":1259.31,"end":1259.47},{"text":"speaking","start":1259.47,"end":1259.95},{"text":"to","start":1259.95,"end":1260.19},{"text":"us","start":1260.19,"end":1260.51},{"text":"about","start":1260.51,"end":1260.79},{"text":"the","start":1260.79,"end":1260.87},{"text":"role","start":1260.87,"end":1261.43},{"text":"of","start":1261.43,"end":1261.59},{"text":"harm","start":1261.59,"end":1261.87},{"text":"reduction","start":1261.87,"end":1262.67},{"text":"and","start":1262.91,"end":1263.19},{"text":"decriminalization","start":1263.19,"end":1264.59},{"text":"in","start":1264.59,"end":1264.75},{"text":"Czech","start":1264.75,"end":1265.07},{"text":"drug","start":1265.07,"end":1265.31},{"text":"policy.","start":1265.31,"end":1266.03}]},{"text":"Please take us away.","start":1266.43,"end":1268.99,"topics":[],"words":[{"text":"Please","start":1266.43,"end":1267.07},{"text":"take","start":1267.39,"end":1267.87},{"text":"us","start":1268.19,"end":1268.43},{"text":"away.","start":1268.51,"end":1268.99}]},{"text":"I understand that Mr. Jindrich has not arrived, so we will go directly into Mr. Reubi.","start":1272.19,"end":1281.39,"topics":[],"words":[{"text":"I","start":1272.19,"end":1272.35},{"text":"understand","start":1272.35,"end":1272.99},{"text":"that","start":1272.99,"end":1273.39},{"text":"Mr.","start":1273.39,"end":1273.71},{"text":"Jindrich","start":1273.71,"end":1274.43},{"text":"has","start":1274.43,"end":1274.67},{"text":"not","start":1274.67,"end":1274.91},{"text":"arrived,","start":1274.91,"end":1275.51},{"text":"so","start":1275.87,"end":1276.43},{"text":"we","start":1276.43,"end":1276.63},{"text":"will","start":1276.63,"end":1276.75},{"text":"go","start":1276.75,"end":1277.07},{"text":"directly","start":1277.07,"end":1278.11},{"text":"into","start":1278.59,"end":1279.07},{"text":"Mr.","start":1279.95,"end":1280.59},{"text":"Reubi.","start":1280.75,"end":1281.39}]},{"text":"Thank you very much for being here.","start":1283.11,"end":1286.15,"topics":[],"words":[{"text":"Thank","start":1283.11,"end":1283.35},{"text":"you","start":1283.35,"end":1283.43},{"text":"very","start":1283.43,"end":1283.67},{"text":"much","start":1283.67,"end":1284.31},{"text":"for","start":1285.03,"end":1285.31},{"text":"being","start":1285.31,"end":1285.51},{"text":"here.","start":1285.51,"end":1286.15}]},{"text":"You are our second panel speaker, but now you have become number one.","start":1287.35,"end":1291.35,"topics":[],"words":[{"text":"You","start":1287.35,"end":1287.67},{"text":"are","start":1287.67,"end":1288.23},{"text":"our","start":1288.23,"end":1288.31},{"text":"second","start":1288.31,"end":1288.71},{"text":"panel","start":1288.71,"end":1289.03},{"text":"speaker,","start":1289.03,"end":1289.51},{"text":"but","start":1289.51,"end":1289.71},{"text":"now","start":1289.71,"end":1289.91},{"text":"you","start":1289.99,"end":1290.11},{"text":"have","start":1290.11,"end":1290.27},{"text":"become","start":1290.27,"end":1290.63},{"text":"number","start":1290.63,"end":1290.95},{"text":"one.","start":1290.95,"end":1291.35}]},{"text":"He comes from Switzerland, who will be telling us about Switzerland's harm reduction model and also about their multilateral engagement around this important concept.","start":1291.51,"end":1302.31,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"He","start":1291.51,"end":1291.67},{"text":"comes","start":1291.67,"end":1292.03},{"text":"from","start":1292.03,"end":1292.23},{"text":"Switzerland,","start":1292.23,"end":1293.19},{"text":"who","start":1293.59,"end":1293.83},{"text":"will","start":1293.83,"end":1293.99},{"text":"be","start":1293.99,"end":1294.23},{"text":"telling","start":1294.47,"end":1295.03},{"text":"us","start":1295.03,"end":1295.27},{"text":"about","start":1295.27,"end":1295.55},{"text":"Switzerland's","start":1295.59,"end":1296.39},{"text":"harm","start":1296.39,"end":1296.71},{"text":"reduction","start":1296.71,"end":1297.27},{"text":"model","start":1297.27,"end":1297.83},{"text":"and","start":1298.07,"end":1298.31},{"text":"also","start":1298.31,"end":1298.63},{"text":"about","start":1298.63,"end":1298.91},{"text":"their","start":1298.91,"end":1299.11},{"text":"multilateral","start":1299.11,"end":1299.91},{"text":"engagement","start":1299.91,"end":1300.71},{"text":"around","start":1300.71,"end":1301.15},{"text":"this","start":1301.15,"end":1301.27},{"text":"important","start":1301.27,"end":1301.83},{"text":"concept.","start":1301.83,"end":1302.31}]},{"text":"Please, Mr. Secretary, you have the floor.","start":1302.63,"end":1304.55,"topics":[],"words":[{"text":"Please,","start":1302.63,"end":1302.87},{"text":"Mr.","start":1302.87,"end":1303.23},{"text":"Secretary,","start":1303.23,"end":1303.75},{"text":"you","start":1303.75,"end":1303.91},{"text":"have","start":1303.91,"end":1304.07},{"text":"the","start":1304.07,"end":1304.19},{"text":"floor.","start":1304.19,"end":1304.55}]}]}],"speaker":{"affiliation":"MEX","group":null,"function":"Deputy Permanent Representative","affiliation_full":"Mexico"}},{"statement_number":7,"start":1307.23,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=21:48","paragraphs":[{"sentences":[{"text":"Thank you very much, Mrs. Ambassador Maciel, and thank you for leading this discussion and leading also this topic on behalf of Mexico.","start":1307.23,"end":1317.39,"topics":[],"words":[{"text":"Thank","start":1307.23,"end":1307.47},{"text":"you","start":1307.47,"end":1307.55},{"text":"very","start":1307.55,"end":1307.79},{"text":"much,","start":1307.79,"end":1308.03},{"text":"Mrs.","start":1308.03,"end":1308.39},{"text":"Ambassador","start":1308.39,"end":1308.91},{"text":"Maciel,","start":1308.91,"end":1309.31},{"text":"and","start":1309.31,"end":1309.47},{"text":"thank","start":1309.47,"end":1309.71},{"text":"you","start":1309.71,"end":1309.79},{"text":"for","start":1309.79,"end":1310.19},{"text":"leading","start":1310.59,"end":1310.99},{"text":"this","start":1310.99,"end":1311.23},{"text":"discussion","start":1311.23,"end":1311.91},{"text":"and","start":1311.91,"end":1312.11},{"text":"leading","start":1312.11,"end":1312.51},{"text":"also","start":1312.51,"end":1312.91},{"text":"this","start":1313.27,"end":1313.47},{"text":"topic","start":1313.47,"end":1314.03},{"text":"on","start":1315.27,"end":1315.39},{"text":"behalf","start":1315.39,"end":1315.95},{"text":"of","start":1316.55,"end":1316.67},{"text":"Mexico.","start":1316.67,"end":1317.39}]},{"text":"I'm very grateful to be part of this panel and to be able to share some Swiss national experience with respect to development of harm reduction, as well as to flash some lights on our agenda on this topic within the United Nations.","start":1317.63,"end":1333.55,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"I'm","start":1317.63,"end":1317.83},{"text":"very","start":1317.83,"end":1318.07},{"text":"grateful","start":1318.07,"end":1318.67},{"text":"to","start":1318.67,"end":1318.75},{"text":"be","start":1318.75,"end":1318.91},{"text":"part","start":1318.91,"end":1319.23},{"text":"of","start":1319.23,"end":1319.35},{"text":"this","start":1319.35,"end":1319.55},{"text":"panel","start":1319.55,"end":1320.11},{"text":"and","start":1320.19,"end":1320.35},{"text":"to","start":1320.35,"end":1320.43},{"text":"be","start":1320.43,"end":1320.59},{"text":"able","start":1320.59,"end":1320.91},{"text":"to","start":1320.91,"end":1320.99},{"text":"share","start":1320.99,"end":1321.55},{"text":"some","start":1322.19,"end":1322.59},{"text":"Swiss","start":1322.59,"end":1322.99},{"text":"national","start":1322.99,"end":1323.47},{"text":"experience","start":1323.47,"end":1324.35},{"text":"with","start":1324.35,"end":1324.51},{"text":"respect","start":1324.51,"end":1325.11},{"text":"to","start":1325.11,"end":1325.19},{"text":"development","start":1325.19,"end":1325.83},{"text":"of","start":1325.83,"end":1325.95},{"text":"harm","start":1325.95,"end":1326.27},{"text":"reduction,","start":1326.27,"end":1326.91},{"text":"as","start":1327.39,"end":1327.55},{"text":"well","start":1327.55,"end":1327.87},{"text":"as","start":1327.87,"end":1328.03},{"text":"to","start":1328.03,"end":1328.15},{"text":"flash","start":1328.15,"end":1328.51},{"text":"some","start":1328.51,"end":1328.75},{"text":"lights","start":1328.75,"end":1329.23},{"text":"on","start":1329.23,"end":1329.47},{"text":"our","start":1329.47,"end":1329.71},{"text":"agenda","start":1329.95,"end":1330.47},{"text":"on","start":1330.47,"end":1330.59},{"text":"this","start":1330.59,"end":1330.79},{"text":"topic","start":1330.79,"end":1331.87},{"text":"within","start":1331.87,"end":1332.35},{"text":"the","start":1332.35,"end":1332.47},{"text":"United","start":1332.51,"end":1332.99},{"text":"Nations.","start":1332.99,"end":1333.55}]},{"text":"I think it's fair to say that Switzerland has played a pioneer in the development of harm reduction.","start":1333.87,"end":1339.07,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"I","start":1333.87,"end":1334.03},{"text":"think","start":1334.03,"end":1334.31},{"text":"it's","start":1334.31,"end":1334.55},{"text":"fair","start":1334.55,"end":1334.75},{"text":"to","start":1334.75,"end":1334.87},{"text":"say","start":1334.87,"end":1335.15},{"text":"that","start":1335.15,"end":1335.31},{"text":"Switzerland","start":1335.31,"end":1335.83},{"text":"has","start":1335.83,"end":1335.95},{"text":"played","start":1335.95,"end":1336.35},{"text":"a","start":1336.35,"end":1336.43},{"text":"pioneer","start":1336.43,"end":1337.11},{"text":"in","start":1337.19,"end":1337.31},{"text":"the","start":1337.31,"end":1337.39},{"text":"development","start":1337.39,"end":1338.03},{"text":"of","start":1338.03,"end":1338.15},{"text":"harm","start":1338.15,"end":1338.43},{"text":"reduction.","start":1338.43,"end":1339.07}]},{"text":"In the '80s and '90s of the last century, we faced a catastrophic heroin and AIDS epidemic.","start":1340.59,"end":1348.75,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"In","start":1340.59,"end":1340.75},{"text":"the","start":1340.79,"end":1340.87},{"text":"'80s","start":1340.99,"end":1341.75},{"text":"and","start":1341.75,"end":1341.99},{"text":"'90s","start":1341.99,"end":1342.91},{"text":"of","start":1343.43,"end":1343.59},{"text":"the","start":1343.59,"end":1343.71},{"text":"last","start":1343.71,"end":1343.99},{"text":"century,","start":1343.99,"end":1344.51},{"text":"we","start":1344.51,"end":1344.67},{"text":"faced","start":1344.67,"end":1345.15},{"text":"a","start":1345.15,"end":1345.23},{"text":"catastrophic","start":1345.23,"end":1346.27},{"text":"heroin","start":1346.27,"end":1346.91},{"text":"and","start":1347.31,"end":1347.55},{"text":"AIDS","start":1347.55,"end":1347.95},{"text":"epidemic.","start":1347.95,"end":1348.75}]},{"text":"This forced us to question what we had taken for granted so far, as we realized that a society free of drug was maybe a myth that was causing more harm than good.","start":1348.75,"end":1362.67,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"This","start":1348.75,"end":1348.99},{"text":"forced","start":1348.99,"end":1349.39},{"text":"us","start":1349.39,"end":1349.63},{"text":"to","start":1349.63,"end":1349.71},{"text":"question","start":1349.71,"end":1350.35},{"text":"what","start":1350.71,"end":1351.07},{"text":"we","start":1351.07,"end":1351.23},{"text":"had","start":1351.23,"end":1351.35},{"text":"taken","start":1351.35,"end":1351.87},{"text":"for","start":1351.87,"end":1352.03},{"text":"granted","start":1352.03,"end":1352.55},{"text":"so","start":1352.55,"end":1352.75},{"text":"far,","start":1352.75,"end":1353.31},{"text":"as","start":1353.63,"end":1353.87},{"text":"we","start":1353.87,"end":1354.11},{"text":"realized","start":1354.11,"end":1354.75},{"text":"that","start":1354.75,"end":1354.99},{"text":"a","start":1355.07,"end":1355.15},{"text":"society","start":1355.15,"end":1356.11},{"text":"free","start":1356.11,"end":1356.75},{"text":"of","start":1357.35,"end":1357.63},{"text":"drug","start":1357.79,"end":1358.23},{"text":"was","start":1358.51,"end":1358.91},{"text":"maybe","start":1358.91,"end":1359.31},{"text":"a","start":1359.31,"end":1359.39},{"text":"myth","start":1359.39,"end":1359.71},{"text":"that","start":1360.11,"end":1360.35},{"text":"was","start":1360.35,"end":1360.59},{"text":"causing","start":1360.59,"end":1361.07},{"text":"more","start":1361.07,"end":1361.31},{"text":"harm","start":1361.31,"end":1361.79},{"text":"than","start":1361.95,"end":1362.19},{"text":"good.","start":1362.19,"end":1362.67}]},{"text":"This crisis has led to numerous new initiatives from grassroots associations, social workers, and medical professionals.","start":1363.39,"end":1373.07,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"This","start":1363.39,"end":1363.51},{"text":"crisis","start":1363.51,"end":1364.19},{"text":"has","start":1364.19,"end":1364.51},{"text":"led","start":1364.51,"end":1364.79},{"text":"to","start":1364.79,"end":1364.99},{"text":"numerous","start":1364.99,"end":1365.55},{"text":"new","start":1365.55,"end":1365.71},{"text":"initiatives","start":1365.71,"end":1366.51},{"text":"from","start":1366.51,"end":1366.71},{"text":"grassroots","start":1366.71,"end":1367.39},{"text":"associations,","start":1367.39,"end":1368.67},{"text":"social","start":1369.07,"end":1369.63},{"text":"workers,","start":1369.63,"end":1370.35},{"text":"and","start":1370.43,"end":1370.59},{"text":"medical","start":1370.59,"end":1371.75},{"text":"professionals.","start":1372.23,"end":1373.07}]},{"text":"This all made it possible that in 1986, we had the opening of the world's first drug consumption room in my hometown in Bern.","start":1374.19,"end":1387.99,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"This","start":1374.19,"end":1374.39},{"text":"all","start":1374.39,"end":1374.59},{"text":"made","start":1374.59,"end":1374.75},{"text":"it","start":1374.75,"end":1374.91},{"text":"possible","start":1374.91,"end":1375.51},{"text":"that","start":1375.51,"end":1375.95},{"text":"in","start":1376.11,"end":1376.43},{"text":"1986,","start":1376.99,"end":1378.83},{"text":"we","start":1379.95,"end":1380.19},{"text":"had","start":1380.19,"end":1380.75},{"text":"the","start":1380.87,"end":1380.95},{"text":"opening","start":1381.07,"end":1381.87},{"text":"of","start":1382.19,"end":1382.43},{"text":"the","start":1382.43,"end":1382.51},{"text":"world's","start":1382.51,"end":1383.19},{"text":"first","start":1383.23,"end":1383.95},{"text":"drug","start":1384.11,"end":1384.35},{"text":"consumption","start":1384.35,"end":1385.23},{"text":"room","start":1385.23,"end":1385.63},{"text":"in","start":1386.23,"end":1386.47},{"text":"my","start":1386.47,"end":1386.63},{"text":"hometown","start":1386.63,"end":1387.27},{"text":"in","start":1387.27,"end":1387.43},{"text":"Bern.","start":1387.43,"end":1387.99}]},{"text":"I remember I was 13 years old, and this made the news in Switzerland, but also internationally.","start":1388.31,"end":1394.95,"topics":[],"words":[{"text":"I","start":1388.31,"end":1388.39},{"text":"remember","start":1388.39,"end":1388.87},{"text":"I","start":1388.87,"end":1388.95},{"text":"was","start":1388.95,"end":1389.19},{"text":"13","start":1389.19,"end":1389.59},{"text":"years","start":1389.59,"end":1389.91},{"text":"old,","start":1389.91,"end":1390.23},{"text":"and","start":1390.23,"end":1390.83},{"text":"this","start":1390.83,"end":1391.03},{"text":"made","start":1391.03,"end":1391.39},{"text":"the","start":1391.39,"end":1391.47},{"text":"news","start":1391.47,"end":1391.83},{"text":"in","start":1391.83,"end":1391.95},{"text":"Switzerland,","start":1391.95,"end":1392.55},{"text":"but","start":1392.71,"end":1392.91},{"text":"also","start":1392.91,"end":1393.43},{"text":"internationally.","start":1393.83,"end":1394.95}]},{"text":"Big debates whether this was a good idea, or at least it was a big change to the policy that we had made so far.","start":1395.35,"end":1406.07,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Big","start":1395.35,"end":1395.63},{"text":"debates","start":1395.63,"end":1396.39},{"text":"whether","start":1396.39,"end":1396.79},{"text":"this","start":1396.79,"end":1397.03},{"text":"was","start":1397.03,"end":1397.43},{"text":"a","start":1397.59,"end":1397.63},{"text":"good","start":1397.63,"end":1397.91},{"text":"idea,","start":1397.91,"end":1398.47},{"text":"or","start":1398.95,"end":1399.43},{"text":"at","start":1400.31,"end":1400.55},{"text":"least","start":1400.55,"end":1400.83},{"text":"it","start":1400.83,"end":1400.95},{"text":"was","start":1400.95,"end":1401.27},{"text":"a","start":1401.27,"end":1401.35},{"text":"big","start":1401.91,"end":1402.23},{"text":"change","start":1402.23,"end":1402.71},{"text":"to","start":1402.71,"end":1402.83},{"text":"the","start":1402.83,"end":1402.95},{"text":"policy","start":1402.95,"end":1403.51},{"text":"that","start":1403.51,"end":1403.75},{"text":"we","start":1404.23,"end":1404.47},{"text":"had","start":1404.63,"end":1404.87},{"text":"made","start":1404.87,"end":1405.11},{"text":"so","start":1405.27,"end":1405.59},{"text":"far.","start":1405.59,"end":1406.07}]},{"text":"Multiple other programs followed, such as heroin-assisted treatment, drug checking, as well as syringes and needles exchanges.","start":1406.47,"end":1416.67,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"Multiple","start":1406.47,"end":1407.07},{"text":"other","start":1407.07,"end":1407.27},{"text":"programs","start":1407.27,"end":1408.23},{"text":"followed,","start":1408.31,"end":1408.87},{"text":"such","start":1408.87,"end":1409.19},{"text":"as","start":1409.19,"end":1409.43},{"text":"heroin-assisted","start":1409.67,"end":1410.99},{"text":"treatment,","start":1410.99,"end":1411.83},{"text":"drug","start":1412.23,"end":1412.55},{"text":"checking,","start":1412.55,"end":1413.15},{"text":"as","start":1413.15,"end":1413.27},{"text":"well","start":1413.27,"end":1413.55},{"text":"as","start":1413.55,"end":1413.83},{"text":"syringes","start":1414.35,"end":1415.03},{"text":"and","start":1415.03,"end":1415.15},{"text":"needles","start":1415.15,"end":1415.71},{"text":"exchanges.","start":1415.71,"end":1416.67}]},{"text":"These programs were very successful as we saw a massive decrease in the number of new heroin users, the number of drug-related deaths decreased, and the number of HIV infections as well.","start":1417.23,"end":1431.07,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"These","start":1417.23,"end":1417.47},{"text":"programs","start":1417.47,"end":1418.03},{"text":"were","start":1418.03,"end":1418.27},{"text":"very","start":1418.27,"end":1418.51},{"text":"successful","start":1418.51,"end":1419.27},{"text":"as","start":1419.27,"end":1419.39},{"text":"we","start":1419.39,"end":1419.55},{"text":"saw","start":1419.55,"end":1419.83},{"text":"a","start":1419.83,"end":1419.87},{"text":"massive","start":1419.87,"end":1420.43},{"text":"decrease","start":1420.43,"end":1421.07},{"text":"in","start":1421.39,"end":1421.59},{"text":"the","start":1421.59,"end":1421.71},{"text":"number","start":1421.71,"end":1422.11},{"text":"of","start":1422.11,"end":1422.27},{"text":"new","start":1422.27,"end":1422.59},{"text":"heroin","start":1422.59,"end":1423.15},{"text":"users,","start":1423.15,"end":1423.79},{"text":"the","start":1424.31,"end":1424.39},{"text":"number","start":1424.39,"end":1424.75},{"text":"of","start":1424.75,"end":1424.99},{"text":"drug-related","start":1425.07,"end":1425.99},{"text":"deaths","start":1425.99,"end":1426.43},{"text":"decreased,","start":1426.51,"end":1427.31},{"text":"and","start":1427.79,"end":1427.95},{"text":"the","start":1427.95,"end":1428.03},{"text":"number","start":1428.03,"end":1428.39},{"text":"of","start":1428.39,"end":1428.59},{"text":"HIV","start":1428.75,"end":1429.63},{"text":"infections","start":1429.71,"end":1430.59},{"text":"as","start":1430.59,"end":1430.67},{"text":"well.","start":1430.67,"end":1431.07}]},{"text":"As an example, a study has shown that In the period between 1980 and 2015, the introduction of harm reduction programs prevented some 16,000 HIV infections, some 5,500 AIDS deaths, and a peak HIV prevalence of 15.7 percent among injected drug users.","start":1431.47,"end":1457.11,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"As","start":1431.47,"end":1431.67},{"text":"an","start":1431.67,"end":1431.79},{"text":"example,","start":1431.79,"end":1432.43},{"text":"a","start":1432.43,"end":1432.51},{"text":"study","start":1432.51,"end":1432.99},{"text":"has","start":1432.99,"end":1433.15},{"text":"shown","start":1433.15,"end":1433.47},{"text":"that","start":1433.47,"end":1433.79},{"text":"In","start":1434.39,"end":1434.47},{"text":"the","start":1434.47,"end":1434.55},{"text":"period","start":1434.55,"end":1435.07},{"text":"between","start":1435.07,"end":1435.35},{"text":"1980","start":1435.35,"end":1436.35},{"text":"and","start":1436.35,"end":1436.51},{"text":"2015,","start":1436.51,"end":1437.99},{"text":"the","start":1438.31,"end":1438.39},{"text":"introduction","start":1438.39,"end":1439.27},{"text":"of","start":1439.35,"end":1439.75},{"text":"harm","start":1439.83,"end":1440.15},{"text":"reduction","start":1440.15,"end":1440.63},{"text":"programs","start":1440.63,"end":1441.27},{"text":"prevented","start":1441.27,"end":1442.07},{"text":"some","start":1442.07,"end":1442.55},{"text":"16,000","start":1442.63,"end":1443.91},{"text":"HIV","start":1443.99,"end":1444.55},{"text":"infections,","start":1444.55,"end":1445.43},{"text":"some","start":1445.99,"end":1446.47},{"text":"5,500","start":1446.55,"end":1448.39},{"text":"AIDS","start":1448.47,"end":1448.95},{"text":"deaths,","start":1448.95,"end":1449.51},{"text":"and","start":1449.91,"end":1450.23},{"text":"a","start":1450.23,"end":1450.31},{"text":"peak","start":1450.31,"end":1450.79},{"text":"HIV","start":1450.79,"end":1451.75},{"text":"prevalence","start":1452.07,"end":1452.79},{"text":"of","start":1452.79,"end":1452.95},{"text":"15.7","start":1452.95,"end":1454.23},{"text":"percent","start":1454.79,"end":1455.35},{"text":"among","start":1455.35,"end":1455.67},{"text":"injected","start":1455.67,"end":1456.19},{"text":"drug","start":1456.19,"end":1456.47},{"text":"users.","start":1456.47,"end":1457.11}]},{"text":"This past experience of Switzerland, and I think we can be proud of it, should not make us think that there is nothing more to be done.","start":1457.79,"end":1465.15,"topics":[],"words":[{"text":"This","start":1457.79,"end":1457.95},{"text":"past","start":1457.95,"end":1458.27},{"text":"experience","start":1458.27,"end":1458.91},{"text":"of","start":1458.91,"end":1459.07},{"text":"Switzerland,","start":1459.07,"end":1459.79},{"text":"and","start":1459.87,"end":1460.11},{"text":"I","start":1460.11,"end":1460.19},{"text":"think","start":1460.19,"end":1460.39},{"text":"we","start":1460.39,"end":1460.51},{"text":"can","start":1460.51,"end":1460.75},{"text":"be","start":1460.75,"end":1460.91},{"text":"proud","start":1460.91,"end":1461.27},{"text":"of","start":1461.27,"end":1461.39},{"text":"it,","start":1461.39,"end":1461.63},{"text":"should","start":1462.03,"end":1462.23},{"text":"not","start":1462.23,"end":1462.51},{"text":"make","start":1462.51,"end":1462.75},{"text":"us","start":1462.75,"end":1462.99},{"text":"think","start":1462.99,"end":1463.23},{"text":"that","start":1463.23,"end":1463.39},{"text":"there","start":1463.39,"end":1463.63},{"text":"is","start":1463.63,"end":1463.79},{"text":"nothing","start":1463.79,"end":1464.19},{"text":"more","start":1464.19,"end":1464.43},{"text":"to","start":1464.43,"end":1464.59},{"text":"be","start":1464.59,"end":1464.75},{"text":"done.","start":1464.75,"end":1465.15}]},{"text":"While a broad range of harm reduction services are available today in Switzerland, we still face political resistance and backlash in this area.","start":1466.07,"end":1476.35,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"While","start":1466.07,"end":1466.43},{"text":"a","start":1466.43,"end":1466.47},{"text":"broad","start":1466.47,"end":1466.83},{"text":"range","start":1466.83,"end":1467.19},{"text":"of","start":1467.19,"end":1467.31},{"text":"harm","start":1467.31,"end":1467.63},{"text":"reduction","start":1467.63,"end":1468.19},{"text":"services","start":1468.19,"end":1468.83},{"text":"are","start":1468.83,"end":1468.95},{"text":"available","start":1468.95,"end":1469.47},{"text":"today","start":1469.47,"end":1469.75},{"text":"in","start":1469.75,"end":1469.87},{"text":"Switzerland,","start":1469.87,"end":1470.59},{"text":"we","start":1471.39,"end":1471.59},{"text":"still","start":1471.59,"end":1471.87},{"text":"face","start":1471.87,"end":1472.27},{"text":"political","start":1472.27,"end":1473.23},{"text":"resistance","start":1473.23,"end":1474.11},{"text":"and","start":1474.19,"end":1474.59},{"text":"backlash","start":1474.59,"end":1475.39},{"text":"in","start":1475.39,"end":1475.55},{"text":"this","start":1475.55,"end":1475.79},{"text":"area.","start":1475.79,"end":1476.35}]},{"text":"We also encounter difficulties in ensuring broad access to harm reduction services for our entire population.","start":1476.83,"end":1484.19,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"We","start":1476.83,"end":1477.07},{"text":"also","start":1477.07,"end":1477.47},{"text":"encounter","start":1477.47,"end":1478.03},{"text":"difficulties","start":1478.03,"end":1478.99},{"text":"in","start":1479.23,"end":1479.43},{"text":"ensuring","start":1479.43,"end":1480.03},{"text":"broad","start":1480.03,"end":1480.35},{"text":"access","start":1480.35,"end":1480.83},{"text":"to","start":1480.83,"end":1480.99},{"text":"harm","start":1480.99,"end":1481.27},{"text":"reduction","start":1481.27,"end":1481.79},{"text":"services","start":1481.79,"end":1482.51},{"text":"for","start":1482.51,"end":1482.75},{"text":"our","start":1482.75,"end":1482.83},{"text":"entire","start":1482.83,"end":1483.31},{"text":"population.","start":1483.31,"end":1484.19}]},{"text":"This applies specifically to people living outside of major urban centres, to minors and to people living in detention centres.","start":1484.67,"end":1495.15,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"This","start":1484.67,"end":1484.83},{"text":"applies","start":1484.83,"end":1485.27},{"text":"specifically","start":1485.27,"end":1486.67},{"text":"to","start":1486.67,"end":1486.99},{"text":"people","start":1487.07,"end":1487.63},{"text":"living","start":1487.95,"end":1488.43},{"text":"outside","start":1488.43,"end":1489.03},{"text":"of","start":1489.03,"end":1489.15},{"text":"major","start":1489.15,"end":1489.63},{"text":"urban","start":1489.63,"end":1489.95},{"text":"centres,","start":1489.95,"end":1490.59},{"text":"to","start":1490.91,"end":1491.07},{"text":"minors","start":1491.07,"end":1491.95},{"text":"and","start":1492.59,"end":1492.83},{"text":"to","start":1492.83,"end":1492.91},{"text":"people","start":1492.91,"end":1493.35},{"text":"living","start":1493.35,"end":1493.67},{"text":"in","start":1493.67,"end":1493.79},{"text":"detention","start":1493.79,"end":1494.43},{"text":"centres.","start":1494.43,"end":1495.15}]},{"text":"Switzerland is not the only country facing this challenge, as the issue of accessibility to harm reduction has been highlighted in the last report of the High Commissioner for Human Rights.","start":1495.55,"end":1507.79,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Switzerland","start":1495.55,"end":1496.19},{"text":"is","start":1496.19,"end":1496.27},{"text":"not","start":1496.27,"end":1496.63},{"text":"the","start":1496.63,"end":1496.71},{"text":"only","start":1496.71,"end":1496.99},{"text":"country","start":1496.99,"end":1497.47},{"text":"facing","start":1497.47,"end":1497.95},{"text":"this","start":1497.95,"end":1498.19},{"text":"challenge,","start":1498.19,"end":1498.75},{"text":"as","start":1499.23,"end":1499.47},{"text":"the","start":1499.47,"end":1499.59},{"text":"issue","start":1499.59,"end":1500.11},{"text":"of","start":1500.11,"end":1500.35},{"text":"accessibility","start":1500.91,"end":1501.95},{"text":"to","start":1501.95,"end":1502.11},{"text":"harm","start":1502.11,"end":1502.35},{"text":"reduction","start":1502.35,"end":1502.87},{"text":"has","start":1502.87,"end":1503.07},{"text":"been","start":1503.07,"end":1503.31},{"text":"highlighted","start":1503.31,"end":1504.03},{"text":"in","start":1504.35,"end":1504.51},{"text":"the","start":1504.51,"end":1504.59},{"text":"last","start":1504.59,"end":1504.99},{"text":"report","start":1504.99,"end":1505.55},{"text":"of","start":1505.55,"end":1505.67},{"text":"the","start":1505.67,"end":1505.75},{"text":"High","start":1505.75,"end":1505.95},{"text":"Commissioner","start":1505.95,"end":1506.67},{"text":"for","start":1506.67,"end":1506.91},{"text":"Human","start":1506.91,"end":1507.23},{"text":"Rights.","start":1507.23,"end":1507.79}]},{"text":"To such challenge, challenges, the importance of international drug policy should not to face such challenges.","start":1509.31,"end":1517.23,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"To","start":1509.31,"end":1509.47},{"text":"such","start":1509.47,"end":1509.91},{"text":"challenge,","start":1509.91,"end":1510.59},{"text":"challenges,","start":1511.23,"end":1511.71},{"text":"the","start":1511.79,"end":1511.91},{"text":"importance","start":1511.91,"end":1512.83},{"text":"of","start":1512.91,"end":1513.15},{"text":"international","start":1513.15,"end":1513.87},{"text":"drug","start":1513.87,"end":1514.11},{"text":"policy","start":1514.11,"end":1514.75},{"text":"should","start":1514.99,"end":1515.27},{"text":"not","start":1515.27,"end":1515.75},{"text":"to","start":1515.75,"end":1515.83},{"text":"face","start":1515.83,"end":1516.15},{"text":"such","start":1516.15,"end":1516.31},{"text":"challenges.","start":1516.35,"end":1517.23}]},{"text":"The importance of international drug policy should not be underestimated.","start":1517.23,"end":1521.07,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"The","start":1517.23,"end":1517.31},{"text":"importance","start":1517.31,"end":1518.11},{"text":"of","start":1518.11,"end":1518.27},{"text":"international","start":1518.27,"end":1518.87},{"text":"drug","start":1518.87,"end":1519.07},{"text":"policy","start":1519.07,"end":1519.47},{"text":"should","start":1519.47,"end":1519.63},{"text":"not","start":1519.63,"end":1519.87},{"text":"be","start":1519.87,"end":1520.03},{"text":"underestimated.","start":1520.03,"end":1521.07}]},{"text":"One example is the resolution on overdose prevention and response adopted in March 2024 in Vienna.","start":1521.63,"end":1529.07,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"One","start":1521.63,"end":1521.91},{"text":"example","start":1521.91,"end":1522.43},{"text":"is","start":1522.43,"end":1522.59},{"text":"the","start":1522.59,"end":1522.67},{"text":"resolution","start":1522.67,"end":1523.55},{"text":"on","start":1523.71,"end":1523.95},{"text":"overdose","start":1523.95,"end":1524.59},{"text":"prevention","start":1524.59,"end":1525.19},{"text":"and","start":1525.19,"end":1525.35},{"text":"response","start":1525.35,"end":1525.87},{"text":"adopted","start":1525.87,"end":1526.35},{"text":"in","start":1526.35,"end":1526.51},{"text":"March","start":1526.51,"end":1526.83},{"text":"2024","start":1526.83,"end":1528.11},{"text":"in","start":1528.35,"end":1528.51},{"text":"Vienna.","start":1528.51,"end":1529.07}]},{"text":"This resolution was a major success as it recognized for the very first time harm reduction measures in the context of the UN Commission on Narcotic Drugs, CND.","start":1529.31,"end":1540.19,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"This","start":1529.31,"end":1529.63},{"text":"resolution","start":1529.63,"end":1530.35},{"text":"was","start":1530.35,"end":1530.51},{"text":"a","start":1530.51,"end":1530.59},{"text":"major","start":1530.59,"end":1531.03},{"text":"success","start":1531.03,"end":1531.71},{"text":"as","start":1532.19,"end":1532.43},{"text":"it","start":1532.43,"end":1532.55},{"text":"recognized","start":1532.55,"end":1533.23},{"text":"for","start":1533.23,"end":1533.43},{"text":"the","start":1533.43,"end":1533.51},{"text":"very","start":1533.51,"end":1533.79},{"text":"first","start":1533.79,"end":1534.23},{"text":"time","start":1534.23,"end":1534.67},{"text":"harm","start":1534.67,"end":1535.07},{"text":"reduction","start":1535.07,"end":1535.55},{"text":"measures","start":1535.55,"end":1536.11},{"text":"in","start":1536.35,"end":1536.51},{"text":"the","start":1536.51,"end":1536.67},{"text":"context","start":1536.67,"end":1537.27},{"text":"of","start":1537.27,"end":1537.47},{"text":"the","start":1537.47,"end":1537.55},{"text":"UN","start":1537.55,"end":1537.79},{"text":"Commission","start":1537.79,"end":1538.35},{"text":"on","start":1538.35,"end":1538.43},{"text":"Narcotic","start":1538.43,"end":1539.19},{"text":"Drugs,","start":1539.19,"end":1539.55},{"text":"CND.","start":1539.55,"end":1540.19}]},{"text":"It might seem strange that after 40, 50 years of experience, this is the first time harm reduction was actually mentioned in a CND resolution.","start":1540.63,"end":1552.23,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"It","start":1540.63,"end":1540.71},{"text":"might","start":1540.71,"end":1540.99},{"text":"seem","start":1540.99,"end":1541.27},{"text":"strange","start":1541.27,"end":1541.83},{"text":"that","start":1541.83,"end":1542.07},{"text":"after","start":1542.07,"end":1542.55},{"text":"40,","start":1542.95,"end":1543.75},{"text":"50","start":1543.75,"end":1544.31},{"text":"years","start":1544.31,"end":1544.59},{"text":"of","start":1544.59,"end":1544.71},{"text":"experience,","start":1544.71,"end":1545.51},{"text":"this","start":1545.75,"end":1546.03},{"text":"is","start":1546.03,"end":1546.15},{"text":"the","start":1546.15,"end":1546.23},{"text":"first","start":1546.23,"end":1546.95},{"text":"time","start":1546.95,"end":1547.35},{"text":"harm","start":1548.31,"end":1548.59},{"text":"reduction","start":1548.59,"end":1549.19},{"text":"was","start":1549.19,"end":1549.35},{"text":"actually","start":1549.35,"end":1549.67},{"text":"mentioned","start":1549.67,"end":1550.15},{"text":"in","start":1550.15,"end":1550.31},{"text":"a","start":1550.31,"end":1550.35},{"text":"CND","start":1550.35,"end":1551.03},{"text":"resolution.","start":1551.19,"end":1552.23}]},{"text":"However, this recognition is crucial.","start":1552.23,"end":1555.99,"topics":[],"words":[{"text":"However,","start":1552.23,"end":1552.63},{"text":"this","start":1552.63,"end":1552.79},{"text":"recognition","start":1552.79,"end":1554.47},{"text":"is","start":1555.19,"end":1555.35},{"text":"crucial.","start":1555.35,"end":1555.99}]},{"text":"It should help us to tackle the challenges of tomorrow.","start":1555.99,"end":1560.55,"topics":[],"words":[{"text":"It","start":1555.99,"end":1556.11},{"text":"should","start":1556.11,"end":1556.31},{"text":"help","start":1556.31,"end":1556.63},{"text":"us","start":1556.63,"end":1556.95},{"text":"to","start":1557.35,"end":1557.59},{"text":"tackle","start":1557.75,"end":1558.31},{"text":"the","start":1558.31,"end":1558.39},{"text":"challenges","start":1558.39,"end":1559.27},{"text":"of","start":1559.27,"end":1559.59},{"text":"tomorrow.","start":1559.83,"end":1560.55}]},{"text":"It should help us at international level to increase our collaboration.","start":1560.87,"end":1566.47,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"It","start":1560.87,"end":1561.07},{"text":"should","start":1561.07,"end":1561.27},{"text":"help","start":1561.27,"end":1561.59},{"text":"us","start":1561.59,"end":1561.83},{"text":"at","start":1561.83,"end":1562.15},{"text":"international","start":1562.15,"end":1562.91},{"text":"level","start":1562.91,"end":1563.31},{"text":"to","start":1563.59,"end":1563.79},{"text":"increase","start":1563.79,"end":1564.55},{"text":"our","start":1565.27,"end":1565.43},{"text":"collaboration.","start":1565.43,"end":1566.47}]},{"text":"It should help us to resolve and encourage all countries to share their experience in national programs.","start":1566.71,"end":1575.43,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"It","start":1566.71,"end":1566.91},{"text":"should","start":1566.91,"end":1567.11},{"text":"help","start":1567.11,"end":1567.43},{"text":"us","start":1567.43,"end":1567.83},{"text":"to","start":1568.23,"end":1568.63},{"text":"resolve","start":1569.43,"end":1570.19},{"text":"and","start":1571.03,"end":1571.19},{"text":"encourage","start":1571.19,"end":1571.75},{"text":"all","start":1571.75,"end":1571.99},{"text":"countries","start":1571.99,"end":1572.47},{"text":"to","start":1572.47,"end":1572.63},{"text":"share","start":1572.63,"end":1572.99},{"text":"their","start":1572.99,"end":1573.19},{"text":"experience","start":1573.19,"end":1573.99},{"text":"in","start":1573.99,"end":1574.19},{"text":"national","start":1574.19,"end":1574.63},{"text":"programs.","start":1574.63,"end":1575.43}]},{"text":"On national level, this is a milestone and it should be inspire the state to integrate harm reduction in a national strategy.","start":1576.03,"end":1583.43,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"On","start":1576.03,"end":1576.19},{"text":"national","start":1576.19,"end":1576.67},{"text":"level,","start":1576.67,"end":1577.11},{"text":"this","start":1577.59,"end":1577.75},{"text":"is","start":1577.75,"end":1577.91},{"text":"a","start":1577.91,"end":1577.99},{"text":"milestone","start":1577.99,"end":1578.79},{"text":"and","start":1578.79,"end":1578.91},{"text":"it","start":1578.91,"end":1578.99},{"text":"should","start":1578.99,"end":1579.19},{"text":"be","start":1579.19,"end":1579.51},{"text":"inspire","start":1579.51,"end":1580.11},{"text":"the","start":1580.11,"end":1580.23},{"text":"state","start":1580.23,"end":1580.59},{"text":"to","start":1580.59,"end":1580.67},{"text":"integrate","start":1580.67,"end":1581.27},{"text":"harm","start":1581.27,"end":1581.51},{"text":"reduction","start":1581.51,"end":1582.07},{"text":"in","start":1582.07,"end":1582.15},{"text":"a","start":1582.15,"end":1582.19},{"text":"national","start":1582.19,"end":1582.71},{"text":"strategy.","start":1582.71,"end":1583.43}]},{"text":"However, policies should be designed to improve access to these services and ensure broad coverage, as I have mentioned, to their population.","start":1584.07,"end":1592.95,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"However,","start":1584.07,"end":1584.63},{"text":"policies","start":1584.63,"end":1585.19},{"text":"should","start":1585.19,"end":1585.39},{"text":"be","start":1585.39,"end":1585.51},{"text":"designed","start":1585.51,"end":1586.15},{"text":"to","start":1586.15,"end":1586.27},{"text":"improve","start":1586.27,"end":1586.71},{"text":"access","start":1586.71,"end":1587.19},{"text":"to","start":1587.19,"end":1587.35},{"text":"these","start":1587.35,"end":1587.59},{"text":"services","start":1587.59,"end":1588.31},{"text":"and","start":1588.55,"end":1588.75},{"text":"ensure","start":1588.75,"end":1589.35},{"text":"broad","start":1589.35,"end":1589.51},{"text":"coverage,","start":1589.51,"end":1590.07},{"text":"as","start":1590.07,"end":1590.31},{"text":"I","start":1590.31,"end":1590.39},{"text":"have","start":1590.39,"end":1590.55},{"text":"mentioned,","start":1590.55,"end":1591.11},{"text":"to","start":1591.11,"end":1591.35},{"text":"their","start":1591.35,"end":1591.75},{"text":"population.","start":1591.99,"end":1592.95}]},{"text":"Indeed, and very often, and this is a very strong link, I think, to the HLPF and to the SDGs, the civil society has been instrumental for pushing this initiative forward.","start":1593.87,"end":1609.39,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"Indeed,","start":1593.87,"end":1594.35},{"text":"and","start":1594.35,"end":1594.55},{"text":"very","start":1594.55,"end":1594.75},{"text":"often,","start":1594.75,"end":1595.15},{"text":"and","start":1595.15,"end":1595.27},{"text":"this","start":1595.27,"end":1595.39},{"text":"is","start":1595.39,"end":1595.55},{"text":"a","start":1595.55,"end":1595.63},{"text":"very","start":1595.63,"end":1595.87},{"text":"strong","start":1595.87,"end":1596.35},{"text":"link,","start":1596.35,"end":1596.75},{"text":"I","start":1596.75,"end":1596.83},{"text":"think,","start":1596.83,"end":1597.07},{"text":"to","start":1597.07,"end":1597.23},{"text":"the","start":1597.23,"end":1597.35},{"text":"HLPF","start":1597.35,"end":1598.23},{"text":"and","start":1598.23,"end":1598.39},{"text":"to","start":1598.39,"end":1598.51},{"text":"the","start":1598.51,"end":1598.59},{"text":"SDGs,","start":1598.59,"end":1599.47},{"text":"the","start":1601.55,"end":1601.71},{"text":"civil","start":1601.71,"end":1602.03},{"text":"society","start":1602.03,"end":1602.91},{"text":"has","start":1603.31,"end":1603.63},{"text":"been","start":1603.63,"end":1604.03},{"text":"instrumental","start":1604.27,"end":1605.39},{"text":"for","start":1605.79,"end":1606.35},{"text":"pushing","start":1607.47,"end":1607.91},{"text":"this","start":1607.91,"end":1608.11},{"text":"initiative","start":1608.11,"end":1608.71},{"text":"forward.","start":1608.71,"end":1609.39}]},{"text":"As a matter of fact, most of the innovation in this field of harm reduction is a result of the involvement of civil society and grassroots organizations.","start":1610.27,"end":1619.07,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"As","start":1610.27,"end":1610.51},{"text":"a","start":1610.51,"end":1610.55},{"text":"matter","start":1610.55,"end":1610.83},{"text":"of","start":1610.83,"end":1610.91},{"text":"fact,","start":1610.91,"end":1611.23},{"text":"most","start":1611.23,"end":1611.51},{"text":"of","start":1611.51,"end":1611.63},{"text":"the","start":1611.63,"end":1611.71},{"text":"innovation","start":1611.71,"end":1612.35},{"text":"in","start":1612.35,"end":1612.43},{"text":"this","start":1612.43,"end":1612.67},{"text":"field","start":1612.67,"end":1612.95},{"text":"of","start":1612.95,"end":1613.07},{"text":"harm","start":1613.07,"end":1613.27},{"text":"reduction","start":1613.27,"end":1613.87},{"text":"is","start":1614.03,"end":1614.23},{"text":"a","start":1614.23,"end":1614.27},{"text":"result","start":1614.27,"end":1614.87},{"text":"of","start":1614.87,"end":1614.99},{"text":"the","start":1614.99,"end":1615.11},{"text":"involvement","start":1615.11,"end":1615.79},{"text":"of","start":1615.79,"end":1615.95},{"text":"civil","start":1615.95,"end":1616.27},{"text":"society","start":1616.27,"end":1617.07},{"text":"and","start":1617.35,"end":1617.59},{"text":"grassroots","start":1617.59,"end":1618.11},{"text":"organizations.","start":1618.11,"end":1619.07}]},{"text":"These efforts may face, they face challenges, but they deserve our recognition and support.","start":1619.47,"end":1626.95,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"These","start":1619.47,"end":1619.71},{"text":"efforts","start":1619.71,"end":1620.23},{"text":"may","start":1620.35,"end":1620.59},{"text":"face,","start":1620.59,"end":1621.07},{"text":"they","start":1622.19,"end":1622.35},{"text":"face","start":1622.35,"end":1622.67},{"text":"challenges,","start":1622.67,"end":1623.47},{"text":"but","start":1623.99,"end":1624.19},{"text":"they","start":1624.19,"end":1624.39},{"text":"deserve","start":1624.47,"end":1625.11},{"text":"our","start":1625.19,"end":1625.39},{"text":"recognition","start":1625.39,"end":1626.15},{"text":"and","start":1626.15,"end":1626.35},{"text":"support.","start":1626.35,"end":1626.95}]},{"text":"While the world drug situation is very difficult, we can benefit from the current momentum, a momentum resulting from a public health crisis.","start":1627.47,"end":1635.99,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"While","start":1627.47,"end":1627.75},{"text":"the","start":1627.75,"end":1627.91},{"text":"world","start":1627.91,"end":1628.11},{"text":"drug","start":1628.11,"end":1628.35},{"text":"situation","start":1628.35,"end":1628.91},{"text":"is","start":1628.91,"end":1629.03},{"text":"very","start":1629.03,"end":1629.23},{"text":"difficult,","start":1629.23,"end":1629.99},{"text":"we","start":1630.31,"end":1630.51},{"text":"can","start":1630.51,"end":1630.71},{"text":"benefit","start":1630.71,"end":1631.35},{"text":"from","start":1631.35,"end":1631.59},{"text":"the","start":1631.59,"end":1631.67},{"text":"current","start":1631.67,"end":1632.03},{"text":"momentum,","start":1632.03,"end":1632.71},{"text":"a","start":1632.95,"end":1633.03},{"text":"momentum","start":1633.03,"end":1633.59},{"text":"resulting","start":1633.59,"end":1634.31},{"text":"from","start":1634.31,"end":1634.47},{"text":"a","start":1634.47,"end":1634.55},{"text":"public","start":1634.55,"end":1635.03},{"text":"health","start":1635.03,"end":1635.27},{"text":"crisis.","start":1635.27,"end":1635.99}]},{"text":"We must use this as an opportunity to make further progress towards drugs policy centered around health, public health, and human rights for our population in its entirety.","start":1636.23,"end":1647.75,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"We","start":1636.23,"end":1636.43},{"text":"must","start":1636.43,"end":1636.87},{"text":"use","start":1636.87,"end":1637.15},{"text":"this","start":1637.15,"end":1637.35},{"text":"as","start":1637.35,"end":1637.51},{"text":"an","start":1637.51,"end":1637.63},{"text":"opportunity","start":1637.63,"end":1638.47},{"text":"to","start":1638.71,"end":1638.87},{"text":"make","start":1638.87,"end":1639.11},{"text":"further","start":1639.11,"end":1639.47},{"text":"progress","start":1639.47,"end":1639.91},{"text":"towards","start":1639.91,"end":1640.47},{"text":"drugs","start":1640.47,"end":1640.87},{"text":"policy","start":1640.87,"end":1641.51},{"text":"centered","start":1641.83,"end":1642.31},{"text":"around","start":1642.31,"end":1642.71},{"text":"health,","start":1642.71,"end":1643.11},{"text":"public","start":1643.27,"end":1643.75},{"text":"health,","start":1643.75,"end":1644.07},{"text":"and","start":1644.31,"end":1644.63},{"text":"human","start":1644.63,"end":1644.95},{"text":"rights","start":1644.95,"end":1645.43},{"text":"for","start":1645.59,"end":1645.83},{"text":"our","start":1645.83,"end":1645.99},{"text":"population","start":1645.99,"end":1646.79},{"text":"in","start":1646.79,"end":1646.87},{"text":"its","start":1646.87,"end":1647.03},{"text":"entirety.","start":1647.03,"end":1647.75}]},{"text":"Thank you very much, Ambassador.","start":1647.75,"end":1649.27,"topics":[],"words":[{"text":"Thank","start":1647.75,"end":1648.03},{"text":"you","start":1648.03,"end":1648.11},{"text":"very","start":1648.11,"end":1648.31},{"text":"much,","start":1648.31,"end":1648.59},{"text":"Ambassador.","start":1648.59,"end":1649.27}]}]}],"speaker":{"affiliation":"CHE","group":null,"function":"Secretary","affiliation_full":"Switzerland"}},{"statement_number":8,"start":1650.15,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=27:31","paragraphs":[{"sentences":[{"text":"On the contrary, Secretary Reuvi, thank you for sharing with us what Switzerland, your country, has been doing and the successes around your harm reduction model.","start":1650.15,"end":1660.43,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"On","start":1650.15,"end":1650.19},{"text":"the","start":1650.19,"end":1650.35},{"text":"contrary,","start":1650.35,"end":1651.07},{"text":"Secretary","start":1651.15,"end":1651.71},{"text":"Reuvi,","start":1651.71,"end":1652.35},{"text":"thank","start":1652.59,"end":1652.91},{"text":"you","start":1652.91,"end":1653.07},{"text":"for","start":1653.07,"end":1653.23},{"text":"sharing","start":1653.23,"end":1653.79},{"text":"with","start":1653.79,"end":1654.03},{"text":"us","start":1654.03,"end":1654.23},{"text":"what","start":1654.23,"end":1654.55},{"text":"Switzerland,","start":1654.55,"end":1655.27},{"text":"your","start":1655.27,"end":1655.39},{"text":"country,","start":1655.39,"end":1655.79},{"text":"has","start":1655.79,"end":1655.91},{"text":"been","start":1655.99,"end":1656.15},{"text":"doing","start":1656.15,"end":1656.59},{"text":"and","start":1656.91,"end":1657.11},{"text":"the","start":1657.11,"end":1657.19},{"text":"successes","start":1657.19,"end":1657.95},{"text":"around","start":1657.95,"end":1658.43},{"text":"your","start":1658.43,"end":1658.59},{"text":"harm","start":1658.59,"end":1658.91},{"text":"reduction","start":1658.91,"end":1659.55},{"text":"model.","start":1659.79,"end":1660.43}]},{"text":"Here in multilateral fora, we have witnessed firsthand and how passionate you are about this concept and your tireless promotion to move us towards more humane and international drug policy.","start":1660.75,"end":1674.23,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Here","start":1660.75,"end":1661.15},{"text":"in","start":1661.15,"end":1661.47},{"text":"multilateral","start":1661.47,"end":1662.27},{"text":"fora,","start":1662.27,"end":1662.75},{"text":"we","start":1662.75,"end":1662.91},{"text":"have","start":1662.91,"end":1663.15},{"text":"witnessed","start":1663.15,"end":1663.75},{"text":"firsthand","start":1663.75,"end":1664.51},{"text":"and","start":1664.75,"end":1664.99},{"text":"how","start":1664.99,"end":1665.23},{"text":"passionate","start":1665.23,"end":1665.95},{"text":"you","start":1665.95,"end":1666.11},{"text":"are","start":1666.11,"end":1666.27},{"text":"about","start":1666.27,"end":1666.55},{"text":"this","start":1666.59,"end":1666.83},{"text":"concept","start":1666.83,"end":1667.31},{"text":"and","start":1667.87,"end":1668.11},{"text":"your","start":1668.11,"end":1668.35},{"text":"tireless","start":1668.35,"end":1668.91},{"text":"promotion","start":1668.91,"end":1669.47},{"text":"to","start":1669.47,"end":1669.63},{"text":"move","start":1669.63,"end":1669.87},{"text":"us","start":1669.87,"end":1670.03},{"text":"towards","start":1670.03,"end":1670.75},{"text":"more","start":1670.99,"end":1671.31},{"text":"humane","start":1671.31,"end":1671.87},{"text":"and","start":1671.87,"end":1672.07},{"text":"international","start":1672.07,"end":1672.83},{"text":"drug","start":1673.43,"end":1673.59},{"text":"policy.","start":1673.59,"end":1674.23}]},{"text":"Thank you for that.","start":1674.63,"end":1675.51,"topics":[],"words":[{"text":"Thank","start":1674.63,"end":1674.87},{"text":"you","start":1674.87,"end":1674.95},{"text":"for","start":1674.95,"end":1675.11},{"text":"that.","start":1675.11,"end":1675.51}]},{"text":"And we now move to our third speaker, which will be the second, who will be joining us online.","start":1675.75,"end":1681.83,"topics":[],"words":[{"text":"And","start":1675.75,"end":1675.95},{"text":"we","start":1675.95,"end":1676.07},{"text":"now","start":1676.07,"end":1676.39},{"text":"move","start":1676.39,"end":1676.71},{"text":"to","start":1676.71,"end":1676.83},{"text":"our","start":1676.83,"end":1677.43},{"text":"third","start":1677.59,"end":1677.99},{"text":"speaker,","start":1677.99,"end":1678.63},{"text":"which","start":1678.63,"end":1678.87},{"text":"will","start":1678.87,"end":1679.03},{"text":"be","start":1679.03,"end":1679.19},{"text":"the","start":1679.19,"end":1679.31},{"text":"second,","start":1679.31,"end":1679.75},{"text":"who","start":1679.75,"end":1679.95},{"text":"will","start":1679.95,"end":1680.07},{"text":"be","start":1680.15,"end":1680.31},{"text":"joining","start":1680.31,"end":1680.87},{"text":"us","start":1680.87,"end":1681.27},{"text":"online.","start":1681.27,"end":1681.83}]},{"text":"This is Mr. Anton Vassenko.","start":1682.15,"end":1685.19,"topics":[],"words":[{"text":"This","start":1682.15,"end":1682.39},{"text":"is","start":1682.39,"end":1682.55},{"text":"Mr.","start":1682.55,"end":1683.03},{"text":"Anton","start":1683.91,"end":1684.47},{"text":"Vassenko.","start":1684.47,"end":1685.19}]},{"text":"He's the executive director of the International Network of People Who Use Drugs, and who will be speaking to us about community perspectives and structural barriers to access services for people who use drugs.","start":1685.43,"end":1699.03,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"He's","start":1685.43,"end":1685.71},{"text":"the","start":1685.71,"end":1685.79},{"text":"executive","start":1685.79,"end":1686.47},{"text":"director","start":1686.47,"end":1687.27},{"text":"of","start":1687.67,"end":1687.87},{"text":"the","start":1687.87,"end":1687.95},{"text":"International","start":1687.95,"end":1688.71},{"text":"Network","start":1688.71,"end":1689.23},{"text":"of","start":1689.23,"end":1689.43},{"text":"People","start":1689.43,"end":1689.83},{"text":"Who","start":1689.83,"end":1689.99},{"text":"Use","start":1690.07,"end":1690.27},{"text":"Drugs,","start":1690.31,"end":1690.79},{"text":"and","start":1691.03,"end":1691.23},{"text":"who","start":1691.23,"end":1691.39},{"text":"will","start":1691.39,"end":1691.59},{"text":"be","start":1691.59,"end":1691.75},{"text":"speaking","start":1691.75,"end":1692.31},{"text":"to","start":1692.71,"end":1692.95},{"text":"us","start":1692.95,"end":1693.19},{"text":"about","start":1693.19,"end":1693.51},{"text":"community","start":1693.51,"end":1694.11},{"text":"perspectives","start":1694.11,"end":1694.95},{"text":"and","start":1695.19,"end":1695.39},{"text":"structural","start":1695.39,"end":1696.07},{"text":"barriers","start":1696.07,"end":1696.63},{"text":"to","start":1696.63,"end":1696.79},{"text":"access","start":1696.79,"end":1697.19},{"text":"services","start":1697.19,"end":1697.75},{"text":"for","start":1697.75,"end":1697.91},{"text":"people","start":1697.91,"end":1698.27},{"text":"who","start":1698.27,"end":1698.39},{"text":"use","start":1698.47,"end":1698.67},{"text":"drugs.","start":1698.67,"end":1699.03}]},{"text":"Please, Mr. Vassenko, you have the floor.","start":1699.47,"end":1701.75,"topics":[],"words":[{"text":"Please,","start":1699.47,"end":1699.75},{"text":"Mr.","start":1699.75,"end":1700.07},{"text":"Vassenko,","start":1700.07,"end":1700.79},{"text":"you","start":1700.79,"end":1701.03},{"text":"have","start":1701.03,"end":1701.27},{"text":"the","start":1701.27,"end":1701.39},{"text":"floor.","start":1701.39,"end":1701.75}]}]}],"speaker":{"affiliation":"MEX","group":null,"function":"Deputy Permanent Representative","affiliation_full":"Mexico"}},{"statement_number":9,"start":1705.03,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=28:26","paragraphs":[{"sentences":[{"text":"Thank you. Thank you, Chair.","start":1705.03,"end":1706.39,"topics":[],"words":[{"text":"Thank","start":1705.03,"end":1705.31},{"text":"you.","start":1705.31,"end":1705.51},{"text":"Thank","start":1705.59,"end":1705.83},{"text":"you,","start":1705.83,"end":1705.91},{"text":"Chair.","start":1705.91,"end":1706.39}]},{"text":"Hello, everyone.","start":1706.63,"end":1708.63,"topics":[],"words":[{"text":"Hello,","start":1706.63,"end":1706.91},{"text":"everyone.","start":1708.07,"end":1708.63}]},{"text":"Thank you, dear delegates, excellencies, I guess.","start":1711.11,"end":1714.79,"topics":[],"words":[{"text":"Thank","start":1711.11,"end":1711.35},{"text":"you,","start":1711.35,"end":1711.59},{"text":"dear","start":1711.99,"end":1712.47},{"text":"delegates,","start":1712.51,"end":1713.03},{"text":"excellencies,","start":1713.03,"end":1713.99},{"text":"I","start":1714.23,"end":1714.31},{"text":"guess.","start":1714.31,"end":1714.79}]},{"text":"Thank you to the organizers for ensuring this space, which includes the voices of our communities, not just about us, but with us.","start":1717.03,"end":1727.03,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Thank","start":1717.03,"end":1717.19},{"text":"you","start":1717.19,"end":1717.27},{"text":"to","start":1717.27,"end":1717.43},{"text":"the","start":1717.43,"end":1717.55},{"text":"organizers","start":1717.55,"end":1718.15},{"text":"for","start":1718.15,"end":1718.47},{"text":"ensuring","start":1718.55,"end":1719.03},{"text":"this","start":1719.03,"end":1719.23},{"text":"space,","start":1719.23,"end":1719.91},{"text":"which","start":1721.07,"end":1721.27},{"text":"includes","start":1721.27,"end":1721.67},{"text":"the","start":1721.67,"end":1721.79},{"text":"voices","start":1721.79,"end":1722.19},{"text":"of","start":1722.19,"end":1722.31},{"text":"our","start":1722.95,"end":1723.11},{"text":"communities,","start":1723.11,"end":1723.91},{"text":"not","start":1724.47,"end":1724.71},{"text":"just","start":1724.79,"end":1725.27},{"text":"about","start":1725.51,"end":1725.95},{"text":"us,","start":1725.95,"end":1726.07},{"text":"but","start":1726.15,"end":1726.39},{"text":"with","start":1726.47,"end":1726.79},{"text":"us.","start":1726.79,"end":1727.03}]},{"text":"Can I my slides on the screen, if possible.","start":1730.47,"end":1734.91,"topics":[],"words":[{"text":"Can","start":1730.47,"end":1730.71},{"text":"I","start":1730.71,"end":1730.79},{"text":"my","start":1732.19,"end":1732.27},{"text":"slides","start":1732.27,"end":1733.07},{"text":"on","start":1733.07,"end":1733.23},{"text":"the","start":1733.23,"end":1733.31},{"text":"screen,","start":1733.31,"end":1733.95},{"text":"if","start":1734.11,"end":1734.23},{"text":"possible.","start":1734.35,"end":1734.91}]},{"text":"Yeah, thank you.","start":1737.71,"end":1738.83,"topics":[],"words":[{"text":"Yeah,","start":1737.71,"end":1737.95},{"text":"thank","start":1738.51,"end":1738.75},{"text":"you.","start":1738.75,"end":1738.83}]},{"text":"I speak on behalf of international network of people who use drugs and also as someone who has survived the realities behind the policies we are discussing.","start":1742.19,"end":1752.83,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"I","start":1742.19,"end":1742.43},{"text":"speak","start":1742.43,"end":1742.75},{"text":"on","start":1742.75,"end":1742.83},{"text":"behalf","start":1742.83,"end":1743.11},{"text":"of","start":1743.11,"end":1743.31},{"text":"international","start":1744.11,"end":1744.83},{"text":"network","start":1744.83,"end":1745.23},{"text":"of","start":1745.23,"end":1745.31},{"text":"people","start":1745.31,"end":1745.71},{"text":"who","start":1745.71,"end":1745.87},{"text":"use","start":1745.87,"end":1746.11},{"text":"drugs","start":1746.19,"end":1746.83},{"text":"and","start":1746.83,"end":1747.23},{"text":"also","start":1747.23,"end":1747.95},{"text":"as","start":1747.95,"end":1748.03},{"text":"someone","start":1748.03,"end":1748.43},{"text":"who","start":1748.43,"end":1748.63},{"text":"has","start":1748.63,"end":1748.83},{"text":"survived","start":1748.83,"end":1749.43},{"text":"the","start":1749.43,"end":1749.55},{"text":"realities","start":1749.55,"end":1750.35},{"text":"behind","start":1750.99,"end":1751.43},{"text":"the","start":1751.43,"end":1751.51},{"text":"policies","start":1751.51,"end":1752.03},{"text":"we","start":1752.03,"end":1752.15},{"text":"are","start":1752.15,"end":1752.27},{"text":"discussing.","start":1752.27,"end":1752.83}]},{"text":"I began using drugs when I was 14.","start":1753.23,"end":1755.31,"topics":[],"words":[{"text":"I","start":1753.23,"end":1753.47},{"text":"began","start":1753.47,"end":1753.71},{"text":"using","start":1753.71,"end":1753.99},{"text":"drugs","start":1753.99,"end":1754.23},{"text":"when","start":1754.23,"end":1754.43},{"text":"I","start":1754.43,"end":1754.51},{"text":"was","start":1754.51,"end":1754.67},{"text":"14.","start":1754.67,"end":1755.31}]},{"text":"I injected for the first time at 16.","start":1755.95,"end":1758.67,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"I","start":1755.95,"end":1756.11},{"text":"injected","start":1756.11,"end":1756.91},{"text":"for","start":1756.95,"end":1757.07},{"text":"the","start":1757.07,"end":1757.19},{"text":"first","start":1757.19,"end":1757.59},{"text":"time","start":1757.59,"end":1757.79},{"text":"at","start":1757.79,"end":1757.95},{"text":"16.","start":1757.95,"end":1758.67}]},{"text":"I received my first clean needle when harm reduction programs finally appeared in my country, in Ukraine, when I was 23.","start":1759.31,"end":1766.99,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"I","start":1759.31,"end":1759.32},{"text":"received","start":1759.31,"end":1759.75},{"text":"my","start":1760.43,"end":1760.67},{"text":"first","start":1760.67,"end":1761.07},{"text":"clean","start":1761.07,"end":1761.43},{"text":"needle","start":1761.43,"end":1761.83},{"text":"when","start":1761.83,"end":1762.07},{"text":"harm","start":1762.07,"end":1762.31},{"text":"reduction","start":1762.31,"end":1762.91},{"text":"programs","start":1763.07,"end":1763.51},{"text":"finally","start":1763.51,"end":1763.95},{"text":"appeared","start":1763.95,"end":1764.35},{"text":"in","start":1764.35,"end":1764.47},{"text":"my","start":1764.47,"end":1764.59},{"text":"country,","start":1764.59,"end":1765.03},{"text":"in","start":1765.03,"end":1765.11},{"text":"Ukraine,","start":1765.11,"end":1765.59},{"text":"when","start":1765.59,"end":1765.79},{"text":"I","start":1765.79,"end":1765.87},{"text":"was","start":1765.87,"end":1766.03},{"text":"23.","start":1766.03,"end":1766.99}]},{"text":"And in the same year, I was diagnosed with both HIV and hepatitis C. I waited 712 days to access antiretroviral therapy.","start":1767.15,"end":1776.71,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"And","start":1767.15,"end":1767.27},{"text":"in","start":1767.31,"end":1767.55},{"text":"the","start":1767.55,"end":1767.67},{"text":"same","start":1767.67,"end":1768.03},{"text":"year,","start":1768.03,"end":1768.43},{"text":"I","start":1768.75,"end":1768.83},{"text":"was","start":1768.83,"end":1768.99},{"text":"diagnosed","start":1768.99,"end":1769.47},{"text":"with","start":1769.47,"end":1769.67},{"text":"both","start":1769.67,"end":1770.03},{"text":"HIV","start":1770.11,"end":1770.67},{"text":"and","start":1770.91,"end":1771.07},{"text":"hepatitis","start":1771.07,"end":1771.67},{"text":"C.","start":1771.67,"end":1771.95},{"text":"I","start":1772.59,"end":1772.83},{"text":"waited","start":1772.83,"end":1773.23},{"text":"712","start":1773.23,"end":1774.67},{"text":"days","start":1774.67,"end":1774.99},{"text":"to","start":1774.99,"end":1775.11},{"text":"access","start":1775.11,"end":1775.47},{"text":"antiretroviral","start":1775.47,"end":1776.35},{"text":"therapy.","start":1776.35,"end":1776.71}]},{"text":"I waited over 13 years for hepatitis C treatment.","start":1776.99,"end":1781.11,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"I","start":1776.99,"end":1777.15},{"text":"waited","start":1777.15,"end":1777.55},{"text":"over","start":1777.55,"end":1778.03},{"text":"13","start":1778.27,"end":1778.83},{"text":"years","start":1779.15,"end":1779.63},{"text":"for","start":1779.63,"end":1779.79},{"text":"hepatitis","start":1779.79,"end":1780.39},{"text":"C","start":1780.39,"end":1780.59},{"text":"treatment.","start":1780.59,"end":1781.11}]},{"text":"I survived six overdoses.","start":1781.63,"end":1783.47,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"I","start":1781.63,"end":1781.79},{"text":"survived","start":1781.79,"end":1782.27},{"text":"six","start":1782.27,"end":1782.75},{"text":"overdoses.","start":1782.75,"end":1783.47}]},{"text":"I was denied medical care three times.","start":1783.87,"end":1786.11,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"I","start":1783.87,"end":1784.03},{"text":"was","start":1784.11,"end":1784.27},{"text":"denied","start":1784.27,"end":1784.67},{"text":"medical","start":1784.67,"end":1785.07},{"text":"care","start":1785.07,"end":1785.31},{"text":"three","start":1785.31,"end":1785.63},{"text":"times.","start":1785.63,"end":1786.11}]},{"text":"lost two jobs because of my status, and narrowly avoided prison on four occasions.","start":1786.87,"end":1793.03,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"lost","start":1786.87,"end":1786.99},{"text":"two","start":1786.99,"end":1787.15},{"text":"jobs","start":1787.15,"end":1787.63},{"text":"because","start":1788.35,"end":1789.15},{"text":"of","start":1789.43,"end":1789.51},{"text":"my","start":1789.55,"end":1789.71},{"text":"status,","start":1789.71,"end":1790.27},{"text":"and","start":1790.27,"end":1790.55},{"text":"narrowly","start":1790.55,"end":1791.15},{"text":"avoided","start":1791.15,"end":1791.63},{"text":"prison","start":1791.63,"end":1792.11},{"text":"on","start":1792.11,"end":1792.19},{"text":"four","start":1792.19,"end":1792.47},{"text":"occasions.","start":1792.47,"end":1793.03}]},{"text":"I lost close friends to preventable illnesses and criminalization, and still, I was one of the lucky ones.","start":1793.87,"end":1800.91,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"I","start":1793.87,"end":1794.03},{"text":"lost","start":1794.03,"end":1794.31},{"text":"close","start":1794.31,"end":1794.67},{"text":"friends","start":1794.67,"end":1795.23},{"text":"to","start":1795.63,"end":1795.75},{"text":"preventable","start":1795.75,"end":1796.43},{"text":"illnesses","start":1796.43,"end":1796.99},{"text":"and","start":1796.99,"end":1797.15},{"text":"criminalization,","start":1797.15,"end":1798.11},{"text":"and","start":1798.11,"end":1798.35},{"text":"still,","start":1798.35,"end":1798.91},{"text":"I","start":1799.39,"end":1799.63},{"text":"was","start":1799.63,"end":1799.79},{"text":"one","start":1799.79,"end":1799.99},{"text":"of","start":1799.99,"end":1800.11},{"text":"the","start":1800.11,"end":1800.19},{"text":"lucky","start":1800.19,"end":1800.55},{"text":"ones.","start":1800.55,"end":1800.91}]},{"text":"These aren't statistics.","start":1801.71,"end":1803.23,"topics":[],"words":[{"text":"These","start":1801.71,"end":1801.95},{"text":"aren't","start":1801.95,"end":1802.51},{"text":"statistics.","start":1802.51,"end":1803.23}]},{"text":"They are human cost of failing to put people, not politics, at the center of drug policy.","start":1803.31,"end":1812.43,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"They","start":1803.31,"end":1803.55},{"text":"are","start":1803.55,"end":1803.95},{"text":"human","start":1804.11,"end":1804.51},{"text":"cost","start":1804.51,"end":1804.91},{"text":"of","start":1804.95,"end":1805.15},{"text":"failing","start":1805.63,"end":1806.11},{"text":"to","start":1806.35,"end":1806.67},{"text":"put","start":1807.87,"end":1808.15},{"text":"people,","start":1808.19,"end":1808.91},{"text":"not","start":1809.63,"end":1809.95},{"text":"politics,","start":1809.95,"end":1810.67},{"text":"at","start":1810.67,"end":1810.91},{"text":"the","start":1810.91,"end":1811.03},{"text":"center","start":1811.03,"end":1811.51},{"text":"of","start":1811.51,"end":1811.63},{"text":"drug","start":1811.63,"end":1811.87},{"text":"policy.","start":1811.87,"end":1812.43}]},{"text":"I still recall the day a young friend and community member, please the first slide, the very first slide.","start":1813.35,"end":1820.95,"topics":[],"words":[{"text":"I","start":1813.35,"end":1813.36},{"text":"still","start":1813.35,"end":1813.55},{"text":"recall","start":1813.55,"end":1813.99},{"text":"the","start":1813.99,"end":1814.11},{"text":"day","start":1814.11,"end":1814.55},{"text":"a","start":1814.79,"end":1814.87},{"text":"young","start":1815.43,"end":1815.67},{"text":"friend","start":1815.67,"end":1816.23},{"text":"and","start":1816.47,"end":1816.71},{"text":"community","start":1816.71,"end":1817.27},{"text":"member,","start":1817.27,"end":1817.83},{"text":"please","start":1818.71,"end":1819.03},{"text":"the","start":1819.03,"end":1819.15},{"text":"first","start":1819.15,"end":1819.39},{"text":"slide,","start":1819.39,"end":1819.71},{"text":"the","start":1820.07,"end":1820.19},{"text":"very","start":1820.19,"end":1820.47},{"text":"first","start":1820.47,"end":1820.75},{"text":"slide.","start":1820.75,"end":1820.95}]},{"text":"Thank you.","start":1826.51,"end":1826.87,"topics":[],"words":[{"text":"Thank","start":1826.51,"end":1826.75},{"text":"you.","start":1826.75,"end":1826.87}]},{"text":"I still recall the day a young friend and community member died of an overdose, alone and afraid, because the nearest harm reduction service had shut down.","start":1827.15,"end":1838.59,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"I","start":1827.15,"end":1827.39},{"text":"still","start":1827.39,"end":1828.11},{"text":"recall","start":1828.83,"end":1829.31},{"text":"the","start":1829.31,"end":1829.43},{"text":"day","start":1829.47,"end":1830.27},{"text":"a","start":1830.27,"end":1830.31},{"text":"young","start":1830.31,"end":1830.51},{"text":"friend","start":1830.51,"end":1830.83},{"text":"and","start":1830.83,"end":1830.95},{"text":"community","start":1830.95,"end":1831.39},{"text":"member","start":1831.39,"end":1831.71},{"text":"died","start":1831.71,"end":1832.11},{"text":"of","start":1832.23,"end":1832.31},{"text":"an","start":1832.31,"end":1832.43},{"text":"overdose,","start":1832.43,"end":1833.23},{"text":"alone","start":1833.47,"end":1834.15},{"text":"and","start":1834.19,"end":1834.47},{"text":"afraid,","start":1834.47,"end":1834.95},{"text":"because","start":1835.31,"end":1835.63},{"text":"the","start":1835.63,"end":1835.71},{"text":"nearest","start":1835.71,"end":1836.15},{"text":"harm","start":1836.15,"end":1836.31},{"text":"reduction","start":1836.31,"end":1836.75},{"text":"service","start":1836.75,"end":1837.39},{"text":"had","start":1837.47,"end":1837.71},{"text":"shut","start":1837.79,"end":1837.99},{"text":"down.","start":1837.99,"end":1838.59}]},{"text":"As someone who has lived through the fear and stigma of criminalization, I know firsthand How punitive laws turn health issues into life or death struggles.","start":1838.99,"end":1848.95,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"As","start":1838.99,"end":1839.11},{"text":"someone","start":1839.11,"end":1839.71},{"text":"who","start":1839.95,"end":1840.03},{"text":"has","start":1840.03,"end":1840.27},{"text":"lived","start":1840.27,"end":1840.55},{"text":"through","start":1840.55,"end":1840.75},{"text":"the","start":1840.75,"end":1840.83},{"text":"fear","start":1840.83,"end":1841.15},{"text":"and","start":1841.15,"end":1841.27},{"text":"stigma","start":1841.27,"end":1841.63},{"text":"of","start":1841.63,"end":1841.71},{"text":"criminalization,","start":1841.71,"end":1842.67},{"text":"I","start":1842.99,"end":1843.23},{"text":"know","start":1843.23,"end":1843.47},{"text":"firsthand","start":1843.47,"end":1844.27},{"text":"How","start":1844.75,"end":1844.87},{"text":"punitive","start":1844.87,"end":1845.35},{"text":"laws","start":1845.35,"end":1845.83},{"text":"turn","start":1845.99,"end":1846.23},{"text":"health","start":1846.23,"end":1846.63},{"text":"issues","start":1846.67,"end":1847.03},{"text":"into","start":1847.03,"end":1847.35},{"text":"life","start":1847.35,"end":1847.67},{"text":"or","start":1847.67,"end":1847.91},{"text":"death","start":1847.91,"end":1848.11},{"text":"struggles.","start":1848.11,"end":1848.95}]},{"text":"In my own life, every encounter with police or barriers to care has driven me and others underground.","start":1849.43,"end":1856.55,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"In","start":1849.43,"end":1849.59},{"text":"my","start":1849.59,"end":1849.75},{"text":"own","start":1849.75,"end":1849.87},{"text":"life,","start":1849.87,"end":1850.39},{"text":"every","start":1850.39,"end":1850.83},{"text":"encounter","start":1850.83,"end":1851.51},{"text":"with","start":1851.51,"end":1851.67},{"text":"police","start":1851.67,"end":1852.23},{"text":"or","start":1852.39,"end":1852.55},{"text":"barriers","start":1852.55,"end":1853.03},{"text":"to","start":1853.03,"end":1853.19},{"text":"care","start":1853.19,"end":1853.67},{"text":"has","start":1853.91,"end":1854.07},{"text":"driven","start":1854.07,"end":1854.47},{"text":"me","start":1854.47,"end":1854.87},{"text":"and","start":1855.07,"end":1855.31},{"text":"others","start":1855.31,"end":1855.75},{"text":"underground.","start":1855.91,"end":1856.55}]},{"text":"This personal experience reminds us why drug policy must be rooted in human rights and real world evidence, not in fear or ideology.","start":1857.11,"end":1865.99,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"This","start":1857.11,"end":1857.27},{"text":"personal","start":1857.27,"end":1857.75},{"text":"experience","start":1857.75,"end":1858.23},{"text":"reminds","start":1858.23,"end":1858.87},{"text":"us","start":1858.95,"end":1859.03},{"text":"why","start":1859.11,"end":1859.59},{"text":"drug","start":1859.59,"end":1859.91},{"text":"policy","start":1859.91,"end":1860.71},{"text":"must","start":1860.71,"end":1861.03},{"text":"be","start":1861.03,"end":1861.19},{"text":"rooted","start":1861.19,"end":1861.59},{"text":"in","start":1861.59,"end":1861.75},{"text":"human","start":1861.75,"end":1862.07},{"text":"rights","start":1862.07,"end":1862.39},{"text":"and","start":1862.43,"end":1862.59},{"text":"real","start":1862.59,"end":1862.79},{"text":"world","start":1862.79,"end":1863.11},{"text":"evidence,","start":1863.11,"end":1863.75},{"text":"not","start":1863.83,"end":1864.07},{"text":"in","start":1864.07,"end":1864.23},{"text":"fear","start":1864.23,"end":1864.79},{"text":"or","start":1864.87,"end":1865.11},{"text":"ideology.","start":1865.11,"end":1865.99}]},{"text":"Next slide, please.","start":1867.11,"end":1868.07,"topics":[],"words":[{"text":"Next","start":1867.11,"end":1867.39},{"text":"slide,","start":1867.39,"end":1867.67},{"text":"please.","start":1867.67,"end":1868.07}]},{"text":"Our recent input survey in April 2025 confirms what our hearts already know.","start":1870.03,"end":1876.03,"topics":[],"words":[{"text":"Our","start":1870.03,"end":1870.23},{"text":"recent","start":1870.23,"end":1870.63},{"text":"input","start":1870.63,"end":1871.07},{"text":"survey","start":1871.07,"end":1871.79},{"text":"in","start":1871.79,"end":1871.95},{"text":"April","start":1871.95,"end":1872.27},{"text":"2025","start":1872.27,"end":1873.47},{"text":"confirms","start":1873.47,"end":1874.35},{"text":"what","start":1874.35,"end":1874.67},{"text":"our","start":1874.67,"end":1874.83},{"text":"hearts","start":1874.83,"end":1875.19},{"text":"already","start":1875.19,"end":1875.63},{"text":"know.","start":1875.63,"end":1876.03}]},{"text":"Criminalization and lack of support are crushing our communities.","start":1876.35,"end":1880.91,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Criminalization","start":1876.35,"end":1877.47},{"text":"and","start":1877.47,"end":1877.75},{"text":"lack","start":1877.75,"end":1877.91},{"text":"of","start":1877.91,"end":1877.99},{"text":"support","start":1877.99,"end":1878.67},{"text":"are","start":1878.83,"end":1878.99},{"text":"crushing","start":1878.99,"end":1879.63},{"text":"our","start":1879.79,"end":1880.03},{"text":"communities.","start":1880.03,"end":1880.91}]},{"text":"In just 12 days of data collection, 101 respondents, 65% from community-led organizations in low and middle income countries reported severe disruptions to essential services.","start":1880.99,"end":1893.31,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"In","start":1880.99,"end":1881.15},{"text":"just","start":1881.15,"end":1881.51},{"text":"12","start":1881.51,"end":1881.79},{"text":"days","start":1881.79,"end":1882.15},{"text":"of","start":1882.15,"end":1882.27},{"text":"data","start":1882.27,"end":1882.59},{"text":"collection,","start":1882.59,"end":1883.15},{"text":"101","start":1883.47,"end":1884.19},{"text":"respondents,","start":1884.19,"end":1885.23},{"text":"65%","start":1885.23,"end":1885.27},{"text":"from","start":1885.27,"end":1886.03},{"text":"community-led","start":1886.03,"end":1886.99},{"text":"organizations","start":1886.99,"end":1887.87},{"text":"in","start":1888.11,"end":1888.35},{"text":"low","start":1888.35,"end":1888.67},{"text":"and","start":1888.67,"end":1888.79},{"text":"middle","start":1888.79,"end":1889.07},{"text":"income","start":1889.07,"end":1889.39},{"text":"countries","start":1889.39,"end":1889.95},{"text":"reported","start":1890.03,"end":1890.67},{"text":"severe","start":1890.67,"end":1891.23},{"text":"disruptions","start":1891.23,"end":1891.95},{"text":"to","start":1891.95,"end":1892.07},{"text":"essential","start":1892.07,"end":1892.59},{"text":"services.","start":1892.59,"end":1893.31}]},{"text":"Next slide, please.","start":1893.31,"end":1894.19,"topics":[],"words":[{"text":"Next","start":1893.31,"end":1893.59},{"text":"slide,","start":1893.59,"end":1893.87},{"text":"please.","start":1893.87,"end":1894.19}]},{"text":"Nearly two-thirds, 63%, said that withdrawal of funding had a significant to severe impact on their ability to stay afloat.","start":1896.19,"end":1904.11,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"Nearly","start":1896.19,"end":1896.51},{"text":"two-thirds,","start":1896.51,"end":1897.07},{"text":"63%,","start":1897.07,"end":1897.11},{"text":"said","start":1897.11,"end":1898.51},{"text":"that","start":1898.51,"end":1898.83},{"text":"withdrawal","start":1898.83,"end":1899.63},{"text":"of","start":1899.63,"end":1899.71},{"text":"funding","start":1899.71,"end":1900.23},{"text":"had","start":1900.23,"end":1900.43},{"text":"a","start":1900.43,"end":1900.47},{"text":"significant","start":1900.47,"end":1901.23},{"text":"to","start":1901.23,"end":1901.31},{"text":"severe","start":1901.31,"end":1901.79},{"text":"impact","start":1901.79,"end":1902.23},{"text":"on","start":1902.23,"end":1902.35},{"text":"their","start":1902.35,"end":1902.63},{"text":"ability","start":1902.63,"end":1903.03},{"text":"to","start":1903.03,"end":1903.11},{"text":"stay","start":1903.15,"end":1903.55},{"text":"afloat.","start":1903.55,"end":1904.11}]},{"text":"Almost half lost from 26 to 100% of their budgets overnight, forcing clinics to close, outreach to stop, and peer educators to lose their jobs.","start":1904.59,"end":1916.03,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Almost","start":1904.59,"end":1905.15},{"text":"half","start":1905.15,"end":1905.63},{"text":"lost","start":1905.95,"end":1906.43},{"text":"from","start":1907.31,"end":1907.47},{"text":"26","start":1907.47,"end":1908.75},{"text":"to","start":1908.75,"end":1908.91},{"text":"100%","start":1908.91,"end":1908.95},{"text":"of","start":1908.95,"end":1909.07},{"text":"their","start":1909.07,"end":1909.31},{"text":"budgets","start":1909.31,"end":1909.79},{"text":"overnight,","start":1909.79,"end":1910.59},{"text":"forcing","start":1910.83,"end":1911.19},{"text":"clinics","start":1911.19,"end":1911.63},{"text":"to","start":1911.63,"end":1911.75},{"text":"close,","start":1911.75,"end":1912.35},{"text":"outreach","start":1912.43,"end":1912.99},{"text":"to","start":1912.99,"end":1913.07},{"text":"stop,","start":1913.07,"end":1913.55},{"text":"and","start":1913.75,"end":1913.95},{"text":"peer","start":1913.95,"end":1914.19},{"text":"educators","start":1914.19,"end":1914.83},{"text":"to","start":1914.83,"end":1914.99},{"text":"lose","start":1914.99,"end":1915.31},{"text":"their","start":1915.31,"end":1915.55},{"text":"jobs.","start":1915.55,"end":1916.03}]},{"text":"The human cost is already evident.","start":1916.43,"end":1918.91,"topics":[],"words":[{"text":"The","start":1916.43,"end":1916.59},{"text":"human","start":1916.59,"end":1916.99},{"text":"cost","start":1916.99,"end":1917.47},{"text":"is","start":1917.55,"end":1917.79},{"text":"already","start":1917.79,"end":1918.27},{"text":"evident.","start":1918.27,"end":1918.91}]},{"text":"46% of our respondents say people are forced to turn to underground sources for clean syringes and naloxone, and 30% report an increase in overdose death in their communities.","start":1919.39,"end":1930.75,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"46%","start":1919.39,"end":1919.4},{"text":"of","start":1919.39,"end":1919.51},{"text":"our","start":1919.59,"end":1919.67},{"text":"respondents","start":1919.91,"end":1921.31},{"text":"say","start":1921.31,"end":1921.51},{"text":"people","start":1921.51,"end":1921.91},{"text":"are","start":1921.91,"end":1921.99},{"text":"forced","start":1921.99,"end":1922.43},{"text":"to","start":1922.43,"end":1922.51},{"text":"turn","start":1922.51,"end":1922.95},{"text":"to","start":1922.95,"end":1923.11},{"text":"underground","start":1923.11,"end":1923.67},{"text":"sources","start":1923.67,"end":1924.15},{"text":"for","start":1924.15,"end":1924.31},{"text":"clean","start":1924.31,"end":1924.55},{"text":"syringes","start":1924.55,"end":1925.11},{"text":"and","start":1925.11,"end":1925.51},{"text":"naloxone,","start":1925.75,"end":1926.95},{"text":"and","start":1926.95,"end":1927.11},{"text":"30%","start":1927.27,"end":1927.31},{"text":"report","start":1927.35,"end":1927.95},{"text":"an","start":1927.95,"end":1928.03},{"text":"increase","start":1928.03,"end":1928.59},{"text":"in","start":1928.59,"end":1928.87},{"text":"overdose","start":1928.87,"end":1929.35},{"text":"death","start":1929.35,"end":1929.67},{"text":"in","start":1929.91,"end":1930.07},{"text":"their","start":1930.07,"end":1930.23},{"text":"communities.","start":1930.23,"end":1930.75}]},{"text":"Each of these statistics is a stark warning.","start":1931.19,"end":1934.23,"topics":[],"words":[{"text":"Each","start":1931.19,"end":1931.39},{"text":"of","start":1931.39,"end":1931.51},{"text":"these","start":1931.51,"end":1931.71},{"text":"statistics","start":1931.71,"end":1932.39},{"text":"is","start":1932.47,"end":1932.59},{"text":"a","start":1932.59,"end":1932.63},{"text":"stark","start":1932.63,"end":1933.19},{"text":"warning.","start":1933.59,"end":1934.23}]},{"text":"Years of progress against HIV, hepatitis C, and overdose are unraveling right before our eyes today.","start":1934.63,"end":1942.55,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"Years","start":1934.63,"end":1935.19},{"text":"of","start":1935.19,"end":1935.27},{"text":"progress","start":1935.27,"end":1935.75},{"text":"against","start":1935.75,"end":1936.15},{"text":"HIV,","start":1936.15,"end":1936.79},{"text":"hepatitis","start":1937.03,"end":1937.79},{"text":"C,","start":1937.79,"end":1938.23},{"text":"and","start":1938.23,"end":1938.43},{"text":"overdose","start":1938.43,"end":1939.11},{"text":"are","start":1939.11,"end":1939.43},{"text":"unraveling","start":1939.43,"end":1940.31},{"text":"right","start":1940.47,"end":1940.95},{"text":"before","start":1941.03,"end":1941.43},{"text":"our","start":1941.43,"end":1941.75},{"text":"eyes","start":1941.75,"end":1941.99},{"text":"today.","start":1941.99,"end":1942.55}]},{"text":"Next slide, please.","start":1942.55,"end":1943.51,"topics":[],"words":[{"text":"Next","start":1942.55,"end":1942.91},{"text":"slide,","start":1942.91,"end":1943.23},{"text":"please.","start":1943.23,"end":1943.51}]},{"text":"This data is backed by decades of research.","start":1945.47,"end":1947.79,"topics":[],"words":[{"text":"This","start":1945.47,"end":1945.63},{"text":"data","start":1945.63,"end":1945.91},{"text":"is","start":1945.91,"end":1946.11},{"text":"backed","start":1946.11,"end":1946.43},{"text":"by","start":1946.43,"end":1946.59},{"text":"decades","start":1946.59,"end":1947.19},{"text":"of","start":1947.19,"end":1947.31},{"text":"research.","start":1947.31,"end":1947.79}]},{"text":"We know that outside an evidence-based framework, criminalizing drugs has devastating consequences.","start":1947.79,"end":1953.23,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"We","start":1947.79,"end":1947.87},{"text":"know","start":1947.87,"end":1948.11},{"text":"that","start":1948.11,"end":1948.35},{"text":"outside","start":1948.35,"end":1948.87},{"text":"an","start":1948.87,"end":1948.99},{"text":"evidence-based","start":1948.99,"end":1949.59},{"text":"framework,","start":1949.59,"end":1950.07},{"text":"criminalizing","start":1950.07,"end":1950.79},{"text":"drugs","start":1950.79,"end":1951.23},{"text":"has","start":1951.23,"end":1951.39},{"text":"devastating","start":1951.39,"end":1952.11},{"text":"consequences.","start":1952.11,"end":1953.23}]},{"text":"Criminal laws put people who use drugs at 35 times higher risk of HIV infection than the general population.","start":1953.31,"end":1959.23,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"Criminal","start":1953.31,"end":1953.91},{"text":"laws","start":1953.91,"end":1954.03},{"text":"put","start":1954.03,"end":1954.19},{"text":"people","start":1954.19,"end":1954.51},{"text":"who","start":1954.51,"end":1954.67},{"text":"use","start":1954.67,"end":1954.83},{"text":"drugs","start":1954.83,"end":1955.23},{"text":"at","start":1955.23,"end":1955.39},{"text":"35","start":1955.39,"end":1956.11},{"text":"times","start":1956.11,"end":1956.39},{"text":"higher","start":1956.39,"end":1956.71},{"text":"risk","start":1956.71,"end":1956.91},{"text":"of","start":1956.91,"end":1956.99},{"text":"HIV","start":1956.99,"end":1957.35},{"text":"infection","start":1957.35,"end":1957.87},{"text":"than","start":1957.87,"end":1958.03},{"text":"the","start":1958.03,"end":1958.15},{"text":"general","start":1958.15,"end":1958.55},{"text":"population.","start":1958.55,"end":1959.23}]},{"text":"Globally today, 152 countries still criminalize possession of even small amounts of drugs, driving users away from healthcare and into the shadows.","start":1959.59,"end":1969.87,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Globally","start":1959.59,"end":1960.15},{"text":"today,","start":1960.15,"end":1960.67},{"text":"152","start":1960.79,"end":1962.03},{"text":"countries","start":1962.03,"end":1962.51},{"text":"still","start":1962.51,"end":1962.83},{"text":"criminalize","start":1962.83,"end":1963.39},{"text":"possession","start":1963.39,"end":1964.11},{"text":"of","start":1964.19,"end":1964.43},{"text":"even","start":1964.43,"end":1964.59},{"text":"small","start":1964.59,"end":1965.03},{"text":"amounts","start":1965.03,"end":1965.47},{"text":"of","start":1965.47,"end":1965.55},{"text":"drugs,","start":1965.55,"end":1965.95},{"text":"driving","start":1966.27,"end":1966.75},{"text":"users","start":1966.75,"end":1967.15},{"text":"away","start":1967.15,"end":1967.55},{"text":"from","start":1967.55,"end":1967.79},{"text":"healthcare","start":1967.79,"end":1968.51},{"text":"and","start":1968.51,"end":1968.63},{"text":"into","start":1968.63,"end":1969.07},{"text":"the","start":1969.07,"end":1969.23},{"text":"shadows.","start":1969.23,"end":1969.87}]},{"text":"These punitive laws are in abstract numbers.","start":1970.55,"end":1972.71,"topics":[],"words":[{"text":"These","start":1970.55,"end":1970.71},{"text":"punitive","start":1970.71,"end":1971.19},{"text":"laws","start":1971.19,"end":1971.51},{"text":"are","start":1971.51,"end":1971.71},{"text":"in","start":1971.71,"end":1971.83},{"text":"abstract","start":1971.83,"end":1972.27},{"text":"numbers.","start":1972.27,"end":1972.71}]},{"text":"They mean that people who need syringe exchange, opioid agonist therapy, or even emergency care face arrest or denial of services.","start":1972.71,"end":1981.75,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"They","start":1972.71,"end":1972.87},{"text":"mean","start":1972.87,"end":1973.11},{"text":"that","start":1973.11,"end":1973.23},{"text":"people","start":1973.23,"end":1973.55},{"text":"who","start":1973.55,"end":1973.67},{"text":"need","start":1973.67,"end":1973.91},{"text":"syringe","start":1973.91,"end":1974.67},{"text":"exchange,","start":1974.67,"end":1975.27},{"text":"opioid","start":1975.35,"end":1975.75},{"text":"agonist","start":1975.75,"end":1976.19},{"text":"therapy,","start":1976.19,"end":1976.71},{"text":"or","start":1977.11,"end":1977.59},{"text":"even","start":1977.59,"end":1977.87},{"text":"emergency","start":1977.87,"end":1978.39},{"text":"care","start":1978.39,"end":1978.87},{"text":"face","start":1978.87,"end":1979.27},{"text":"arrest","start":1979.27,"end":1979.83},{"text":"or","start":1980.07,"end":1980.23},{"text":"denial","start":1980.23,"end":1980.87},{"text":"of","start":1980.95,"end":1981.03},{"text":"services.","start":1981.03,"end":1981.75}]},{"text":"As our survey respondents noted, community members are being denied or excluded from essential services simply because they use drugs.","start":1982.23,"end":1991.67,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"As","start":1982.23,"end":1982.39},{"text":"our","start":1982.39,"end":1982.63},{"text":"survey","start":1982.63,"end":1982.99},{"text":"respondents","start":1982.99,"end":1983.67},{"text":"noted,","start":1983.67,"end":1984.23},{"text":"community","start":1984.71,"end":1985.23},{"text":"members","start":1985.23,"end":1985.67},{"text":"are","start":1985.67,"end":1985.83},{"text":"being","start":1985.83,"end":1986.15},{"text":"denied","start":1986.15,"end":1986.79},{"text":"or","start":1986.79,"end":1987.11},{"text":"excluded","start":1987.11,"end":1987.83},{"text":"from","start":1987.83,"end":1988.23},{"text":"essential","start":1988.23,"end":1988.95},{"text":"services","start":1988.95,"end":1989.43},{"text":"simply","start":1989.43,"end":1989.83},{"text":"because","start":1989.83,"end":1990.23},{"text":"they","start":1990.31,"end":1990.47},{"text":"use","start":1990.47,"end":1990.87},{"text":"drugs.","start":1991.31,"end":1991.67}]},{"text":"This is not only cruel, it is unscientific.","start":1992.15,"end":1995.27,"topics":[],"words":[{"text":"This","start":1992.15,"end":1992.39},{"text":"is","start":1992.39,"end":1992.47},{"text":"not","start":1992.47,"end":1992.67},{"text":"only","start":1992.67,"end":1992.87},{"text":"cruel,","start":1992.87,"end":1993.43},{"text":"it","start":1993.67,"end":1993.91},{"text":"is","start":1993.91,"end":1994.23},{"text":"unscientific.","start":1994.23,"end":1995.27}]},{"text":"No major health or human rights body recommends it.","start":1995.59,"end":1999.07,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"No","start":1995.59,"end":1995.99},{"text":"major","start":1995.99,"end":1996.47},{"text":"health","start":1996.47,"end":1996.87},{"text":"or","start":1996.95,"end":1997.11},{"text":"human","start":1997.11,"end":1997.51},{"text":"rights","start":1997.51,"end":1997.75},{"text":"body","start":1997.75,"end":1998.15},{"text":"recommends","start":1998.31,"end":1998.95},{"text":"it.","start":1998.95,"end":1999.07}]},{"text":"Next slide, please.","start":1999.51,"end":2000.35,"topics":[],"words":[{"text":"Next","start":1999.51,"end":1999.71},{"text":"slide,","start":1999.71,"end":1999.95},{"text":"please.","start":1999.95,"end":2000.35}]},{"text":"At Harm Reduction Conference 25 in Bogota recently, I said, \"We are not a burden, we are the evidence.","start":2000.67,"end":2007.67,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"At","start":2000.67,"end":2000.75},{"text":"Harm","start":2001.95,"end":2002.19},{"text":"Reduction","start":2002.19,"end":2002.59},{"text":"Conference","start":2002.59,"end":2003.39},{"text":"25","start":2003.63,"end":2004.11},{"text":"in","start":2004.11,"end":2004.27},{"text":"Bogota","start":2004.27,"end":2004.59},{"text":"recently,","start":2004.59,"end":2005.11},{"text":"I","start":2005.11,"end":2005.23},{"text":"said,","start":2005.23,"end":2005.47},{"text":"\"We","start":2005.47,"end":2005.55},{"text":"are","start":2005.55,"end":2005.63},{"text":"not","start":2005.63,"end":2005.91},{"text":"a","start":2005.91,"end":2005.95},{"text":"burden,","start":2005.95,"end":2006.35},{"text":"we","start":2006.35,"end":2006.51},{"text":"are","start":2006.51,"end":2006.83},{"text":"the","start":2006.83,"end":2007.03},{"text":"evidence.","start":2007.07,"end":2007.67}]},{"text":"We are not the problem, we are the frontline solution.\"","start":2007.79,"end":2011.23,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"We","start":2007.79,"end":2008.03},{"text":"are","start":2008.03,"end":2008.11},{"text":"not","start":2008.11,"end":2008.51},{"text":"the","start":2008.51,"end":2008.63},{"text":"problem,","start":2008.63,"end":2009.23},{"text":"we","start":2009.31,"end":2009.59},{"text":"are","start":2009.59,"end":2009.67},{"text":"the","start":2009.67,"end":2009.79},{"text":"frontline","start":2009.79,"end":2010.51},{"text":"solution.\"","start":2010.51,"end":2011.23}]},{"text":"And that message remains true here today in this UN room as we talk about how to reach the Sustainable Development Goals as well.","start":2011.23,"end":2019.55,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"And","start":2011.23,"end":2011.43},{"text":"that","start":2011.43,"end":2011.63},{"text":"message","start":2011.63,"end":2012.03},{"text":"remains","start":2012.03,"end":2012.59},{"text":"true","start":2012.59,"end":2012.83},{"text":"here","start":2012.83,"end":2013.23},{"text":"today","start":2013.31,"end":2013.87},{"text":"in","start":2013.87,"end":2014.03},{"text":"this","start":2014.03,"end":2014.27},{"text":"UN","start":2014.27,"end":2014.59},{"text":"room","start":2014.59,"end":2014.99},{"text":"as","start":2015.63,"end":2015.79},{"text":"we","start":2015.79,"end":2015.95},{"text":"talk","start":2015.95,"end":2016.19},{"text":"about","start":2016.19,"end":2016.51},{"text":"how","start":2016.51,"end":2016.75},{"text":"to","start":2016.75,"end":2016.91},{"text":"reach","start":2016.91,"end":2017.31},{"text":"the","start":2017.31,"end":2017.39},{"text":"Sustainable","start":2017.39,"end":2018.11},{"text":"Development","start":2018.11,"end":2018.67},{"text":"Goals","start":2018.67,"end":2019.03},{"text":"as","start":2019.03,"end":2019.23},{"text":"well.","start":2019.23,"end":2019.55}]},{"text":"SDG 3 will not be achieved if people who use drugs are dying in back alleys and prisons.","start":2019.87,"end":2026.19,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"SDG","start":2019.87,"end":2020.43},{"text":"3","start":2020.43,"end":2020.99},{"text":"will","start":2021.15,"end":2021.47},{"text":"not","start":2021.47,"end":2021.71},{"text":"be","start":2021.71,"end":2021.87},{"text":"achieved","start":2021.87,"end":2022.35},{"text":"if","start":2022.35,"end":2022.51},{"text":"people","start":2022.51,"end":2022.87},{"text":"who","start":2022.87,"end":2022.99},{"text":"use","start":2022.99,"end":2023.19},{"text":"drugs","start":2023.19,"end":2023.55},{"text":"are","start":2023.55,"end":2023.71},{"text":"dying","start":2023.71,"end":2024.19},{"text":"in","start":2024.35,"end":2024.51},{"text":"back","start":2024.51,"end":2024.87},{"text":"alleys","start":2024.87,"end":2025.43},{"text":"and","start":2025.43,"end":2025.59},{"text":"prisons.","start":2025.59,"end":2026.19}]},{"text":"SDG 5 will not be achieved if women who use drugs are criminalized, sterilized, or turned away from care.","start":2026.63,"end":2034.03,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"SDG","start":2026.63,"end":2027.07},{"text":"5","start":2027.07,"end":2027.71},{"text":"will","start":2027.79,"end":2028.11},{"text":"not","start":2028.11,"end":2028.27},{"text":"be","start":2028.27,"end":2028.47},{"text":"achieved","start":2028.47,"end":2028.87},{"text":"if","start":2028.87,"end":2028.99},{"text":"women","start":2028.99,"end":2029.39},{"text":"who","start":2029.39,"end":2029.47},{"text":"use","start":2029.47,"end":2029.67},{"text":"drugs","start":2029.67,"end":2030.11},{"text":"are","start":2030.19,"end":2030.35},{"text":"criminalized,","start":2030.35,"end":2031.19},{"text":"sterilized,","start":2031.47,"end":2032.31},{"text":"or","start":2032.51,"end":2032.75},{"text":"turned","start":2032.75,"end":2033.07},{"text":"away","start":2033.07,"end":2033.39},{"text":"from","start":2033.39,"end":2033.63},{"text":"care.","start":2033.63,"end":2034.03}]},{"text":"SDG 16 will not be achieved if police violence and punitive drug laws remain the first point of contact between us and the state.","start":2034.35,"end":2043.07,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"SDG","start":2034.35,"end":2034.91},{"text":"16","start":2034.91,"end":2035.63},{"text":"will","start":2035.79,"end":2036.11},{"text":"not","start":2036.11,"end":2036.27},{"text":"be","start":2036.27,"end":2036.47},{"text":"achieved","start":2036.47,"end":2036.83},{"text":"if","start":2036.83,"end":2036.99},{"text":"police","start":2036.99,"end":2037.31},{"text":"violence","start":2037.31,"end":2037.95},{"text":"and","start":2038.07,"end":2038.23},{"text":"punitive","start":2038.23,"end":2038.75},{"text":"drug","start":2038.75,"end":2039.03},{"text":"laws","start":2039.03,"end":2039.47},{"text":"remain","start":2039.55,"end":2039.87},{"text":"the","start":2039.87,"end":2039.99},{"text":"first","start":2039.99,"end":2040.35},{"text":"point","start":2040.35,"end":2040.71},{"text":"of","start":2040.71,"end":2040.83},{"text":"contact","start":2040.83,"end":2041.27},{"text":"between","start":2041.39,"end":2041.87},{"text":"us","start":2041.87,"end":2042.19},{"text":"and","start":2042.27,"end":2042.51},{"text":"the","start":2042.51,"end":2042.59},{"text":"state.","start":2042.59,"end":2043.07}]},{"text":"Next slide, please.","start":2043.39,"end":2044.27,"topics":[],"words":[{"text":"Next","start":2043.39,"end":2043.67},{"text":"slide,","start":2043.67,"end":2043.95},{"text":"please.","start":2043.95,"end":2044.27}]},{"text":"To turn the tide, we need bold policy reforms.","start":2045.55,"end":2048.91,"topics":[],"words":[{"text":"To","start":2045.55,"end":2045.71},{"text":"turn","start":2045.71,"end":2046.03},{"text":"the","start":2046.03,"end":2046.15},{"text":"tide,","start":2046.15,"end":2046.67},{"text":"we","start":2046.83,"end":2047.07},{"text":"need","start":2047.07,"end":2047.47},{"text":"bold","start":2047.47,"end":2047.83},{"text":"policy","start":2047.83,"end":2048.31},{"text":"reforms.","start":2048.31,"end":2048.91}]},{"text":"First, decriminalize drug use and possession.","start":2048.91,"end":2052.35,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"First,","start":2048.91,"end":2049.47},{"text":"decriminalize","start":2049.55,"end":2051.07},{"text":"drug","start":2051.07,"end":2051.31},{"text":"use","start":2051.31,"end":2051.59},{"text":"and","start":2051.59,"end":2051.71},{"text":"possession.","start":2051.71,"end":2052.35}]},{"text":"Removing criminal penalties is the critical legal reform for public health.","start":2052.79,"end":2056.79,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Removing","start":2052.79,"end":2053.15},{"text":"criminal","start":2053.15,"end":2053.55},{"text":"penalties","start":2053.55,"end":2054.19},{"text":"is","start":2054.19,"end":2054.35},{"text":"the","start":2054.35,"end":2054.43},{"text":"critical","start":2054.43,"end":2055.07},{"text":"legal","start":2055.07,"end":2055.31},{"text":"reform","start":2055.31,"end":2055.79},{"text":"for","start":2055.87,"end":2056.03},{"text":"public","start":2056.03,"end":2056.43},{"text":"health.","start":2056.43,"end":2056.79}]},{"text":"Evidence shows that decriminalization reduces HIV infections and saves lives.","start":2057.07,"end":2062.11,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"Evidence","start":2057.07,"end":2057.55},{"text":"shows","start":2057.55,"end":2058.03},{"text":"that","start":2058.03,"end":2058.27},{"text":"decriminalization","start":2058.27,"end":2059.39},{"text":"reduces","start":2059.47,"end":2060.03},{"text":"HIV","start":2060.03,"end":2060.31},{"text":"infections","start":2060.31,"end":2060.91},{"text":"and","start":2061.07,"end":2061.27},{"text":"saves","start":2061.27,"end":2061.67},{"text":"lives.","start":2061.67,"end":2062.11}]},{"text":"Modeling suggests averting one-third to one-half of new infections among sex workers, for example, each time governments acted.","start":2062.43,"end":2071.27,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"Modeling","start":2062.43,"end":2063.15},{"text":"suggests","start":2063.15,"end":2063.79},{"text":"averting","start":2063.79,"end":2064.35},{"text":"one-third","start":2064.35,"end":2064.99},{"text":"to","start":2064.99,"end":2065.19},{"text":"one-half","start":2065.19,"end":2065.83},{"text":"of","start":2065.83,"end":2065.95},{"text":"new","start":2065.95,"end":2066.11},{"text":"infections","start":2066.11,"end":2066.75},{"text":"among","start":2066.91,"end":2067.23},{"text":"sex","start":2067.23,"end":2067.55},{"text":"workers,","start":2067.55,"end":2067.99},{"text":"for","start":2067.99,"end":2068.19},{"text":"example,","start":2068.19,"end":2068.75},{"text":"each","start":2069.31,"end":2069.51},{"text":"time","start":2069.51,"end":2070.11},{"text":"governments","start":2070.11,"end":2070.75},{"text":"acted.","start":2070.83,"end":2071.27}]},{"text":"Key population networks demand that decriminalization be at the heart of any effective HIV and health strategy.","start":2072.39,"end":2079.71,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Key","start":2072.39,"end":2072.51},{"text":"population","start":2072.51,"end":2073.19},{"text":"networks","start":2073.19,"end":2073.63},{"text":"demand","start":2073.63,"end":2074.11},{"text":"that","start":2074.11,"end":2074.27},{"text":"decriminalization","start":2074.27,"end":2075.31},{"text":"be","start":2075.31,"end":2075.63},{"text":"at","start":2075.63,"end":2075.79},{"text":"the","start":2075.79,"end":2075.91},{"text":"heart","start":2075.91,"end":2076.27},{"text":"of","start":2076.39,"end":2076.51},{"text":"any","start":2076.59,"end":2076.91},{"text":"effective","start":2077.07,"end":2077.71},{"text":"HIV","start":2077.79,"end":2078.43},{"text":"and","start":2078.43,"end":2078.55},{"text":"health","start":2078.55,"end":2078.91},{"text":"strategy.","start":2078.99,"end":2079.71}]},{"text":"Only by taking the threat of arrest off the table can people who use drugs seek help and practice safer use without fear.","start":2079.95,"end":2088.35,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"Only","start":2079.95,"end":2080.27},{"text":"by","start":2080.27,"end":2080.51},{"text":"taking","start":2080.51,"end":2080.91},{"text":"the","start":2080.91,"end":2081.07},{"text":"threat","start":2081.07,"end":2081.55},{"text":"of","start":2081.55,"end":2081.67},{"text":"arrest","start":2081.67,"end":2082.11},{"text":"off","start":2082.11,"end":2082.43},{"text":"the","start":2082.43,"end":2082.51},{"text":"table","start":2082.51,"end":2083.23},{"text":"can","start":2083.31,"end":2083.63},{"text":"people","start":2083.95,"end":2084.31},{"text":"who","start":2084.31,"end":2084.43},{"text":"use","start":2084.43,"end":2084.71},{"text":"drugs","start":2084.71,"end":2085.03},{"text":"seek","start":2085.03,"end":2085.39},{"text":"help","start":2085.39,"end":2085.71},{"text":"and","start":2085.91,"end":2086.11},{"text":"practice","start":2086.11,"end":2086.63},{"text":"safer","start":2086.63,"end":2086.99},{"text":"use","start":2086.99,"end":2087.31},{"text":"without","start":2087.47,"end":2087.95},{"text":"fear.","start":2087.95,"end":2088.35}]},{"text":"Second, recognize and fund community-led organizations as equal partners.","start":2088.83,"end":2093.79,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"Second,","start":2088.83,"end":2089.39},{"text":"recognize","start":2089.63,"end":2090.43},{"text":"and","start":2090.51,"end":2090.75},{"text":"fund","start":2090.75,"end":2091.15},{"text":"community-led","start":2091.23,"end":2091.99},{"text":"organizations","start":2091.99,"end":2092.71},{"text":"as","start":2092.71,"end":2092.91},{"text":"equal","start":2092.91,"end":2093.15},{"text":"partners.","start":2093.15,"end":2093.79}]},{"text":"As our survey makes clear, the majority of frontline services today are run by peers and grassroots groups.","start":2094.03,"end":2102.19,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"As","start":2094.03,"end":2094.27},{"text":"our","start":2094.27,"end":2094.51},{"text":"survey","start":2094.51,"end":2095.15},{"text":"makes","start":2095.39,"end":2095.87},{"text":"clear,","start":2095.91,"end":2096.27},{"text":"the","start":2096.27,"end":2096.39},{"text":"majority","start":2096.39,"end":2097.15},{"text":"of","start":2097.15,"end":2097.23},{"text":"frontline","start":2097.23,"end":2097.79},{"text":"services","start":2097.79,"end":2098.43},{"text":"today","start":2099.63,"end":2100.11},{"text":"are","start":2100.11,"end":2100.39},{"text":"run","start":2100.39,"end":2100.59},{"text":"by","start":2100.59,"end":2100.75},{"text":"peers","start":2100.75,"end":2101.15},{"text":"and","start":2101.15,"end":2101.27},{"text":"grassroots","start":2101.27,"end":2101.71},{"text":"groups.","start":2101.75,"end":2102.19}]},{"text":"Yet these groups operate on shoestring budgets.","start":2102.27,"end":2105.51,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"Yet","start":2102.27,"end":2102.59},{"text":"these","start":2102.59,"end":2102.91},{"text":"groups","start":2102.91,"end":2103.23},{"text":"operate","start":2103.23,"end":2103.71},{"text":"on","start":2103.79,"end":2104.03},{"text":"shoestring","start":2104.11,"end":2104.99},{"text":"budgets.","start":2104.99,"end":2105.51}]},{"text":"Communities deliver results, but chronic underfunding and rigid grant rules keep them from scaling up.","start":2106.15,"end":2111.63,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"Communities","start":2106.15,"end":2106.83},{"text":"deliver","start":2106.83,"end":2107.19},{"text":"results,","start":2107.19,"end":2107.71},{"text":"but","start":2107.71,"end":2107.99},{"text":"chronic","start":2107.99,"end":2108.35},{"text":"underfunding","start":2108.35,"end":2109.11},{"text":"and","start":2109.11,"end":2109.31},{"text":"rigid","start":2109.31,"end":2109.63},{"text":"grant","start":2109.63,"end":2110.03},{"text":"rules","start":2110.03,"end":2110.43},{"text":"keep","start":2110.55,"end":2110.71},{"text":"them","start":2110.71,"end":2110.87},{"text":"from","start":2110.87,"end":2111.07},{"text":"scaling","start":2111.07,"end":2111.47},{"text":"up.","start":2111.47,"end":2111.63}]},{"text":"We urge donors and governments to prioritize core and flexible funding for drug users networks.","start":2111.79,"end":2117.91,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"We","start":2111.79,"end":2112.27},{"text":"urge","start":2112.27,"end":2112.59},{"text":"donors","start":2112.59,"end":2113.15},{"text":"and","start":2113.23,"end":2113.43},{"text":"governments","start":2113.43,"end":2113.95},{"text":"to","start":2113.95,"end":2114.23},{"text":"prioritize","start":2114.23,"end":2114.99},{"text":"core","start":2114.99,"end":2115.63},{"text":"and","start":2115.63,"end":2115.95},{"text":"flexible","start":2115.95,"end":2116.51},{"text":"funding","start":2116.51,"end":2116.91},{"text":"for","start":2116.91,"end":2117.03},{"text":"drug","start":2117.03,"end":2117.23},{"text":"users","start":2117.23,"end":2117.51},{"text":"networks.","start":2117.51,"end":2117.91}]},{"text":"Trust these organizations with resources, not just as implementers, but as a strategic partners.","start":2118.27,"end":2124.19,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Trust","start":2118.27,"end":2118.67},{"text":"these","start":2118.67,"end":2118.99},{"text":"organizations","start":2118.99,"end":2119.87},{"text":"with","start":2120.03,"end":2120.35},{"text":"resources,","start":2120.35,"end":2121.07},{"text":"not","start":2121.23,"end":2121.51},{"text":"just","start":2121.51,"end":2121.79},{"text":"as","start":2121.79,"end":2121.91},{"text":"implementers,","start":2121.91,"end":2122.59},{"text":"but","start":2122.59,"end":2122.83},{"text":"as","start":2122.83,"end":2122.95},{"text":"a","start":2122.95,"end":2122.99},{"text":"strategic","start":2122.99,"end":2123.67},{"text":"partners.","start":2123.67,"end":2124.19}]},{"text":"This means fair remuneration for peer outreach, less punitive grant conditions, no more punishing results only funding, and long-term investment in our infrastructure.","start":2124.67,"end":2135.07,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"This","start":2124.67,"end":2124.99},{"text":"means","start":2124.99,"end":2125.39},{"text":"fair","start":2125.71,"end":2125.91},{"text":"remuneration","start":2125.91,"end":2126.67},{"text":"for","start":2126.67,"end":2126.91},{"text":"peer","start":2126.91,"end":2127.23},{"text":"outreach,","start":2127.23,"end":2127.79},{"text":"less","start":2128.03,"end":2128.35},{"text":"punitive","start":2128.35,"end":2128.83},{"text":"grant","start":2128.83,"end":2129.07},{"text":"conditions,","start":2129.07,"end":2129.71},{"text":"no","start":2129.95,"end":2130.27},{"text":"more","start":2130.27,"end":2130.43},{"text":"punishing","start":2130.43,"end":2130.95},{"text":"results","start":2130.95,"end":2131.47},{"text":"only","start":2131.47,"end":2131.79},{"text":"funding,","start":2131.79,"end":2132.43},{"text":"and","start":2132.51,"end":2132.71},{"text":"long-term","start":2132.71,"end":2133.19},{"text":"investment","start":2133.19,"end":2133.79},{"text":"in","start":2133.87,"end":2134.03},{"text":"our","start":2134.03,"end":2134.27},{"text":"infrastructure.","start":2134.27,"end":2135.07}]},{"text":"In the words of many in our community, Leap service to organizations have equitable budgets and real power in decision making.","start":2135.39,"end":2142.79,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"In","start":2135.39,"end":2135.55},{"text":"the","start":2135.55,"end":2135.67},{"text":"words","start":2135.67,"end":2135.99},{"text":"of","start":2135.99,"end":2136.11},{"text":"many","start":2136.11,"end":2136.39},{"text":"in","start":2136.39,"end":2136.51},{"text":"our","start":2136.51,"end":2136.67},{"text":"community,","start":2136.67,"end":2137.39},{"text":"Leap","start":2137.39,"end":2137.71},{"text":"service","start":2137.71,"end":2138.11},{"text":"to","start":2138.11,"end":2138.23},{"text":"organizations","start":2138.23,"end":2139.07},{"text":"have","start":2139.23,"end":2139.55},{"text":"equitable","start":2139.63,"end":2140.19},{"text":"budgets","start":2140.19,"end":2140.67},{"text":"and","start":2140.79,"end":2140.99},{"text":"real","start":2140.99,"end":2141.23},{"text":"power","start":2141.23,"end":2141.71},{"text":"in","start":2141.79,"end":2141.95},{"text":"decision","start":2141.95,"end":2142.43},{"text":"making.","start":2142.43,"end":2142.79}]},{"text":"Next slide, please.","start":2142.83,"end":2143.79,"topics":[],"words":[{"text":"Next","start":2142.83,"end":2143.19},{"text":"slide,","start":2143.19,"end":2143.43},{"text":"please.","start":2143.43,"end":2143.79}]},{"text":"Third, repeal punitive and discriminatory laws that block health access.","start":2145.39,"end":2149.39,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Third,","start":2145.39,"end":2145.63},{"text":"repeal","start":2145.87,"end":2146.27},{"text":"punitive","start":2146.27,"end":2146.83},{"text":"and","start":2146.83,"end":2147.03},{"text":"discriminatory","start":2147.03,"end":2147.71},{"text":"laws","start":2147.71,"end":2148.19},{"text":"that","start":2148.19,"end":2148.35},{"text":"block","start":2148.35,"end":2148.67},{"text":"health","start":2148.67,"end":2148.99},{"text":"access.","start":2148.99,"end":2149.39}]},{"text":"We need an end to laws that drive people into the streets.","start":2149.47,"end":2152.67,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"We","start":2149.47,"end":2149.63},{"text":"need","start":2149.63,"end":2149.87},{"text":"an","start":2149.87,"end":2150.03},{"text":"end","start":2150.03,"end":2150.23},{"text":"to","start":2150.23,"end":2150.43},{"text":"laws","start":2150.43,"end":2150.83},{"text":"that","start":2150.83,"end":2150.99},{"text":"drive","start":2150.99,"end":2151.39},{"text":"people","start":2151.39,"end":2151.71},{"text":"into","start":2151.71,"end":2152.03},{"text":"the","start":2152.03,"end":2152.15},{"text":"streets.","start":2152.15,"end":2152.67}]},{"text":"Stop and search, compulsory detention treatment, age-old, vagrancy or morality laws that target drug users.","start":2152.75,"end":2160.51,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Stop","start":2152.75,"end":2153.23},{"text":"and","start":2153.23,"end":2153.55},{"text":"search,","start":2153.55,"end":2154.19},{"text":"compulsory","start":2154.39,"end":2155.03},{"text":"detention","start":2155.03,"end":2155.63},{"text":"treatment,","start":2155.63,"end":2156.27},{"text":"age-old,","start":2156.27,"end":2157.39},{"text":"vagrancy","start":2157.47,"end":2158.11},{"text":"or","start":2158.11,"end":2158.27},{"text":"morality","start":2158.27,"end":2158.83},{"text":"laws","start":2158.83,"end":2159.23},{"text":"that","start":2159.23,"end":2159.51},{"text":"target","start":2159.51,"end":2159.83},{"text":"drug","start":2159.83,"end":2160.07},{"text":"users.","start":2160.07,"end":2160.51}]},{"text":"Every country with harmful drug laws is a lost opportunity to curb HIV and hepatitis.","start":2161.15,"end":2167.31,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"Every","start":2161.15,"end":2161.55},{"text":"country","start":2161.55,"end":2162.11},{"text":"with","start":2162.11,"end":2162.35},{"text":"harmful","start":2162.35,"end":2162.83},{"text":"drug","start":2162.83,"end":2163.07},{"text":"laws","start":2163.07,"end":2163.47},{"text":"is","start":2163.79,"end":2163.99},{"text":"a","start":2163.99,"end":2164.03},{"text":"lost","start":2164.03,"end":2164.39},{"text":"opportunity","start":2164.39,"end":2165.15},{"text":"to","start":2165.15,"end":2165.31},{"text":"curb","start":2165.31,"end":2165.75},{"text":"HIV","start":2165.87,"end":2166.51},{"text":"and","start":2166.51,"end":2166.75},{"text":"hepatitis.","start":2166.75,"end":2167.31}]},{"text":"Input and other Global Key Population Network position paper reminds us that criminalization, stigma, and anti-rights movements all undermine public health.","start":2168.03,"end":2177.47,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"Input","start":2168.03,"end":2168.43},{"text":"and","start":2168.43,"end":2168.63},{"text":"other","start":2168.63,"end":2168.83},{"text":"Global","start":2168.83,"end":2169.11},{"text":"Key","start":2169.11,"end":2169.27},{"text":"Population","start":2169.27,"end":2169.87},{"text":"Network","start":2169.87,"end":2170.19},{"text":"position","start":2170.19,"end":2170.63},{"text":"paper","start":2170.63,"end":2171.19},{"text":"reminds","start":2171.59,"end":2172.15},{"text":"us","start":2172.15,"end":2172.47},{"text":"that","start":2172.47,"end":2172.71},{"text":"criminalization,","start":2172.71,"end":2173.75},{"text":"stigma,","start":2173.75,"end":2174.43},{"text":"and","start":2174.43,"end":2174.59},{"text":"anti-rights","start":2174.59,"end":2175.19},{"text":"movements","start":2175.19,"end":2175.75},{"text":"all","start":2175.83,"end":2176.19},{"text":"undermine","start":2176.19,"end":2176.79},{"text":"public","start":2176.79,"end":2177.19},{"text":"health.","start":2177.19,"end":2177.47}]},{"text":"Governments must roll back laws that ban needle exchange, that detain pregnant people who use drugs, or that stigmatize those who test positive for HIV or hepatitis C. We must integrate healthcare with dignity.","start":2177.91,"end":2190.71,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Governments","start":2177.91,"end":2178.55},{"text":"must","start":2178.71,"end":2179.27},{"text":"roll","start":2179.27,"end":2179.59},{"text":"back","start":2179.59,"end":2180.15},{"text":"laws","start":2180.23,"end":2180.63},{"text":"that","start":2180.63,"end":2180.87},{"text":"ban","start":2180.87,"end":2181.31},{"text":"needle","start":2181.31,"end":2181.59},{"text":"exchange,","start":2181.59,"end":2182.15},{"text":"that","start":2182.31,"end":2182.47},{"text":"detain","start":2182.47,"end":2182.87},{"text":"pregnant","start":2182.87,"end":2183.31},{"text":"people","start":2183.31,"end":2183.59},{"text":"who","start":2183.59,"end":2183.75},{"text":"use","start":2183.75,"end":2183.95},{"text":"drugs,","start":2183.95,"end":2184.47},{"text":"or","start":2184.55,"end":2184.79},{"text":"that","start":2184.79,"end":2184.95},{"text":"stigmatize","start":2184.95,"end":2185.67},{"text":"those","start":2185.67,"end":2185.99},{"text":"who","start":2185.99,"end":2186.07},{"text":"test","start":2186.07,"end":2186.31},{"text":"positive","start":2186.31,"end":2186.71},{"text":"for","start":2186.71,"end":2186.91},{"text":"HIV","start":2186.91,"end":2187.23},{"text":"or","start":2187.23,"end":2187.35},{"text":"hepatitis","start":2187.35,"end":2187.95},{"text":"C.","start":2187.95,"end":2188.23},{"text":"We","start":2188.31,"end":2188.47},{"text":"must","start":2188.47,"end":2188.79},{"text":"integrate","start":2188.79,"end":2189.35},{"text":"healthcare","start":2189.35,"end":2189.83},{"text":"with","start":2189.83,"end":2190.03},{"text":"dignity.","start":2190.03,"end":2190.71}]},{"text":"As our survey respondents reported, cutting harm reduction has already caused fatal outcomes Imagine the lives saved if instead we invested in compassionate care from the start.","start":2190.75,"end":2202.71,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"As","start":2190.75,"end":2190.95},{"text":"our","start":2190.95,"end":2191.19},{"text":"survey","start":2191.19,"end":2191.75},{"text":"respondents","start":2191.83,"end":2192.55},{"text":"reported,","start":2192.55,"end":2193.11},{"text":"cutting","start":2193.27,"end":2193.71},{"text":"harm","start":2193.71,"end":2193.95},{"text":"reduction","start":2193.95,"end":2194.47},{"text":"has","start":2194.63,"end":2194.87},{"text":"already","start":2194.87,"end":2195.27},{"text":"caused","start":2195.27,"end":2195.67},{"text":"fatal","start":2195.75,"end":2196.39},{"text":"outcomes","start":2196.39,"end":2196.95},{"text":"Imagine","start":2197.43,"end":2197.91},{"text":"the","start":2197.91,"end":2197.99},{"text":"lives","start":2197.99,"end":2198.39},{"text":"saved","start":2198.39,"end":2198.95},{"text":"if","start":2199.31,"end":2199.43},{"text":"instead","start":2199.43,"end":2199.99},{"text":"we","start":2200.07,"end":2200.27},{"text":"invested","start":2200.27,"end":2200.87},{"text":"in","start":2200.95,"end":2201.11},{"text":"compassionate","start":2201.11,"end":2201.67},{"text":"care","start":2201.67,"end":2201.95},{"text":"from","start":2201.95,"end":2202.15},{"text":"the","start":2202.15,"end":2202.23},{"text":"start.","start":2202.23,"end":2202.71}]},{"text":"And finally, put people who use drugs in the driver's seat.","start":2203.11,"end":2207.79,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"And","start":2203.11,"end":2203.27},{"text":"finally,","start":2203.27,"end":2203.91},{"text":"put","start":2204.35,"end":2204.71},{"text":"people","start":2204.87,"end":2205.35},{"text":"who","start":2205.35,"end":2205.51},{"text":"use","start":2205.51,"end":2205.75},{"text":"drugs","start":2205.75,"end":2206.23},{"text":"in","start":2206.71,"end":2206.87},{"text":"the","start":2206.87,"end":2206.95},{"text":"driver's","start":2206.95,"end":2207.47},{"text":"seat.","start":2207.47,"end":2207.79}]},{"text":"We are the ones who know these problems inside and out.","start":2207.91,"end":2210.71,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"We","start":2207.91,"end":2208.19},{"text":"are","start":2208.19,"end":2208.31},{"text":"the","start":2208.31,"end":2208.43},{"text":"ones","start":2208.43,"end":2208.79},{"text":"who","start":2208.79,"end":2208.87},{"text":"know","start":2208.87,"end":2209.19},{"text":"these","start":2209.19,"end":2209.39},{"text":"problems","start":2209.39,"end":2209.83},{"text":"inside","start":2209.83,"end":2210.23},{"text":"and","start":2210.23,"end":2210.39},{"text":"out.","start":2210.39,"end":2210.71}]},{"text":"Every policy, every program should include us meaningfully at every stage.","start":2210.95,"end":2216.31,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Every","start":2210.95,"end":2211.35},{"text":"policy,","start":2211.35,"end":2211.91},{"text":"every","start":2211.91,"end":2212.31},{"text":"program","start":2212.31,"end":2212.79},{"text":"should","start":2212.95,"end":2213.19},{"text":"include","start":2213.19,"end":2213.59},{"text":"us","start":2213.67,"end":2213.99},{"text":"meaningfully","start":2214.15,"end":2214.95},{"text":"at","start":2214.95,"end":2215.11},{"text":"every","start":2215.11,"end":2215.67},{"text":"stage.","start":2215.75,"end":2216.31}]},{"text":"This means representation on national drug commissions and health planning committees.","start":2216.79,"end":2221.83,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"This","start":2216.79,"end":2216.95},{"text":"means","start":2216.95,"end":2217.35},{"text":"representation","start":2217.51,"end":2218.47},{"text":"on","start":2218.47,"end":2218.91},{"text":"national","start":2218.91,"end":2219.35},{"text":"drug","start":2219.35,"end":2219.59},{"text":"commissions","start":2219.59,"end":2220.31},{"text":"and","start":2220.39,"end":2220.59},{"text":"health","start":2220.59,"end":2220.91},{"text":"planning","start":2220.91,"end":2221.27},{"text":"committees.","start":2221.27,"end":2221.83}]},{"text":"But more importantly, it means power sharing, actual decision-making authority, not just talking consultations.","start":2221.99,"end":2229.27,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"But","start":2221.99,"end":2222.23},{"text":"more","start":2222.23,"end":2222.47},{"text":"importantly,","start":2222.47,"end":2223.07},{"text":"it","start":2223.07,"end":2223.27},{"text":"means","start":2223.27,"end":2223.67},{"text":"power","start":2223.83,"end":2224.39},{"text":"sharing,","start":2224.55,"end":2225.11},{"text":"actual","start":2225.11,"end":2225.55},{"text":"decision-making","start":2225.55,"end":2226.31},{"text":"authority,","start":2226.31,"end":2226.75},{"text":"not","start":2226.75,"end":2227.03},{"text":"just","start":2227.03,"end":2227.43},{"text":"talking","start":2227.71,"end":2228.15},{"text":"consultations.","start":2228.15,"end":2229.27}]},{"text":"The path to ending HIV and improving health for all is to value the expertise of people who use drugs alongside scientists and clinicians.","start":2229.75,"end":2238.71,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"The","start":2229.75,"end":2229.87},{"text":"path","start":2229.91,"end":2230.11},{"text":"to","start":2230.11,"end":2230.31},{"text":"ending","start":2230.31,"end":2230.75},{"text":"HIV","start":2230.75,"end":2231.23},{"text":"and","start":2231.23,"end":2231.35},{"text":"improving","start":2231.35,"end":2231.79},{"text":"health","start":2231.79,"end":2232.15},{"text":"for","start":2232.39,"end":2232.67},{"text":"all","start":2232.67,"end":2232.95},{"text":"is","start":2232.95,"end":2233.19},{"text":"to","start":2233.19,"end":2233.35},{"text":"value","start":2233.35,"end":2233.91},{"text":"the","start":2234.23,"end":2234.35},{"text":"expertise","start":2234.35,"end":2234.99},{"text":"of","start":2234.99,"end":2235.11},{"text":"people","start":2235.11,"end":2235.47},{"text":"who","start":2235.47,"end":2235.55},{"text":"use","start":2235.55,"end":2235.75},{"text":"drugs","start":2235.75,"end":2236.23},{"text":"alongside","start":2236.87,"end":2237.43},{"text":"scientists","start":2237.43,"end":2237.95},{"text":"and","start":2237.95,"end":2238.07},{"text":"clinicians.","start":2238.07,"end":2238.71}]},{"text":"We ask UN agencies, member states, and donors, center us, listen to us.","start":2238.71,"end":2243.59,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"We","start":2238.71,"end":2238.95},{"text":"ask","start":2239.03,"end":2239.27},{"text":"UN","start":2239.27,"end":2239.51},{"text":"agencies,","start":2239.51,"end":2240.15},{"text":"member","start":2240.31,"end":2240.71},{"text":"states,","start":2240.71,"end":2241.11},{"text":"and","start":2241.11,"end":2241.31},{"text":"donors,","start":2241.31,"end":2241.71},{"text":"center","start":2241.71,"end":2242.35},{"text":"us,","start":2242.35,"end":2242.55},{"text":"listen","start":2242.63,"end":2243.03},{"text":"to","start":2243.03,"end":2243.27},{"text":"us.","start":2243.27,"end":2243.59}]},{"text":"as equals, the position papers, vision of communities at the center isn't abstract, is the only way to ensure policies work on the ground.","start":2244.07,"end":2253.19,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"as","start":2244.07,"end":2244.63},{"text":"equals,","start":2244.63,"end":2245.27},{"text":"the","start":2245.51,"end":2245.63},{"text":"position","start":2245.63,"end":2246.15},{"text":"papers,","start":2246.15,"end":2246.59},{"text":"vision","start":2246.59,"end":2246.95},{"text":"of","start":2246.95,"end":2247.03},{"text":"communities","start":2247.03,"end":2247.63},{"text":"at","start":2247.63,"end":2247.75},{"text":"the","start":2247.75,"end":2247.87},{"text":"center","start":2247.87,"end":2248.39},{"text":"isn't","start":2248.39,"end":2248.75},{"text":"abstract,","start":2248.75,"end":2249.19},{"text":"is","start":2249.59,"end":2249.75},{"text":"the","start":2249.75,"end":2249.87},{"text":"only","start":2249.99,"end":2250.39},{"text":"way","start":2250.39,"end":2250.71},{"text":"to","start":2250.71,"end":2250.87},{"text":"ensure","start":2250.91,"end":2251.35},{"text":"policies","start":2251.35,"end":2251.83},{"text":"work","start":2251.83,"end":2252.19},{"text":"on","start":2252.43,"end":2252.55},{"text":"the","start":2252.55,"end":2252.71},{"text":"ground.","start":2252.71,"end":2253.19}]},{"text":"And in closing, I call on governments, donors, and UN bodies to act on these facts and values now, right now.","start":2253.51,"end":2261.99,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"And","start":2253.51,"end":2253.91},{"text":"in","start":2253.91,"end":2254.07},{"text":"closing,","start":2254.07,"end":2254.71},{"text":"I","start":2255.27,"end":2255.35},{"text":"call","start":2255.35,"end":2255.59},{"text":"on","start":2255.59,"end":2255.67},{"text":"governments,","start":2255.67,"end":2256.23},{"text":"donors,","start":2256.31,"end":2256.71},{"text":"and","start":2256.71,"end":2256.87},{"text":"UN","start":2256.87,"end":2257.11},{"text":"bodies","start":2257.11,"end":2257.51},{"text":"to","start":2257.75,"end":2257.91},{"text":"act","start":2257.91,"end":2258.23},{"text":"on","start":2258.23,"end":2258.39},{"text":"these","start":2258.39,"end":2258.63},{"text":"facts","start":2258.63,"end":2259.03},{"text":"and","start":2259.11,"end":2259.35},{"text":"values","start":2259.35,"end":2259.83},{"text":"now,","start":2259.91,"end":2260.31},{"text":"right","start":2260.79,"end":2261.35},{"text":"now.","start":2261.59,"end":2261.99}]},{"text":"The data is clear and the moral choice is clear.","start":2262.23,"end":2265.27,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"The","start":2262.23,"end":2262.43},{"text":"data","start":2262.43,"end":2262.79},{"text":"is","start":2262.79,"end":2262.95},{"text":"clear","start":2262.95,"end":2263.43},{"text":"and","start":2263.59,"end":2263.79},{"text":"the","start":2263.79,"end":2263.87},{"text":"moral","start":2263.87,"end":2264.23},{"text":"choice","start":2264.23,"end":2264.63},{"text":"is","start":2264.63,"end":2264.87},{"text":"clear.","start":2264.87,"end":2265.27}]},{"text":"Prioritize human life, community leadership, and justice in global drug policy.","start":2265.59,"end":2270.31,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Prioritize","start":2265.59,"end":2266.19},{"text":"human","start":2266.19,"end":2266.47},{"text":"life,","start":2266.47,"end":2266.79},{"text":"community","start":2267.15,"end":2267.67},{"text":"leadership,","start":2267.67,"end":2268.23},{"text":"and","start":2268.55,"end":2268.71},{"text":"justice","start":2268.71,"end":2269.11},{"text":"in","start":2269.11,"end":2269.23},{"text":"global","start":2269.23,"end":2269.55},{"text":"drug","start":2269.55,"end":2269.75},{"text":"policy.","start":2269.75,"end":2270.31}]},{"text":"The question is not if we will act, but how urgently we will begin.","start":2270.63,"end":2275.03,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"The","start":2270.63,"end":2270.75},{"text":"question","start":2270.79,"end":2271.19},{"text":"is","start":2271.19,"end":2271.35},{"text":"not","start":2271.35,"end":2271.59},{"text":"if","start":2271.59,"end":2271.75},{"text":"we","start":2271.75,"end":2271.91},{"text":"will","start":2271.91,"end":2272.31},{"text":"act,","start":2272.31,"end":2272.63},{"text":"but","start":2273.07,"end":2273.19},{"text":"how","start":2273.19,"end":2273.43},{"text":"urgently","start":2273.43,"end":2274.15},{"text":"we","start":2274.15,"end":2274.31},{"text":"will","start":2274.35,"end":2274.51},{"text":"begin.","start":2274.51,"end":2275.03}]},{"text":"Let's not wait for more lives to be lost.","start":2275.51,"end":2277.63,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Let's","start":2275.51,"end":2275.83},{"text":"not","start":2275.83,"end":2275.99},{"text":"wait","start":2275.99,"end":2276.39},{"text":"for","start":2276.39,"end":2276.55},{"text":"more","start":2276.55,"end":2276.75},{"text":"lives","start":2276.75,"end":2277.03},{"text":"to","start":2277.03,"end":2277.19},{"text":"be","start":2277.19,"end":2277.31},{"text":"lost.","start":2277.31,"end":2277.63}]},{"text":"Let's build a future where people who use drugs don't just survive, we lead, we thrive, and we are no longer punished for being who we are.","start":2278.23,"end":2287.27,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Let's","start":2278.23,"end":2278.59},{"text":"build","start":2278.63,"end":2278.91},{"text":"a","start":2278.91,"end":2278.95},{"text":"future","start":2278.95,"end":2279.23},{"text":"where","start":2279.23,"end":2279.39},{"text":"people","start":2279.39,"end":2279.63},{"text":"who","start":2279.63,"end":2279.75},{"text":"use","start":2279.75,"end":2279.95},{"text":"drugs","start":2279.95,"end":2280.39},{"text":"don't","start":2280.71,"end":2281.07},{"text":"just","start":2281.07,"end":2281.31},{"text":"survive,","start":2281.31,"end":2281.83},{"text":"we","start":2281.91,"end":2282.15},{"text":"lead,","start":2282.15,"end":2282.55},{"text":"we","start":2282.87,"end":2283.11},{"text":"thrive,","start":2283.11,"end":2283.67},{"text":"and","start":2283.91,"end":2284.15},{"text":"we","start":2284.15,"end":2284.27},{"text":"are","start":2284.27,"end":2284.35},{"text":"no","start":2284.35,"end":2284.55},{"text":"longer","start":2284.55,"end":2284.95},{"text":"punished","start":2284.95,"end":2285.43},{"text":"for","start":2285.59,"end":2285.75},{"text":"being","start":2285.75,"end":2286.23},{"text":"who","start":2286.67,"end":2286.75},{"text":"we","start":2286.75,"end":2286.95},{"text":"are.","start":2286.95,"end":2287.27}]},{"text":"Next slide.","start":2287.91,"end":2288.63,"topics":[],"words":[{"text":"Next","start":2287.91,"end":2288.23},{"text":"slide.","start":2288.23,"end":2288.63}]},{"text":"Thank you.","start":2290.07,"end":2290.47,"topics":[],"words":[{"text":"Thank","start":2290.07,"end":2290.39},{"text":"you.","start":2290.39,"end":2290.47}]}]}],"speaker":{"affiliation":"INPUD","group":null,"function":"Executive Director","affiliation_full":"INPUD"}},{"statement_number":10,"start":2298.07,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=38:19","paragraphs":[{"sentences":[{"text":"I would like to thank Mr. Anto Vasinco for your intervention and a very important one.","start":2298.07,"end":2305.11,"topics":[],"words":[{"text":"I","start":2298.07,"end":2298.23},{"text":"would","start":2298.23,"end":2298.39},{"text":"like","start":2298.39,"end":2298.71},{"text":"to","start":2298.71,"end":2298.83},{"text":"thank","start":2298.87,"end":2299.27},{"text":"Mr.","start":2299.27,"end":2299.63},{"text":"Anto","start":2299.63,"end":2300.15},{"text":"Vasinco","start":2300.19,"end":2301.03},{"text":"for","start":2302.03,"end":2302.15},{"text":"your","start":2302.15,"end":2302.47},{"text":"intervention","start":2302.47,"end":2303.51},{"text":"and","start":2303.51,"end":2303.67},{"text":"a","start":2303.67,"end":2303.71},{"text":"very","start":2303.71,"end":2304.23},{"text":"important","start":2304.23,"end":2304.79},{"text":"one.","start":2304.79,"end":2305.11}]},{"text":"Thank you very, very much.","start":2305.11,"end":2307.11,"topics":[],"words":[{"text":"Thank","start":2305.11,"end":2305.43},{"text":"you","start":2305.43,"end":2305.67},{"text":"very,","start":2305.87,"end":2306.23},{"text":"very","start":2306.23,"end":2306.55},{"text":"much.","start":2306.55,"end":2307.11}]},{"text":"I would like now want to be give the floor back to Mr. Jindrich Fofrill, who is the advisor to the Prime Minister in the Czech Republic.","start":2308.31,"end":2322.95,"topics":[],"words":[{"text":"I","start":2308.31,"end":2308.47},{"text":"would","start":2308.47,"end":2308.63},{"text":"like","start":2308.63,"end":2308.95},{"text":"now","start":2308.95,"end":2309.43},{"text":"want","start":2310.47,"end":2310.91},{"text":"to","start":2310.91,"end":2310.99},{"text":"be","start":2310.99,"end":2311.19},{"text":"give","start":2311.19,"end":2311.51},{"text":"the","start":2312.07,"end":2312.23},{"text":"floor","start":2312.23,"end":2312.63},{"text":"back","start":2312.63,"end":2313.11},{"text":"to","start":2313.59,"end":2313.83},{"text":"Mr.","start":2315.91,"end":2316.39},{"text":"Jindrich","start":2317.03,"end":2317.75},{"text":"Fofrill,","start":2317.75,"end":2318.55},{"text":"who","start":2318.87,"end":2319.19},{"text":"is","start":2319.19,"end":2319.59},{"text":"the","start":2319.79,"end":2319.87},{"text":"advisor","start":2319.87,"end":2320.47},{"text":"to","start":2320.47,"end":2320.59},{"text":"the","start":2320.59,"end":2320.71},{"text":"Prime","start":2320.71,"end":2320.99},{"text":"Minister","start":2320.99,"end":2321.59},{"text":"in","start":2321.59,"end":2321.75},{"text":"the","start":2321.75,"end":2321.91},{"text":"Czech","start":2321.91,"end":2322.15},{"text":"Republic.","start":2322.15,"end":2322.95}]},{"text":"He will be joining us online, and he will be speaking to us about the role of harm reduction and decriminalization in the Czech Republic and talking about Czech drug policy.","start":2323.43,"end":2335.99,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"He","start":2323.43,"end":2323.75},{"text":"will","start":2323.75,"end":2323.91},{"text":"be","start":2323.91,"end":2324.15},{"text":"joining","start":2324.15,"end":2324.63},{"text":"us","start":2324.63,"end":2324.95},{"text":"online,","start":2324.95,"end":2325.83},{"text":"and","start":2325.99,"end":2326.19},{"text":"he","start":2326.23,"end":2326.39},{"text":"will","start":2326.39,"end":2326.55},{"text":"be","start":2326.55,"end":2326.71},{"text":"speaking","start":2326.71,"end":2327.27},{"text":"to","start":2327.27,"end":2327.43},{"text":"us","start":2327.43,"end":2327.67},{"text":"about","start":2327.67,"end":2327.95},{"text":"the","start":2327.95,"end":2328.03},{"text":"role","start":2328.03,"end":2328.55},{"text":"of","start":2328.55,"end":2328.71},{"text":"harm","start":2328.71,"end":2329.03},{"text":"reduction","start":2329.03,"end":2329.75},{"text":"and","start":2329.99,"end":2330.35},{"text":"decriminalization","start":2330.35,"end":2331.67},{"text":"in","start":2331.75,"end":2331.91},{"text":"the","start":2331.91,"end":2332.07},{"text":"Czech","start":2332.07,"end":2332.47},{"text":"Republic","start":2332.47,"end":2333.27},{"text":"and","start":2333.99,"end":2334.23},{"text":"talking","start":2334.23,"end":2334.55},{"text":"about","start":2334.55,"end":2334.83},{"text":"Czech","start":2334.87,"end":2335.19},{"text":"drug","start":2335.19,"end":2335.43},{"text":"policy.","start":2335.43,"end":2335.99}]},{"text":"Please take us away, Mr. Fofrill.","start":2336.39,"end":2338.55,"topics":[],"words":[{"text":"Please","start":2336.39,"end":2336.79},{"text":"take","start":2336.95,"end":2337.19},{"text":"us","start":2337.19,"end":2337.35},{"text":"away,","start":2337.35,"end":2337.75},{"text":"Mr.","start":2337.75,"end":2338.15},{"text":"Fofrill.","start":2338.15,"end":2338.55}]}]}],"speaker":{"affiliation":"MEX","group":null,"function":"Deputy Permanent Representative","affiliation_full":"Mexico"}},{"statement_number":11,"start":2342.79,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=39:03","paragraphs":[{"sentences":[{"text":"Hello.","start":2342.79,"end":2343.19,"topics":[],"words":[{"text":"Hello.","start":2342.79,"end":2343.19}]},{"text":"Can you all hear me?","start":2343.35,"end":2344.55,"topics":[],"words":[{"text":"Can","start":2343.35,"end":2343.59},{"text":"you","start":2343.63,"end":2343.71},{"text":"all","start":2343.95,"end":2344.07},{"text":"hear","start":2344.07,"end":2344.27},{"text":"me?","start":2344.27,"end":2344.55}]}]}],"speaker":{"affiliation":"CZE","group":null,"function":"Advisor to the Prime Minister","affiliation_full":"Czechia"}},{"statement_number":12,"start":2344.87,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=39:05","paragraphs":[{"sentences":[{"text":"Yes.","start":2344.87,"end":2345.43,"topics":[],"words":[{"text":"Yes.","start":2344.87,"end":2345.43}]}]}],"speaker":{"affiliation":"MEX","group":null,"function":"Deputy Permanent Representative","affiliation_full":"Mexico"}},{"statement_number":13,"start":2347.03,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=39:08","paragraphs":[{"sentences":[{"text":"Okay, thank you, Chair, for giving me the floor.","start":2347.03,"end":2349.27,"topics":[],"words":[{"text":"Okay,","start":2347.03,"end":2347.35},{"text":"thank","start":2347.35,"end":2347.59},{"text":"you,","start":2347.59,"end":2347.67},{"text":"Chair,","start":2347.67,"end":2348.07},{"text":"for","start":2348.07,"end":2348.39},{"text":"giving","start":2348.39,"end":2348.59},{"text":"me","start":2348.59,"end":2348.75},{"text":"the","start":2348.75,"end":2348.83},{"text":"floor.","start":2348.83,"end":2349.27}]},{"text":"Dear Excellencies, dear participants, let me first congratulate you for putting such an important meeting together.","start":2349.51,"end":2359.99,"topics":[],"words":[{"text":"Dear","start":2349.51,"end":2349.99},{"text":"Excellencies,","start":2350.07,"end":2351.19},{"text":"dear","start":2352.39,"end":2352.55},{"text":"participants,","start":2352.55,"end":2353.59},{"text":"let","start":2354.79,"end":2355.03},{"text":"me","start":2355.03,"end":2355.19},{"text":"first","start":2355.19,"end":2355.51},{"text":"congratulate","start":2355.51,"end":2356.47},{"text":"you","start":2356.47,"end":2356.71},{"text":"for","start":2356.71,"end":2357.11},{"text":"putting","start":2357.19,"end":2357.67},{"text":"such","start":2358.31,"end":2358.47},{"text":"an","start":2358.47,"end":2358.55},{"text":"important","start":2358.55,"end":2359.11},{"text":"meeting","start":2359.11,"end":2359.43},{"text":"together.","start":2359.43,"end":2359.99}]},{"text":"I would like to start with some reflection on Czech drug policy.","start":2361.19,"end":2365.99,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"I","start":2361.19,"end":2361.23},{"text":"would","start":2361.23,"end":2361.35},{"text":"like","start":2361.35,"end":2361.55},{"text":"to","start":2361.55,"end":2361.67},{"text":"start","start":2361.67,"end":2362.23},{"text":"with","start":2362.23,"end":2362.47},{"text":"some","start":2362.55,"end":2363.03},{"text":"reflection","start":2363.03,"end":2363.75},{"text":"on","start":2363.75,"end":2364.07},{"text":"Czech","start":2364.07,"end":2364.47},{"text":"drug","start":2365.07,"end":2365.27},{"text":"policy.","start":2365.27,"end":2365.99}]},{"text":"You might know that the Czech Republic is one of the eight countries that repeatedly report in less than 1% of HIV among injecting drug users still remains the same last 20 years.","start":2367.67,"end":2386.03,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"You","start":2367.67,"end":2367.83},{"text":"might","start":2367.83,"end":2368.39},{"text":"know","start":2368.79,"end":2369.19},{"text":"that","start":2369.35,"end":2369.59},{"text":"the","start":2369.59,"end":2369.67},{"text":"Czech","start":2369.83,"end":2369.99},{"text":"Republic","start":2369.99,"end":2370.55},{"text":"is","start":2370.55,"end":2370.87},{"text":"one","start":2370.95,"end":2371.19},{"text":"of","start":2371.19,"end":2371.35},{"text":"the","start":2371.39,"end":2371.51},{"text":"eight","start":2371.59,"end":2372.07},{"text":"countries","start":2372.83,"end":2373.47},{"text":"that","start":2373.47,"end":2373.87},{"text":"repeatedly","start":2373.87,"end":2374.83},{"text":"report","start":2375.23,"end":2375.87},{"text":"in","start":2375.87,"end":2376.27},{"text":"less","start":2376.27,"end":2376.67},{"text":"than","start":2376.67,"end":2377.79},{"text":"1%","start":2378.27,"end":2378.31},{"text":"of","start":2378.35,"end":2378.43},{"text":"HIV","start":2378.43,"end":2379.23},{"text":"among","start":2379.23,"end":2379.79},{"text":"injecting","start":2379.79,"end":2380.43},{"text":"drug","start":2380.67,"end":2380.87},{"text":"users","start":2380.91,"end":2381.55},{"text":"still","start":2382.35,"end":2382.75},{"text":"remains","start":2382.75,"end":2383.71},{"text":"the","start":2383.71,"end":2383.83},{"text":"same","start":2383.83,"end":2384.35},{"text":"last","start":2384.51,"end":2384.99},{"text":"20","start":2385.07,"end":2385.55},{"text":"years.","start":2385.55,"end":2386.03}]},{"text":"So I would say we might have done something right when the revolution started or happened in 1989.","start":2387.71,"end":2398.99,"topics":[],"words":[{"text":"So","start":2387.71,"end":2387.91},{"text":"I","start":2388.03,"end":2388.07},{"text":"would","start":2388.07,"end":2388.27},{"text":"say","start":2388.27,"end":2388.75},{"text":"we","start":2389.39,"end":2389.51},{"text":"might","start":2389.51,"end":2389.71},{"text":"have","start":2389.71,"end":2389.87},{"text":"done","start":2389.87,"end":2390.27},{"text":"something","start":2390.27,"end":2390.83},{"text":"right","start":2390.83,"end":2391.31},{"text":"when","start":2391.87,"end":2392.11},{"text":"the","start":2392.23,"end":2392.35},{"text":"revolution","start":2392.59,"end":2393.31},{"text":"started","start":2393.63,"end":2394.59},{"text":"or","start":2394.59,"end":2395.23},{"text":"happened","start":2395.95,"end":2396.51},{"text":"in","start":2396.51,"end":2396.63},{"text":"1989.","start":2396.63,"end":2398.99}]},{"text":"The country was almost broke economically and the drug problem started rising because the Iron Curtain fall.","start":2401.51,"end":2411.43,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"The","start":2401.51,"end":2401.55},{"text":"country","start":2401.59,"end":2401.99},{"text":"was","start":2401.99,"end":2402.23},{"text":"almost","start":2402.23,"end":2402.75},{"text":"broke","start":2402.75,"end":2403.27},{"text":"economically","start":2403.91,"end":2404.71},{"text":"and","start":2405.99,"end":2406.27},{"text":"the","start":2406.27,"end":2406.39},{"text":"drug","start":2406.95,"end":2407.15},{"text":"problem","start":2407.15,"end":2407.67},{"text":"started","start":2407.67,"end":2408.07},{"text":"rising","start":2408.07,"end":2408.55},{"text":"because","start":2408.55,"end":2408.95},{"text":"the","start":2408.95,"end":2409.07},{"text":"Iron","start":2409.59,"end":2410.07},{"text":"Curtain","start":2410.07,"end":2410.71},{"text":"fall.","start":2410.95,"end":2411.43}]},{"text":"But at that point, we decided to reverse our policies to the usual based, usual policies.","start":2412.39,"end":2422.87,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"But","start":2412.39,"end":2412.51},{"text":"at","start":2412.51,"end":2412.59},{"text":"that","start":2412.59,"end":2412.79},{"text":"point,","start":2412.79,"end":2413.43},{"text":"we","start":2414.15,"end":2414.39},{"text":"decided","start":2414.39,"end":2415.07},{"text":"to","start":2415.07,"end":2415.43},{"text":"reverse","start":2415.43,"end":2416.31},{"text":"our","start":2417.27,"end":2417.51},{"text":"policies","start":2417.51,"end":2418.23},{"text":"to","start":2418.23,"end":2418.47},{"text":"the","start":2418.47,"end":2418.59},{"text":"usual","start":2418.59,"end":2419.27},{"text":"based,","start":2420.07,"end":2420.63},{"text":"usual","start":2421.83,"end":2422.15},{"text":"policies.","start":2422.15,"end":2422.87}]},{"text":"Because usually the policies are based on the idea of abstinence, abstinence as the prime goal.","start":2423.95,"end":2432.15,"topics":[],"words":[{"text":"Because","start":2423.95,"end":2424.15},{"text":"usually","start":2424.31,"end":2424.87},{"text":"the","start":2424.87,"end":2424.95},{"text":"policies","start":2424.95,"end":2425.43},{"text":"are","start":2425.43,"end":2425.55},{"text":"based","start":2425.55,"end":2426.03},{"text":"on","start":2426.39,"end":2426.79},{"text":"the","start":2426.79,"end":2426.99},{"text":"idea","start":2426.99,"end":2427.79},{"text":"of","start":2427.79,"end":2427.91},{"text":"abstinence,","start":2427.99,"end":2428.71},{"text":"abstinence","start":2429.27,"end":2430.31},{"text":"as","start":2430.31,"end":2430.39},{"text":"the","start":2430.39,"end":2430.47},{"text":"prime","start":2430.47,"end":2430.95},{"text":"goal.","start":2431.59,"end":2432.15}]},{"text":"So we reversed it and said, okay, the country doesn't have so much money.","start":2433.11,"end":2439.43,"topics":[],"words":[{"text":"So","start":2433.11,"end":2433.51},{"text":"we","start":2433.51,"end":2433.91},{"text":"reversed","start":2434.31,"end":2434.95},{"text":"it","start":2434.95,"end":2435.35},{"text":"and","start":2435.51,"end":2435.91},{"text":"said,","start":2435.91,"end":2436.31},{"text":"okay,","start":2436.31,"end":2436.71},{"text":"the","start":2436.71,"end":2436.87},{"text":"country","start":2437.03,"end":2437.75},{"text":"doesn't","start":2438.15,"end":2438.47},{"text":"have","start":2438.47,"end":2438.59},{"text":"so","start":2438.59,"end":2438.75},{"text":"much","start":2438.75,"end":2439.03},{"text":"money.","start":2439.03,"end":2439.43}]},{"text":"We need to find some very practical solutions.","start":2440.39,"end":2443.83,"topics":[],"words":[{"text":"We","start":2440.39,"end":2440.63},{"text":"need","start":2440.63,"end":2440.83},{"text":"to","start":2440.83,"end":2441.11},{"text":"find","start":2441.11,"end":2441.55},{"text":"some","start":2441.55,"end":2441.99},{"text":"very","start":2441.99,"end":2442.39},{"text":"practical","start":2442.39,"end":2443.03},{"text":"solutions.","start":2443.03,"end":2443.83}]},{"text":"And then we decided and slowly defined our policy as based on harm reduction, where abstinence is part of the solution, but not the only option, not the only choice.","start":2443.83,"end":2460.99,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"And","start":2443.83,"end":2444.23},{"text":"then","start":2444.55,"end":2444.87},{"text":"we","start":2444.87,"end":2445.11},{"text":"decided","start":2445.43,"end":2446.19},{"text":"and","start":2446.19,"end":2446.39},{"text":"slowly","start":2446.39,"end":2447.11},{"text":"defined","start":2448.95,"end":2450.07},{"text":"our","start":2450.07,"end":2450.31},{"text":"policy","start":2450.31,"end":2450.95},{"text":"as","start":2451.23,"end":2451.43},{"text":"based","start":2451.43,"end":2451.87},{"text":"on","start":2451.87,"end":2451.99},{"text":"harm","start":2451.99,"end":2452.23},{"text":"reduction,","start":2452.23,"end":2452.79},{"text":"where","start":2453.95,"end":2454.47},{"text":"abstinence","start":2454.63,"end":2455.59},{"text":"is","start":2455.83,"end":2456.07},{"text":"part","start":2456.07,"end":2456.47},{"text":"of","start":2456.47,"end":2456.55},{"text":"the","start":2456.55,"end":2456.67},{"text":"solution,","start":2456.67,"end":2457.27},{"text":"but","start":2457.27,"end":2457.47},{"text":"not","start":2457.47,"end":2457.75},{"text":"the","start":2457.75,"end":2457.87},{"text":"only","start":2457.91,"end":2458.55},{"text":"option,","start":2459.15,"end":2459.55},{"text":"not","start":2459.63,"end":2459.95},{"text":"the","start":2459.95,"end":2460.11},{"text":"only","start":2460.11,"end":2460.43},{"text":"choice.","start":2460.43,"end":2460.99}]},{"text":"When we talk about harm reduction policy, we talk about the policy approach, not harm reduction strategies, not harm reduction interventions.","start":2461.67,"end":2471.71,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"When","start":2461.67,"end":2461.95},{"text":"we","start":2461.95,"end":2462.03},{"text":"talk","start":2462.03,"end":2462.27},{"text":"about","start":2462.27,"end":2462.59},{"text":"harm","start":2462.59,"end":2462.83},{"text":"reduction","start":2462.83,"end":2463.23},{"text":"policy,","start":2463.23,"end":2463.71},{"text":"we","start":2463.71,"end":2463.87},{"text":"talk","start":2463.87,"end":2464.11},{"text":"about","start":2464.11,"end":2464.75},{"text":"the","start":2465.47,"end":2465.59},{"text":"policy","start":2465.87,"end":2466.31},{"text":"approach,","start":2466.31,"end":2466.75},{"text":"not","start":2466.75,"end":2467.07},{"text":"harm","start":2467.71,"end":2467.95},{"text":"reduction","start":2467.95,"end":2468.51},{"text":"strategies,","start":2468.51,"end":2469.15},{"text":"not","start":2469.15,"end":2469.55},{"text":"harm","start":2469.79,"end":2470.03},{"text":"reduction","start":2470.03,"end":2470.75},{"text":"interventions.","start":2470.83,"end":2471.71}]},{"text":"We talk about harm reduction policy.","start":2472.11,"end":2473.75,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"We","start":2472.11,"end":2472.19},{"text":"talk","start":2472.19,"end":2472.43},{"text":"about","start":2472.43,"end":2472.75},{"text":"harm","start":2472.75,"end":2472.95},{"text":"reduction","start":2472.95,"end":2473.35},{"text":"policy.","start":2473.35,"end":2473.75}]},{"text":"And what does it mean for us?","start":2473.75,"end":2475.47,"topics":[],"words":[{"text":"And","start":2473.75,"end":2474.19},{"text":"what","start":2474.23,"end":2474.39},{"text":"does","start":2474.39,"end":2474.51},{"text":"it","start":2474.51,"end":2474.63},{"text":"mean","start":2474.63,"end":2474.91},{"text":"for","start":2474.91,"end":2475.15},{"text":"us?","start":2475.15,"end":2475.47}]},{"text":"It means legislation, starts with legislation.","start":2476.35,"end":2478.99,"topics":[],"words":[{"text":"It","start":2476.35,"end":2476.51},{"text":"means","start":2476.51,"end":2476.91},{"text":"legislation,","start":2476.91,"end":2477.71},{"text":"starts","start":2477.71,"end":2478.11},{"text":"with","start":2478.11,"end":2478.27},{"text":"legislation.","start":2478.27,"end":2478.99}]},{"text":"So as the predecessor speaker said, it's decriminalization.","start":2479.47,"end":2486.43,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"So","start":2479.47,"end":2479.79},{"text":"as","start":2479.95,"end":2480.51},{"text":"the","start":2480.99,"end":2481.11},{"text":"predecessor","start":2481.39,"end":2482.43},{"text":"speaker","start":2482.75,"end":2483.23},{"text":"said,","start":2483.23,"end":2483.63},{"text":"it's","start":2484.11,"end":2484.51},{"text":"decriminalization.","start":2485.35,"end":2486.43}]},{"text":"This is a must.","start":2487.27,"end":2488.19,"topics":[],"words":[{"text":"This","start":2487.27,"end":2487.39},{"text":"is","start":2487.39,"end":2487.63},{"text":"a","start":2487.63,"end":2487.71},{"text":"must.","start":2487.71,"end":2488.19}]},{"text":"We decriminalized the possession for personal use at the end of '90s.","start":2488.75,"end":2493.23,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"We","start":2488.75,"end":2489.07},{"text":"decriminalized","start":2489.07,"end":2489.95},{"text":"the","start":2489.95,"end":2490.03},{"text":"possession","start":2490.03,"end":2490.51},{"text":"for","start":2490.51,"end":2490.67},{"text":"personal","start":2490.67,"end":2491.03},{"text":"use","start":2491.03,"end":2491.39},{"text":"at","start":2491.95,"end":2492.03},{"text":"the","start":2492.03,"end":2492.15},{"text":"end","start":2492.15,"end":2492.39},{"text":"of","start":2492.39,"end":2492.51},{"text":"'90s.","start":2492.51,"end":2493.23}]},{"text":"And then the following government reversed it back to criminalization.","start":2493.23,"end":2498.43,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"And","start":2493.23,"end":2493.43},{"text":"then","start":2493.43,"end":2493.55},{"text":"the","start":2493.55,"end":2493.71},{"text":"following","start":2494.11,"end":2494.59},{"text":"government","start":2494.59,"end":2495.31},{"text":"reversed","start":2496.11,"end":2496.67},{"text":"it","start":2496.67,"end":2496.75},{"text":"back","start":2496.75,"end":2497.15},{"text":"to","start":2497.15,"end":2497.47},{"text":"criminalization.","start":2497.47,"end":2498.43}]},{"text":"But at the same time, they launched a study to see-- that government launched a study to see what is happening with the effects of the law.","start":2498.43,"end":2510.23,"topics":[],"words":[{"text":"But","start":2498.43,"end":2498.71},{"text":"at","start":2498.71,"end":2498.83},{"text":"the","start":2498.83,"end":2499.23},{"text":"same","start":2499.23,"end":2499.55},{"text":"time,","start":2499.55,"end":2500.03},{"text":"they","start":2500.43,"end":2500.83},{"text":"launched","start":2500.83,"end":2501.47},{"text":"a","start":2501.47,"end":2501.55},{"text":"study","start":2501.55,"end":2502.19},{"text":"to","start":2502.19,"end":2502.27},{"text":"see--","start":2502.43,"end":2503.07},{"text":"that","start":2503.87,"end":2504.11},{"text":"government","start":2504.11,"end":2504.75},{"text":"launched","start":2504.91,"end":2505.35},{"text":"a","start":2505.35,"end":2505.39},{"text":"study","start":2505.39,"end":2505.87},{"text":"to","start":2505.87,"end":2506.03},{"text":"see","start":2506.03,"end":2506.59},{"text":"what","start":2506.67,"end":2507.23},{"text":"is","start":2507.23,"end":2507.39},{"text":"happening","start":2507.39,"end":2508.11},{"text":"with","start":2508.11,"end":2508.47},{"text":"the","start":2508.47,"end":2508.83},{"text":"effects","start":2508.83,"end":2509.63},{"text":"of","start":2509.63,"end":2509.71},{"text":"the","start":2509.71,"end":2509.83},{"text":"law.","start":2509.83,"end":2510.23}]},{"text":"And the effects became worse and worse.","start":2510.23,"end":2514.43,"topics":[],"words":[{"text":"And","start":2510.23,"end":2510.55},{"text":"the","start":2510.55,"end":2510.63},{"text":"effects","start":2510.63,"end":2511.23},{"text":"became","start":2512.67,"end":2513.23},{"text":"worse","start":2513.55,"end":2513.83},{"text":"and","start":2513.83,"end":2513.99},{"text":"worse.","start":2513.99,"end":2514.43}]},{"text":"So 2010, we decided to go back to decriminalization.","start":2515.63,"end":2520.11,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"So","start":2515.63,"end":2515.71},{"text":"2010,","start":2515.71,"end":2516.83},{"text":"we","start":2516.83,"end":2517.07},{"text":"decided","start":2517.07,"end":2517.67},{"text":"to","start":2517.67,"end":2517.79},{"text":"go","start":2517.79,"end":2518.03},{"text":"back","start":2518.03,"end":2518.35},{"text":"to","start":2518.35,"end":2518.59},{"text":"decriminalization.","start":2519.07,"end":2520.11}]},{"text":"So this is one of the key possibilities, as Anton before me said, for people who use drugs to actually access any kind of service without being a stigmatized or approaching problems.","start":2520.11,"end":2547.35,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"So","start":2520.11,"end":2520.31},{"text":"this","start":2520.31,"end":2520.51},{"text":"is","start":2520.51,"end":2520.75},{"text":"one","start":2521.55,"end":2521.75},{"text":"of","start":2521.75,"end":2521.87},{"text":"the","start":2521.87,"end":2521.95},{"text":"key","start":2522.35,"end":2522.83},{"text":"possibilities,","start":2524.27,"end":2525.71},{"text":"as","start":2526.11,"end":2526.35},{"text":"Anton","start":2526.35,"end":2526.91},{"text":"before","start":2526.91,"end":2527.31},{"text":"me","start":2527.31,"end":2527.47},{"text":"said,","start":2527.47,"end":2527.83},{"text":"for","start":2529.31,"end":2529.79},{"text":"people","start":2529.95,"end":2530.35},{"text":"who","start":2530.35,"end":2530.51},{"text":"use","start":2530.51,"end":2530.79},{"text":"drugs","start":2530.79,"end":2531.31},{"text":"to","start":2531.47,"end":2531.63},{"text":"actually","start":2531.63,"end":2532.11},{"text":"access","start":2532.11,"end":2532.91},{"text":"any","start":2534.11,"end":2534.35},{"text":"kind","start":2534.35,"end":2534.67},{"text":"of","start":2534.67,"end":2534.75},{"text":"service","start":2534.75,"end":2535.47},{"text":"without","start":2535.47,"end":2535.91},{"text":"being","start":2535.91,"end":2536.35},{"text":"a","start":2540.19,"end":2540.35},{"text":"stigmatized","start":2542.15,"end":2543.07},{"text":"or","start":2543.19,"end":2543.75},{"text":"approaching","start":2545.83,"end":2546.43},{"text":"problems.","start":2546.47,"end":2547.35}]},{"text":"So that proved to be a policy even not in terms of people who use drugs, but also in terms of organized crimes, organized crime and security actually.","start":2549.35,"end":2562.23,"topics":[],"words":[{"text":"So","start":2549.35,"end":2549.59},{"text":"that","start":2549.59,"end":2549.99},{"text":"proved","start":2550.15,"end":2550.55},{"text":"to","start":2550.55,"end":2550.71},{"text":"be","start":2550.71,"end":2551.03},{"text":"a","start":2551.59,"end":2551.63},{"text":"policy","start":2551.63,"end":2552.27},{"text":"even","start":2552.27,"end":2552.75},{"text":"not","start":2552.75,"end":2553.19},{"text":"in","start":2553.99,"end":2554.55},{"text":"terms","start":2554.55,"end":2554.95},{"text":"of","start":2554.95,"end":2555.43},{"text":"people","start":2555.67,"end":2555.99},{"text":"who","start":2555.99,"end":2556.23},{"text":"use","start":2556.23,"end":2556.55},{"text":"drugs,","start":2556.55,"end":2556.95},{"text":"but","start":2556.95,"end":2557.11},{"text":"also","start":2557.11,"end":2557.51},{"text":"in","start":2557.51,"end":2557.75},{"text":"terms","start":2557.75,"end":2558.07},{"text":"of","start":2558.07,"end":2558.39},{"text":"organized","start":2558.55,"end":2559.03},{"text":"crimes,","start":2559.03,"end":2559.51},{"text":"organized","start":2559.99,"end":2560.51},{"text":"crime","start":2560.51,"end":2560.75},{"text":"and","start":2560.75,"end":2560.87},{"text":"security","start":2560.87,"end":2561.51},{"text":"actually.","start":2561.51,"end":2562.23}]},{"text":"is maintained and as probably similar to Switzerland and other countries experience the same, if you come with a harm reduction approach policy, you realize that organized crime doesn't have enough food to feed on.","start":2563.99,"end":2578.71,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"is","start":2563.99,"end":2564.15},{"text":"maintained","start":2564.15,"end":2564.79},{"text":"and","start":2564.79,"end":2565.27},{"text":"as","start":2565.39,"end":2565.67},{"text":"probably","start":2565.67,"end":2566.15},{"text":"similar","start":2566.15,"end":2566.67},{"text":"to","start":2566.67,"end":2566.87},{"text":"Switzerland","start":2566.87,"end":2567.59},{"text":"and","start":2567.59,"end":2567.75},{"text":"other","start":2567.75,"end":2567.91},{"text":"countries","start":2567.91,"end":2568.35},{"text":"experience","start":2568.35,"end":2568.87},{"text":"the","start":2568.87,"end":2568.95},{"text":"same,","start":2568.95,"end":2569.35},{"text":"if","start":2570.23,"end":2570.47},{"text":"you","start":2570.47,"end":2570.71},{"text":"come","start":2570.79,"end":2571.03},{"text":"with","start":2571.03,"end":2571.27},{"text":"a","start":2571.35,"end":2571.39},{"text":"harm","start":2571.39,"end":2571.59},{"text":"reduction","start":2571.59,"end":2572.07},{"text":"approach","start":2572.07,"end":2572.55},{"text":"policy,","start":2572.55,"end":2573.19},{"text":"you","start":2573.51,"end":2573.83},{"text":"realize","start":2573.83,"end":2574.39},{"text":"that","start":2574.39,"end":2574.55},{"text":"organized","start":2574.63,"end":2575.27},{"text":"crime","start":2575.27,"end":2575.75},{"text":"doesn't","start":2575.99,"end":2576.47},{"text":"have","start":2576.47,"end":2576.95},{"text":"enough","start":2577.43,"end":2577.87},{"text":"food","start":2577.87,"end":2578.07},{"text":"to","start":2578.07,"end":2578.27},{"text":"feed","start":2578.27,"end":2578.55},{"text":"on.","start":2578.55,"end":2578.71}]},{"text":"The other area is of course budget and financial mechanisms, as Anton also mentioned before me, without money You can speak about policy, you can design policies, you can have nice papers, we can have nice conferences, but nothing happens in the field at the end for the people who are suffering or are in vulnerable situation.","start":2581.19,"end":2605.79,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"The","start":2581.19,"end":2581.43},{"text":"other","start":2581.51,"end":2581.99},{"text":"area","start":2582.15,"end":2582.55},{"text":"is","start":2582.55,"end":2582.71},{"text":"of","start":2582.71,"end":2582.87},{"text":"course","start":2582.87,"end":2583.11},{"text":"budget","start":2583.11,"end":2583.75},{"text":"and","start":2583.87,"end":2584.03},{"text":"financial","start":2584.03,"end":2584.55},{"text":"mechanisms,","start":2584.55,"end":2585.27},{"text":"as","start":2585.75,"end":2585.95},{"text":"Anton","start":2585.95,"end":2586.55},{"text":"also","start":2586.55,"end":2587.19},{"text":"mentioned","start":2587.19,"end":2587.75},{"text":"before","start":2587.91,"end":2588.27},{"text":"me,","start":2588.27,"end":2588.55},{"text":"without","start":2589.35,"end":2589.91},{"text":"money","start":2589.91,"end":2590.47},{"text":"You","start":2591.07,"end":2591.23},{"text":"can","start":2591.23,"end":2591.47},{"text":"speak","start":2591.47,"end":2591.79},{"text":"about","start":2591.79,"end":2592.07},{"text":"policy,","start":2592.07,"end":2592.47},{"text":"you","start":2592.47,"end":2592.59},{"text":"can","start":2592.59,"end":2592.75},{"text":"design","start":2592.75,"end":2593.23},{"text":"policies,","start":2593.23,"end":2593.63},{"text":"you","start":2593.63,"end":2593.71},{"text":"can","start":2593.71,"end":2593.87},{"text":"have","start":2593.87,"end":2594.03},{"text":"nice","start":2594.03,"end":2594.27},{"text":"papers,","start":2594.27,"end":2594.79},{"text":"we","start":2594.79,"end":2594.91},{"text":"can","start":2594.91,"end":2595.07},{"text":"have","start":2595.07,"end":2595.31},{"text":"nice","start":2595.47,"end":2595.79},{"text":"conferences,","start":2595.79,"end":2596.59},{"text":"but","start":2596.99,"end":2597.47},{"text":"nothing","start":2597.55,"end":2597.95},{"text":"happens","start":2597.95,"end":2598.43},{"text":"in","start":2598.43,"end":2598.63},{"text":"the","start":2598.63,"end":2598.75},{"text":"field","start":2598.75,"end":2599.11},{"text":"at","start":2599.11,"end":2599.19},{"text":"the","start":2599.19,"end":2599.35},{"text":"end","start":2599.35,"end":2599.59},{"text":"for","start":2599.59,"end":2599.79},{"text":"the","start":2599.79,"end":2599.87},{"text":"people","start":2599.87,"end":2600.23},{"text":"who","start":2600.23,"end":2600.43},{"text":"are","start":2600.43,"end":2600.83},{"text":"suffering","start":2601.15,"end":2601.71},{"text":"or","start":2603.07,"end":2603.39},{"text":"are","start":2603.39,"end":2603.79},{"text":"in","start":2603.79,"end":2604.11},{"text":"vulnerable","start":2604.11,"end":2604.83},{"text":"situation.","start":2604.99,"end":2605.79}]},{"text":"We, in a country of 10 million people, managed to establish 160, let's say, harm reduction intervention type community centers, so it's accessible to every citizen in the country.","start":2606.99,"end":2624.67,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"We,","start":2606.99,"end":2607.39},{"text":"in","start":2607.39,"end":2607.63},{"text":"a","start":2607.63,"end":2607.67},{"text":"country","start":2607.67,"end":2608.15},{"text":"of","start":2608.15,"end":2608.27},{"text":"10","start":2608.27,"end":2608.51},{"text":"million","start":2608.51,"end":2609.15},{"text":"people,","start":2609.27,"end":2609.87},{"text":"managed","start":2610.43,"end":2610.95},{"text":"to","start":2610.95,"end":2611.27},{"text":"establish","start":2611.27,"end":2612.11},{"text":"160,","start":2612.11,"end":2613.03},{"text":"let's","start":2615.07,"end":2615.35},{"text":"say,","start":2615.35,"end":2615.47},{"text":"harm","start":2615.47,"end":2615.71},{"text":"reduction","start":2615.71,"end":2616.11},{"text":"intervention","start":2616.11,"end":2616.99},{"text":"type","start":2617.03,"end":2617.55},{"text":"community","start":2619.19,"end":2619.63},{"text":"centers,","start":2619.63,"end":2620.23},{"text":"so","start":2620.23,"end":2620.71},{"text":"it's","start":2620.71,"end":2621.27},{"text":"accessible","start":2621.27,"end":2621.91},{"text":"to","start":2622.15,"end":2622.39},{"text":"every","start":2622.39,"end":2622.95},{"text":"citizen","start":2622.95,"end":2623.83},{"text":"in","start":2623.83,"end":2624.07},{"text":"the","start":2624.07,"end":2624.19},{"text":"country.","start":2624.19,"end":2624.67}]},{"text":"And I think this is one of the key issues why people have no HIV among injecting drug users in the Czech Republic.","start":2624.67,"end":2632.31,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"And","start":2624.67,"end":2624.83},{"text":"I","start":2624.83,"end":2624.87},{"text":"think","start":2624.87,"end":2625.07},{"text":"this","start":2625.07,"end":2625.19},{"text":"is","start":2625.19,"end":2625.31},{"text":"one","start":2625.31,"end":2625.47},{"text":"of","start":2625.47,"end":2625.55},{"text":"the","start":2625.55,"end":2625.67},{"text":"key","start":2625.67,"end":2626.03},{"text":"issues","start":2626.03,"end":2626.55},{"text":"why","start":2626.87,"end":2627.35},{"text":"people","start":2627.91,"end":2628.23},{"text":"have","start":2628.23,"end":2628.63},{"text":"no","start":2628.63,"end":2629.03},{"text":"HIV","start":2629.03,"end":2629.67},{"text":"among","start":2629.67,"end":2629.99},{"text":"injecting","start":2629.99,"end":2630.39},{"text":"drug","start":2630.39,"end":2630.63},{"text":"users","start":2630.63,"end":2631.11},{"text":"in","start":2631.11,"end":2631.35},{"text":"the","start":2631.35,"end":2631.43},{"text":"Czech","start":2631.43,"end":2631.67},{"text":"Republic.","start":2631.67,"end":2632.31}]},{"text":"These two main, the two main kind of pillars of our policy.","start":2633.11,"end":2643.59,"topics":[],"words":[{"text":"These","start":2633.11,"end":2633.35},{"text":"two","start":2633.35,"end":2633.91},{"text":"main,","start":2634.79,"end":2635.35},{"text":"the","start":2636.95,"end":2637.19},{"text":"two","start":2637.35,"end":2637.99},{"text":"main","start":2637.99,"end":2638.55},{"text":"kind","start":2641.35,"end":2641.55},{"text":"of","start":2641.55,"end":2641.67},{"text":"pillars","start":2641.67,"end":2642.15},{"text":"of","start":2642.15,"end":2642.39},{"text":"our","start":2642.39,"end":2642.79},{"text":"policy.","start":2643.11,"end":2643.59}]},{"text":"Another area that we are trying to push for is something that we call substituted market.","start":2644.07,"end":2651.47,"topics":[],"words":[{"text":"Another","start":2644.07,"end":2644.71},{"text":"area","start":2644.79,"end":2645.15},{"text":"that","start":2645.15,"end":2645.43},{"text":"we","start":2645.43,"end":2645.83},{"text":"are","start":2645.91,"end":2646.11},{"text":"trying","start":2646.11,"end":2646.55},{"text":"to","start":2646.55,"end":2647.51},{"text":"push","start":2647.51,"end":2647.75},{"text":"for","start":2647.75,"end":2648.15},{"text":"is","start":2648.15,"end":2648.55},{"text":"something","start":2649.07,"end":2649.39},{"text":"that","start":2649.39,"end":2649.51},{"text":"we","start":2649.51,"end":2649.63},{"text":"call","start":2649.63,"end":2649.87},{"text":"substituted","start":2649.87,"end":2650.75},{"text":"market.","start":2650.75,"end":2651.47}]},{"text":"We decided and designed a new law, psycho-moderatory substances, we call it, when we say let's regulate substances which are not currently based on the international ban.","start":2653.87,"end":2668.91,"topics":[],"words":[{"text":"We","start":2653.87,"end":2654.03},{"text":"decided","start":2654.03,"end":2654.83},{"text":"and","start":2654.83,"end":2655.03},{"text":"designed","start":2655.03,"end":2655.63},{"text":"a","start":2655.71,"end":2655.75},{"text":"new","start":2655.75,"end":2656.03},{"text":"law,","start":2656.03,"end":2656.43},{"text":"psycho-moderatory","start":2656.59,"end":2657.39},{"text":"substances,","start":2657.39,"end":2658.35},{"text":"we","start":2658.35,"end":2658.43},{"text":"call","start":2658.43,"end":2658.75},{"text":"it,","start":2658.75,"end":2658.91},{"text":"when","start":2659.35,"end":2659.63},{"text":"we","start":2659.63,"end":2659.79},{"text":"say","start":2659.79,"end":2660.11},{"text":"let's","start":2660.11,"end":2660.59},{"text":"regulate","start":2660.67,"end":2661.71},{"text":"substances","start":2662.51,"end":2663.63},{"text":"which","start":2663.95,"end":2664.19},{"text":"are","start":2664.19,"end":2664.27},{"text":"not","start":2664.27,"end":2664.51},{"text":"currently","start":2664.51,"end":2665.31},{"text":"based","start":2665.79,"end":2666.27},{"text":"on","start":2666.27,"end":2666.43},{"text":"the","start":2666.43,"end":2666.91},{"text":"international","start":2666.99,"end":2667.87},{"text":"ban.","start":2668.43,"end":2668.91}]},{"text":"According to the risks, let's substitute market with less risky possibilities, let's say.","start":2670.47,"end":2679.99,"topics":[],"words":[{"text":"According","start":2670.47,"end":2670.99},{"text":"to","start":2670.99,"end":2671.11},{"text":"the","start":2671.11,"end":2671.19},{"text":"risks,","start":2671.19,"end":2671.79},{"text":"let's","start":2673.07,"end":2673.63},{"text":"substitute","start":2673.63,"end":2674.19},{"text":"market","start":2674.19,"end":2674.91},{"text":"with","start":2675.15,"end":2675.39},{"text":"less","start":2675.47,"end":2675.95},{"text":"risky","start":2676.11,"end":2676.75},{"text":"possibilities,","start":2678.67,"end":2679.51},{"text":"let's","start":2679.51,"end":2679.79},{"text":"say.","start":2679.79,"end":2679.99}]},{"text":"One of the areas is, for example, that we can choose to, one is from medical means.","start":2680.63,"end":2688.55,"topics":[],"words":[{"text":"One","start":2680.63,"end":2680.91},{"text":"of","start":2680.91,"end":2681.03},{"text":"the","start":2681.03,"end":2681.11},{"text":"areas","start":2681.27,"end":2681.83},{"text":"is,","start":2681.83,"end":2681.99},{"text":"for","start":2681.99,"end":2682.23},{"text":"example,","start":2682.23,"end":2682.79},{"text":"that","start":2682.79,"end":2683.03},{"text":"we","start":2683.03,"end":2683.19},{"text":"can","start":2683.19,"end":2683.59},{"text":"choose","start":2683.99,"end":2685.15},{"text":"to,","start":2685.15,"end":2685.23},{"text":"one","start":2685.23,"end":2685.47},{"text":"is","start":2685.47,"end":2685.67},{"text":"from","start":2685.67,"end":2685.99},{"text":"medical","start":2686.15,"end":2686.79},{"text":"means.","start":2687.67,"end":2688.55}]},{"text":"We had a heroin epidemic about 15 years ago.","start":2689.43,"end":2694.23,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"We","start":2689.43,"end":2689.67},{"text":"had","start":2689.67,"end":2690.07},{"text":"a","start":2690.07,"end":2690.15},{"text":"heroin","start":2690.47,"end":2691.11},{"text":"epidemic","start":2691.19,"end":2691.91},{"text":"about","start":2692.55,"end":2693.03},{"text":"15","start":2693.03,"end":2693.51},{"text":"years","start":2693.51,"end":2693.75},{"text":"ago.","start":2693.75,"end":2694.23}]},{"text":"Now it's almost gone.","start":2695.35,"end":2696.71,"topics":[],"words":[{"text":"Now","start":2695.35,"end":2695.59},{"text":"it's","start":2695.59,"end":2695.83},{"text":"almost","start":2695.83,"end":2696.39},{"text":"gone.","start":2696.39,"end":2696.71}]},{"text":"One of the main reasons is very easy access to lower risk substance, as you all know, called buprenorphine, which goes through every GP clinic.","start":2697.79,"end":2708.39,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"One","start":2697.79,"end":2697.91},{"text":"of","start":2697.91,"end":2697.99},{"text":"the","start":2697.99,"end":2698.07},{"text":"main","start":2698.07,"end":2698.39},{"text":"reasons","start":2698.39,"end":2698.83},{"text":"is","start":2698.83,"end":2699.19},{"text":"very","start":2699.35,"end":2700.07},{"text":"easy","start":2700.23,"end":2700.63},{"text":"access","start":2700.63,"end":2701.27},{"text":"to","start":2701.27,"end":2701.51},{"text":"lower","start":2701.51,"end":2702.15},{"text":"risk","start":2702.15,"end":2702.39},{"text":"substance,","start":2702.39,"end":2702.99},{"text":"as","start":2702.99,"end":2703.11},{"text":"you","start":2703.11,"end":2703.27},{"text":"all","start":2703.27,"end":2703.43},{"text":"know,","start":2703.43,"end":2703.83},{"text":"called","start":2704.23,"end":2704.67},{"text":"buprenorphine,","start":2704.87,"end":2705.91},{"text":"which","start":2706.19,"end":2706.39},{"text":"goes","start":2706.39,"end":2706.75},{"text":"through","start":2706.75,"end":2706.95},{"text":"every","start":2706.95,"end":2707.35},{"text":"GP","start":2707.35,"end":2707.83},{"text":"clinic.","start":2707.83,"end":2708.39}]},{"text":"And what I'm arguing later, if we have a risk of fentanyl coming to Europe, we should even think of over-the-counter limited access to buprenorphine.","start":2709.27,"end":2724.79,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"And","start":2709.27,"end":2709.55},{"text":"what","start":2709.55,"end":2709.71},{"text":"I'm","start":2709.71,"end":2709.91},{"text":"arguing","start":2709.91,"end":2710.43},{"text":"later,","start":2710.43,"end":2710.95},{"text":"if","start":2710.95,"end":2711.27},{"text":"we","start":2711.27,"end":2711.35},{"text":"have","start":2711.35,"end":2711.75},{"text":"a","start":2711.75,"end":2711.79},{"text":"risk","start":2711.79,"end":2712.23},{"text":"of","start":2712.31,"end":2712.71},{"text":"fentanyl","start":2712.95,"end":2713.83},{"text":"coming","start":2714.71,"end":2715.03},{"text":"to","start":2715.03,"end":2715.11},{"text":"Europe,","start":2715.11,"end":2715.67},{"text":"we","start":2715.75,"end":2715.99},{"text":"should","start":2715.99,"end":2716.23},{"text":"even","start":2716.23,"end":2716.79},{"text":"think","start":2717.51,"end":2718.07},{"text":"of","start":2718.07,"end":2718.63},{"text":"over-the-counter","start":2718.87,"end":2719.99},{"text":"limited","start":2720.63,"end":2721.51},{"text":"access","start":2721.59,"end":2722.47},{"text":"to","start":2723.43,"end":2723.55},{"text":"buprenorphine.","start":2723.55,"end":2724.79}]},{"text":"And that, played an important role of almost diminishing heroin issue in Czech Republic.","start":2726.47,"end":2735.11,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"And","start":2726.47,"end":2726.59},{"text":"that,","start":2726.59,"end":2726.95},{"text":"played","start":2727.79,"end":2728.15},{"text":"an","start":2728.31,"end":2728.55},{"text":"important","start":2728.55,"end":2729.11},{"text":"role","start":2729.11,"end":2729.71},{"text":"of","start":2729.71,"end":2729.99},{"text":"almost","start":2730.31,"end":2730.91},{"text":"diminishing","start":2730.91,"end":2731.51},{"text":"heroin","start":2731.51,"end":2732.23},{"text":"issue","start":2732.95,"end":2733.59},{"text":"in","start":2733.59,"end":2734.23},{"text":"Czech","start":2734.23,"end":2734.43},{"text":"Republic.","start":2734.43,"end":2735.11}]},{"text":"I would like to stress, if you allow me two more minutes, a few wealth kind of facts.","start":2737.43,"end":2746.15,"topics":[],"words":[{"text":"I","start":2737.43,"end":2737.51},{"text":"would","start":2737.51,"end":2737.67},{"text":"like","start":2737.67,"end":2737.91},{"text":"to","start":2737.91,"end":2738.07},{"text":"stress,","start":2738.07,"end":2739.03},{"text":"if","start":2739.03,"end":2739.19},{"text":"you","start":2739.19,"end":2739.27},{"text":"allow","start":2739.27,"end":2739.47},{"text":"me","start":2739.47,"end":2739.75},{"text":"two","start":2739.75,"end":2740.23},{"text":"more","start":2741.19,"end":2741.35},{"text":"minutes,","start":2741.35,"end":2741.99},{"text":"a","start":2743.43,"end":2743.47},{"text":"few","start":2743.47,"end":2743.91},{"text":"wealth","start":2743.91,"end":2744.55},{"text":"kind","start":2744.71,"end":2744.95},{"text":"of","start":2744.95,"end":2745.03},{"text":"facts.","start":2745.03,"end":2746.15}]},{"text":"Today we still have almost 3 million people out of 11 million from the prison population, 2.7 million people who are in prison because of drug offenses.","start":2747.91,"end":2761.79,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Today","start":2747.91,"end":2748.31},{"text":"we","start":2748.31,"end":2748.47},{"text":"still","start":2748.47,"end":2748.79},{"text":"have","start":2748.79,"end":2749.35},{"text":"almost","start":2750.07,"end":2750.91},{"text":"3","start":2750.91,"end":2751.19},{"text":"million","start":2751.19,"end":2751.67},{"text":"people","start":2751.67,"end":2752.31},{"text":"out","start":2753.23,"end":2753.35},{"text":"of","start":2753.35,"end":2753.55},{"text":"11","start":2753.63,"end":2754.15},{"text":"million","start":2754.15,"end":2754.83},{"text":"from","start":2755.23,"end":2755.51},{"text":"the","start":2755.51,"end":2755.63},{"text":"prison","start":2755.63,"end":2755.95},{"text":"population,","start":2755.95,"end":2756.75},{"text":"2.7","start":2756.75,"end":2758.27},{"text":"million","start":2758.27,"end":2758.59},{"text":"people","start":2758.59,"end":2758.99},{"text":"who","start":2758.99,"end":2759.15},{"text":"are","start":2759.15,"end":2759.47},{"text":"in","start":2759.47,"end":2759.71},{"text":"prison","start":2759.71,"end":2760.03},{"text":"because","start":2760.03,"end":2760.43},{"text":"of","start":2760.43,"end":2760.55},{"text":"drug","start":2760.55,"end":2760.83},{"text":"offenses.","start":2760.83,"end":2761.79}]},{"text":"More than half million people are imprisoned for simple possession, just possession of drugs for personal use.","start":2763.39,"end":2774.91,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"More","start":2763.39,"end":2763.75},{"text":"than","start":2763.75,"end":2763.87},{"text":"half","start":2763.87,"end":2764.67},{"text":"million","start":2765.55,"end":2766.03},{"text":"people","start":2766.03,"end":2766.59},{"text":"are","start":2766.59,"end":2767.07},{"text":"imprisoned","start":2767.39,"end":2768.35},{"text":"for","start":2769.07,"end":2769.55},{"text":"simple","start":2769.55,"end":2770.11},{"text":"possession,","start":2770.11,"end":2770.99},{"text":"just","start":2771.39,"end":2771.75},{"text":"possession","start":2771.75,"end":2772.51},{"text":"of","start":2772.51,"end":2772.75},{"text":"drugs","start":2772.75,"end":2773.23},{"text":"for","start":2773.55,"end":2773.91},{"text":"personal","start":2773.91,"end":2774.39},{"text":"use.","start":2774.39,"end":2774.91}]},{"text":"40% executions worldwide are for drug offenses still today.","start":2778.59,"end":2784.27,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"40%","start":2778.59,"end":2778.63},{"text":"executions","start":2778.63,"end":2779.87},{"text":"worldwide","start":2779.87,"end":2780.75},{"text":"are","start":2782.27,"end":2782.35},{"text":"for","start":2782.35,"end":2782.59},{"text":"drug","start":2782.59,"end":2782.83},{"text":"offenses","start":2782.83,"end":2783.35},{"text":"still","start":2783.35,"end":2783.79},{"text":"today.","start":2783.79,"end":2784.27}]},{"text":"It's around 1,000 people, 700 to 1,000 people every year sentenced to death.","start":2786.75,"end":2793.47,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"It's","start":2786.75,"end":2787.03},{"text":"around","start":2787.03,"end":2787.43},{"text":"1,000","start":2787.47,"end":2788.15},{"text":"people,","start":2788.15,"end":2788.67},{"text":"700","start":2789.63,"end":2790.27},{"text":"to","start":2790.27,"end":2790.35},{"text":"1,000","start":2790.35,"end":2790.87},{"text":"people","start":2790.87,"end":2791.31},{"text":"every","start":2791.67,"end":2791.95},{"text":"year","start":2791.95,"end":2792.35},{"text":"sentenced","start":2792.35,"end":2793.03},{"text":"to","start":2793.03,"end":2793.11},{"text":"death.","start":2793.11,"end":2793.47}]},{"text":"In some countries, the drug offenses are higher than child abuse or rape.","start":2795.95,"end":2804.83,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"In","start":2795.95,"end":2796.11},{"text":"some","start":2796.11,"end":2796.35},{"text":"countries,","start":2796.35,"end":2797.31},{"text":"the","start":2798.19,"end":2798.43},{"text":"drug","start":2798.43,"end":2798.79},{"text":"offenses","start":2798.79,"end":2799.87},{"text":"are","start":2800.11,"end":2800.43},{"text":"higher","start":2800.43,"end":2801.15},{"text":"than","start":2802.11,"end":2802.59},{"text":"child","start":2802.59,"end":2803.07},{"text":"abuse","start":2803.07,"end":2803.71},{"text":"or","start":2804.27,"end":2804.55},{"text":"rape.","start":2804.55,"end":2804.83}]},{"text":"So we have this harsh policies based on ideology of abstinence, but at the same time, as we all know, the problem is rising.","start":2809.11,"end":2819.83,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"So","start":2809.11,"end":2809.19},{"text":"we","start":2809.19,"end":2809.31},{"text":"have","start":2809.31,"end":2809.51},{"text":"this","start":2809.51,"end":2809.83},{"text":"harsh","start":2809.83,"end":2810.23},{"text":"policies","start":2810.23,"end":2810.87},{"text":"based","start":2810.87,"end":2811.51},{"text":"on","start":2811.51,"end":2811.91},{"text":"ideology","start":2812.63,"end":2813.35},{"text":"of","start":2813.35,"end":2813.51},{"text":"abstinence,","start":2813.51,"end":2814.39},{"text":"but","start":2815.03,"end":2815.15},{"text":"at","start":2815.15,"end":2815.23},{"text":"the","start":2815.23,"end":2815.31},{"text":"same","start":2815.31,"end":2815.67},{"text":"time,","start":2815.67,"end":2816.07},{"text":"as","start":2816.11,"end":2816.55},{"text":"we","start":2816.55,"end":2816.79},{"text":"all","start":2816.79,"end":2816.87},{"text":"know,","start":2816.87,"end":2817.35},{"text":"the","start":2817.59,"end":2817.83},{"text":"problem","start":2817.83,"end":2818.39},{"text":"is","start":2818.63,"end":2818.87},{"text":"rising.","start":2818.87,"end":2819.83}]},{"text":"In 1998, we said, \"Well, free of drugs, we can do it.\"","start":2819.95,"end":2824.31,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"In","start":2819.95,"end":2820.03},{"text":"1998,","start":2820.03,"end":2820.95},{"text":"we","start":2820.95,"end":2821.03},{"text":"said,","start":2821.03,"end":2821.43},{"text":"\"Well,","start":2821.43,"end":2821.75},{"text":"free","start":2822.31,"end":2822.55},{"text":"of","start":2822.55,"end":2822.71},{"text":"drugs,","start":2822.71,"end":2823.27},{"text":"we","start":2823.35,"end":2823.59},{"text":"can","start":2823.59,"end":2823.75},{"text":"do","start":2823.75,"end":2823.99},{"text":"it.\"","start":2823.99,"end":2824.31}]},{"text":"By 2008, it doubled, and until today, it quadrupled.","start":2825.03,"end":2829.95,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"By","start":2825.03,"end":2825.35},{"text":"2008,","start":2825.35,"end":2826.39},{"text":"it","start":2826.47,"end":2826.87},{"text":"doubled,","start":2826.95,"end":2827.43},{"text":"and","start":2827.91,"end":2828.15},{"text":"until","start":2828.15,"end":2828.55},{"text":"today,","start":2828.55,"end":2828.87},{"text":"it","start":2828.87,"end":2829.27},{"text":"quadrupled.","start":2829.39,"end":2829.95}]},{"text":"The illicit market today, as we see it, is a bigger threat than the substances and the health risk itself, because the money flowing from this market is so big.","start":2831.91,"end":2845.59,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"The","start":2831.91,"end":2832.11},{"text":"illicit","start":2832.11,"end":2832.71},{"text":"market","start":2832.71,"end":2833.31},{"text":"today,","start":2833.31,"end":2833.91},{"text":"as","start":2834.67,"end":2834.79},{"text":"we","start":2834.79,"end":2834.95},{"text":"see","start":2834.95,"end":2835.43},{"text":"it,","start":2835.43,"end":2835.67},{"text":"is","start":2835.75,"end":2835.99},{"text":"a","start":2835.99,"end":2836.07},{"text":"bigger","start":2836.07,"end":2836.63},{"text":"threat","start":2836.63,"end":2837.27},{"text":"than","start":2838.27,"end":2838.43},{"text":"the","start":2838.43,"end":2838.51},{"text":"substances","start":2838.51,"end":2839.35},{"text":"and","start":2839.35,"end":2839.51},{"text":"the","start":2839.51,"end":2839.59},{"text":"health","start":2839.59,"end":2839.95},{"text":"risk","start":2839.95,"end":2840.27},{"text":"itself,","start":2840.27,"end":2840.91},{"text":"because","start":2841.31,"end":2841.79},{"text":"the","start":2841.79,"end":2841.87},{"text":"money","start":2841.87,"end":2842.35},{"text":"flowing","start":2842.35,"end":2842.99},{"text":"from","start":2843.79,"end":2844.19},{"text":"this","start":2844.19,"end":2844.51},{"text":"market","start":2844.51,"end":2844.91},{"text":"is","start":2844.91,"end":2845.03},{"text":"so","start":2845.03,"end":2845.31},{"text":"big.","start":2845.31,"end":2845.59}]},{"text":"So it's exceeding any previous situation, and it's one of the three biggest areas in money laundering and money flowing to global terrorism.","start":2846.83,"end":2864.43,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"So","start":2846.83,"end":2847.15},{"text":"it's","start":2847.15,"end":2847.51},{"text":"exceeding","start":2847.51,"end":2848.07},{"text":"any","start":2848.35,"end":2848.83},{"text":"previous","start":2848.91,"end":2849.51},{"text":"situation,","start":2849.51,"end":2850.43},{"text":"and","start":2850.43,"end":2850.67},{"text":"it's","start":2850.67,"end":2850.91},{"text":"one","start":2850.91,"end":2851.19},{"text":"of","start":2851.19,"end":2851.27},{"text":"the","start":2851.27,"end":2851.39},{"text":"three","start":2851.39,"end":2851.95},{"text":"biggest","start":2852.43,"end":2853.03},{"text":"areas","start":2855.63,"end":2856.43},{"text":"in","start":2856.43,"end":2856.67},{"text":"money","start":2856.67,"end":2857.15},{"text":"laundering","start":2857.15,"end":2857.75},{"text":"and","start":2857.87,"end":2858.35},{"text":"money","start":2858.75,"end":2859.23},{"text":"flowing","start":2859.55,"end":2860.27},{"text":"to","start":2860.27,"end":2860.75},{"text":"global","start":2863.23,"end":2863.63},{"text":"terrorism.","start":2863.63,"end":2864.43}]},{"text":"totalitarian states, you name it.","start":2866.31,"end":2868.23,"topics":[],"words":[{"text":"totalitarian","start":2866.31,"end":2867.03},{"text":"states,","start":2867.03,"end":2867.59},{"text":"you","start":2867.59,"end":2867.75},{"text":"name","start":2867.75,"end":2867.99},{"text":"it.","start":2867.99,"end":2868.23}]},{"text":"And the last thing I want to mention, people dependent or addicted on drugs who are diagnosed with, according to the medical manual, are still put to prison.","start":2873.55,"end":2892.39,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"And","start":2873.55,"end":2873.71},{"text":"the","start":2873.71,"end":2873.79},{"text":"last","start":2873.79,"end":2874.07},{"text":"thing","start":2874.07,"end":2874.23},{"text":"I","start":2874.23,"end":2874.31},{"text":"want","start":2874.31,"end":2874.51},{"text":"to","start":2874.51,"end":2874.63},{"text":"mention,","start":2874.63,"end":2875.27},{"text":"people","start":2877.99,"end":2878.39},{"text":"dependent","start":2878.39,"end":2879.27},{"text":"or","start":2879.35,"end":2879.83},{"text":"addicted","start":2879.83,"end":2880.47},{"text":"on","start":2880.47,"end":2880.63},{"text":"drugs","start":2880.63,"end":2881.35},{"text":"who","start":2883.79,"end":2883.91},{"text":"are","start":2883.91,"end":2884.19},{"text":"diagnosed","start":2884.19,"end":2885.23},{"text":"with,","start":2885.27,"end":2885.67},{"text":"according","start":2886.47,"end":2886.95},{"text":"to","start":2886.95,"end":2887.27},{"text":"the","start":2887.31,"end":2887.43},{"text":"medical","start":2887.99,"end":2888.55},{"text":"manual,","start":2888.71,"end":2889.35},{"text":"are","start":2890.87,"end":2891.03},{"text":"still","start":2891.03,"end":2891.43},{"text":"put","start":2891.43,"end":2891.79},{"text":"to","start":2891.79,"end":2891.87},{"text":"prison.","start":2891.91,"end":2892.39}]},{"text":"which as we see it is a clear breach of the human rights and it's a human rights violation per se.","start":2894.07,"end":2905.39,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"which","start":2894.07,"end":2894.35},{"text":"as","start":2894.35,"end":2894.59},{"text":"we","start":2894.59,"end":2894.75},{"text":"see","start":2894.75,"end":2895.31},{"text":"it","start":2895.39,"end":2896.27},{"text":"is","start":2896.67,"end":2897.23},{"text":"a","start":2898.43,"end":2898.51},{"text":"clear","start":2899.07,"end":2899.63},{"text":"breach","start":2899.79,"end":2900.51},{"text":"of","start":2901.31,"end":2901.47},{"text":"the","start":2901.47,"end":2901.59},{"text":"human","start":2901.59,"end":2901.95},{"text":"rights","start":2901.95,"end":2902.31},{"text":"and","start":2902.31,"end":2902.43},{"text":"it's","start":2902.43,"end":2902.67},{"text":"a","start":2902.67,"end":2902.75},{"text":"human","start":2902.83,"end":2903.23},{"text":"rights","start":2903.23,"end":2903.47},{"text":"violation","start":2903.47,"end":2904.43},{"text":"per","start":2905.07,"end":2905.23},{"text":"se.","start":2905.23,"end":2905.39}]},{"text":"So I think this is still happening today and unless we radically call for change and unless we start naming it together, this will only continue.","start":2908.03,"end":2924.77,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"So","start":2908.03,"end":2908.23},{"text":"I","start":2908.23,"end":2908.35},{"text":"think","start":2908.35,"end":2908.55},{"text":"this","start":2908.75,"end":2908.99},{"text":"is","start":2908.99,"end":2909.11},{"text":"still","start":2909.11,"end":2909.51},{"text":"happening","start":2909.51,"end":2909.95},{"text":"today","start":2909.95,"end":2910.51},{"text":"and","start":2911.67,"end":2911.83},{"text":"unless","start":2911.95,"end":2912.51},{"text":"we","start":2912.61,"end":2913.01},{"text":"radically","start":2913.65,"end":2914.61},{"text":"call","start":2915.49,"end":2915.89},{"text":"for","start":2915.89,"end":2916.13},{"text":"change","start":2916.13,"end":2916.77},{"text":"and","start":2918.09,"end":2918.37},{"text":"unless","start":2919.57,"end":2919.97},{"text":"we","start":2919.97,"end":2920.21},{"text":"start","start":2920.21,"end":2920.69},{"text":"naming","start":2921.01,"end":2921.41},{"text":"it","start":2921.41,"end":2921.61},{"text":"together,","start":2921.61,"end":2922.29},{"text":"this","start":2923.25,"end":2923.65},{"text":"will","start":2923.65,"end":2923.89},{"text":"only","start":2923.89,"end":2924.25},{"text":"continue.","start":2924.25,"end":2924.77}]},{"text":"So let me point out at the end a Council conclusion that was taken 2022 by the European Union led through the Czech presidency.","start":2925.97,"end":2942.49,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"So","start":2925.97,"end":2926.21},{"text":"let","start":2926.21,"end":2926.45},{"text":"me","start":2926.45,"end":2926.77},{"text":"point","start":2926.77,"end":2927.25},{"text":"out","start":2927.25,"end":2927.73},{"text":"at","start":2928.61,"end":2928.77},{"text":"the","start":2928.77,"end":2928.89},{"text":"end","start":2928.93,"end":2929.33},{"text":"a","start":2929.41,"end":2929.49},{"text":"Council","start":2930.69,"end":2931.17},{"text":"conclusion","start":2931.17,"end":2932.13},{"text":"that","start":2933.01,"end":2933.21},{"text":"was","start":2933.25,"end":2933.49},{"text":"taken","start":2933.49,"end":2934.13},{"text":"2022","start":2934.17,"end":2935.89},{"text":"by","start":2936.45,"end":2936.77},{"text":"the","start":2936.77,"end":2936.89},{"text":"European","start":2936.89,"end":2937.73},{"text":"Union","start":2937.73,"end":2938.45},{"text":"led","start":2939.21,"end":2939.69},{"text":"through","start":2939.89,"end":2940.49},{"text":"the","start":2940.57,"end":2940.77},{"text":"Czech","start":2940.89,"end":2941.21},{"text":"presidency.","start":2941.21,"end":2942.49}]},{"text":"I put it in the chat, so I'm not sure if you can all access it.","start":2942.57,"end":2946.57,"topics":[],"words":[{"text":"I","start":2942.57,"end":2942.73},{"text":"put","start":2942.73,"end":2943.05},{"text":"it","start":2943.05,"end":2943.29},{"text":"in","start":2943.37,"end":2943.93},{"text":"the","start":2943.93,"end":2944.05},{"text":"chat,","start":2944.05,"end":2944.41},{"text":"so","start":2944.41,"end":2944.53},{"text":"I'm","start":2944.53,"end":2944.73},{"text":"not","start":2944.73,"end":2944.89},{"text":"sure","start":2944.89,"end":2945.13},{"text":"if","start":2945.13,"end":2945.29},{"text":"you","start":2945.29,"end":2945.37},{"text":"can","start":2945.37,"end":2945.61},{"text":"all","start":2945.61,"end":2945.77},{"text":"access","start":2945.77,"end":2946.33},{"text":"it.","start":2946.33,"end":2946.57}]},{"text":"The Council conclusion is Human Rights Council conclusion on a human rights-based policy approach, drug policy approach, 2022, where we also point out issues such as gender inequality in a situation of access to services.","start":2947.29,"end":2971.29,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."}],"words":[{"text":"The","start":2947.29,"end":2947.49},{"text":"Council","start":2947.49,"end":2947.93},{"text":"conclusion","start":2947.93,"end":2948.49},{"text":"is","start":2948.49,"end":2948.65},{"text":"Human","start":2948.65,"end":2949.05},{"text":"Rights","start":2949.05,"end":2949.45},{"text":"Council","start":2950.17,"end":2950.49},{"text":"conclusion","start":2950.49,"end":2951.21},{"text":"on","start":2951.21,"end":2951.45},{"text":"a","start":2951.45,"end":2951.53},{"text":"human","start":2954.49,"end":2954.89},{"text":"rights-based","start":2954.89,"end":2955.65},{"text":"policy","start":2956.17,"end":2956.53},{"text":"approach,","start":2956.53,"end":2957.05},{"text":"drug","start":2957.05,"end":2957.25},{"text":"policy","start":2957.25,"end":2957.61},{"text":"approach,","start":2957.61,"end":2958.17},{"text":"2022,","start":2958.25,"end":2959.45},{"text":"where","start":2959.89,"end":2960.21},{"text":"we","start":2960.21,"end":2960.33},{"text":"also","start":2960.33,"end":2960.89},{"text":"point","start":2960.89,"end":2961.29},{"text":"out","start":2961.29,"end":2961.69},{"text":"issues","start":2964.17,"end":2964.61},{"text":"such","start":2964.61,"end":2964.97},{"text":"as","start":2965.09,"end":2965.37},{"text":"gender","start":2965.45,"end":2966.17},{"text":"inequality","start":2966.33,"end":2967.13},{"text":"in","start":2967.13,"end":2968.05},{"text":"a","start":2968.05,"end":2968.09},{"text":"situation","start":2968.09,"end":2968.77},{"text":"of","start":2968.77,"end":2968.89},{"text":"access","start":2968.89,"end":2969.69},{"text":"to","start":2970.29,"end":2970.37},{"text":"services.","start":2970.37,"end":2971.29}]},{"text":"And of course, as I mentioned a minute ago, the situation with people who are actually users diagnosed with, according to medical manual, and have no access to substitutions.","start":2973.53,"end":2992.97,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"And","start":2973.53,"end":2974.01},{"text":"of","start":2974.45,"end":2974.57},{"text":"course,","start":2974.57,"end":2975.05},{"text":"as","start":2975.45,"end":2975.69},{"text":"I","start":2975.69,"end":2975.77},{"text":"mentioned","start":2975.77,"end":2976.33},{"text":"a","start":2976.57,"end":2976.65},{"text":"minute","start":2976.65,"end":2977.05},{"text":"ago,","start":2977.05,"end":2977.53},{"text":"the","start":2977.85,"end":2977.97},{"text":"situation","start":2977.97,"end":2978.81},{"text":"with","start":2978.81,"end":2979.29},{"text":"people","start":2980.17,"end":2980.53},{"text":"who","start":2980.53,"end":2980.73},{"text":"are","start":2980.73,"end":2981.13},{"text":"actually","start":2981.13,"end":2981.85},{"text":"users","start":2983.93,"end":2984.81},{"text":"diagnosed","start":2984.89,"end":2985.73},{"text":"with,","start":2985.93,"end":2986.41},{"text":"according","start":2987.57,"end":2988.01},{"text":"to","start":2988.01,"end":2988.13},{"text":"medical","start":2988.65,"end":2989.05},{"text":"manual,","start":2989.05,"end":2989.61},{"text":"and","start":2989.61,"end":2989.85},{"text":"have","start":2989.85,"end":2990.17},{"text":"no","start":2990.17,"end":2990.41},{"text":"access","start":2990.41,"end":2991.13},{"text":"to","start":2991.53,"end":2991.85},{"text":"substitutions.","start":2991.85,"end":2992.97}]},{"text":"necessary substitution or prescriptions criminalized for their own diagnosable situation.","start":2994.49,"end":3007.61,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"necessary","start":2994.49,"end":2995.05},{"text":"substitution","start":2995.05,"end":2995.85},{"text":"or","start":2995.85,"end":2996.09},{"text":"prescriptions","start":2996.09,"end":2997.13},{"text":"criminalized","start":2999.69,"end":3000.73},{"text":"for","start":3001.05,"end":3001.49},{"text":"their","start":3001.49,"end":3001.69},{"text":"own","start":3001.69,"end":3002.09},{"text":"diagnosable","start":3004.01,"end":3005.13},{"text":"situation.","start":3006.81,"end":3007.61}]},{"text":"So I'm very glad that we gathered together like this, and I hope this conference will result in some very strong united voice to send the message for change.","start":3009.61,"end":3025.89,"topics":[],"words":[{"text":"So","start":3009.61,"end":3010.09},{"text":"I'm","start":3011.13,"end":3011.33},{"text":"very","start":3011.33,"end":3011.61},{"text":"glad","start":3011.61,"end":3011.97},{"text":"that","start":3011.97,"end":3012.25},{"text":"we","start":3012.25,"end":3012.65},{"text":"gathered","start":3013.37,"end":3013.77},{"text":"together","start":3013.77,"end":3014.33},{"text":"like","start":3014.33,"end":3014.57},{"text":"this,","start":3014.57,"end":3015.13},{"text":"and","start":3015.49,"end":3015.61},{"text":"I","start":3015.61,"end":3015.77},{"text":"hope","start":3015.77,"end":3016.01},{"text":"this","start":3016.01,"end":3016.49},{"text":"conference","start":3016.65,"end":3017.29},{"text":"will","start":3017.29,"end":3017.45},{"text":"result","start":3017.45,"end":3018.25},{"text":"in","start":3018.65,"end":3018.81},{"text":"some","start":3018.81,"end":3019.05},{"text":"very","start":3019.05,"end":3019.37},{"text":"strong","start":3019.37,"end":3019.93},{"text":"united","start":3019.93,"end":3020.57},{"text":"voice","start":3020.57,"end":3021.21},{"text":"to","start":3022.21,"end":3022.93},{"text":"send","start":3022.93,"end":3023.57},{"text":"the","start":3023.73,"end":3024.17},{"text":"message","start":3024.37,"end":3024.93},{"text":"for","start":3025.25,"end":3025.41},{"text":"change.","start":3025.41,"end":3025.89}]}]}],"speaker":{"affiliation":"CZE","group":null,"function":"Advisor to the Prime Minister","affiliation_full":"Czechia"}},{"statement_number":14,"start":3029.57,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=50:30","paragraphs":[{"sentences":[{"text":"Thank you very much to Mr. Jindrich Bobosil.","start":3029.57,"end":3033.57,"topics":[],"words":[{"text":"Thank","start":3029.57,"end":3029.89},{"text":"you","start":3029.89,"end":3029.97},{"text":"very","start":3029.97,"end":3030.21},{"text":"much","start":3030.21,"end":3030.69},{"text":"to","start":3031.01,"end":3031.17},{"text":"Mr.","start":3031.17,"end":3031.49},{"text":"Jindrich","start":3031.49,"end":3032.05},{"text":"Bobosil.","start":3032.69,"end":3033.57}]},{"text":"And now I give the floor to our next speaker, who will also be joining us online.","start":3033.97,"end":3039.41,"topics":[],"words":[{"text":"And","start":3033.97,"end":3034.17},{"text":"now","start":3034.17,"end":3034.53},{"text":"I","start":3034.85,"end":3035.09},{"text":"give","start":3035.09,"end":3035.33},{"text":"the","start":3035.33,"end":3035.45},{"text":"floor","start":3035.45,"end":3035.73},{"text":"to","start":3035.73,"end":3035.85},{"text":"our","start":3035.85,"end":3036.13},{"text":"next","start":3036.13,"end":3036.49},{"text":"speaker,","start":3036.49,"end":3037.01},{"text":"who","start":3037.01,"end":3037.17},{"text":"will","start":3037.17,"end":3037.57},{"text":"also","start":3037.57,"end":3037.93},{"text":"be","start":3037.93,"end":3038.13},{"text":"joining","start":3038.13,"end":3038.69},{"text":"us","start":3038.69,"end":3038.89},{"text":"online.","start":3038.89,"end":3039.41}]},{"text":"That is Ms. Catherine Cook, who is the acting executive director of Harm Reduction International.","start":3039.81,"end":3047.09,"topics":[],"words":[{"text":"That","start":3039.81,"end":3040.05},{"text":"is","start":3040.05,"end":3040.21},{"text":"Ms.","start":3040.89,"end":3041.25},{"text":"Catherine","start":3041.25,"end":3041.73},{"text":"Cook,","start":3041.73,"end":3042.13},{"text":"who","start":3042.37,"end":3042.61},{"text":"is","start":3042.69,"end":3042.85},{"text":"the","start":3042.85,"end":3043.01},{"text":"acting","start":3043.41,"end":3043.89},{"text":"executive","start":3043.89,"end":3044.57},{"text":"director","start":3044.57,"end":3045.21},{"text":"of","start":3045.21,"end":3045.33},{"text":"Harm","start":3045.33,"end":3045.65},{"text":"Reduction","start":3045.65,"end":3046.25},{"text":"International.","start":3046.25,"end":3047.09}]},{"text":"She will speak to us about financing harm reduction and some global trends regarding the matter.","start":3047.33,"end":3053.33,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"She","start":3047.33,"end":3047.57},{"text":"will","start":3047.57,"end":3047.73},{"text":"speak","start":3047.73,"end":3048.05},{"text":"to","start":3048.05,"end":3048.29},{"text":"us","start":3048.29,"end":3048.49},{"text":"about","start":3048.49,"end":3048.81},{"text":"financing","start":3048.81,"end":3049.49},{"text":"harm","start":3049.49,"end":3049.73},{"text":"reduction","start":3049.73,"end":3050.45},{"text":"and","start":3050.61,"end":3050.85},{"text":"some","start":3050.85,"end":3051.17},{"text":"global","start":3051.21,"end":3051.53},{"text":"trends","start":3051.65,"end":3052.13},{"text":"regarding","start":3052.13,"end":3052.77},{"text":"the","start":3052.77,"end":3052.89},{"text":"matter.","start":3052.89,"end":3053.33}]},{"text":"Please, Ms. Cook, you have the floor.","start":3053.57,"end":3055.33,"topics":[],"words":[{"text":"Please,","start":3053.57,"end":3053.89},{"text":"Ms.","start":3053.89,"end":3054.13},{"text":"Cook,","start":3054.13,"end":3054.45},{"text":"you","start":3054.45,"end":3054.61},{"text":"have","start":3054.61,"end":3054.85},{"text":"the","start":3054.85,"end":3054.93},{"text":"floor.","start":3054.93,"end":3055.33}]}]}],"speaker":{"affiliation":"MEX","group":null,"function":"Deputy Permanent Representative","affiliation_full":"Mexico"}},{"statement_number":15,"start":3060.29,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=51:01","paragraphs":[{"sentences":[{"text":"Thank you so much, Chair, and good afternoon, excellencies and participants.","start":3060.29,"end":3065.53,"topics":[],"words":[{"text":"Thank","start":3060.29,"end":3060.45},{"text":"you","start":3060.45,"end":3060.53},{"text":"so","start":3060.53,"end":3060.69},{"text":"much,","start":3060.69,"end":3061.21},{"text":"Chair,","start":3061.21,"end":3061.49},{"text":"and","start":3061.73,"end":3062.13},{"text":"good","start":3062.97,"end":3063.09},{"text":"afternoon,","start":3063.13,"end":3063.49},{"text":"excellencies","start":3063.49,"end":3064.45},{"text":"and","start":3064.45,"end":3064.69},{"text":"participants.","start":3064.69,"end":3065.53}]},{"text":"Thank you for the opportunity to join this important discussion today.","start":3065.53,"end":3069.41,"topics":[],"words":[{"text":"Thank","start":3065.53,"end":3065.73},{"text":"you","start":3065.73,"end":3065.81},{"text":"for","start":3065.81,"end":3065.97},{"text":"the","start":3065.97,"end":3066.09},{"text":"opportunity","start":3066.09,"end":3066.61},{"text":"to","start":3066.61,"end":3066.77},{"text":"join","start":3066.77,"end":3067.13},{"text":"this","start":3067.13,"end":3067.41},{"text":"important","start":3067.73,"end":3068.33},{"text":"discussion","start":3068.33,"end":3068.85},{"text":"today.","start":3068.85,"end":3069.41}]},{"text":"Can you see my slides?","start":3069.69,"end":3071.17,"topics":[],"words":[{"text":"Can","start":3069.69,"end":3069.89},{"text":"you","start":3069.89,"end":3069.97},{"text":"see","start":3069.97,"end":3070.21},{"text":"my","start":3070.21,"end":3070.37},{"text":"slides?","start":3070.37,"end":3071.17}]},{"text":"Yes.","start":3072.57,"end":3072.73,"topics":[],"words":[{"text":"Yes.","start":3072.57,"end":3072.73}]},{"text":"Great.","start":3074.89,"end":3075.41,"topics":[],"words":[{"text":"Great.","start":3074.89,"end":3075.41}]},{"text":"Okay.","start":3075.65,"end":3076.05,"topics":[],"words":[{"text":"Okay.","start":3075.65,"end":3076.05}]},{"text":"My name is Catherine Cook.","start":3076.45,"end":3077.45,"topics":[],"words":[{"text":"My","start":3076.45,"end":3076.65},{"text":"name","start":3076.65,"end":3076.81},{"text":"is","start":3076.81,"end":3076.93},{"text":"Catherine","start":3076.93,"end":3077.25},{"text":"Cook.","start":3077.25,"end":3077.45}]},{"text":"I'm from Harm Reduction International, and I'm going to talk a bit about the global state of harm reduction to look at what is at stake in this changing funding and political landscape we're currently in, and to point to some critical actions required to protect harm reduction programs.","start":3077.45,"end":3092.41,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"I'm","start":3077.45,"end":3077.65},{"text":"from","start":3077.65,"end":3077.81},{"text":"Harm","start":3077.81,"end":3078.01},{"text":"Reduction","start":3078.01,"end":3078.37},{"text":"International,","start":3078.37,"end":3079.01},{"text":"and","start":3079.01,"end":3079.13},{"text":"I'm","start":3079.13,"end":3079.33},{"text":"going","start":3079.33,"end":3079.49},{"text":"to","start":3079.49,"end":3079.73},{"text":"talk","start":3079.73,"end":3079.85},{"text":"a","start":3079.85,"end":3079.89},{"text":"bit","start":3079.89,"end":3080.09},{"text":"about","start":3080.09,"end":3080.53},{"text":"the","start":3081.05,"end":3081.17},{"text":"global","start":3081.17,"end":3081.53},{"text":"state","start":3081.53,"end":3081.81},{"text":"of","start":3081.81,"end":3081.89},{"text":"harm","start":3081.89,"end":3082.09},{"text":"reduction","start":3082.09,"end":3082.65},{"text":"to","start":3082.65,"end":3082.73},{"text":"look","start":3082.73,"end":3082.97},{"text":"at","start":3082.97,"end":3083.05},{"text":"what","start":3083.05,"end":3083.25},{"text":"is","start":3083.25,"end":3083.61},{"text":"at","start":3083.61,"end":3083.77},{"text":"stake","start":3083.77,"end":3084.41},{"text":"in","start":3084.41,"end":3084.57},{"text":"this","start":3084.57,"end":3084.73},{"text":"changing","start":3084.73,"end":3085.21},{"text":"funding","start":3085.21,"end":3085.57},{"text":"and","start":3085.57,"end":3085.69},{"text":"political","start":3085.69,"end":3086.13},{"text":"landscape","start":3086.13,"end":3086.73},{"text":"we're","start":3086.73,"end":3086.93},{"text":"currently","start":3086.93,"end":3087.45},{"text":"in,","start":3087.45,"end":3087.77},{"text":"and","start":3088.01,"end":3088.21},{"text":"to","start":3088.21,"end":3088.29},{"text":"point","start":3088.29,"end":3088.77},{"text":"to","start":3088.77,"end":3088.85},{"text":"some","start":3088.85,"end":3089.17},{"text":"critical","start":3089.17,"end":3089.61},{"text":"actions","start":3089.61,"end":3090.01},{"text":"required","start":3090.01,"end":3090.49},{"text":"to","start":3090.49,"end":3090.61},{"text":"protect","start":3090.61,"end":3091.05},{"text":"harm","start":3091.05,"end":3091.21},{"text":"reduction","start":3091.21,"end":3091.61},{"text":"programs.","start":3091.61,"end":3092.41}]},{"text":"Harm reduction is much broader than the provision of needle and syringe programs or opioid agonist therapies, but on the screen here, I'm showing figures on some of the core interventions that the World Health Organization, UNAIDS and UNODC recommend countries implement as part of their health responses.","start":3094.49,"end":3109.45,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"Harm","start":3094.49,"end":3094.69},{"text":"reduction","start":3094.69,"end":3095.13},{"text":"is","start":3095.13,"end":3095.29},{"text":"much","start":3095.29,"end":3095.53},{"text":"broader","start":3095.53,"end":3095.93},{"text":"than","start":3095.93,"end":3096.09},{"text":"the","start":3096.09,"end":3096.17},{"text":"provision","start":3096.17,"end":3096.61},{"text":"of","start":3096.61,"end":3096.73},{"text":"needle","start":3096.73,"end":3096.97},{"text":"and","start":3096.97,"end":3097.09},{"text":"syringe","start":3097.09,"end":3097.45},{"text":"programs","start":3097.45,"end":3098.01},{"text":"or","start":3098.01,"end":3098.29},{"text":"opioid","start":3098.29,"end":3098.65},{"text":"agonist","start":3098.65,"end":3099.09},{"text":"therapies,","start":3099.09,"end":3099.61},{"text":"but","start":3099.61,"end":3099.73},{"text":"on","start":3099.73,"end":3099.93},{"text":"the","start":3099.93,"end":3100.01},{"text":"screen","start":3100.01,"end":3100.33},{"text":"here,","start":3100.33,"end":3100.57},{"text":"I'm","start":3100.57,"end":3100.81},{"text":"showing","start":3100.81,"end":3101.13},{"text":"figures","start":3101.13,"end":3101.61},{"text":"on","start":3101.81,"end":3101.89},{"text":"some","start":3101.93,"end":3102.13},{"text":"of","start":3102.13,"end":3102.21},{"text":"the","start":3102.21,"end":3102.29},{"text":"core","start":3102.29,"end":3102.57},{"text":"interventions","start":3102.57,"end":3103.33},{"text":"that","start":3103.33,"end":3103.45},{"text":"the","start":3103.45,"end":3103.57},{"text":"World","start":3103.57,"end":3103.85},{"text":"Health","start":3103.85,"end":3104.09},{"text":"Organization,","start":3104.09,"end":3104.57},{"text":"UNAIDS","start":3104.57,"end":3105.45},{"text":"and","start":3105.45,"end":3105.61},{"text":"UNODC","start":3105.61,"end":3106.41},{"text":"recommend","start":3106.41,"end":3106.97},{"text":"countries","start":3106.97,"end":3107.37},{"text":"implement","start":3107.37,"end":3107.89},{"text":"as","start":3107.89,"end":3108.01},{"text":"part","start":3108.01,"end":3108.21},{"text":"of","start":3108.21,"end":3108.33},{"text":"their","start":3108.33,"end":3108.45},{"text":"health","start":3108.45,"end":3108.65},{"text":"responses.","start":3108.65,"end":3109.45}]},{"text":"We've monitored at HRI, we've monitored the global state of harm reduction since 2008, and we've seen slow but steady increase in the number of countries introducing harm reduction in implementation and in their national policies.","start":3110.01,"end":3123.21,"topics":[],"words":[{"text":"We've","start":3110.01,"end":3110.25},{"text":"monitored","start":3110.25,"end":3110.97},{"text":"at","start":3110.97,"end":3111.21},{"text":"HRI,","start":3111.21,"end":3111.69},{"text":"we've","start":3111.69,"end":3111.85},{"text":"monitored","start":3111.85,"end":3112.33},{"text":"the","start":3112.41,"end":3112.53},{"text":"global","start":3112.53,"end":3112.81},{"text":"state","start":3112.81,"end":3113.01},{"text":"of","start":3113.01,"end":3113.13},{"text":"harm","start":3113.13,"end":3113.29},{"text":"reduction","start":3113.29,"end":3113.69},{"text":"since","start":3113.69,"end":3114.01},{"text":"2008,","start":3114.01,"end":3115.13},{"text":"and","start":3115.53,"end":3115.69},{"text":"we've","start":3115.69,"end":3115.85},{"text":"seen","start":3115.85,"end":3116.09},{"text":"slow","start":3116.09,"end":3116.65},{"text":"but","start":3116.65,"end":3116.81},{"text":"steady","start":3116.81,"end":3117.21},{"text":"increase","start":3117.21,"end":3117.77},{"text":"in","start":3117.77,"end":3117.93},{"text":"the","start":3117.93,"end":3118.01},{"text":"number","start":3118.01,"end":3118.37},{"text":"of","start":3118.37,"end":3118.49},{"text":"countries","start":3118.49,"end":3118.97},{"text":"introducing","start":3118.97,"end":3119.61},{"text":"harm","start":3119.61,"end":3119.77},{"text":"reduction","start":3119.77,"end":3120.41},{"text":"in","start":3120.57,"end":3120.69},{"text":"implementation","start":3120.69,"end":3121.61},{"text":"and","start":3121.61,"end":3121.85},{"text":"in","start":3121.85,"end":3121.93},{"text":"their","start":3121.93,"end":3122.05},{"text":"national","start":3122.05,"end":3122.49},{"text":"policies.","start":3122.49,"end":3123.21}]},{"text":"Governments have signed up to high level targets and commitments on scaling up harm reduction and community led responses and on decriminalisation.","start":3124.85,"end":3132.89,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Governments","start":3124.85,"end":3125.29},{"text":"have","start":3125.29,"end":3125.41},{"text":"signed","start":3125.41,"end":3125.85},{"text":"up","start":3125.85,"end":3125.97},{"text":"to","start":3125.97,"end":3126.13},{"text":"high","start":3126.25,"end":3126.49},{"text":"level","start":3126.49,"end":3126.73},{"text":"targets","start":3126.73,"end":3127.37},{"text":"and","start":3127.37,"end":3127.53},{"text":"commitments","start":3127.53,"end":3128.17},{"text":"on","start":3128.17,"end":3128.33},{"text":"scaling","start":3128.33,"end":3128.73},{"text":"up","start":3128.73,"end":3128.89},{"text":"harm","start":3128.89,"end":3129.05},{"text":"reduction","start":3129.05,"end":3129.57},{"text":"and","start":3129.57,"end":3129.69},{"text":"community","start":3129.69,"end":3130.17},{"text":"led","start":3130.17,"end":3130.41},{"text":"responses","start":3130.49,"end":3131.29},{"text":"and","start":3131.29,"end":3131.53},{"text":"on","start":3131.57,"end":3131.77},{"text":"decriminalisation.","start":3131.77,"end":3132.89}]},{"text":"Harm reduction is emphasised more than ever before in international commitments, and this is not by accident.","start":3133.69,"end":3139.05,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Harm","start":3133.69,"end":3133.93},{"text":"reduction","start":3133.93,"end":3134.33},{"text":"is","start":3134.33,"end":3134.49},{"text":"emphasised","start":3134.49,"end":3135.13},{"text":"more","start":3135.13,"end":3135.29},{"text":"than","start":3135.29,"end":3135.45},{"text":"ever","start":3135.45,"end":3135.65},{"text":"before","start":3135.65,"end":3136.05},{"text":"in","start":3136.05,"end":3136.17},{"text":"international","start":3136.17,"end":3136.73},{"text":"commitments,","start":3136.73,"end":3137.37},{"text":"and","start":3137.45,"end":3137.65},{"text":"this","start":3137.65,"end":3137.77},{"text":"is","start":3137.77,"end":3137.93},{"text":"not","start":3137.93,"end":3138.09},{"text":"by","start":3138.09,"end":3138.25},{"text":"accident.","start":3138.25,"end":3139.05}]},{"text":"This is because it is effective and cost effective and a necessary component to reaching global health goals.","start":3139.33,"end":3145.57,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"This","start":3139.33,"end":3139.53},{"text":"is","start":3139.53,"end":3139.65},{"text":"because","start":3139.65,"end":3140.13},{"text":"it","start":3140.13,"end":3140.45},{"text":"is","start":3140.45,"end":3140.61},{"text":"effective","start":3140.61,"end":3141.41},{"text":"and","start":3141.41,"end":3141.57},{"text":"cost","start":3141.57,"end":3141.89},{"text":"effective","start":3141.89,"end":3142.45},{"text":"and","start":3142.53,"end":3142.73},{"text":"a","start":3142.73,"end":3142.77},{"text":"necessary","start":3142.77,"end":3143.29},{"text":"component","start":3143.29,"end":3143.93},{"text":"to","start":3143.93,"end":3144.01},{"text":"reaching","start":3144.01,"end":3144.37},{"text":"global","start":3144.37,"end":3144.69},{"text":"health","start":3144.69,"end":3145.01},{"text":"goals.","start":3145.01,"end":3145.57}]},{"text":"Harm reduction is valued on paper and many countries are implementing harm reduction, but we also look at harm reduction funding because budgets are the real value statements, as the previous speaker mentioned.","start":3146.05,"end":3161.17,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"Harm","start":3146.05,"end":3146.29},{"text":"reduction","start":3146.29,"end":3146.65},{"text":"is","start":3146.65,"end":3146.77},{"text":"valued","start":3146.77,"end":3147.25},{"text":"on","start":3147.29,"end":3147.41},{"text":"paper","start":3147.41,"end":3147.85},{"text":"and","start":3148.57,"end":3148.73},{"text":"many","start":3148.73,"end":3148.97},{"text":"countries","start":3148.97,"end":3149.41},{"text":"are","start":3150.17,"end":3150.37},{"text":"implementing","start":3150.61,"end":3152.65},{"text":"harm","start":3152.65,"end":3152.85},{"text":"reduction,","start":3152.85,"end":3153.49},{"text":"but","start":3153.73,"end":3153.97},{"text":"we","start":3153.97,"end":3154.13},{"text":"also","start":3154.13,"end":3154.69},{"text":"look","start":3154.77,"end":3155.25},{"text":"at","start":3155.25,"end":3155.41},{"text":"harm","start":3155.41,"end":3155.57},{"text":"reduction","start":3155.57,"end":3155.97},{"text":"funding","start":3155.97,"end":3156.37},{"text":"because","start":3156.37,"end":3156.69},{"text":"budgets","start":3156.69,"end":3157.33},{"text":"are","start":3157.49,"end":3157.57},{"text":"the","start":3157.65,"end":3157.73},{"text":"real","start":3157.73,"end":3158.05},{"text":"value","start":3158.05,"end":3158.37},{"text":"statements,","start":3158.37,"end":3159.17},{"text":"as","start":3159.17,"end":3159.33},{"text":"the","start":3159.33,"end":3159.45},{"text":"previous","start":3159.81,"end":3160.21},{"text":"speaker","start":3160.21,"end":3160.53},{"text":"mentioned.","start":3160.53,"end":3161.17}]},{"text":"In lower middle income countries in particular, the availability of funding for harm reduction has always fallen far short.","start":3163.57,"end":3170.21,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"In","start":3163.57,"end":3163.65},{"text":"lower","start":3163.73,"end":3163.97},{"text":"middle","start":3164.29,"end":3164.61},{"text":"income","start":3164.61,"end":3164.93},{"text":"countries","start":3164.93,"end":3165.25},{"text":"in","start":3165.25,"end":3165.33},{"text":"particular,","start":3165.33,"end":3165.97},{"text":"the","start":3165.97,"end":3166.17},{"text":"availability","start":3166.17,"end":3166.81},{"text":"of","start":3166.81,"end":3166.89},{"text":"funding","start":3166.89,"end":3167.29},{"text":"for","start":3167.29,"end":3167.41},{"text":"harm","start":3167.41,"end":3167.57},{"text":"reduction","start":3167.57,"end":3167.97},{"text":"has","start":3167.97,"end":3168.21},{"text":"always","start":3168.21,"end":3168.77},{"text":"fallen","start":3169.01,"end":3169.33},{"text":"far","start":3169.33,"end":3169.57},{"text":"short.","start":3169.57,"end":3170.21}]},{"text":"While the overall HIV response had a 26% funding gap, in 2022, harm reduction had a funding gap of 94%.","start":3170.65,"end":3177.61,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"While","start":3170.65,"end":3170.93},{"text":"the","start":3170.93,"end":3171.05},{"text":"overall","start":3171.05,"end":3171.49},{"text":"HIV","start":3171.49,"end":3171.97},{"text":"response","start":3171.97,"end":3173.57},{"text":"had","start":3173.57,"end":3173.69},{"text":"a","start":3173.69,"end":3173.73},{"text":"26%","start":3173.73,"end":3173.77},{"text":"funding","start":3173.77,"end":3174.13},{"text":"gap,","start":3174.13,"end":3174.37},{"text":"in","start":3174.69,"end":3174.85},{"text":"2022,","start":3174.85,"end":3175.81},{"text":"harm","start":3175.81,"end":3176.05},{"text":"reduction","start":3176.05,"end":3176.53},{"text":"had","start":3176.53,"end":3176.65},{"text":"a","start":3176.65,"end":3176.69},{"text":"funding","start":3176.69,"end":3177.05},{"text":"gap","start":3177.05,"end":3177.41},{"text":"of","start":3177.41,"end":3177.57},{"text":"94%.","start":3177.57,"end":3177.61}]},{"text":"Harm reduction is very reliant on donors, and it has become increasingly reliant on the Global Fund, which accounted for 73% of all donor funding for harm reduction in 2022, compared to just 31% in 2007.","start":3177.65,"end":3193.01,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"Harm","start":3177.65,"end":3178.45},{"text":"reduction","start":3179.97,"end":3180.37},{"text":"is","start":3180.37,"end":3180.53},{"text":"very","start":3180.53,"end":3180.85},{"text":"reliant","start":3180.85,"end":3181.37},{"text":"on","start":3181.37,"end":3181.49},{"text":"donors,","start":3181.49,"end":3182.05},{"text":"and","start":3182.05,"end":3182.25},{"text":"it","start":3182.25,"end":3182.33},{"text":"has","start":3182.33,"end":3182.53},{"text":"become","start":3182.53,"end":3182.85},{"text":"increasingly","start":3182.85,"end":3183.49},{"text":"reliant","start":3183.49,"end":3183.97},{"text":"on","start":3183.97,"end":3184.05},{"text":"the","start":3184.05,"end":3184.17},{"text":"Global","start":3184.17,"end":3184.53},{"text":"Fund,","start":3184.53,"end":3184.93},{"text":"which","start":3185.17,"end":3185.41},{"text":"accounted","start":3185.41,"end":3186.37},{"text":"for","start":3186.37,"end":3186.61},{"text":"73%","start":3186.77,"end":3186.81},{"text":"of","start":3186.85,"end":3187.09},{"text":"all","start":3187.09,"end":3187.25},{"text":"donor","start":3187.25,"end":3187.57},{"text":"funding","start":3187.57,"end":3187.93},{"text":"for","start":3187.93,"end":3188.05},{"text":"harm","start":3188.05,"end":3188.21},{"text":"reduction","start":3188.21,"end":3188.77},{"text":"in","start":3188.77,"end":3188.93},{"text":"2022,","start":3188.93,"end":3189.81},{"text":"compared","start":3189.97,"end":3190.45},{"text":"to","start":3190.45,"end":3191.25},{"text":"just","start":3191.37,"end":3191.69},{"text":"31%","start":3191.69,"end":3191.73},{"text":"in","start":3191.73,"end":3191.89},{"text":"2007.","start":3191.89,"end":3193.01}]},{"text":"PEPFAR was the second largest donor in 2022, contributing 8% of donor investment in harm reduction.","start":3193.49,"end":3200.33,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"PEPFAR","start":3193.49,"end":3194.45},{"text":"was","start":3194.45,"end":3194.57},{"text":"the","start":3194.57,"end":3194.65},{"text":"second","start":3194.65,"end":3195.01},{"text":"largest","start":3195.01,"end":3195.41},{"text":"donor","start":3195.41,"end":3195.85},{"text":"in","start":3195.85,"end":3195.97},{"text":"2022,","start":3195.97,"end":3196.89},{"text":"contributing","start":3196.89,"end":3197.81},{"text":"8%","start":3197.81,"end":3197.85},{"text":"of","start":3197.85,"end":3197.93},{"text":"donor","start":3198.21,"end":3198.69},{"text":"investment","start":3198.69,"end":3199.33},{"text":"in","start":3199.33,"end":3199.45},{"text":"harm","start":3199.45,"end":3199.61},{"text":"reduction.","start":3199.61,"end":3200.33}]},{"text":"And we found nine other donors, including the Robert Carr Fund, Open Society Foundations, and the Elton John AIDS Foundation, who provided 5% or less.","start":3200.65,"end":3208.81,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"And","start":3200.65,"end":3200.81},{"text":"we","start":3200.81,"end":3200.97},{"text":"found","start":3200.97,"end":3201.33},{"text":"nine","start":3201.33,"end":3201.61},{"text":"other","start":3201.61,"end":3201.81},{"text":"donors,","start":3201.81,"end":3202.21},{"text":"including","start":3202.21,"end":3202.65},{"text":"the","start":3202.65,"end":3202.73},{"text":"Robert","start":3202.73,"end":3202.97},{"text":"Carr","start":3202.97,"end":3203.25},{"text":"Fund,","start":3203.25,"end":3203.69},{"text":"Open","start":3203.69,"end":3204.01},{"text":"Society","start":3204.01,"end":3204.57},{"text":"Foundations,","start":3204.57,"end":3205.29},{"text":"and","start":3205.45,"end":3205.65},{"text":"the","start":3205.65,"end":3205.73},{"text":"Elton","start":3205.73,"end":3205.93},{"text":"John","start":3205.93,"end":3206.17},{"text":"AIDS","start":3206.17,"end":3206.41},{"text":"Foundation,","start":3206.41,"end":3207.05},{"text":"who","start":3207.05,"end":3207.17},{"text":"provided","start":3207.17,"end":3208.21},{"text":"5%","start":3208.21,"end":3208.25},{"text":"or","start":3208.25,"end":3208.33},{"text":"less.","start":3208.33,"end":3208.81}]},{"text":"In 2022 and 20-- sorry, in 2023 and 2024, there were hopeful indications that harm reduction funding was on the increase.","start":3210.09,"end":3217.93,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"In","start":3210.09,"end":3210.25},{"text":"2022","start":3210.25,"end":3211.29},{"text":"and","start":3211.29,"end":3211.45},{"text":"20--","start":3211.45,"end":3211.77},{"text":"sorry,","start":3211.77,"end":3212.21},{"text":"in","start":3212.21,"end":3212.29},{"text":"2023","start":3212.29,"end":3213.21},{"text":"and","start":3213.21,"end":3213.33},{"text":"2024,","start":3213.33,"end":3214.25},{"text":"there","start":3214.25,"end":3214.45},{"text":"were","start":3214.45,"end":3214.57},{"text":"hopeful","start":3214.57,"end":3214.97},{"text":"indications","start":3214.97,"end":3215.77},{"text":"that","start":3215.77,"end":3215.89},{"text":"harm","start":3215.89,"end":3216.09},{"text":"reduction","start":3216.09,"end":3216.49},{"text":"funding","start":3216.49,"end":3216.81},{"text":"was","start":3216.81,"end":3217.01},{"text":"on","start":3217.01,"end":3217.13},{"text":"the","start":3217.13,"end":3217.25},{"text":"increase.","start":3217.25,"end":3217.93}]},{"text":"Data from the Global Fund showed that allocations for needle and syringe programs had increased by over 50% between grant cycles.","start":3218.41,"end":3224.97,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"Data","start":3218.41,"end":3218.73},{"text":"from","start":3218.73,"end":3218.89},{"text":"the","start":3218.89,"end":3218.97},{"text":"Global","start":3218.97,"end":3219.29},{"text":"Fund","start":3219.29,"end":3219.61},{"text":"showed","start":3219.61,"end":3219.89},{"text":"that","start":3219.89,"end":3220.01},{"text":"allocations","start":3220.01,"end":3220.65},{"text":"for","start":3220.65,"end":3220.77},{"text":"needle","start":3220.77,"end":3221.01},{"text":"and","start":3221.01,"end":3221.17},{"text":"syringe","start":3221.17,"end":3221.45},{"text":"programs","start":3221.45,"end":3221.93},{"text":"had","start":3221.93,"end":3222.09},{"text":"increased","start":3222.09,"end":3222.57},{"text":"by","start":3222.57,"end":3222.69},{"text":"over","start":3222.69,"end":3222.93},{"text":"50%","start":3222.93,"end":3222.97},{"text":"between","start":3222.97,"end":3223.97},{"text":"grant","start":3223.97,"end":3224.25},{"text":"cycles.","start":3224.25,"end":3224.97}]},{"text":"A recent study from funders concerned about AIDS found philanthropic HIV donors had increased funding for harm reduction by 21% between 2022 and 2023.","start":3225.69,"end":3234.97,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"A","start":3225.69,"end":3225.73},{"text":"recent","start":3225.73,"end":3226.13},{"text":"study","start":3226.13,"end":3226.41},{"text":"from","start":3226.41,"end":3226.57},{"text":"funders","start":3226.57,"end":3226.97},{"text":"concerned","start":3226.97,"end":3227.41},{"text":"about","start":3227.41,"end":3227.61},{"text":"AIDS","start":3227.61,"end":3228.01},{"text":"found","start":3228.01,"end":3228.25},{"text":"philanthropic","start":3228.25,"end":3228.89},{"text":"HIV","start":3228.89,"end":3229.37},{"text":"donors","start":3229.37,"end":3229.69},{"text":"had","start":3229.69,"end":3229.85},{"text":"increased","start":3229.85,"end":3230.25},{"text":"funding","start":3230.25,"end":3230.65},{"text":"for","start":3230.65,"end":3230.77},{"text":"harm","start":3230.77,"end":3230.97},{"text":"reduction","start":3230.97,"end":3231.41},{"text":"by","start":3231.41,"end":3231.57},{"text":"21%","start":3231.57,"end":3231.61},{"text":"between","start":3231.61,"end":3232.49},{"text":"2022","start":3232.89,"end":3233.89},{"text":"and","start":3233.89,"end":3234.01},{"text":"2023.","start":3234.01,"end":3234.97}]},{"text":"And lastly, PEPFAR budget data for 2024 to 2025 showed that their harm reduction funding was set to more than double, reaching around 17 million.","start":3235.53,"end":3245.61,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"And","start":3235.53,"end":3235.69},{"text":"lastly,","start":3235.69,"end":3236.01},{"text":"PEPFAR","start":3236.01,"end":3236.93},{"text":"budget","start":3236.93,"end":3237.25},{"text":"data","start":3237.25,"end":3237.53},{"text":"for","start":3237.53,"end":3237.65},{"text":"2024","start":3237.65,"end":3238.61},{"text":"to","start":3238.61,"end":3238.81},{"text":"2025","start":3238.81,"end":3239.93},{"text":"showed","start":3240.17,"end":3240.45},{"text":"that","start":3240.45,"end":3240.57},{"text":"their","start":3240.57,"end":3240.81},{"text":"harm","start":3240.81,"end":3241.05},{"text":"reduction","start":3241.05,"end":3241.45},{"text":"funding","start":3241.45,"end":3241.81},{"text":"was","start":3241.81,"end":3241.93},{"text":"set","start":3241.93,"end":3242.29},{"text":"to","start":3242.29,"end":3242.37},{"text":"more","start":3242.37,"end":3242.49},{"text":"than","start":3242.49,"end":3242.65},{"text":"double,","start":3242.65,"end":3243.21},{"text":"reaching","start":3243.53,"end":3244.01},{"text":"around","start":3244.01,"end":3244.33},{"text":"17","start":3244.33,"end":3244.97},{"text":"million.","start":3245.13,"end":3245.61}]},{"text":"But as Anton has already outlined, the drastic changes following the US government pause and subsequent terminations in foreign aid contracts have had severe impacts on harm reduction and the wider infrastructure that it relies upon.","start":3246.85,"end":3259.09,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"But","start":3246.85,"end":3247.01},{"text":"as","start":3247.05,"end":3247.17},{"text":"Anton","start":3247.17,"end":3247.65},{"text":"has","start":3247.65,"end":3247.89},{"text":"already","start":3247.89,"end":3248.21},{"text":"outlined,","start":3248.21,"end":3248.69},{"text":"the","start":3248.69,"end":3248.81},{"text":"drastic","start":3248.81,"end":3249.25},{"text":"changes","start":3249.25,"end":3249.77},{"text":"following","start":3249.77,"end":3250.13},{"text":"the","start":3250.13,"end":3250.41},{"text":"US","start":3250.41,"end":3250.53},{"text":"government","start":3250.53,"end":3250.93},{"text":"pause","start":3250.93,"end":3251.29},{"text":"and","start":3251.29,"end":3251.41},{"text":"subsequent","start":3251.41,"end":3252.13},{"text":"terminations","start":3252.21,"end":3253.01},{"text":"in","start":3253.01,"end":3253.09},{"text":"foreign","start":3253.09,"end":3253.49},{"text":"aid","start":3253.49,"end":3253.65},{"text":"contracts","start":3253.65,"end":3254.29},{"text":"have","start":3254.53,"end":3254.69},{"text":"had","start":3254.69,"end":3254.85},{"text":"severe","start":3254.85,"end":3255.29},{"text":"impacts","start":3255.29,"end":3255.81},{"text":"on","start":3255.81,"end":3255.89},{"text":"harm","start":3255.89,"end":3256.13},{"text":"reduction","start":3256.13,"end":3256.53},{"text":"and","start":3256.53,"end":3256.69},{"text":"the","start":3256.69,"end":3256.77},{"text":"wider","start":3256.77,"end":3257.13},{"text":"infrastructure","start":3257.13,"end":3257.81},{"text":"that","start":3257.81,"end":3258.21},{"text":"it","start":3258.21,"end":3258.37},{"text":"relies","start":3258.37,"end":3258.73},{"text":"upon.","start":3258.73,"end":3259.09}]},{"text":"There is a really real danger that our next assessment of the funding landscape will be really stark as many institutions undergo prioritisation and streamlining processes in 2025.","start":3259.57,"end":3271.97,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"There","start":3259.57,"end":3259.77},{"text":"is","start":3259.77,"end":3259.89},{"text":"a","start":3259.89,"end":3259.93},{"text":"really","start":3259.93,"end":3260.29},{"text":"real","start":3260.29,"end":3260.53},{"text":"danger","start":3260.53,"end":3261.09},{"text":"that","start":3261.09,"end":3261.25},{"text":"our","start":3261.25,"end":3261.41},{"text":"next","start":3261.41,"end":3261.97},{"text":"assessment","start":3261.97,"end":3262.45},{"text":"of","start":3262.69,"end":3262.85},{"text":"the","start":3262.85,"end":3262.93},{"text":"funding","start":3262.93,"end":3263.29},{"text":"landscape","start":3263.29,"end":3264.37},{"text":"will","start":3264.37,"end":3264.53},{"text":"be","start":3264.53,"end":3264.77},{"text":"really","start":3264.85,"end":3265.17},{"text":"stark","start":3265.17,"end":3265.73},{"text":"as","start":3266.37,"end":3266.61},{"text":"many","start":3266.69,"end":3267.05},{"text":"institutions","start":3267.05,"end":3267.73},{"text":"undergo","start":3267.73,"end":3268.13},{"text":"prioritisation","start":3268.13,"end":3269.09},{"text":"and","start":3269.09,"end":3269.25},{"text":"streamlining","start":3269.25,"end":3270.29},{"text":"processes","start":3270.29,"end":3270.85},{"text":"in","start":3270.85,"end":3271.09},{"text":"2025.","start":3271.09,"end":3271.97}]},{"text":"The gains made and the lives saved through precious investment so far are now under threat and in some cases already tragically lost.","start":3273.17,"end":3279.73,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"The","start":3273.17,"end":3273.21},{"text":"gains","start":3273.21,"end":3273.57},{"text":"made","start":3273.57,"end":3273.97},{"text":"and","start":3273.97,"end":3274.13},{"text":"the","start":3274.13,"end":3274.21},{"text":"lives","start":3274.21,"end":3274.57},{"text":"saved","start":3274.57,"end":3275.01},{"text":"through","start":3275.01,"end":3275.25},{"text":"precious","start":3275.25,"end":3275.65},{"text":"investment","start":3275.65,"end":3276.09},{"text":"so","start":3276.09,"end":3276.25},{"text":"far","start":3276.25,"end":3276.57},{"text":"are","start":3276.57,"end":3276.65},{"text":"now","start":3276.65,"end":3276.97},{"text":"under","start":3276.97,"end":3277.21},{"text":"threat","start":3277.21,"end":3277.57},{"text":"and","start":3277.57,"end":3277.69},{"text":"in","start":3277.69,"end":3277.81},{"text":"some","start":3277.81,"end":3278.05},{"text":"cases","start":3278.05,"end":3278.45},{"text":"already","start":3278.45,"end":3278.77},{"text":"tragically","start":3278.77,"end":3279.25},{"text":"lost.","start":3279.25,"end":3279.73}]},{"text":"Too few governments are using domestic budgets to fund harm reduction.","start":3280.89,"end":3284.53,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"Too","start":3280.89,"end":3281.09},{"text":"few","start":3281.09,"end":3281.33},{"text":"governments","start":3281.33,"end":3281.97},{"text":"are","start":3281.97,"end":3282.05},{"text":"using","start":3282.05,"end":3282.37},{"text":"domestic","start":3282.37,"end":3282.85},{"text":"budgets","start":3282.85,"end":3283.17},{"text":"to","start":3283.17,"end":3283.29},{"text":"fund","start":3283.29,"end":3283.65},{"text":"harm","start":3283.65,"end":3283.89},{"text":"reduction.","start":3283.89,"end":3284.53}]},{"text":"Our tracking found 27 lower middle income countries with domestic funding for harm reduction in 2022, together accounting for around one third of all harm reduction funding that year.","start":3285.41,"end":3294.93,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"Our","start":3285.41,"end":3285.53},{"text":"tracking","start":3285.57,"end":3285.97},{"text":"found","start":3285.97,"end":3286.25},{"text":"27","start":3286.25,"end":3287.09},{"text":"lower","start":3287.09,"end":3287.33},{"text":"middle","start":3287.33,"end":3287.57},{"text":"income","start":3287.57,"end":3287.81},{"text":"countries","start":3287.81,"end":3288.33},{"text":"with","start":3288.33,"end":3288.45},{"text":"domestic","start":3288.45,"end":3288.93},{"text":"funding","start":3288.93,"end":3289.21},{"text":"for","start":3289.21,"end":3289.33},{"text":"harm","start":3289.33,"end":3289.49},{"text":"reduction","start":3289.49,"end":3289.89},{"text":"in","start":3289.89,"end":3289.97},{"text":"2022,","start":3289.97,"end":3290.93},{"text":"together","start":3291.25,"end":3291.77},{"text":"accounting","start":3291.77,"end":3292.37},{"text":"for","start":3292.37,"end":3292.49},{"text":"around","start":3292.49,"end":3292.77},{"text":"one","start":3292.77,"end":3293.01},{"text":"third","start":3293.01,"end":3293.25},{"text":"of","start":3293.25,"end":3293.37},{"text":"all","start":3293.37,"end":3293.49},{"text":"harm","start":3293.49,"end":3293.69},{"text":"reduction","start":3293.69,"end":3294.05},{"text":"funding","start":3294.05,"end":3294.45},{"text":"that","start":3294.45,"end":3294.61},{"text":"year.","start":3294.61,"end":3294.93}]},{"text":"And yet.","start":3296.05,"end":3296.69,"topics":[],"words":[{"text":"And","start":3296.05,"end":3296.25},{"text":"yet.","start":3296.29,"end":3296.69}]},{"text":"While harm reduction is facing its most profound moment of crisis, governments and donors spend vast amounts on punitive drug approaches around the world.","start":3297.53,"end":3304.61,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"While","start":3297.53,"end":3297.73},{"text":"harm","start":3297.73,"end":3297.97},{"text":"reduction","start":3297.97,"end":3298.37},{"text":"is","start":3298.37,"end":3298.49},{"text":"facing","start":3298.49,"end":3298.89},{"text":"its","start":3298.89,"end":3299.01},{"text":"most","start":3299.01,"end":3299.25},{"text":"profound","start":3299.25,"end":3299.73},{"text":"moment","start":3299.73,"end":3300.09},{"text":"of","start":3300.09,"end":3300.17},{"text":"crisis,","start":3300.17,"end":3300.85},{"text":"governments","start":3300.85,"end":3301.29},{"text":"and","start":3301.29,"end":3301.45},{"text":"donors","start":3301.45,"end":3301.77},{"text":"spend","start":3301.77,"end":3302.05},{"text":"vast","start":3302.05,"end":3302.33},{"text":"amounts","start":3302.33,"end":3302.69},{"text":"on","start":3302.69,"end":3302.77},{"text":"punitive","start":3302.77,"end":3303.25},{"text":"drug","start":3303.25,"end":3303.45},{"text":"approaches","start":3303.45,"end":3303.89},{"text":"around","start":3303.89,"end":3304.17},{"text":"the","start":3304.17,"end":3304.25},{"text":"world.","start":3304.25,"end":3304.61}]},{"text":"Since the UNGASS on drugs in 2016, many in the harm reduction and drug policy sector have been calling for governments and donors to look critically at this spending and the evidence of a failed war on drugs and the damage this has caused, calling for a redirection of investments into drug responses rooted in communities, health and justice.","start":3304.61,"end":3323.81,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"Since","start":3304.61,"end":3304.77},{"text":"the","start":3304.97,"end":3305.05},{"text":"UNGASS","start":3305.05,"end":3305.97},{"text":"on","start":3305.97,"end":3306.09},{"text":"drugs","start":3306.09,"end":3306.41},{"text":"in","start":3306.41,"end":3306.53},{"text":"2016,","start":3306.53,"end":3307.89},{"text":"many","start":3307.89,"end":3308.25},{"text":"in","start":3308.25,"end":3308.33},{"text":"the","start":3308.33,"end":3308.45},{"text":"harm","start":3308.45,"end":3308.65},{"text":"reduction","start":3308.65,"end":3309.01},{"text":"and","start":3309.01,"end":3309.13},{"text":"drug","start":3309.13,"end":3309.33},{"text":"policy","start":3309.33,"end":3309.73},{"text":"sector","start":3309.73,"end":3310.21},{"text":"have","start":3310.37,"end":3310.49},{"text":"been","start":3310.49,"end":3310.69},{"text":"calling","start":3310.69,"end":3311.09},{"text":"for","start":3311.09,"end":3311.21},{"text":"governments","start":3311.21,"end":3311.65},{"text":"and","start":3311.65,"end":3311.77},{"text":"donors","start":3311.77,"end":3312.13},{"text":"to","start":3312.13,"end":3312.29},{"text":"look","start":3312.29,"end":3312.65},{"text":"critically","start":3312.65,"end":3313.09},{"text":"at","start":3313.09,"end":3313.17},{"text":"this","start":3313.17,"end":3313.37},{"text":"spending","start":3313.37,"end":3313.89},{"text":"and","start":3314.13,"end":3314.33},{"text":"the","start":3314.33,"end":3314.41},{"text":"evidence","start":3314.41,"end":3314.81},{"text":"of","start":3314.81,"end":3314.89},{"text":"a","start":3314.89,"end":3314.93},{"text":"failed","start":3314.93,"end":3315.33},{"text":"war","start":3315.33,"end":3315.53},{"text":"on","start":3315.53,"end":3315.69},{"text":"drugs","start":3315.69,"end":3316.13},{"text":"and","start":3316.37,"end":3316.57},{"text":"the","start":3316.57,"end":3316.65},{"text":"damage","start":3316.65,"end":3316.97},{"text":"this","start":3316.97,"end":3317.13},{"text":"has","start":3317.13,"end":3317.25},{"text":"caused,","start":3317.25,"end":3317.89},{"text":"calling","start":3318.37,"end":3318.77},{"text":"for","start":3318.77,"end":3318.89},{"text":"a","start":3318.89,"end":3318.93},{"text":"redirection","start":3318.93,"end":3319.53},{"text":"of","start":3319.53,"end":3319.61},{"text":"investments","start":3319.61,"end":3320.17},{"text":"into","start":3320.17,"end":3320.45},{"text":"drug","start":3320.45,"end":3320.69},{"text":"responses","start":3320.69,"end":3321.17},{"text":"rooted","start":3321.17,"end":3321.65},{"text":"in","start":3321.65,"end":3321.89},{"text":"communities,","start":3321.89,"end":3322.61},{"text":"health","start":3322.61,"end":3322.93},{"text":"and","start":3322.97,"end":3323.17},{"text":"justice.","start":3323.17,"end":3323.81}]},{"text":"It is not that there is no money to provide life saving services to people that need them.","start":3325.21,"end":3329.53,"topics":[],"words":[{"text":"It","start":3325.21,"end":3325.37},{"text":"is","start":3325.37,"end":3325.53},{"text":"not","start":3325.53,"end":3325.73},{"text":"that","start":3325.73,"end":3325.85},{"text":"there","start":3325.85,"end":3326.05},{"text":"is","start":3326.05,"end":3326.17},{"text":"no","start":3326.17,"end":3326.33},{"text":"money","start":3326.33,"end":3326.73},{"text":"to","start":3326.73,"end":3326.85},{"text":"provide","start":3326.85,"end":3327.29},{"text":"life","start":3327.45,"end":3327.69},{"text":"saving","start":3327.69,"end":3328.09},{"text":"services","start":3328.09,"end":3328.53},{"text":"to","start":3328.53,"end":3328.65},{"text":"people","start":3328.65,"end":3328.93},{"text":"that","start":3328.93,"end":3329.05},{"text":"need","start":3329.05,"end":3329.33},{"text":"them.","start":3329.33,"end":3329.53}]},{"text":"It is just that it's been spent on punitive approaches that not only do not work to achieve their stated aim of reducing drug use, but also directly impede access to essential health services and stigmatize people.","start":3329.53,"end":3341.13,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"It","start":3329.53,"end":3329.69},{"text":"is","start":3329.69,"end":3329.85},{"text":"just","start":3329.85,"end":3330.05},{"text":"that","start":3330.05,"end":3330.17},{"text":"it's","start":3330.17,"end":3330.41},{"text":"been","start":3330.41,"end":3330.57},{"text":"spent","start":3330.57,"end":3331.01},{"text":"on","start":3331.01,"end":3331.21},{"text":"punitive","start":3331.21,"end":3331.69},{"text":"approaches","start":3331.69,"end":3332.25},{"text":"that","start":3332.25,"end":3332.49},{"text":"not","start":3332.49,"end":3332.69},{"text":"only","start":3332.69,"end":3332.97},{"text":"do","start":3332.97,"end":3333.09},{"text":"not","start":3333.09,"end":3333.29},{"text":"work","start":3333.29,"end":3333.61},{"text":"to","start":3333.61,"end":3333.81},{"text":"achieve","start":3333.81,"end":3334.17},{"text":"their","start":3334.17,"end":3334.29},{"text":"stated","start":3334.29,"end":3334.73},{"text":"aim","start":3334.73,"end":3334.97},{"text":"of","start":3334.97,"end":3335.05},{"text":"reducing","start":3335.05,"end":3335.53},{"text":"drug","start":3335.53,"end":3335.77},{"text":"use,","start":3335.77,"end":3336.01},{"text":"but","start":3336.25,"end":3336.45},{"text":"also","start":3336.45,"end":3336.73},{"text":"directly","start":3336.73,"end":3337.29},{"text":"impede","start":3337.29,"end":3337.77},{"text":"access","start":3337.77,"end":3338.33},{"text":"to","start":3338.33,"end":3338.53},{"text":"essential","start":3338.53,"end":3338.97},{"text":"health","start":3338.97,"end":3339.17},{"text":"services","start":3339.17,"end":3339.77},{"text":"and","start":3339.77,"end":3340.01},{"text":"stigmatize","start":3340.01,"end":3340.65},{"text":"people.","start":3340.65,"end":3341.13}]},{"text":"So within this changing landscape, what are the critical actions to take?","start":3342.97,"end":3346.89,"topics":[],"words":[{"text":"So","start":3342.97,"end":3343.21},{"text":"within","start":3343.21,"end":3343.49},{"text":"this","start":3343.49,"end":3343.69},{"text":"changing","start":3343.69,"end":3344.09},{"text":"landscape,","start":3344.09,"end":3344.61},{"text":"what","start":3344.61,"end":3344.81},{"text":"are","start":3344.81,"end":3344.89},{"text":"the","start":3344.89,"end":3344.97},{"text":"critical","start":3344.97,"end":3345.77},{"text":"actions","start":3345.77,"end":3346.25},{"text":"to","start":3346.25,"end":3346.53},{"text":"take?","start":3346.53,"end":3346.89}]},{"text":"Governments prioritizing harm reduction in their domestic budgets is the most sustainable option to avoid unnecessary deaths and achieve global health targets.","start":3348.41,"end":3356.81,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"Governments","start":3348.41,"end":3348.89},{"text":"prioritizing","start":3348.89,"end":3349.57},{"text":"harm","start":3349.57,"end":3349.77},{"text":"reduction","start":3349.77,"end":3350.17},{"text":"in","start":3350.17,"end":3350.25},{"text":"their","start":3350.25,"end":3350.37},{"text":"domestic","start":3350.37,"end":3351.25},{"text":"budgets","start":3351.25,"end":3351.77},{"text":"is","start":3351.77,"end":3352.01},{"text":"the","start":3352.01,"end":3352.13},{"text":"most","start":3352.17,"end":3352.49},{"text":"sustainable","start":3352.49,"end":3352.97},{"text":"option","start":3352.97,"end":3353.53},{"text":"to","start":3353.53,"end":3353.73},{"text":"avoid","start":3353.73,"end":3354.09},{"text":"unnecessary","start":3354.09,"end":3354.73},{"text":"deaths","start":3354.73,"end":3355.09},{"text":"and","start":3355.09,"end":3355.25},{"text":"achieve","start":3355.25,"end":3355.61},{"text":"global","start":3355.61,"end":3355.89},{"text":"health","start":3355.89,"end":3356.17},{"text":"targets.","start":3356.17,"end":3356.81}]},{"text":"This is a moment to spotlight domestic investment in harm reduction to amplify the positive experiences.","start":3357.13,"end":3362.65,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"This","start":3357.13,"end":3357.45},{"text":"is","start":3357.45,"end":3357.57},{"text":"a","start":3357.57,"end":3357.61},{"text":"moment","start":3357.61,"end":3358.05},{"text":"to","start":3358.05,"end":3358.13},{"text":"spotlight","start":3358.13,"end":3358.73},{"text":"domestic","start":3358.73,"end":3359.17},{"text":"investment","start":3359.17,"end":3359.61},{"text":"in","start":3359.61,"end":3359.69},{"text":"harm","start":3359.69,"end":3359.85},{"text":"reduction","start":3359.85,"end":3360.41},{"text":"to","start":3360.41,"end":3360.57},{"text":"amplify","start":3360.57,"end":3361.13},{"text":"the","start":3361.13,"end":3361.25},{"text":"positive","start":3361.25,"end":3361.69},{"text":"experiences.","start":3361.69,"end":3362.65}]},{"text":"like we've heard from Switzerland and Czechia, where this has yielded health, social and economic benefits, to draw attention to the evidence from all parts of the world that harm reduction is not only evidence-based and life-saving, also cost-effective and cost-saving.","start":3363.13,"end":3378.17,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"like","start":3363.13,"end":3363.33},{"text":"we've","start":3363.33,"end":3363.53},{"text":"heard","start":3363.53,"end":3363.69},{"text":"from","start":3363.69,"end":3363.85},{"text":"Switzerland","start":3363.85,"end":3364.65},{"text":"and","start":3364.65,"end":3364.97},{"text":"Czechia,","start":3365.13,"end":3365.69},{"text":"where","start":3365.93,"end":3366.25},{"text":"this","start":3366.25,"end":3366.41},{"text":"has","start":3366.41,"end":3366.53},{"text":"yielded","start":3366.65,"end":3367.53},{"text":"health,","start":3367.61,"end":3368.09},{"text":"social","start":3368.09,"end":3368.69},{"text":"and","start":3368.69,"end":3368.97},{"text":"economic","start":3369.01,"end":3369.45},{"text":"benefits,","start":3369.45,"end":3370.09},{"text":"to","start":3370.33,"end":3370.41},{"text":"draw","start":3370.41,"end":3370.57},{"text":"attention","start":3370.57,"end":3371.21},{"text":"to","start":3371.21,"end":3371.29},{"text":"the","start":3371.29,"end":3371.41},{"text":"evidence","start":3371.41,"end":3371.81},{"text":"from","start":3371.81,"end":3372.01},{"text":"all","start":3372.01,"end":3372.17},{"text":"parts","start":3372.17,"end":3372.45},{"text":"of","start":3372.45,"end":3372.53},{"text":"the","start":3372.53,"end":3372.61},{"text":"world","start":3372.61,"end":3372.85},{"text":"that","start":3372.85,"end":3372.97},{"text":"harm","start":3372.97,"end":3373.29},{"text":"reduction","start":3373.29,"end":3373.77},{"text":"is","start":3373.77,"end":3373.93},{"text":"not","start":3373.93,"end":3374.13},{"text":"only","start":3374.13,"end":3374.41},{"text":"evidence-based","start":3374.41,"end":3375.17},{"text":"and","start":3375.17,"end":3375.33},{"text":"life-saving,","start":3375.33,"end":3376.09},{"text":"also","start":3376.33,"end":3376.65},{"text":"cost-effective","start":3376.65,"end":3377.41},{"text":"and","start":3377.41,"end":3377.53},{"text":"cost-saving.","start":3377.53,"end":3378.17}]},{"text":"It is a wise investment.","start":3378.17,"end":3379.77,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"It","start":3378.17,"end":3378.37},{"text":"is","start":3378.37,"end":3378.49},{"text":"a","start":3378.49,"end":3378.57},{"text":"wise","start":3378.57,"end":3378.97},{"text":"investment.","start":3378.97,"end":3379.77}]},{"text":"HIV sustainability plans must include harm reduction and community-led responses.","start":3380.81,"end":3385.37,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"HIV","start":3380.81,"end":3381.37},{"text":"sustainability","start":3381.37,"end":3382.09},{"text":"plans","start":3382.09,"end":3382.57},{"text":"must","start":3382.57,"end":3382.77},{"text":"include","start":3382.77,"end":3383.21},{"text":"harm","start":3383.21,"end":3383.37},{"text":"reduction","start":3383.37,"end":3383.85},{"text":"and","start":3383.85,"end":3384.01},{"text":"community-led","start":3384.01,"end":3384.65},{"text":"responses.","start":3384.65,"end":3385.37}]},{"text":"Recent WHO guidance classifies harm reduction as tier one, meaning that it must be funded even in the face of resource constraints.","start":3385.85,"end":3393.13,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"Recent","start":3385.85,"end":3386.69},{"text":"WHO","start":3386.69,"end":3386.81},{"text":"guidance","start":3386.81,"end":3387.37},{"text":"classifies","start":3387.37,"end":3387.89},{"text":"harm","start":3387.89,"end":3388.09},{"text":"reduction","start":3388.09,"end":3388.49},{"text":"as","start":3388.49,"end":3388.65},{"text":"tier","start":3388.65,"end":3388.97},{"text":"one,","start":3388.97,"end":3389.45},{"text":"meaning","start":3389.69,"end":3390.01},{"text":"that","start":3390.01,"end":3390.17},{"text":"it","start":3390.17,"end":3390.25},{"text":"must","start":3390.25,"end":3390.53},{"text":"be","start":3390.53,"end":3390.65},{"text":"funded","start":3390.65,"end":3391.21},{"text":"even","start":3391.21,"end":3391.49},{"text":"in","start":3391.49,"end":3391.57},{"text":"the","start":3391.57,"end":3391.65},{"text":"face","start":3391.65,"end":3391.93},{"text":"of","start":3391.93,"end":3392.01},{"text":"resource","start":3392.01,"end":3392.41},{"text":"constraints.","start":3392.41,"end":3393.13}]},{"text":"But we must make sure that community and civil society organisations receive direct funding through social contracting as they are the backbone of the response in many countries.","start":3393.85,"end":3403.85,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"But","start":3393.85,"end":3394.01},{"text":"we","start":3394.01,"end":3394.17},{"text":"must","start":3394.17,"end":3394.41},{"text":"make","start":3394.41,"end":3394.57},{"text":"sure","start":3394.57,"end":3394.81},{"text":"that","start":3394.81,"end":3394.93},{"text":"community","start":3394.93,"end":3395.61},{"text":"and","start":3395.61,"end":3395.85},{"text":"civil","start":3395.85,"end":3396.05},{"text":"society","start":3396.05,"end":3396.57},{"text":"organisations","start":3396.57,"end":3398.17},{"text":"receive","start":3398.41,"end":3398.89},{"text":"direct","start":3398.89,"end":3399.37},{"text":"funding","start":3399.37,"end":3399.77},{"text":"through","start":3399.77,"end":3400.01},{"text":"social","start":3400.01,"end":3400.37},{"text":"contracting","start":3400.37,"end":3401.05},{"text":"as","start":3401.21,"end":3401.37},{"text":"they","start":3401.37,"end":3401.53},{"text":"are","start":3401.53,"end":3401.61},{"text":"the","start":3401.61,"end":3401.77},{"text":"backbone","start":3401.77,"end":3402.17},{"text":"of","start":3402.17,"end":3402.25},{"text":"the","start":3402.25,"end":3402.37},{"text":"response","start":3402.37,"end":3402.81},{"text":"in","start":3402.81,"end":3402.93},{"text":"many","start":3402.93,"end":3403.13},{"text":"countries.","start":3403.13,"end":3403.85}]},{"text":"As governments look at how to fill funding gaps, let's encourage frank dialogue on the benefits of decriminalisation, including the economic benefits.","start":3404.73,"end":3412.89,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"As","start":3404.73,"end":3404.93},{"text":"governments","start":3404.93,"end":3405.37},{"text":"look","start":3405.37,"end":3405.61},{"text":"at","start":3405.61,"end":3405.69},{"text":"how","start":3405.69,"end":3405.85},{"text":"to","start":3405.85,"end":3405.93},{"text":"fill","start":3405.93,"end":3406.17},{"text":"funding","start":3406.17,"end":3406.57},{"text":"gaps,","start":3406.57,"end":3406.85},{"text":"let's","start":3406.85,"end":3407.13},{"text":"encourage","start":3407.13,"end":3407.81},{"text":"frank","start":3407.93,"end":3408.41},{"text":"dialogue","start":3408.41,"end":3408.89},{"text":"on","start":3408.89,"end":3409.05},{"text":"the","start":3409.05,"end":3409.17},{"text":"benefits","start":3409.17,"end":3409.61},{"text":"of","start":3409.61,"end":3409.69},{"text":"decriminalisation,","start":3409.69,"end":3410.81},{"text":"including","start":3410.89,"end":3411.53},{"text":"the","start":3411.53,"end":3411.65},{"text":"economic","start":3411.65,"end":3412.17},{"text":"benefits.","start":3412.17,"end":3412.89}]},{"text":"The money is there.","start":3413.29,"end":3414.25,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"The","start":3413.29,"end":3413.37},{"text":"money","start":3413.37,"end":3413.69},{"text":"is","start":3413.69,"end":3413.85},{"text":"there.","start":3413.85,"end":3414.25}]},{"text":"Vast amounts are spent on criminalisation and imprisoning people who use drugs.","start":3414.29,"end":3419.13,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"Vast","start":3414.29,"end":3414.73},{"text":"amounts","start":3414.73,"end":3415.13},{"text":"are","start":3415.25,"end":3415.61},{"text":"spent","start":3415.61,"end":3415.89},{"text":"on","start":3415.89,"end":3416.01},{"text":"criminalisation","start":3416.01,"end":3417.05},{"text":"and","start":3417.37,"end":3417.53},{"text":"imprisoning","start":3417.53,"end":3418.01},{"text":"people","start":3418.01,"end":3418.33},{"text":"who","start":3418.33,"end":3418.41},{"text":"use","start":3418.41,"end":3418.65},{"text":"drugs.","start":3418.65,"end":3419.13}]},{"text":"This must be divested and invested in community health and justice.","start":3419.37,"end":3423.05,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"This","start":3419.37,"end":3419.61},{"text":"must","start":3419.61,"end":3419.89},{"text":"be","start":3419.89,"end":3420.01},{"text":"divested","start":3420.01,"end":3420.81},{"text":"and","start":3420.81,"end":3421.05},{"text":"invested","start":3421.05,"end":3421.49},{"text":"in","start":3421.49,"end":3421.61},{"text":"community","start":3421.61,"end":3422.05},{"text":"health","start":3422.05,"end":3422.33},{"text":"and","start":3422.33,"end":3422.45},{"text":"justice.","start":3422.45,"end":3423.05}]},{"text":"We also must look at the bigger picture.","start":3423.77,"end":3425.37,"topics":[],"words":[{"text":"We","start":3423.77,"end":3423.93},{"text":"also","start":3423.93,"end":3424.17},{"text":"must","start":3424.17,"end":3424.41},{"text":"look","start":3424.41,"end":3424.53},{"text":"at","start":3424.53,"end":3424.61},{"text":"the","start":3424.61,"end":3424.69},{"text":"bigger","start":3424.69,"end":3424.97},{"text":"picture.","start":3424.97,"end":3425.37}]},{"text":"We must make a loud call for economic justice and to move away from a colonial aid system.","start":3425.61,"end":3430.57,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"We","start":3425.61,"end":3425.77},{"text":"must","start":3425.77,"end":3425.93},{"text":"make","start":3425.93,"end":3426.17},{"text":"a","start":3426.17,"end":3426.21},{"text":"loud","start":3426.21,"end":3426.49},{"text":"call","start":3426.49,"end":3426.81},{"text":"for","start":3426.81,"end":3427.05},{"text":"economic","start":3427.21,"end":3427.73},{"text":"justice","start":3427.73,"end":3428.25},{"text":"and","start":3428.25,"end":3428.45},{"text":"to","start":3428.45,"end":3428.53},{"text":"move","start":3428.53,"end":3428.77},{"text":"away","start":3428.77,"end":3429.05},{"text":"from","start":3429.05,"end":3429.25},{"text":"a","start":3429.25,"end":3429.29},{"text":"colonial","start":3429.29,"end":3429.85},{"text":"aid","start":3429.85,"end":3430.05},{"text":"system.","start":3430.05,"end":3430.57}]},{"text":"We need to see debt cancellation and donors decolonising their approaches.","start":3430.97,"end":3435.05,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"We","start":3430.97,"end":3431.09},{"text":"need","start":3431.09,"end":3431.25},{"text":"to","start":3431.25,"end":3431.41},{"text":"see","start":3431.41,"end":3431.61},{"text":"debt","start":3431.61,"end":3431.81},{"text":"cancellation","start":3431.81,"end":3432.65},{"text":"and","start":3432.65,"end":3432.85},{"text":"donors","start":3432.85,"end":3433.29},{"text":"decolonising","start":3433.29,"end":3434.09},{"text":"their","start":3434.09,"end":3434.29},{"text":"approaches.","start":3434.29,"end":3435.05}]},{"text":"And we must be realists that the global health architecture is changing as aid is deprioritised in favour of military spend.","start":3435.93,"end":3443.77,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"And","start":3435.93,"end":3436.01},{"text":"we","start":3436.01,"end":3436.09},{"text":"must","start":3436.09,"end":3436.41},{"text":"be","start":3436.41,"end":3436.73},{"text":"realists","start":3437.13,"end":3437.85},{"text":"that","start":3437.85,"end":3438.17},{"text":"the","start":3438.17,"end":3438.29},{"text":"global","start":3438.29,"end":3438.65},{"text":"health","start":3438.65,"end":3438.89},{"text":"architecture","start":3438.89,"end":3440.09},{"text":"is","start":3440.09,"end":3440.25},{"text":"changing","start":3440.25,"end":3440.89},{"text":"as","start":3440.89,"end":3441.05},{"text":"aid","start":3441.05,"end":3441.37},{"text":"is","start":3441.37,"end":3441.45},{"text":"deprioritised","start":3441.45,"end":3442.25},{"text":"in","start":3442.25,"end":3442.41},{"text":"favour","start":3442.41,"end":3442.73},{"text":"of","start":3442.73,"end":3442.81},{"text":"military","start":3442.81,"end":3443.29},{"text":"spend.","start":3443.29,"end":3443.77}]},{"text":"We still need a fully funded global fund, and this will require governments and the philanthropic and private sector to step up with strong pledges later this year.","start":3444.17,"end":3452.73,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"We","start":3444.17,"end":3444.41},{"text":"still","start":3444.41,"end":3444.65},{"text":"need","start":3444.65,"end":3444.97},{"text":"a","start":3444.97,"end":3445.01},{"text":"fully","start":3445.01,"end":3445.29},{"text":"funded","start":3445.29,"end":3445.61},{"text":"global","start":3445.61,"end":3445.97},{"text":"fund,","start":3445.97,"end":3446.33},{"text":"and","start":3446.33,"end":3446.53},{"text":"this","start":3446.53,"end":3446.73},{"text":"will","start":3446.73,"end":3446.93},{"text":"require","start":3446.93,"end":3447.45},{"text":"governments","start":3447.45,"end":3448.01},{"text":"and","start":3448.01,"end":3448.21},{"text":"the","start":3448.21,"end":3448.29},{"text":"philanthropic","start":3448.29,"end":3448.93},{"text":"and","start":3448.93,"end":3449.05},{"text":"private","start":3449.05,"end":3449.37},{"text":"sector","start":3449.37,"end":3449.85},{"text":"to","start":3449.85,"end":3449.93},{"text":"step","start":3450.01,"end":3450.57},{"text":"up","start":3450.57,"end":3450.69},{"text":"with","start":3450.69,"end":3450.85},{"text":"strong","start":3450.85,"end":3451.13},{"text":"pledges","start":3451.13,"end":3451.93},{"text":"later","start":3451.93,"end":3452.25},{"text":"this","start":3452.25,"end":3452.41},{"text":"year.","start":3452.41,"end":3452.73}]},{"text":"Within this picture, we need increased advocacy funding.","start":3454.45,"end":3457.41,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Within","start":3454.45,"end":3454.73},{"text":"this","start":3454.73,"end":3454.89},{"text":"picture,","start":3454.89,"end":3455.37},{"text":"we","start":3455.37,"end":3455.53},{"text":"need","start":3455.53,"end":3455.77},{"text":"increased","start":3455.77,"end":3456.41},{"text":"advocacy","start":3456.41,"end":3456.97},{"text":"funding.","start":3456.97,"end":3457.41}]},{"text":"It's more important than ever to protect harm reduction and help drive the drug law and policy reform required for sustainable harm reduction responses.","start":3457.41,"end":3464.57,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"It's","start":3457.41,"end":3457.65},{"text":"more","start":3457.65,"end":3457.77},{"text":"important","start":3457.77,"end":3458.17},{"text":"than","start":3458.17,"end":3458.33},{"text":"ever","start":3458.33,"end":3458.65},{"text":"to","start":3458.65,"end":3458.81},{"text":"protect","start":3458.81,"end":3459.21},{"text":"harm","start":3459.21,"end":3459.41},{"text":"reduction","start":3459.41,"end":3459.85},{"text":"and","start":3459.85,"end":3459.97},{"text":"help","start":3459.97,"end":3460.21},{"text":"drive","start":3460.21,"end":3460.57},{"text":"the","start":3460.57,"end":3460.65},{"text":"drug","start":3460.65,"end":3460.89},{"text":"law","start":3460.89,"end":3461.17},{"text":"and","start":3461.17,"end":3461.37},{"text":"policy","start":3461.37,"end":3461.77},{"text":"reform","start":3461.77,"end":3462.09},{"text":"required","start":3462.09,"end":3462.49},{"text":"for","start":3462.49,"end":3462.65},{"text":"sustainable","start":3462.65,"end":3463.21},{"text":"harm","start":3463.21,"end":3463.37},{"text":"reduction","start":3463.37,"end":3463.77},{"text":"responses.","start":3463.77,"end":3464.57}]},{"text":"And community-led organizations must be funded to create and protect resilient and sustainable harm reduction responses.","start":3465.17,"end":3473.49,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"And","start":3465.17,"end":3465.29},{"text":"community-led","start":3465.29,"end":3465.93},{"text":"organizations","start":3465.93,"end":3466.61},{"text":"must","start":3466.61,"end":3467.09},{"text":"be","start":3467.81,"end":3467.97},{"text":"funded","start":3467.97,"end":3468.45},{"text":"to","start":3468.77,"end":3468.85},{"text":"create","start":3468.85,"end":3469.29},{"text":"and","start":3469.29,"end":3469.41},{"text":"protect","start":3469.41,"end":3469.89},{"text":"resilient","start":3470.05,"end":3470.69},{"text":"and","start":3471.41,"end":3471.57},{"text":"sustainable","start":3471.57,"end":3472.13},{"text":"harm","start":3472.13,"end":3472.29},{"text":"reduction","start":3472.29,"end":3472.69},{"text":"responses.","start":3472.69,"end":3473.49}]},{"text":"There are no overnight solutions, and these are very worrying times.","start":3473.97,"end":3477.73,"topics":[],"words":[{"text":"There","start":3473.97,"end":3474.21},{"text":"are","start":3474.21,"end":3474.41},{"text":"no","start":3474.41,"end":3474.69},{"text":"overnight","start":3474.69,"end":3475.09},{"text":"solutions,","start":3475.09,"end":3475.57},{"text":"and","start":3475.57,"end":3475.77},{"text":"these","start":3475.77,"end":3475.97},{"text":"are","start":3475.97,"end":3476.09},{"text":"very","start":3476.09,"end":3476.61},{"text":"worrying","start":3476.61,"end":3477.01},{"text":"times.","start":3477.01,"end":3477.73}]},{"text":"And I think events like this are so important.","start":3478.73,"end":3480.57,"topics":[],"words":[{"text":"And","start":3478.73,"end":3478.85},{"text":"I","start":3478.85,"end":3478.93},{"text":"think","start":3478.93,"end":3479.13},{"text":"events","start":3479.13,"end":3479.41},{"text":"like","start":3479.41,"end":3479.61},{"text":"this","start":3479.61,"end":3479.81},{"text":"are","start":3479.81,"end":3479.89},{"text":"so","start":3479.89,"end":3480.05},{"text":"important.","start":3480.05,"end":3480.57}]},{"text":"So thank you to UNDP and all the many others involved in bringing us together.","start":3480.57,"end":3484.45,"topics":[],"words":[{"text":"So","start":3480.57,"end":3480.69},{"text":"thank","start":3480.69,"end":3480.97},{"text":"you","start":3480.97,"end":3481.05},{"text":"to","start":3481.05,"end":3481.21},{"text":"UNDP","start":3481.21,"end":3481.97},{"text":"and","start":3481.97,"end":3482.13},{"text":"all","start":3482.13,"end":3482.53},{"text":"the","start":3482.53,"end":3482.65},{"text":"many","start":3482.65,"end":3482.93},{"text":"others","start":3482.93,"end":3483.17},{"text":"involved","start":3483.17,"end":3483.53},{"text":"in","start":3483.53,"end":3483.61},{"text":"bringing","start":3483.61,"end":3483.85},{"text":"us","start":3483.85,"end":3483.97},{"text":"together.","start":3483.97,"end":3484.45}]},{"text":"I will close by just urging all in the room to galvanise the urgent actions that are needed to protect and expand harm reduction and ensure that budget is there to implement these life saving services.","start":3484.85,"end":3496.37,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"I","start":3484.85,"end":3485.01},{"text":"will","start":3485.01,"end":3485.17},{"text":"close","start":3485.17,"end":3485.57},{"text":"by","start":3485.57,"end":3485.73},{"text":"just","start":3485.73,"end":3486.01},{"text":"urging","start":3486.01,"end":3486.33},{"text":"all","start":3486.33,"end":3486.53},{"text":"in","start":3486.53,"end":3486.61},{"text":"the","start":3486.61,"end":3486.73},{"text":"room","start":3486.73,"end":3487.09},{"text":"to","start":3487.09,"end":3487.61},{"text":"galvanise","start":3487.61,"end":3488.33},{"text":"the","start":3488.33,"end":3488.45},{"text":"urgent","start":3488.45,"end":3488.77},{"text":"actions","start":3488.77,"end":3489.33},{"text":"that","start":3489.33,"end":3489.53},{"text":"are","start":3489.53,"end":3489.61},{"text":"needed","start":3489.61,"end":3490.05},{"text":"to","start":3490.05,"end":3490.21},{"text":"protect","start":3490.21,"end":3490.77},{"text":"and","start":3490.77,"end":3490.93},{"text":"expand","start":3490.93,"end":3491.33},{"text":"harm","start":3491.33,"end":3491.57},{"text":"reduction","start":3491.57,"end":3492.13},{"text":"and","start":3492.37,"end":3492.69},{"text":"ensure","start":3492.69,"end":3493.17},{"text":"that","start":3493.17,"end":3493.33},{"text":"budget","start":3493.57,"end":3493.89},{"text":"is","start":3493.89,"end":3494.05},{"text":"there","start":3494.05,"end":3494.33},{"text":"to","start":3494.37,"end":3494.57},{"text":"implement","start":3494.57,"end":3495.05},{"text":"these","start":3495.05,"end":3495.17},{"text":"life","start":3495.17,"end":3495.41},{"text":"saving","start":3495.41,"end":3495.73},{"text":"services.","start":3495.73,"end":3496.37}]},{"text":"Thank you so much.","start":3496.93,"end":3497.81,"topics":[],"words":[{"text":"Thank","start":3496.93,"end":3497.13},{"text":"you","start":3497.13,"end":3497.21},{"text":"so","start":3497.21,"end":3497.29},{"text":"much.","start":3497.29,"end":3497.81}]}]}],"speaker":{"affiliation":"HRI","group":null,"function":"Acting Executive Director","affiliation_full":"HRI"}},{"statement_number":16,"start":3504.13,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=58:25","paragraphs":[{"sentences":[{"text":"I would like to thank Ms. Cook for this very important and interesting intervention.","start":3504.13,"end":3511.33,"topics":[],"words":[{"text":"I","start":3504.13,"end":3504.29},{"text":"would","start":3504.29,"end":3504.45},{"text":"like","start":3504.45,"end":3504.65},{"text":"to","start":3504.65,"end":3504.73},{"text":"thank","start":3504.77,"end":3505.25},{"text":"Ms.","start":3505.29,"end":3506.05},{"text":"Cook","start":3506.85,"end":3507.17},{"text":"for","start":3507.17,"end":3507.41},{"text":"this","start":3507.41,"end":3507.73},{"text":"very","start":3507.73,"end":3508.13},{"text":"important","start":3508.13,"end":3508.73},{"text":"and","start":3508.73,"end":3508.85},{"text":"interesting","start":3508.85,"end":3509.49},{"text":"intervention.","start":3510.29,"end":3511.33}]},{"text":"And I would like to say thank you to everyone for your excellent contributions to this fascinating discussion.","start":3511.65,"end":3520.61,"topics":[],"words":[{"text":"And","start":3511.65,"end":3511.97},{"text":"I","start":3512.13,"end":3512.29},{"text":"would","start":3512.29,"end":3512.49},{"text":"like","start":3512.53,"end":3512.93},{"text":"to","start":3513.73,"end":3513.93},{"text":"say","start":3513.97,"end":3514.29},{"text":"thank","start":3514.29,"end":3514.69},{"text":"you","start":3514.69,"end":3515.01},{"text":"to","start":3515.49,"end":3515.65},{"text":"everyone","start":3515.65,"end":3516.37},{"text":"for","start":3516.37,"end":3516.61},{"text":"your","start":3516.61,"end":3516.93},{"text":"excellent","start":3516.93,"end":3517.49},{"text":"contributions","start":3517.49,"end":3518.37},{"text":"to","start":3518.69,"end":3518.85},{"text":"this","start":3518.85,"end":3519.17},{"text":"fascinating","start":3519.17,"end":3519.89},{"text":"discussion.","start":3519.89,"end":3520.61}]},{"text":"And I will pass now, hand over the floor back to Ms. Mandeep Dhaliwal, who will conduct the next segment.","start":3521.29,"end":3529.53,"topics":[],"words":[{"text":"And","start":3521.29,"end":3521.57},{"text":"I","start":3521.73,"end":3521.97},{"text":"will","start":3521.97,"end":3522.13},{"text":"pass","start":3522.13,"end":3522.53},{"text":"now,","start":3522.53,"end":3523.01},{"text":"hand","start":3523.33,"end":3523.73},{"text":"over","start":3523.73,"end":3524.05},{"text":"the","start":3524.05,"end":3524.17},{"text":"floor","start":3524.17,"end":3524.69},{"text":"back","start":3524.69,"end":3524.97},{"text":"to","start":3524.97,"end":3525.05},{"text":"Ms.","start":3525.05,"end":3525.33},{"text":"Mandeep","start":3525.33,"end":3525.89},{"text":"Dhaliwal,","start":3526.53,"end":3527.33},{"text":"who","start":3527.41,"end":3527.61},{"text":"will","start":3527.61,"end":3527.89},{"text":"conduct","start":3527.89,"end":3528.49},{"text":"the","start":3528.49,"end":3528.65},{"text":"next","start":3528.65,"end":3529.05},{"text":"segment.","start":3529.05,"end":3529.53}]},{"text":"Thank you.","start":3529.53,"end":3530.05,"topics":[],"words":[{"text":"Thank","start":3529.53,"end":3529.97},{"text":"you.","start":3529.97,"end":3530.05}]}]}],"speaker":{"affiliation":"MEX","group":null,"function":"Deputy Permanent Representative","affiliation_full":"Mexico"}},{"statement_number":17,"start":3531.21,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=58:52","paragraphs":[{"sentences":[{"text":"Thank you, Ambassador.","start":3531.21,"end":3532.21,"topics":[],"words":[{"text":"Thank","start":3531.21,"end":3531.41},{"text":"you,","start":3531.41,"end":3531.53},{"text":"Ambassador.","start":3531.53,"end":3532.21}]},{"text":"And really just to kick off the next session by saying that we're running over time, I may beg people's indulgence to stay an extra 10 minutes, but I'm really going to ask that we restrict our interventions to two minutes, and I will not be as nice as the ambassador in terms of I will cut people off so that we can get everybody's voices.","start":3534.49,"end":3556.97,"topics":[],"words":[{"text":"And","start":3534.49,"end":3534.73},{"text":"really","start":3534.73,"end":3534.97},{"text":"just","start":3534.97,"end":3535.33},{"text":"to","start":3535.33,"end":3535.45},{"text":"kick","start":3535.45,"end":3535.77},{"text":"off","start":3535.77,"end":3535.97},{"text":"the","start":3535.97,"end":3536.05},{"text":"next","start":3536.05,"end":3536.37},{"text":"session","start":3536.37,"end":3536.65},{"text":"by","start":3536.65,"end":3536.73},{"text":"saying","start":3536.73,"end":3536.97},{"text":"that","start":3536.97,"end":3537.09},{"text":"we're","start":3537.09,"end":3537.25},{"text":"running","start":3537.25,"end":3537.61},{"text":"over","start":3537.61,"end":3537.85},{"text":"time,","start":3537.85,"end":3538.41},{"text":"I","start":3539.45,"end":3539.53},{"text":"may","start":3539.53,"end":3539.77},{"text":"beg","start":3539.77,"end":3540.09},{"text":"people's","start":3540.09,"end":3540.49},{"text":"indulgence","start":3540.49,"end":3541.09},{"text":"to","start":3541.09,"end":3541.17},{"text":"stay","start":3541.17,"end":3541.45},{"text":"an","start":3541.45,"end":3541.53},{"text":"extra","start":3541.53,"end":3541.85},{"text":"10","start":3541.85,"end":3542.09},{"text":"minutes,","start":3542.09,"end":3542.57},{"text":"but","start":3542.97,"end":3543.13},{"text":"I'm","start":3543.13,"end":3543.37},{"text":"really","start":3543.37,"end":3543.69},{"text":"going","start":3543.69,"end":3543.97},{"text":"to","start":3543.97,"end":3544.09},{"text":"ask","start":3544.09,"end":3544.73},{"text":"that","start":3545.13,"end":3545.29},{"text":"we","start":3545.29,"end":3545.93},{"text":"restrict","start":3546.01,"end":3546.57},{"text":"our","start":3546.57,"end":3546.73},{"text":"interventions","start":3546.73,"end":3547.53},{"text":"to","start":3547.53,"end":3547.61},{"text":"two","start":3547.61,"end":3547.85},{"text":"minutes,","start":3547.85,"end":3548.33},{"text":"and","start":3548.65,"end":3548.81},{"text":"I","start":3548.81,"end":3548.97},{"text":"will","start":3548.97,"end":3549.13},{"text":"not","start":3549.13,"end":3549.37},{"text":"be","start":3549.37,"end":3549.57},{"text":"as","start":3549.57,"end":3549.77},{"text":"nice","start":3549.77,"end":3550.13},{"text":"as","start":3550.13,"end":3550.25},{"text":"the","start":3550.25,"end":3550.37},{"text":"ambassador","start":3550.37,"end":3551.21},{"text":"in","start":3551.49,"end":3551.65},{"text":"terms","start":3551.65,"end":3552.09},{"text":"of","start":3552.13,"end":3552.41},{"text":"I","start":3553.21,"end":3553.45},{"text":"will","start":3553.45,"end":3553.61},{"text":"cut","start":3553.61,"end":3553.85},{"text":"people","start":3553.85,"end":3554.29},{"text":"off","start":3554.29,"end":3554.41},{"text":"so","start":3554.81,"end":3555.05},{"text":"that","start":3555.13,"end":3555.29},{"text":"we","start":3555.29,"end":3555.41},{"text":"can","start":3555.41,"end":3555.61},{"text":"get","start":3555.61,"end":3555.77},{"text":"everybody's","start":3555.77,"end":3556.41},{"text":"voices.","start":3556.41,"end":3556.97}]},{"text":"It's so important.","start":3556.97,"end":3558.21,"topics":[],"words":[{"text":"It's","start":3556.97,"end":3557.57},{"text":"so","start":3557.57,"end":3557.69},{"text":"important.","start":3557.69,"end":3558.21}]},{"text":"So we'd like to now invite inputs from member states and then followed by inputs from our colleagues from the UN family.","start":3558.69,"end":3566.29,"topics":[],"words":[{"text":"So","start":3558.69,"end":3558.85},{"text":"we'd","start":3558.85,"end":3559.13},{"text":"like","start":3559.13,"end":3559.25},{"text":"to","start":3559.25,"end":3559.33},{"text":"now","start":3559.33,"end":3559.57},{"text":"invite","start":3559.57,"end":3560.05},{"text":"inputs","start":3560.05,"end":3560.49},{"text":"from","start":3560.49,"end":3560.65},{"text":"member","start":3560.65,"end":3560.93},{"text":"states","start":3560.93,"end":3561.41},{"text":"and","start":3561.41,"end":3561.53},{"text":"then","start":3561.53,"end":3561.73},{"text":"followed","start":3561.73,"end":3562.13},{"text":"by","start":3562.13,"end":3562.53},{"text":"inputs","start":3562.93,"end":3563.37},{"text":"from","start":3563.37,"end":3563.57},{"text":"our","start":3563.57,"end":3563.65},{"text":"colleagues","start":3563.65,"end":3564.37},{"text":"from","start":3565.01,"end":3565.25},{"text":"the","start":3565.25,"end":3565.33},{"text":"UN","start":3565.33,"end":3565.73},{"text":"family.","start":3565.73,"end":3566.29}]},{"text":"So if I if there are any member states who would like to speak or intervene, please.","start":3566.61,"end":3574.13,"topics":[],"words":[{"text":"So","start":3566.61,"end":3567.17},{"text":"if","start":3567.65,"end":3567.89},{"text":"I","start":3567.89,"end":3568.05},{"text":"if","start":3568.45,"end":3568.57},{"text":"there","start":3568.57,"end":3568.69},{"text":"are","start":3568.69,"end":3568.77},{"text":"any","start":3568.77,"end":3568.89},{"text":"member","start":3568.89,"end":3569.17},{"text":"states","start":3569.17,"end":3569.53},{"text":"who","start":3569.53,"end":3569.65},{"text":"would","start":3569.65,"end":3569.77},{"text":"like","start":3569.77,"end":3570.05},{"text":"to","start":3570.05,"end":3570.17},{"text":"speak","start":3570.17,"end":3570.73},{"text":"or","start":3570.73,"end":3570.89},{"text":"intervene,","start":3570.89,"end":3571.65},{"text":"please.","start":3573.53,"end":3574.13}]},{"text":"Raise your flag.","start":3575.97,"end":3576.81,"topics":[],"words":[{"text":"Raise","start":3575.97,"end":3576.29},{"text":"your","start":3576.29,"end":3576.45},{"text":"flag.","start":3576.45,"end":3576.81}]},{"text":"I don't see.","start":3580.37,"end":3581.49,"topics":[],"words":[{"text":"I","start":3580.37,"end":3580.53},{"text":"don't","start":3580.53,"end":3581.41},{"text":"see.","start":3581.41,"end":3581.49}]},{"text":"I see one person here, 654.","start":3583.09,"end":3585.85,"topics":[],"words":[{"text":"I","start":3583.09,"end":3583.33},{"text":"see","start":3583.33,"end":3583.89},{"text":"one","start":3584.13,"end":3584.45},{"text":"person","start":3584.45,"end":3584.85},{"text":"here,","start":3584.85,"end":3585.09},{"text":"654.","start":3585.09,"end":3585.85}]},{"text":"I'm not sure who that is.","start":3585.85,"end":3587.01,"topics":[],"words":[{"text":"I'm","start":3585.85,"end":3586.05},{"text":"not","start":3586.05,"end":3586.21},{"text":"sure","start":3586.21,"end":3586.37},{"text":"who","start":3586.37,"end":3586.53},{"text":"that","start":3586.53,"end":3586.69},{"text":"is.","start":3586.69,"end":3587.01}]},{"text":"Is there someone who would like to take the floor?","start":3588.73,"end":3590.41,"topics":[],"words":[{"text":"Is","start":3588.73,"end":3588.89},{"text":"there","start":3588.89,"end":3589.05},{"text":"someone","start":3589.05,"end":3589.29},{"text":"who","start":3589.29,"end":3589.37},{"text":"would","start":3589.37,"end":3589.49},{"text":"like","start":3589.49,"end":3589.61},{"text":"to","start":3589.61,"end":3589.73},{"text":"take","start":3589.73,"end":3589.93},{"text":"the","start":3589.93,"end":3590.01},{"text":"floor?","start":3590.01,"end":3590.41}]},{"text":"Please go ahead.","start":3590.41,"end":3591.21,"topics":[],"words":[{"text":"Please","start":3590.41,"end":3590.73},{"text":"go","start":3590.73,"end":3590.85},{"text":"ahead.","start":3590.85,"end":3591.21}]},{"text":"And please introduce yourself, please.","start":3592.09,"end":3593.77,"topics":[],"words":[{"text":"And","start":3592.09,"end":3592.25},{"text":"please","start":3592.25,"end":3592.49},{"text":"introduce","start":3592.49,"end":3592.93},{"text":"yourself,","start":3592.93,"end":3593.37},{"text":"please.","start":3593.37,"end":3593.77}]}]}],"speaker":{"affiliation":"UNDP","group":null,"function":null,"affiliation_full":"UNDP"}},{"statement_number":18,"start":3599.84,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:00:00","paragraphs":[{"sentences":[{"text":"Can you hear me?","start":3599.84,"end":3600.48,"topics":[],"words":[{"text":"Can","start":3599.84,"end":3600},{"text":"you","start":3600,"end":3600.08},{"text":"hear","start":3600.08,"end":3600.2},{"text":"me?","start":3600.2,"end":3600.48}]},{"text":"I would like to thank the panelists for your insightful statements.","start":3602,"end":3605.68,"topics":[],"words":[{"text":"I","start":3602,"end":3602.08},{"text":"would","start":3602.08,"end":3602.2},{"text":"like","start":3602.2,"end":3602.36},{"text":"to","start":3602.36,"end":3602.44},{"text":"thank","start":3602.44,"end":3602.72},{"text":"the","start":3602.72,"end":3602.8},{"text":"panelists","start":3602.8,"end":3603.44},{"text":"for","start":3603.44,"end":3603.6},{"text":"your","start":3603.6,"end":3604.6},{"text":"insightful","start":3604.6,"end":3605.12},{"text":"statements.","start":3605.12,"end":3605.68}]},{"text":"My name is Yasmine Amhush.","start":3606.56,"end":3607.76,"topics":[],"words":[{"text":"My","start":3606.56,"end":3606.68},{"text":"name","start":3606.68,"end":3606.84},{"text":"is","start":3606.84,"end":3607},{"text":"Yasmine","start":3607,"end":3607.36},{"text":"Amhush.","start":3607.36,"end":3607.76}]},{"text":"I'm a delegate with the International Federation of Medical Students.","start":3607.76,"end":3610.64,"topics":[],"words":[{"text":"I'm","start":3607.76,"end":3607.96},{"text":"a","start":3607.96,"end":3608},{"text":"delegate","start":3608,"end":3608.4},{"text":"with","start":3608.4,"end":3608.56},{"text":"the","start":3608.56,"end":3608.64},{"text":"International","start":3608.72,"end":3609.28},{"text":"Federation","start":3609.28,"end":3609.72},{"text":"of","start":3609.72,"end":3609.8},{"text":"Medical","start":3609.8,"end":3610.12},{"text":"Students.","start":3610.12,"end":3610.64}]},{"text":"So the panelists have mentioned a collective shift in the perception of people who use drugs.","start":3611.36,"end":3616.64,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"So","start":3611.36,"end":3611.68},{"text":"the","start":3611.68,"end":3611.8},{"text":"panelists","start":3611.8,"end":3612.28},{"text":"have","start":3612.28,"end":3612.4},{"text":"mentioned","start":3612.4,"end":3612.92},{"text":"a","start":3612.92,"end":3612.96},{"text":"collective","start":3613.28,"end":3614.24},{"text":"shift","start":3614.24,"end":3614.6},{"text":"in","start":3614.6,"end":3614.68},{"text":"the","start":3614.68,"end":3614.8},{"text":"perception","start":3614.8,"end":3615.44},{"text":"of","start":3615.48,"end":3615.6},{"text":"people","start":3615.6,"end":3615.84},{"text":"who","start":3615.84,"end":3616.04},{"text":"use","start":3616.04,"end":3616.16},{"text":"drugs.","start":3616.16,"end":3616.64}]},{"text":"towards a more humane, a more understanding approach.","start":3617.33,"end":3620.69,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"towards","start":3617.33,"end":3617.65},{"text":"a","start":3617.65,"end":3617.69},{"text":"more","start":3617.69,"end":3617.97},{"text":"humane,","start":3617.97,"end":3618.45},{"text":"a","start":3618.69,"end":3618.73},{"text":"more","start":3618.73,"end":3619.57},{"text":"understanding","start":3619.57,"end":3620.13},{"text":"approach.","start":3620.13,"end":3620.69}]},{"text":"And I believe this shift is foundational to building effective and inclusive policies.","start":3621.01,"end":3625.33,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"And","start":3621.01,"end":3621.21},{"text":"I","start":3621.21,"end":3621.25},{"text":"believe","start":3621.25,"end":3621.57},{"text":"this","start":3621.57,"end":3621.73},{"text":"shift","start":3621.73,"end":3621.97},{"text":"is","start":3621.97,"end":3622.13},{"text":"foundational","start":3622.13,"end":3622.77},{"text":"to","start":3622.77,"end":3622.85},{"text":"building","start":3622.85,"end":3623.21},{"text":"effective","start":3623.21,"end":3623.81},{"text":"and","start":3623.81,"end":3623.93},{"text":"inclusive","start":3623.93,"end":3624.69},{"text":"policies.","start":3624.69,"end":3625.33}]},{"text":"And as today we are speaking of windows of opportunity, I'd like to highlight one, youth.","start":3625.65,"end":3630.53,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"And","start":3625.65,"end":3626.01},{"text":"as","start":3626.01,"end":3626.21},{"text":"today","start":3626.21,"end":3626.45},{"text":"we","start":3626.45,"end":3626.57},{"text":"are","start":3626.57,"end":3626.69},{"text":"speaking","start":3626.69,"end":3627.09},{"text":"of","start":3627.09,"end":3627.33},{"text":"windows","start":3627.33,"end":3627.81},{"text":"of","start":3627.85,"end":3628.05},{"text":"opportunity,","start":3628.05,"end":3628.69},{"text":"I'd","start":3628.69,"end":3628.89},{"text":"like","start":3628.89,"end":3629.01},{"text":"to","start":3629.01,"end":3629.13},{"text":"highlight","start":3629.13,"end":3629.57},{"text":"one,","start":3629.57,"end":3629.89},{"text":"youth.","start":3630.13,"end":3630.53}]},{"text":"As the statistics show, drugs disproportionately affect young people, but youth are not only vulnerable, we're also engaged, we're informed, and we're ready to be a part of the solution.","start":3631.49,"end":3641.65,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"As","start":3631.49,"end":3631.73},{"text":"the","start":3631.73,"end":3631.85},{"text":"statistics","start":3631.97,"end":3632.61},{"text":"show,","start":3632.61,"end":3632.85},{"text":"drugs","start":3632.85,"end":3633.33},{"text":"disproportionately","start":3633.33,"end":3634.17},{"text":"affect","start":3634.17,"end":3634.53},{"text":"young","start":3634.53,"end":3634.69},{"text":"people,","start":3634.69,"end":3635.09},{"text":"but","start":3635.09,"end":3635.41},{"text":"youth","start":3635.41,"end":3635.65},{"text":"are","start":3635.65,"end":3635.73},{"text":"not","start":3635.73,"end":3635.97},{"text":"only","start":3635.97,"end":3636.45},{"text":"vulnerable,","start":3636.77,"end":3637.49},{"text":"we're","start":3637.49,"end":3637.73},{"text":"also","start":3637.73,"end":3638.09},{"text":"engaged,","start":3638.09,"end":3638.53},{"text":"we're","start":3638.53,"end":3638.69},{"text":"informed,","start":3638.69,"end":3639.25},{"text":"and","start":3639.49,"end":3639.81},{"text":"we're","start":3639.81,"end":3639.97},{"text":"ready","start":3639.97,"end":3640.29},{"text":"to","start":3640.29,"end":3640.37},{"text":"be","start":3640.37,"end":3640.61},{"text":"a","start":3640.61,"end":3640.69},{"text":"part","start":3640.69,"end":3640.89},{"text":"of","start":3640.89,"end":3641.01},{"text":"the","start":3641.01,"end":3641.09},{"text":"solution.","start":3641.09,"end":3641.65}]},{"text":"And like any paradigm shift, this one cannot happen without the meaningful involvement of young people.","start":3641.97,"end":3646.61,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"And","start":3641.97,"end":3642.13},{"text":"like","start":3642.13,"end":3642.45},{"text":"any","start":3642.45,"end":3642.69},{"text":"paradigm","start":3642.69,"end":3643.17},{"text":"shift,","start":3643.17,"end":3643.49},{"text":"this","start":3643.49,"end":3643.69},{"text":"one","start":3643.69,"end":3643.89},{"text":"cannot","start":3643.89,"end":3644.13},{"text":"happen","start":3644.13,"end":3644.53},{"text":"without","start":3644.53,"end":3644.81},{"text":"the","start":3644.85,"end":3645.01},{"text":"meaningful","start":3645.01,"end":3645.49},{"text":"involvement","start":3645.49,"end":3645.97},{"text":"of","start":3645.97,"end":3646.05},{"text":"young","start":3646.05,"end":3646.25},{"text":"people.","start":3646.25,"end":3646.61}]},{"text":"So we need to invest in educating and empowering the next generation because it's a powerful lever for lasting change.","start":3647.37,"end":3653.13,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"So","start":3647.37,"end":3647.57},{"text":"we","start":3647.57,"end":3647.65},{"text":"need","start":3647.65,"end":3647.81},{"text":"to","start":3647.81,"end":3647.89},{"text":"invest","start":3647.89,"end":3648.33},{"text":"in","start":3648.33,"end":3648.49},{"text":"educating","start":3648.49,"end":3649.09},{"text":"and","start":3649.09,"end":3649.21},{"text":"empowering","start":3649.21,"end":3649.61},{"text":"the","start":3649.61,"end":3649.73},{"text":"next","start":3649.73,"end":3650.01},{"text":"generation","start":3650.01,"end":3650.65},{"text":"because","start":3650.65,"end":3650.85},{"text":"it's","start":3650.85,"end":3651.09},{"text":"a","start":3651.09,"end":3651.13},{"text":"powerful","start":3651.13,"end":3651.57},{"text":"lever","start":3651.57,"end":3651.93},{"text":"for","start":3651.93,"end":3652.33},{"text":"lasting","start":3652.33,"end":3652.73},{"text":"change.","start":3652.73,"end":3653.13}]},{"text":"Myself, I see this shift happening among my peers.","start":3653.77,"end":3656.41,"topics":[],"words":[{"text":"Myself,","start":3653.77,"end":3654.33},{"text":"I","start":3654.33,"end":3654.41},{"text":"see","start":3654.41,"end":3654.57},{"text":"this","start":3654.57,"end":3654.73},{"text":"shift","start":3654.73,"end":3655.13},{"text":"happening","start":3655.13,"end":3655.57},{"text":"among","start":3655.57,"end":3655.77},{"text":"my","start":3655.77,"end":3655.93},{"text":"peers.","start":3655.93,"end":3656.41}]},{"text":"At my medical school in Canada, every student carries a naloxone kit, which is an antidote that can reverse the effects of an opioid overdose.","start":3656.77,"end":3665.13,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"At","start":3656.77,"end":3656.89},{"text":"my","start":3656.89,"end":3657.05},{"text":"medical","start":3657.05,"end":3657.49},{"text":"school","start":3657.49,"end":3657.73},{"text":"in","start":3657.73,"end":3657.85},{"text":"Canada,","start":3657.85,"end":3658.33},{"text":"every","start":3658.41,"end":3658.73},{"text":"student","start":3658.73,"end":3659.17},{"text":"carries","start":3659.17,"end":3659.53},{"text":"a","start":3659.53,"end":3659.57},{"text":"naloxone","start":3659.57,"end":3660.17},{"text":"kit,","start":3660.17,"end":3660.53},{"text":"which","start":3660.53,"end":3660.77},{"text":"is","start":3660.77,"end":3660.89},{"text":"an","start":3660.89,"end":3661.05},{"text":"antidote","start":3661.05,"end":3661.53},{"text":"that","start":3661.53,"end":3661.69},{"text":"can","start":3661.69,"end":3661.85},{"text":"reverse","start":3661.85,"end":3662.41},{"text":"the","start":3663.45,"end":3663.65},{"text":"effects","start":3663.65,"end":3664.05},{"text":"of","start":3664.05,"end":3664.13},{"text":"an","start":3664.13,"end":3664.25},{"text":"opioid","start":3664.25,"end":3664.53},{"text":"overdose.","start":3664.57,"end":3665.13}]},{"text":"We are trained in harm reduction, and we support evidence-based harm reduction initiatives that have been mentioned, like supervised injection sites.","start":3665.69,"end":3673.69,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"We","start":3665.69,"end":3665.85},{"text":"are","start":3665.85,"end":3666.01},{"text":"trained","start":3666.01,"end":3666.57},{"text":"in","start":3666.57,"end":3666.73},{"text":"harm","start":3666.73,"end":3666.93},{"text":"reduction,","start":3666.93,"end":3667.69},{"text":"and","start":3667.69,"end":3667.89},{"text":"we","start":3667.89,"end":3668.01},{"text":"support","start":3668.01,"end":3668.41},{"text":"evidence-based","start":3668.41,"end":3669.13},{"text":"harm","start":3669.13,"end":3669.33},{"text":"reduction","start":3669.33,"end":3669.85},{"text":"initiatives","start":3669.85,"end":3670.49},{"text":"that","start":3671.13,"end":3671.29},{"text":"have","start":3671.29,"end":3671.45},{"text":"been","start":3671.45,"end":3671.61},{"text":"mentioned,","start":3671.61,"end":3672.05},{"text":"like","start":3672.05,"end":3672.29},{"text":"supervised","start":3672.29,"end":3672.81},{"text":"injection","start":3672.81,"end":3673.29},{"text":"sites.","start":3673.29,"end":3673.69}]},{"text":"So I will end on that note.","start":3674.33,"end":3675.77,"topics":[],"words":[{"text":"So","start":3674.33,"end":3674.65},{"text":"I","start":3674.65,"end":3674.81},{"text":"will","start":3674.81,"end":3674.97},{"text":"end","start":3674.97,"end":3675.13},{"text":"on","start":3675.13,"end":3675.21},{"text":"that","start":3675.21,"end":3675.45},{"text":"note.","start":3675.45,"end":3675.77}]},{"text":"this is the kind of momentum that we must build on, not just support young people, but to work with them if we truly want to move forward.","start":3676.33,"end":3683.77,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"this","start":3676.33,"end":3676.53},{"text":"is","start":3676.53,"end":3676.61},{"text":"the","start":3676.61,"end":3676.73},{"text":"kind","start":3676.73,"end":3676.93},{"text":"of","start":3676.93,"end":3677.01},{"text":"momentum","start":3677.01,"end":3677.61},{"text":"that","start":3677.61,"end":3677.85},{"text":"we","start":3677.85,"end":3678.09},{"text":"must","start":3678.09,"end":3678.29},{"text":"build","start":3678.29,"end":3678.57},{"text":"on,","start":3678.57,"end":3679.01},{"text":"not","start":3679.01,"end":3679.17},{"text":"just","start":3679.17,"end":3679.33},{"text":"support","start":3679.33,"end":3679.77},{"text":"young","start":3679.77,"end":3679.93},{"text":"people,","start":3679.93,"end":3680.33},{"text":"but","start":3680.33,"end":3680.53},{"text":"to","start":3680.53,"end":3680.61},{"text":"work","start":3680.61,"end":3680.89},{"text":"with","start":3680.89,"end":3681.13},{"text":"them","start":3681.13,"end":3681.37},{"text":"if","start":3681.77,"end":3682.05},{"text":"we","start":3682.05,"end":3682.17},{"text":"truly","start":3682.17,"end":3682.49},{"text":"want","start":3682.49,"end":3682.77},{"text":"to","start":3682.77,"end":3682.85},{"text":"move","start":3683.13,"end":3683.41},{"text":"forward.","start":3683.41,"end":3683.77}]},{"text":"Thank you.","start":3683.93,"end":3684.25,"topics":[],"words":[{"text":"Thank","start":3683.93,"end":3684.09},{"text":"you.","start":3684.09,"end":3684.25}]}]}],"speaker":{"affiliation":"IFMSA","group":null,"function":"Delegate","affiliation_full":"IFMSA"}},{"statement_number":19,"start":3684.49,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:01:25","paragraphs":[{"sentences":[{"text":"Thank you for making such an important point and for modeling the right kind of timing on an intervention.","start":3684.49,"end":3691.61,"topics":[],"words":[{"text":"Thank","start":3684.49,"end":3684.77},{"text":"you","start":3684.77,"end":3684.89},{"text":"for","start":3684.89,"end":3685.01},{"text":"making","start":3685.01,"end":3685.37},{"text":"such","start":3685.37,"end":3685.61},{"text":"an","start":3685.61,"end":3685.69},{"text":"important","start":3685.69,"end":3686.13},{"text":"point","start":3686.13,"end":3686.49},{"text":"and","start":3686.97,"end":3687.21},{"text":"for","start":3687.21,"end":3687.45},{"text":"modeling","start":3687.45,"end":3688.25},{"text":"the","start":3688.97,"end":3689.45},{"text":"right","start":3689.45,"end":3689.69},{"text":"kind","start":3689.69,"end":3690.01},{"text":"of","start":3690.01,"end":3690.17},{"text":"timing","start":3690.17,"end":3690.73},{"text":"on","start":3690.73,"end":3690.81},{"text":"an","start":3690.81,"end":3690.89},{"text":"intervention.","start":3690.89,"end":3691.61}]},{"text":"Much appreciated.","start":3691.61,"end":3692.57,"topics":[],"words":[{"text":"Much","start":3691.61,"end":3691.81},{"text":"appreciated.","start":3691.81,"end":3692.57}]},{"text":"Okay, I have another number here, so I'm just going to go across here.","start":3692.93,"end":3696.49,"topics":[],"words":[{"text":"Okay,","start":3692.93,"end":3693.37},{"text":"I","start":3693.53,"end":3693.69},{"text":"have","start":3693.69,"end":3693.93},{"text":"another","start":3693.93,"end":3694.25},{"text":"number","start":3694.25,"end":3694.65},{"text":"here,","start":3694.65,"end":3694.89},{"text":"so","start":3694.89,"end":3694.97},{"text":"I'm","start":3694.97,"end":3695.17},{"text":"just","start":3695.17,"end":3695.33},{"text":"going","start":3695.33,"end":3695.49},{"text":"to","start":3695.49,"end":3695.57},{"text":"go","start":3695.57,"end":3695.69},{"text":"across","start":3695.69,"end":3696.17},{"text":"here.","start":3696.17,"end":3696.49}]},{"text":"So I'll start there and then just go across, please.","start":3696.81,"end":3699.45,"topics":[],"words":[{"text":"So","start":3696.81,"end":3696.93},{"text":"I'll","start":3696.93,"end":3697.13},{"text":"start","start":3697.13,"end":3697.45},{"text":"there","start":3697.45,"end":3697.77},{"text":"and","start":3697.77,"end":3697.89},{"text":"then","start":3697.89,"end":3698.09},{"text":"just","start":3698.09,"end":3698.45},{"text":"go","start":3698.45,"end":3698.57},{"text":"across,","start":3698.57,"end":3698.97},{"text":"please.","start":3698.97,"end":3699.45}]},{"text":"Apologies, the system is not working, so I can't see names as they come up, so just please go ahead.","start":3700.33,"end":3705.21,"topics":[],"words":[{"text":"Apologies,","start":3700.33,"end":3700.97},{"text":"the","start":3700.97,"end":3701.13},{"text":"system","start":3701.13,"end":3701.57},{"text":"is","start":3701.57,"end":3701.69},{"text":"not","start":3701.69,"end":3701.89},{"text":"working,","start":3701.89,"end":3702.21},{"text":"so","start":3702.21,"end":3702.37},{"text":"I","start":3702.37,"end":3702.41},{"text":"can't","start":3702.41,"end":3702.85},{"text":"see","start":3702.85,"end":3702.93},{"text":"names","start":3702.93,"end":3703.29},{"text":"as","start":3703.29,"end":3703.37},{"text":"they","start":3703.37,"end":3703.53},{"text":"come","start":3703.53,"end":3703.77},{"text":"up,","start":3703.77,"end":3703.93},{"text":"so","start":3703.93,"end":3704.09},{"text":"just","start":3704.09,"end":3704.57},{"text":"please","start":3704.73,"end":3704.89},{"text":"go","start":3704.89,"end":3705.05},{"text":"ahead.","start":3705.05,"end":3705.21}]}]}],"speaker":{"affiliation":"UNDP","group":null,"function":null,"affiliation_full":"UNDP"}},{"statement_number":20,"start":3706.49,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:01:47","paragraphs":[{"sentences":[{"text":"Perfect. Thank you, Chair, Your Excellencies, esteemed guests.","start":3706.49,"end":3710.01,"topics":[],"words":[{"text":"Perfect.","start":3706.49,"end":3706.81},{"text":"Thank","start":3706.89,"end":3707.13},{"text":"you,","start":3707.13,"end":3707.21},{"text":"Chair,","start":3707.21,"end":3707.61},{"text":"Your","start":3707.77,"end":3708.01},{"text":"Excellencies,","start":3708.01,"end":3708.89},{"text":"esteemed","start":3709.13,"end":3709.61},{"text":"guests.","start":3709.61,"end":3710.01}]},{"text":"My name is Divya Sharma, and I'm a student pursuing global political economy at the University of Manitoba.","start":3710.01,"end":3715.21,"topics":[],"words":[{"text":"My","start":3710.01,"end":3710.13},{"text":"name","start":3710.13,"end":3710.33},{"text":"is","start":3710.33,"end":3710.45},{"text":"Divya","start":3710.45,"end":3710.73},{"text":"Sharma,","start":3710.73,"end":3711.17},{"text":"and","start":3711.17,"end":3711.29},{"text":"I'm","start":3711.29,"end":3711.53},{"text":"a","start":3711.77,"end":3711.85},{"text":"student","start":3711.85,"end":3712.21},{"text":"pursuing","start":3712.21,"end":3712.57},{"text":"global","start":3712.57,"end":3712.97},{"text":"political","start":3712.97,"end":3713.33},{"text":"economy","start":3713.33,"end":3713.81},{"text":"at","start":3713.81,"end":3713.93},{"text":"the","start":3713.93,"end":3714.01},{"text":"University","start":3714.01,"end":3714.53},{"text":"of","start":3714.53,"end":3714.61},{"text":"Manitoba.","start":3714.61,"end":3715.21}]},{"text":"We also work to support research in local and national spaces in the Major Projects Office.","start":3715.45,"end":3721.13,"topics":[],"words":[{"text":"We","start":3715.45,"end":3715.57},{"text":"also","start":3715.57,"end":3715.89},{"text":"work","start":3715.89,"end":3716.17},{"text":"to","start":3716.17,"end":3716.37},{"text":"support","start":3716.65,"end":3717.29},{"text":"research","start":3717.29,"end":3717.77},{"text":"in","start":3717.77,"end":3717.93},{"text":"local","start":3717.93,"end":3718.37},{"text":"and","start":3718.37,"end":3718.53},{"text":"national","start":3718.53,"end":3718.97},{"text":"spaces","start":3718.97,"end":3719.53},{"text":"in","start":3719.69,"end":3719.81},{"text":"the","start":3719.81,"end":3719.89},{"text":"Major","start":3719.89,"end":3720.17},{"text":"Projects","start":3720.17,"end":3720.65},{"text":"Office.","start":3720.65,"end":3721.13}]},{"text":"I also serve on the board of the, as a board member of the Manitoba Council for International Cooperation, and I have been honoured to represent civil society on behalf of the Manitoba Council for International Cooperation as a delegate to the 60th United Nations Commission on the Status of Women.","start":3721.37,"end":3738.17,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"I","start":3721.37,"end":3721.53},{"text":"also","start":3721.53,"end":3721.77},{"text":"serve","start":3721.77,"end":3722.09},{"text":"on","start":3722.09,"end":3722.21},{"text":"the","start":3722.21,"end":3722.29},{"text":"board","start":3722.29,"end":3722.61},{"text":"of","start":3722.61,"end":3722.81},{"text":"the,","start":3722.81,"end":3722.93},{"text":"as","start":3723.29,"end":3723.53},{"text":"a","start":3723.53,"end":3723.57},{"text":"board","start":3723.57,"end":3723.81},{"text":"member","start":3723.81,"end":3724.13},{"text":"of","start":3724.13,"end":3724.21},{"text":"the","start":3724.21,"end":3724.33},{"text":"Manitoba","start":3724.33,"end":3724.81},{"text":"Council","start":3724.81,"end":3725.21},{"text":"for","start":3725.21,"end":3725.37},{"text":"International","start":3725.37,"end":3725.93},{"text":"Cooperation,","start":3725.93,"end":3726.89},{"text":"and","start":3727.05,"end":3727.45},{"text":"I","start":3727.45,"end":3727.69},{"text":"have","start":3727.69,"end":3727.97},{"text":"been","start":3727.97,"end":3728.25},{"text":"honoured","start":3728.25,"end":3728.57},{"text":"to","start":3728.57,"end":3728.69},{"text":"represent","start":3728.69,"end":3729.17},{"text":"civil","start":3729.17,"end":3729.45},{"text":"society","start":3729.45,"end":3730.73},{"text":"on","start":3730.73,"end":3730.89},{"text":"behalf","start":3730.89,"end":3731.29},{"text":"of","start":3731.45,"end":3731.69},{"text":"the","start":3731.69,"end":3731.81},{"text":"Manitoba","start":3731.81,"end":3732.33},{"text":"Council","start":3732.33,"end":3732.61},{"text":"for","start":3732.61,"end":3732.73},{"text":"International","start":3732.73,"end":3733.25},{"text":"Cooperation","start":3733.25,"end":3733.93},{"text":"as","start":3734.17,"end":3734.29},{"text":"a","start":3734.29,"end":3734.33},{"text":"delegate","start":3734.33,"end":3734.97},{"text":"to","start":3734.97,"end":3735.05},{"text":"the","start":3735.05,"end":3735.25},{"text":"60th","start":3735.25,"end":3735.85},{"text":"United","start":3735.93,"end":3736.21},{"text":"Nations","start":3736.49,"end":3736.81},{"text":"Commission","start":3736.81,"end":3737.17},{"text":"on","start":3737.17,"end":3737.25},{"text":"the","start":3737.25,"end":3737.33},{"text":"Status","start":3737.33,"end":3737.69},{"text":"of","start":3737.69,"end":3737.77},{"text":"Women.","start":3737.77,"end":3738.17}]},{"text":"This year, I'm proud to join the Canadian delegation on the High-Level Political Forum.","start":3738.41,"end":3742.73,"topics":[],"words":[{"text":"This","start":3738.41,"end":3738.73},{"text":"year,","start":3738.73,"end":3738.93},{"text":"I'm","start":3738.93,"end":3739.13},{"text":"proud","start":3739.13,"end":3739.41},{"text":"to","start":3739.41,"end":3739.57},{"text":"join","start":3739.57,"end":3739.77},{"text":"the","start":3739.77,"end":3739.85},{"text":"Canadian","start":3739.85,"end":3740.25},{"text":"delegation","start":3740.25,"end":3740.97},{"text":"on","start":3740.97,"end":3741.29},{"text":"the","start":3741.29,"end":3741.41},{"text":"High-Level","start":3741.41,"end":3741.93},{"text":"Political","start":3741.93,"end":3742.37},{"text":"Forum.","start":3742.37,"end":3742.73}]},{"text":"My work has focused on ensuring youth and women empowerment, especially when it comes to inclusive policies that reflect the realities of all people, particularly women, marginalized communities, and of course, the HLPF.","start":3743.05,"end":3755.61,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"My","start":3743.05,"end":3743.21},{"text":"work","start":3743.21,"end":3743.57},{"text":"has","start":3743.57,"end":3743.77},{"text":"focused","start":3743.77,"end":3744.21},{"text":"on","start":3744.21,"end":3744.29},{"text":"ensuring","start":3744.29,"end":3744.81},{"text":"youth","start":3744.81,"end":3745.17},{"text":"and","start":3745.29,"end":3745.49},{"text":"women","start":3745.49,"end":3745.73},{"text":"empowerment,","start":3745.73,"end":3746.33},{"text":"especially","start":3746.41,"end":3746.85},{"text":"when","start":3746.85,"end":3747.01},{"text":"it","start":3747.01,"end":3747.09},{"text":"comes","start":3747.09,"end":3747.41},{"text":"to","start":3747.41,"end":3747.49},{"text":"inclusive","start":3747.49,"end":3748.09},{"text":"policies","start":3748.25,"end":3748.89},{"text":"that","start":3749.29,"end":3749.49},{"text":"reflect","start":3749.49,"end":3749.93},{"text":"the","start":3749.93,"end":3750.01},{"text":"realities","start":3750.01,"end":3750.61},{"text":"of","start":3750.61,"end":3750.73},{"text":"all","start":3750.73,"end":3751.05},{"text":"people,","start":3751.05,"end":3751.53},{"text":"particularly","start":3751.53,"end":3752.25},{"text":"women,","start":3752.25,"end":3752.65},{"text":"marginalized","start":3752.65,"end":3753.21},{"text":"communities,","start":3753.21,"end":3753.77},{"text":"and","start":3753.85,"end":3754.01},{"text":"of","start":3754.01,"end":3754.09},{"text":"course,","start":3754.09,"end":3754.49},{"text":"the","start":3754.73,"end":3754.85},{"text":"HLPF.","start":3754.85,"end":3755.61}]},{"text":"We know that SDG 5 is under review, which calls to achieve gender equality and empower all women and girls.","start":3755.85,"end":3761.93,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."}],"words":[{"text":"We","start":3755.85,"end":3756.09},{"text":"know","start":3756.09,"end":3756.25},{"text":"that","start":3756.25,"end":3756.65},{"text":"SDG","start":3756.65,"end":3757.09},{"text":"5","start":3757.13,"end":3757.45},{"text":"is","start":3757.45,"end":3757.61},{"text":"under","start":3757.61,"end":3757.89},{"text":"review,","start":3757.89,"end":3758.17},{"text":"which","start":3758.17,"end":3758.41},{"text":"calls","start":3758.41,"end":3758.81},{"text":"to","start":3758.81,"end":3759.09},{"text":"achieve","start":3759.13,"end":3759.53},{"text":"gender","start":3759.53,"end":3759.81},{"text":"equality","start":3759.81,"end":3760.33},{"text":"and","start":3760.33,"end":3760.49},{"text":"empower","start":3760.49,"end":3760.89},{"text":"all","start":3760.89,"end":3761.13},{"text":"women","start":3761.13,"end":3761.45},{"text":"and","start":3761.45,"end":3761.57},{"text":"girls.","start":3761.57,"end":3761.93}]},{"text":"As we discuss evidence and science-based approaches to drug policy, HIV, and health, I want to highlight a critical gap that persists in our research and policy making, the systemic exclusion of women's bodies and experiences in scientific evidence.","start":3762.57,"end":3777.69,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"As","start":3762.57,"end":3762.81},{"text":"we","start":3762.81,"end":3762.89},{"text":"discuss","start":3762.89,"end":3763.37},{"text":"evidence","start":3763.37,"end":3763.85},{"text":"and","start":3763.85,"end":3764.01},{"text":"science-based","start":3764.01,"end":3764.69},{"text":"approaches","start":3764.69,"end":3765.21},{"text":"to","start":3765.21,"end":3765.33},{"text":"drug","start":3765.33,"end":3765.65},{"text":"policy,","start":3765.65,"end":3766.45},{"text":"HIV,","start":3766.45,"end":3766.85},{"text":"and","start":3766.85,"end":3766.97},{"text":"health,","start":3766.97,"end":3767.37},{"text":"I","start":3767.69,"end":3767.85},{"text":"want","start":3767.85,"end":3768.13},{"text":"to","start":3768.13,"end":3768.21},{"text":"highlight","start":3768.21,"end":3768.69},{"text":"a","start":3768.81,"end":3768.85},{"text":"critical","start":3768.85,"end":3769.21},{"text":"gap","start":3769.21,"end":3769.53},{"text":"that","start":3769.53,"end":3769.69},{"text":"persists","start":3769.69,"end":3770.17},{"text":"in","start":3770.17,"end":3770.25},{"text":"our","start":3770.25,"end":3770.49},{"text":"research","start":3770.65,"end":3771.21},{"text":"and","start":3771.21,"end":3771.33},{"text":"policy","start":3771.33,"end":3771.77},{"text":"making,","start":3771.77,"end":3772.17},{"text":"the","start":3772.33,"end":3772.49},{"text":"systemic","start":3772.49,"end":3773.29},{"text":"exclusion","start":3773.77,"end":3774.41},{"text":"of","start":3774.41,"end":3774.57},{"text":"women's","start":3774.57,"end":3774.97},{"text":"bodies","start":3774.97,"end":3775.45},{"text":"and","start":3775.45,"end":3775.57},{"text":"experiences","start":3775.57,"end":3776.33},{"text":"in","start":3776.33,"end":3776.49},{"text":"scientific","start":3776.49,"end":3777.13},{"text":"evidence.","start":3777.13,"end":3777.69}]},{"text":"For decades, clinical trials, health interventions, and even harm reduction strategies have been tested primarily on men.","start":3778.01,"end":3784.57,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"For","start":3778.01,"end":3778.17},{"text":"decades,","start":3778.17,"end":3778.73},{"text":"clinical","start":3778.73,"end":3779.13},{"text":"trials,","start":3779.13,"end":3779.77},{"text":"health","start":3779.77,"end":3780.13},{"text":"interventions,","start":3780.13,"end":3780.85},{"text":"and","start":3780.85,"end":3781.01},{"text":"even","start":3781.01,"end":3781.21},{"text":"harm","start":3781.21,"end":3781.53},{"text":"reduction","start":3781.53,"end":3781.93},{"text":"strategies","start":3781.93,"end":3782.49},{"text":"have","start":3782.49,"end":3782.61},{"text":"been","start":3782.61,"end":3782.73},{"text":"tested","start":3782.73,"end":3783.21},{"text":"primarily","start":3783.37,"end":3784.09},{"text":"on","start":3784.09,"end":3784.25},{"text":"men.","start":3784.25,"end":3784.57}]},{"text":"then generalized to everyone, despite clear differences in biology, metabolism, and social determinants of health.","start":3785.13,"end":3792.61,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"then","start":3785.13,"end":3785.53},{"text":"generalized","start":3785.85,"end":3786.57},{"text":"to","start":3786.57,"end":3786.69},{"text":"everyone,","start":3786.69,"end":3787.21},{"text":"despite","start":3787.41,"end":3787.93},{"text":"clear","start":3787.93,"end":3788.41},{"text":"differences","start":3788.41,"end":3789.05},{"text":"in","start":3789.05,"end":3789.21},{"text":"biology,","start":3789.21,"end":3789.93},{"text":"metabolism,","start":3789.93,"end":3790.81},{"text":"and","start":3790.81,"end":3790.97},{"text":"social","start":3790.97,"end":3791.37},{"text":"determinants","start":3791.37,"end":3792.09},{"text":"of","start":3792.13,"end":3792.25},{"text":"health.","start":3792.25,"end":3792.61}]},{"text":"If we are truly committed to evidence-based policy, then that evidence must be built inclusively from the start.","start":3793.37,"end":3800.33,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"If","start":3793.37,"end":3793.61},{"text":"we","start":3793.61,"end":3793.73},{"text":"are","start":3793.73,"end":3793.85},{"text":"truly","start":3793.85,"end":3794.41},{"text":"committed","start":3794.41,"end":3794.97},{"text":"to","start":3795.05,"end":3795.17},{"text":"evidence-based","start":3795.17,"end":3796.09},{"text":"policy,","start":3796.09,"end":3796.65},{"text":"then","start":3796.73,"end":3796.93},{"text":"that","start":3796.93,"end":3797.13},{"text":"evidence","start":3797.13,"end":3797.53},{"text":"must","start":3797.61,"end":3798.17},{"text":"be","start":3798.17,"end":3798.49},{"text":"built","start":3798.49,"end":3798.81},{"text":"inclusively","start":3798.81,"end":3799.61},{"text":"from","start":3799.61,"end":3799.81},{"text":"the","start":3799.81,"end":3799.89},{"text":"start.","start":3799.89,"end":3800.33}]},{"text":"We cannot continue to base life-saving interventions on Research that ignores half the population, science and policy that do not account for women's bodies, needs, and context are not just incomplete, they are inequitable and at times dangerous.","start":3800.65,"end":3818.65,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"We","start":3800.65,"end":3800.81},{"text":"cannot","start":3800.81,"end":3801.17},{"text":"continue","start":3801.17,"end":3801.73},{"text":"to","start":3801.73,"end":3801.81},{"text":"base","start":3801.81,"end":3802.17},{"text":"life-saving","start":3802.25,"end":3802.97},{"text":"interventions","start":3802.97,"end":3803.77},{"text":"on","start":3804.17,"end":3804.49},{"text":"Research","start":3805.53,"end":3806.01},{"text":"that","start":3806.01,"end":3806.21},{"text":"ignores","start":3806.21,"end":3806.57},{"text":"half","start":3806.57,"end":3807.05},{"text":"the","start":3807.05,"end":3807.13},{"text":"population,","start":3807.13,"end":3807.93},{"text":"science","start":3808.09,"end":3808.73},{"text":"and","start":3808.73,"end":3808.89},{"text":"policy","start":3808.89,"end":3809.53},{"text":"that","start":3809.61,"end":3809.89},{"text":"do","start":3809.89,"end":3810.09},{"text":"not","start":3810.09,"end":3810.29},{"text":"account","start":3810.29,"end":3810.57},{"text":"for","start":3810.57,"end":3810.73},{"text":"women's","start":3810.73,"end":3811.17},{"text":"bodies,","start":3811.17,"end":3811.53},{"text":"needs,","start":3811.77,"end":3812.33},{"text":"and","start":3812.49,"end":3812.89},{"text":"context","start":3812.89,"end":3813.61},{"text":"are","start":3813.69,"end":3813.85},{"text":"not","start":3813.85,"end":3814.17},{"text":"just","start":3814.17,"end":3814.33},{"text":"incomplete,","start":3814.33,"end":3815.13},{"text":"they","start":3815.29,"end":3815.41},{"text":"are","start":3815.41,"end":3815.61},{"text":"inequitable","start":3815.69,"end":3816.49},{"text":"and","start":3816.57,"end":3817.05},{"text":"at","start":3817.13,"end":3817.49},{"text":"times","start":3817.49,"end":3817.93},{"text":"dangerous.","start":3817.93,"end":3818.65}]},{"text":"I urge all of us here to take this opportunity to not only promote evidence-based approaches, but also to demand that evidence itself is built inclusively, rigorously, and ethically, reflecting the diversity of people we aim to serve.","start":3818.97,"end":3833.29,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"I","start":3818.97,"end":3819.13},{"text":"urge","start":3819.21,"end":3819.53},{"text":"all","start":3819.61,"end":3819.81},{"text":"of","start":3819.81,"end":3819.93},{"text":"us","start":3819.93,"end":3820.09},{"text":"here","start":3820.09,"end":3820.33},{"text":"to","start":3820.33,"end":3820.45},{"text":"take","start":3820.45,"end":3820.61},{"text":"this","start":3820.61,"end":3820.81},{"text":"opportunity","start":3820.81,"end":3821.37},{"text":"to","start":3821.37,"end":3821.49},{"text":"not","start":3821.49,"end":3821.93},{"text":"only","start":3822.09,"end":3822.33},{"text":"promote","start":3822.33,"end":3822.97},{"text":"evidence-based","start":3822.97,"end":3823.65},{"text":"approaches,","start":3823.65,"end":3824.13},{"text":"but","start":3824.13,"end":3824.29},{"text":"also","start":3824.29,"end":3824.65},{"text":"to","start":3824.65,"end":3824.85},{"text":"demand","start":3824.85,"end":3825.25},{"text":"that","start":3825.25,"end":3825.45},{"text":"evidence","start":3825.45,"end":3825.89},{"text":"itself","start":3825.89,"end":3826.41},{"text":"is","start":3826.57,"end":3826.81},{"text":"built","start":3826.81,"end":3827.21},{"text":"inclusively,","start":3827.21,"end":3828.09},{"text":"rigorously,","start":3828.17,"end":3829.05},{"text":"and","start":3829.05,"end":3829.45},{"text":"ethically,","start":3829.45,"end":3830.01},{"text":"reflecting","start":3830.17,"end":3830.73},{"text":"the","start":3830.73,"end":3830.85},{"text":"diversity","start":3830.85,"end":3831.93},{"text":"of","start":3831.93,"end":3832.05},{"text":"people","start":3832.05,"end":3832.49},{"text":"we","start":3832.49,"end":3832.77},{"text":"aim","start":3832.77,"end":3832.89},{"text":"to","start":3832.89,"end":3832.97},{"text":"serve.","start":3832.97,"end":3833.29}]},{"text":"Thank you.","start":3833.53,"end":3833.93,"topics":[],"words":[{"text":"Thank","start":3833.53,"end":3833.85},{"text":"you.","start":3833.85,"end":3833.93}]}]}],"speaker":{"affiliation":null,"group":null,"function":"Student","affiliation_full":null}},{"statement_number":21,"start":3835.41,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:03:56","paragraphs":[{"sentences":[{"text":"Thank you very much.","start":3835.41,"end":3836.33,"topics":[],"words":[{"text":"Thank","start":3835.41,"end":3835.65},{"text":"you","start":3835.65,"end":3835.77},{"text":"very","start":3835.77,"end":3835.97},{"text":"much.","start":3835.97,"end":3836.33}]},{"text":"And let's leave it to the young people to model quick interventions and very impactful ones.","start":3836.33,"end":3842.29,"topics":[],"words":[{"text":"And","start":3836.33,"end":3836.45},{"text":"let's","start":3836.45,"end":3836.73},{"text":"leave","start":3836.73,"end":3836.89},{"text":"it","start":3836.89,"end":3837.05},{"text":"to","start":3837.05,"end":3837.17},{"text":"the","start":3837.17,"end":3837.29},{"text":"young","start":3837.29,"end":3837.57},{"text":"people","start":3837.57,"end":3837.97},{"text":"to","start":3837.97,"end":3838.37},{"text":"model","start":3839.49,"end":3839.97},{"text":"quick","start":3839.97,"end":3840.33},{"text":"interventions","start":3840.33,"end":3841.09},{"text":"and","start":3841.09,"end":3841.21},{"text":"very","start":3841.21,"end":3841.45},{"text":"impactful","start":3841.45,"end":3842.01},{"text":"ones.","start":3842.01,"end":3842.29}]},{"text":"Thank you.","start":3842.29,"end":3842.69,"topics":[],"words":[{"text":"Thank","start":3842.29,"end":3842.53},{"text":"you.","start":3842.53,"end":3842.69}]},{"text":"And could I encourage member states also?","start":3843.17,"end":3845.57,"topics":[],"words":[{"text":"And","start":3843.17,"end":3843.41},{"text":"could","start":3843.73,"end":3843.97},{"text":"I","start":3843.97,"end":3844.01},{"text":"encourage","start":3844.01,"end":3844.45},{"text":"member","start":3844.45,"end":3844.69},{"text":"states","start":3844.69,"end":3845.09},{"text":"also?","start":3845.09,"end":3845.57}]},{"text":"I know we're getting students and civil society, but if member states also want to speak, please do.","start":3845.89,"end":3851.57,"topics":[],"words":[{"text":"I","start":3845.89,"end":3845.97},{"text":"know","start":3845.97,"end":3846.13},{"text":"we're","start":3846.13,"end":3846.29},{"text":"getting","start":3846.29,"end":3846.61},{"text":"students","start":3846.61,"end":3847.09},{"text":"and","start":3847.09,"end":3847.25},{"text":"civil","start":3847.25,"end":3847.45},{"text":"society,","start":3847.45,"end":3848.13},{"text":"but","start":3848.61,"end":3848.85},{"text":"if","start":3848.85,"end":3849.09},{"text":"member","start":3849.09,"end":3849.37},{"text":"states","start":3849.37,"end":3849.69},{"text":"also","start":3849.69,"end":3850.13},{"text":"want","start":3850.37,"end":3850.53},{"text":"to","start":3850.53,"end":3850.61},{"text":"speak,","start":3850.61,"end":3850.93},{"text":"please","start":3850.93,"end":3851.25},{"text":"do.","start":3851.25,"end":3851.57}]}]}],"speaker":{"affiliation":"UNDP","group":null,"function":null,"affiliation_full":"UNDP"}},{"statement_number":22,"start":3853.49,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:04:14","paragraphs":[{"sentences":[{"text":"Hi. My name is Jaime Orellana, and I have always believed that a healthy society is key to eradicating many problems.","start":3853.49,"end":3863.57,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"Hi.","start":3853.49,"end":3853.73},{"text":"My","start":3855.73,"end":3855.97},{"text":"name","start":3855.97,"end":3856.29},{"text":"is","start":3856.29,"end":3856.69},{"text":"Jaime","start":3856.69,"end":3856.97},{"text":"Orellana,","start":3856.97,"end":3857.49},{"text":"and","start":3858.13,"end":3858.29},{"text":"I","start":3858.29,"end":3858.37},{"text":"have","start":3858.45,"end":3858.61},{"text":"always","start":3858.61,"end":3859.01},{"text":"believed","start":3859.01,"end":3859.37},{"text":"that","start":3859.37,"end":3859.61},{"text":"a","start":3859.61,"end":3859.65},{"text":"healthy","start":3859.65,"end":3860.05},{"text":"society","start":3860.05,"end":3861.05},{"text":"is","start":3861.05,"end":3861.33},{"text":"key","start":3861.41,"end":3861.73},{"text":"to","start":3861.73,"end":3861.93},{"text":"eradicating","start":3861.93,"end":3862.69},{"text":"many","start":3862.69,"end":3862.93},{"text":"problems.","start":3862.93,"end":3863.57}]},{"text":"And I think that sports is a great tool not only to keep our youth away from addictions, but also to prevent diseases in adults.","start":3864.21,"end":3872.77,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"And","start":3864.21,"end":3864.41},{"text":"I","start":3864.41,"end":3864.45},{"text":"think","start":3864.45,"end":3864.77},{"text":"that","start":3864.77,"end":3864.93},{"text":"sports","start":3864.93,"end":3865.57},{"text":"is","start":3865.97,"end":3866.13},{"text":"a","start":3866.13,"end":3866.21},{"text":"great","start":3866.21,"end":3866.57},{"text":"tool","start":3866.57,"end":3866.85},{"text":"not","start":3866.85,"end":3867.21},{"text":"only","start":3867.21,"end":3867.49},{"text":"to","start":3867.49,"end":3867.65},{"text":"keep","start":3867.65,"end":3867.97},{"text":"our","start":3867.97,"end":3868.29},{"text":"youth","start":3868.29,"end":3868.53},{"text":"away","start":3868.53,"end":3868.93},{"text":"from","start":3869.25,"end":3869.65},{"text":"addictions,","start":3869.65,"end":3870.37},{"text":"but","start":3870.37,"end":3870.61},{"text":"also","start":3870.61,"end":3870.97},{"text":"to","start":3870.97,"end":3871.09},{"text":"prevent","start":3871.09,"end":3871.49},{"text":"diseases","start":3871.49,"end":3872.05},{"text":"in","start":3872.05,"end":3872.29},{"text":"adults.","start":3872.29,"end":3872.77}]},{"text":"And my question is, what do you believe are the fundamental bases to convince the population that prevention is the best approach to achieving better health?","start":3873.05,"end":3883.73,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"And","start":3873.05,"end":3873.21},{"text":"my","start":3873.21,"end":3873.33},{"text":"question","start":3873.33,"end":3873.89},{"text":"is,","start":3873.89,"end":3874.29},{"text":"what","start":3874.65,"end":3874.89},{"text":"do","start":3874.89,"end":3875.01},{"text":"you","start":3875.01,"end":3875.17},{"text":"believe","start":3875.17,"end":3875.65},{"text":"are","start":3876.21,"end":3876.45},{"text":"the","start":3876.45,"end":3876.53},{"text":"fundamental","start":3876.53,"end":3877.49},{"text":"bases","start":3877.49,"end":3878.13},{"text":"to","start":3878.61,"end":3878.77},{"text":"convince","start":3878.77,"end":3879.21},{"text":"the","start":3879.21,"end":3879.33},{"text":"population","start":3879.33,"end":3879.97},{"text":"that","start":3879.97,"end":3880.13},{"text":"prevention","start":3880.13,"end":3880.85},{"text":"is","start":3881.17,"end":3881.33},{"text":"the","start":3881.33,"end":3881.49},{"text":"best","start":3881.49,"end":3881.77},{"text":"approach","start":3881.77,"end":3882.21},{"text":"to","start":3882.29,"end":3882.49},{"text":"achieving","start":3882.49,"end":3883.01},{"text":"better","start":3883.01,"end":3883.33},{"text":"health?","start":3883.33,"end":3883.73}]},{"text":"Additionally, which programs would you recommend for replication in communities to achieve the best results?","start":3884.21,"end":3890.69,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"Additionally,","start":3884.21,"end":3885.09},{"text":"which","start":3885.21,"end":3885.57},{"text":"programs","start":3885.57,"end":3886.21},{"text":"would","start":3886.21,"end":3886.41},{"text":"you","start":3886.41,"end":3886.61},{"text":"recommend","start":3886.61,"end":3887.21},{"text":"for","start":3887.21,"end":3887.45},{"text":"replication","start":3887.45,"end":3888.05},{"text":"in","start":3888.05,"end":3888.13},{"text":"communities","start":3888.13,"end":3888.85},{"text":"to","start":3889.25,"end":3889.41},{"text":"achieve","start":3889.41,"end":3889.73},{"text":"the","start":3889.73,"end":3889.89},{"text":"best","start":3889.89,"end":3890.13},{"text":"results?","start":3890.13,"end":3890.69}]}]}],"speaker":{"affiliation":null,"group":null,"function":null,"affiliation_full":null}},{"statement_number":23,"start":3892.97,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:04:53","paragraphs":[{"sentences":[{"text":"Thank you, and I'll ask our colleagues from the UN also to respond to that question.","start":3892.97,"end":3899.69,"topics":[],"words":[{"text":"Thank","start":3892.97,"end":3893.21},{"text":"you,","start":3893.21,"end":3893.37},{"text":"and","start":3893.37,"end":3893.53},{"text":"I'll","start":3893.53,"end":3893.77},{"text":"ask","start":3893.77,"end":3894.25},{"text":"our","start":3894.73,"end":3894.85},{"text":"colleagues","start":3894.89,"end":3895.57},{"text":"from","start":3895.57,"end":3895.73},{"text":"the","start":3895.73,"end":3895.81},{"text":"UN","start":3895.81,"end":3896.09},{"text":"also","start":3896.09,"end":3896.49},{"text":"to","start":3896.49,"end":3896.81},{"text":"respond","start":3897.45,"end":3898.33},{"text":"to","start":3898.73,"end":3898.89},{"text":"that","start":3898.89,"end":3899.05},{"text":"question.","start":3899.05,"end":3899.69}]},{"text":"Okay, I'm just gonna go across here, please.","start":3899.69,"end":3901.77,"topics":[],"words":[{"text":"Okay,","start":3899.69,"end":3900.01},{"text":"I'm","start":3900.09,"end":3900.29},{"text":"just","start":3900.29,"end":3900.45},{"text":"gonna","start":3900.45,"end":3900.65},{"text":"go","start":3900.65,"end":3900.77},{"text":"across","start":3900.77,"end":3901.17},{"text":"here,","start":3901.17,"end":3901.37},{"text":"please.","start":3901.37,"end":3901.77}]},{"text":"Go ahead.","start":3902.13,"end":3906.09,"topics":[],"words":[{"text":"Go","start":3902.13,"end":3902.25},{"text":"ahead.","start":3905.93,"end":3906.09}]}]}],"speaker":{"affiliation":"UNDP","group":null,"function":null,"affiliation_full":"UNDP"}},{"statement_number":24,"start":3906.09,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:05:07","paragraphs":[{"sentences":[{"text":"Good afternoon. Good afternoon, I'm John Ngo, a medical student from Hong Kong and part of the International Federation of Medical Student Association.","start":3906.09,"end":3915.61,"topics":[],"words":[{"text":"Good","start":3906.09,"end":3906.25},{"text":"afternoon.","start":3906.25,"end":3906.81},{"text":"Good","start":3909.05,"end":3909.17},{"text":"afternoon,","start":3909.17,"end":3909.69},{"text":"I'm","start":3909.69,"end":3909.93},{"text":"John","start":3909.93,"end":3910.17},{"text":"Ngo,","start":3910.17,"end":3910.41},{"text":"a","start":3910.41,"end":3910.45},{"text":"medical","start":3910.45,"end":3910.81},{"text":"student","start":3910.81,"end":3911.13},{"text":"from","start":3911.13,"end":3911.37},{"text":"Hong","start":3911.37,"end":3911.53},{"text":"Kong","start":3911.53,"end":3911.93},{"text":"and","start":3912.25,"end":3912.57},{"text":"part","start":3912.57,"end":3912.85},{"text":"of","start":3912.85,"end":3912.97},{"text":"the","start":3912.97,"end":3913.05},{"text":"International","start":3913.05,"end":3913.61},{"text":"Federation","start":3913.61,"end":3914.09},{"text":"of","start":3914.09,"end":3914.17},{"text":"Medical","start":3914.17,"end":3914.53},{"text":"Student","start":3914.53,"end":3914.85},{"text":"Association.","start":3914.85,"end":3915.61}]},{"text":"So the panel has rightly highlighted the crucial need for decriminalization and harm reduction in drug policy.","start":3915.93,"end":3922.01,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"So","start":3915.93,"end":3916.13},{"text":"the","start":3916.13,"end":3916.25},{"text":"panel","start":3916.25,"end":3916.57},{"text":"has","start":3916.57,"end":3916.97},{"text":"rightly","start":3916.97,"end":3917.29},{"text":"highlighted","start":3917.29,"end":3917.85},{"text":"the","start":3917.85,"end":3918.01},{"text":"crucial","start":3918.01,"end":3918.45},{"text":"need","start":3918.45,"end":3918.73},{"text":"for","start":3918.81,"end":3919.05},{"text":"decriminalization","start":3919.05,"end":3920.25},{"text":"and","start":3920.37,"end":3920.49},{"text":"harm","start":3920.49,"end":3920.73},{"text":"reduction","start":3920.73,"end":3921.13},{"text":"in","start":3921.13,"end":3921.29},{"text":"drug","start":3921.29,"end":3921.45},{"text":"policy.","start":3921.45,"end":3922.01}]},{"text":"And we also know that drug use and drug use disorders are often driven by deeper social and commercial determinants, such as unemployment, homelessness, poverty, which punitive approaches fail to address all these factors.","start":3922.41,"end":3937.77,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"And","start":3922.41,"end":3922.57},{"text":"we","start":3922.57,"end":3922.65},{"text":"also","start":3922.65,"end":3922.89},{"text":"know","start":3922.89,"end":3923.09},{"text":"that","start":3923.09,"end":3923.45},{"text":"drug","start":3923.45,"end":3923.69},{"text":"use","start":3923.85,"end":3924.33},{"text":"and","start":3924.41,"end":3924.65},{"text":"drug","start":3924.65,"end":3924.81},{"text":"use","start":3924.81,"end":3924.97},{"text":"disorders","start":3924.97,"end":3925.61},{"text":"are","start":3925.77,"end":3925.85},{"text":"often","start":3925.85,"end":3926.09},{"text":"driven","start":3926.09,"end":3926.49},{"text":"by","start":3926.49,"end":3926.73},{"text":"deeper","start":3926.73,"end":3927.13},{"text":"social","start":3927.13,"end":3927.53},{"text":"and","start":3927.53,"end":3927.73},{"text":"commercial","start":3927.73,"end":3928.09},{"text":"determinants,","start":3928.09,"end":3928.81},{"text":"such","start":3929.13,"end":3929.45},{"text":"as","start":3929.45,"end":3929.61},{"text":"unemployment,","start":3929.61,"end":3930.41},{"text":"homelessness,","start":3931.05,"end":3931.93},{"text":"poverty,","start":3932.09,"end":3932.73},{"text":"which","start":3933.97,"end":3934.25},{"text":"punitive","start":3934.25,"end":3934.73},{"text":"approaches","start":3934.73,"end":3935.65},{"text":"fail","start":3935.69,"end":3935.93},{"text":"to","start":3935.93,"end":3936.05},{"text":"address","start":3936.05,"end":3936.41},{"text":"all","start":3936.41,"end":3936.65},{"text":"these","start":3936.65,"end":3937.05},{"text":"factors.","start":3937.13,"end":3937.77}]},{"text":"So we call for governments to address these social and commercial determinants of drug use, such as ensuring safe childhoods, inclusive social networks, and ensuring work security, and so that Environments that will make individuals dependent on drug use can be reduced, and it also helps to improve the conditions for individuals to recover from drug use and integrate back into society.","start":3938.33,"end":3962.45,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"So","start":3938.33,"end":3938.81},{"text":"we","start":3938.81,"end":3939.05},{"text":"call","start":3939.05,"end":3939.21},{"text":"for","start":3939.21,"end":3939.41},{"text":"governments","start":3939.41,"end":3939.89},{"text":"to","start":3939.89,"end":3939.97},{"text":"address","start":3939.97,"end":3940.41},{"text":"these","start":3940.41,"end":3940.81},{"text":"social","start":3940.89,"end":3941.37},{"text":"and","start":3941.37,"end":3941.53},{"text":"commercial","start":3941.53,"end":3941.93},{"text":"determinants","start":3941.93,"end":3942.49},{"text":"of","start":3942.49,"end":3942.57},{"text":"drug","start":3942.57,"end":3942.81},{"text":"use,","start":3942.81,"end":3943.13},{"text":"such","start":3943.37,"end":3943.69},{"text":"as","start":3943.69,"end":3943.85},{"text":"ensuring","start":3944.17,"end":3944.65},{"text":"safe","start":3944.65,"end":3944.89},{"text":"childhoods,","start":3944.89,"end":3945.53},{"text":"inclusive","start":3945.77,"end":3946.29},{"text":"social","start":3946.29,"end":3946.57},{"text":"networks,","start":3946.57,"end":3947.13},{"text":"and","start":3947.45,"end":3947.61},{"text":"ensuring","start":3947.61,"end":3948.05},{"text":"work","start":3948.05,"end":3948.25},{"text":"security,","start":3948.25,"end":3948.97},{"text":"and","start":3949.85,"end":3950.17},{"text":"so","start":3950.25,"end":3950.57},{"text":"that","start":3950.57,"end":3950.89},{"text":"Environments","start":3951.49,"end":3952.13},{"text":"that","start":3952.13,"end":3952.45},{"text":"will","start":3952.45,"end":3952.77},{"text":"make","start":3953.17,"end":3953.41},{"text":"individuals","start":3953.41,"end":3953.89},{"text":"dependent","start":3953.89,"end":3954.33},{"text":"on","start":3954.33,"end":3954.45},{"text":"drug","start":3954.45,"end":3954.61},{"text":"use","start":3954.61,"end":3954.85},{"text":"can","start":3954.85,"end":3955.01},{"text":"be","start":3955.01,"end":3955.09},{"text":"reduced,","start":3955.09,"end":3955.65},{"text":"and","start":3955.89,"end":3956.05},{"text":"it","start":3956.05,"end":3956.13},{"text":"also","start":3956.13,"end":3956.45},{"text":"helps","start":3956.45,"end":3956.81},{"text":"to","start":3956.81,"end":3956.89},{"text":"improve","start":3956.89,"end":3957.25},{"text":"the","start":3957.25,"end":3957.33},{"text":"conditions","start":3957.33,"end":3957.85},{"text":"for","start":3957.85,"end":3957.97},{"text":"individuals","start":3957.97,"end":3958.69},{"text":"to","start":3958.93,"end":3959.01},{"text":"recover","start":3959.01,"end":3959.37},{"text":"from","start":3959.37,"end":3959.57},{"text":"drug","start":3959.57,"end":3959.81},{"text":"use","start":3959.81,"end":3960.13},{"text":"and","start":3960.61,"end":3960.85},{"text":"integrate","start":3960.93,"end":3961.41},{"text":"back","start":3961.41,"end":3961.57},{"text":"into","start":3961.57,"end":3961.81},{"text":"society.","start":3961.81,"end":3962.45}]},{"text":"And it is also vital for the government to address the social needs of vulnerable groups, such as women, ethnic minorities, and those without stable housing, and involve various stakeholders in policy making.","start":3963.49,"end":3974.29,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."}],"words":[{"text":"And","start":3963.49,"end":3963.69},{"text":"it","start":3963.69,"end":3963.81},{"text":"is","start":3963.81,"end":3963.93},{"text":"also","start":3963.93,"end":3964.13},{"text":"vital","start":3964.13,"end":3964.53},{"text":"for","start":3964.53,"end":3964.65},{"text":"the","start":3964.65,"end":3964.73},{"text":"government","start":3964.73,"end":3965.17},{"text":"to","start":3965.17,"end":3965.25},{"text":"address","start":3965.25,"end":3965.65},{"text":"the","start":3965.65,"end":3965.73},{"text":"social","start":3965.73,"end":3966.05},{"text":"needs","start":3966.05,"end":3966.33},{"text":"of","start":3966.33,"end":3966.41},{"text":"vulnerable","start":3966.41,"end":3967.09},{"text":"groups,","start":3967.09,"end":3967.49},{"text":"such","start":3967.81,"end":3968.05},{"text":"as","start":3968.05,"end":3968.21},{"text":"women,","start":3968.21,"end":3968.69},{"text":"ethnic","start":3968.69,"end":3968.93},{"text":"minorities,","start":3968.93,"end":3969.65},{"text":"and","start":3969.81,"end":3970.01},{"text":"those","start":3970.01,"end":3970.21},{"text":"without","start":3970.21,"end":3970.53},{"text":"stable","start":3970.53,"end":3970.85},{"text":"housing,","start":3970.85,"end":3971.25},{"text":"and","start":3971.73,"end":3971.93},{"text":"involve","start":3971.93,"end":3972.25},{"text":"various","start":3972.25,"end":3972.57},{"text":"stakeholders","start":3972.57,"end":3973.25},{"text":"in","start":3973.25,"end":3973.49},{"text":"policy","start":3973.49,"end":3973.89},{"text":"making.","start":3973.89,"end":3974.29}]},{"text":"And we also advocate for strengthening supportive healthcare services for those who use drugs.","start":3975.01,"end":3979.49,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"And","start":3975.01,"end":3975.13},{"text":"we","start":3975.13,"end":3975.25},{"text":"also","start":3975.25,"end":3975.49},{"text":"advocate","start":3975.49,"end":3976.05},{"text":"for","start":3976.05,"end":3976.29},{"text":"strengthening","start":3976.29,"end":3976.77},{"text":"supportive","start":3976.77,"end":3977.25},{"text":"healthcare","start":3977.25,"end":3977.65},{"text":"services","start":3977.65,"end":3978.21},{"text":"for","start":3978.29,"end":3978.49},{"text":"those","start":3978.49,"end":3978.73},{"text":"who","start":3978.73,"end":3978.85},{"text":"use","start":3978.85,"end":3979.01},{"text":"drugs.","start":3979.01,"end":3979.49}]},{"text":"and policies based on harm reduction approaches such as syringe service programs, which have been implemented to reduce the spread of blood-borne viral diseases, as mentioned in the panel before.","start":3980.17,"end":3990.41,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"and","start":3980.17,"end":3980.41},{"text":"policies","start":3980.41,"end":3980.97},{"text":"based","start":3980.97,"end":3981.41},{"text":"on","start":3982.01,"end":3982.09},{"text":"harm","start":3982.09,"end":3982.41},{"text":"reduction","start":3982.41,"end":3982.97},{"text":"approaches","start":3983.05,"end":3983.49},{"text":"such","start":3983.49,"end":3983.73},{"text":"as","start":3983.73,"end":3983.81},{"text":"syringe","start":3983.81,"end":3984.21},{"text":"service","start":3984.21,"end":3984.57},{"text":"programs,","start":3984.57,"end":3985.21},{"text":"which","start":3985.37,"end":3985.57},{"text":"have","start":3985.57,"end":3985.69},{"text":"been","start":3985.69,"end":3985.81},{"text":"implemented","start":3985.81,"end":3986.41},{"text":"to","start":3986.57,"end":3986.65},{"text":"reduce","start":3986.65,"end":3986.93},{"text":"the","start":3986.93,"end":3987.01},{"text":"spread","start":3987.01,"end":3987.37},{"text":"of","start":3987.37,"end":3987.61},{"text":"blood-borne","start":3987.61,"end":3988.13},{"text":"viral","start":3988.13,"end":3988.41},{"text":"diseases,","start":3988.41,"end":3988.97},{"text":"as","start":3989.13,"end":3989.29},{"text":"mentioned","start":3989.29,"end":3989.61},{"text":"in","start":3989.61,"end":3989.69},{"text":"the","start":3989.69,"end":3989.77},{"text":"panel","start":3989.77,"end":3990.01},{"text":"before.","start":3990.01,"end":3990.41}]},{"text":"We cannot tackle the burden posed by drug use disorders imposed on our society without evidence-based harm reduction drug policy and without the government focusing on these social and commercial determinants of drug use and their preventive strategies.","start":3991.21,"end":4006.69,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"We","start":3991.21,"end":3991.45},{"text":"cannot","start":3991.45,"end":3991.73},{"text":"tackle","start":3991.73,"end":3992.01},{"text":"the","start":3992.01,"end":3992.17},{"text":"burden","start":3992.57,"end":3992.97},{"text":"posed","start":3993.13,"end":3993.37},{"text":"by","start":3993.37,"end":3993.61},{"text":"drug","start":3993.61,"end":3993.85},{"text":"use","start":3993.85,"end":3994.01},{"text":"disorders","start":3994.01,"end":3994.57},{"text":"imposed","start":3994.57,"end":3994.97},{"text":"on","start":3994.97,"end":3995.09},{"text":"our","start":3995.09,"end":3995.17},{"text":"society","start":3995.17,"end":3995.77},{"text":"without","start":3996.09,"end":3996.41},{"text":"evidence-based","start":3996.41,"end":3997.21},{"text":"harm","start":3997.21,"end":3997.45},{"text":"reduction","start":3997.45,"end":3997.89},{"text":"drug","start":3997.89,"end":3998.09},{"text":"policy","start":3998.33,"end":3998.81},{"text":"and","start":3999.13,"end":3999.25},{"text":"without","start":3999.25,"end":3999.57},{"text":"the","start":3999.57,"end":3999.69},{"text":"government","start":3999.69,"end":4000.21},{"text":"focusing","start":4000.97,"end":4001.61},{"text":"on","start":4002.13,"end":4002.45},{"text":"these","start":4002.45,"end":4002.73},{"text":"social","start":4002.73,"end":4003.29},{"text":"and","start":4003.29,"end":4003.45},{"text":"commercial","start":4003.45,"end":4003.89},{"text":"determinants","start":4003.89,"end":4004.53},{"text":"of","start":4004.69,"end":4004.89},{"text":"drug","start":4004.89,"end":4005.09},{"text":"use","start":4005.09,"end":4005.33},{"text":"and","start":4005.33,"end":4005.49},{"text":"their","start":4005.49,"end":4005.61},{"text":"preventive","start":4005.61,"end":4006.13},{"text":"strategies.","start":4006.13,"end":4006.69}]},{"text":"Thank you.","start":4006.77,"end":4007.09,"topics":[],"words":[{"text":"Thank","start":4006.77,"end":4007.01},{"text":"you.","start":4007.01,"end":4007.09}]}]}],"speaker":{"affiliation":"IFMSA","group":null,"function":"Medical student","affiliation_full":"IFMSA"}},{"statement_number":25,"start":4007.13,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:06:48","paragraphs":[{"sentences":[{"text":"Thank you very much.","start":4007.13,"end":4008.21,"topics":[],"words":[{"text":"Thank","start":4007.13,"end":4007.41},{"text":"you","start":4007.41,"end":4007.49},{"text":"very","start":4007.49,"end":4007.73},{"text":"much.","start":4007.73,"end":4008.21}]},{"text":"I had two hands over here.","start":4008.37,"end":4010.05,"topics":[],"words":[{"text":"I","start":4008.37,"end":4008.53},{"text":"had","start":4008.53,"end":4008.77},{"text":"two","start":4008.85,"end":4009.09},{"text":"hands","start":4009.09,"end":4009.45},{"text":"over","start":4009.45,"end":4009.65},{"text":"here.","start":4009.65,"end":4010.05}]},{"text":"So one, two, three, and then I'm coming to our UN colleagues, please.","start":4010.29,"end":4014.21,"topics":[],"words":[{"text":"So","start":4010.29,"end":4010.93},{"text":"one,","start":4010.93,"end":4011.41},{"text":"two,","start":4011.41,"end":4011.89},{"text":"three,","start":4011.89,"end":4012.13},{"text":"and","start":4012.13,"end":4012.25},{"text":"then","start":4012.25,"end":4012.37},{"text":"I'm","start":4012.37,"end":4012.57},{"text":"coming","start":4012.57,"end":4012.85},{"text":"to","start":4012.85,"end":4012.97},{"text":"our","start":4012.97,"end":4013.09},{"text":"UN","start":4013.09,"end":4013.41},{"text":"colleagues,","start":4013.41,"end":4013.81},{"text":"please.","start":4013.81,"end":4014.21}]},{"text":"Go ahead and introduce yourself.","start":4015.01,"end":4016.25,"topics":[],"words":[{"text":"Go","start":4015.01,"end":4015.13},{"text":"ahead","start":4015.13,"end":4015.29},{"text":"and","start":4015.29,"end":4015.41},{"text":"introduce","start":4015.41,"end":4015.81},{"text":"yourself.","start":4015.81,"end":4016.25}]}]}],"speaker":{"affiliation":"UNDP","group":null,"function":null,"affiliation_full":"UNDP"}},{"statement_number":26,"start":4017.89,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:06:58","paragraphs":[{"sentences":[{"text":"Hi, everyone.","start":4017.89,"end":4018.69,"topics":[],"words":[{"text":"Hi,","start":4017.89,"end":4018.21},{"text":"everyone.","start":4018.21,"end":4018.69}]},{"text":"My name is Annabelle, and I'm from China originally, and I'm currently living in Canada.","start":4018.77,"end":4023.09,"topics":[],"words":[{"text":"My","start":4018.77,"end":4018.89},{"text":"name","start":4018.89,"end":4019.05},{"text":"is","start":4019.05,"end":4019.17},{"text":"Annabelle,","start":4019.17,"end":4019.73},{"text":"and","start":4019.73,"end":4020.21},{"text":"I'm","start":4020.21,"end":4020.45},{"text":"from","start":4020.45,"end":4020.73},{"text":"China","start":4020.73,"end":4021.05},{"text":"originally,","start":4021.05,"end":4021.49},{"text":"and","start":4021.49,"end":4021.61},{"text":"I'm","start":4021.61,"end":4021.81},{"text":"currently","start":4021.81,"end":4022.17},{"text":"living","start":4022.17,"end":4022.37},{"text":"in","start":4022.37,"end":4022.53},{"text":"Canada.","start":4022.53,"end":4023.09}]},{"text":"I'm here to represent the DMUN Foundation as the youth delegation to the United Nations.","start":4023.37,"end":4029.17,"topics":[],"words":[{"text":"I'm","start":4023.37,"end":4023.57},{"text":"here","start":4023.57,"end":4023.81},{"text":"to","start":4023.81,"end":4023.93},{"text":"represent","start":4023.93,"end":4024.65},{"text":"the","start":4024.65,"end":4024.73},{"text":"DMUN","start":4024.73,"end":4025.53},{"text":"Foundation","start":4025.53,"end":4026.29},{"text":"as","start":4026.29,"end":4026.69},{"text":"the","start":4026.69,"end":4026.81},{"text":"youth","start":4027.17,"end":4027.53},{"text":"delegation","start":4027.53,"end":4028.13},{"text":"to","start":4028.13,"end":4028.21},{"text":"the","start":4028.21,"end":4028.29},{"text":"United","start":4028.29,"end":4028.57},{"text":"Nations.","start":4028.57,"end":4029.17}]},{"text":"I want to emphasize that drug policy is not just a technical issue, it is a deeply personal and political one.","start":4030.17,"end":4037.21,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"I","start":4030.17,"end":4030.25},{"text":"want","start":4030.25,"end":4030.53},{"text":"to","start":4030.53,"end":4030.61},{"text":"emphasize","start":4030.61,"end":4031.45},{"text":"that","start":4031.69,"end":4032.01},{"text":"drug","start":4032.09,"end":4032.41},{"text":"policy","start":4032.41,"end":4032.85},{"text":"is","start":4032.85,"end":4032.97},{"text":"not","start":4032.97,"end":4033.25},{"text":"just","start":4033.25,"end":4033.49},{"text":"a","start":4033.49,"end":4033.53},{"text":"technical","start":4033.53,"end":4033.97},{"text":"issue,","start":4034.01,"end":4034.41},{"text":"it","start":4034.81,"end":4034.93},{"text":"is","start":4034.93,"end":4035.09},{"text":"a","start":4035.09,"end":4035.13},{"text":"deeply","start":4035.13,"end":4035.53},{"text":"personal","start":4035.53,"end":4036.17},{"text":"and","start":4036.17,"end":4036.41},{"text":"political","start":4036.41,"end":4036.85},{"text":"one.","start":4036.85,"end":4037.21}]},{"text":"As someone who studied public policy, these policies shape the lives and health of people in my generation and the generation to come.","start":4037.85,"end":4046.49,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"As","start":4037.85,"end":4038.05},{"text":"someone","start":4038.05,"end":4038.81},{"text":"who","start":4038.81,"end":4038.93},{"text":"studied","start":4038.93,"end":4039.21},{"text":"public","start":4039.21,"end":4039.53},{"text":"policy,","start":4039.53,"end":4040.17},{"text":"these","start":4040.73,"end":4040.97},{"text":"policies","start":4040.97,"end":4041.45},{"text":"shape","start":4041.45,"end":4041.77},{"text":"the","start":4042.01,"end":4042.09},{"text":"lives","start":4042.09,"end":4042.57},{"text":"and","start":4042.57,"end":4042.77},{"text":"health","start":4042.77,"end":4043.13},{"text":"of","start":4043.33,"end":4043.45},{"text":"people","start":4043.45,"end":4043.85},{"text":"in","start":4043.85,"end":4044.01},{"text":"my","start":4044.01,"end":4044.25},{"text":"generation","start":4044.25,"end":4045.05},{"text":"and","start":4045.21,"end":4045.37},{"text":"the","start":4045.37,"end":4045.45},{"text":"generation","start":4045.45,"end":4045.93},{"text":"to","start":4045.93,"end":4046.09},{"text":"come.","start":4046.09,"end":4046.49}]},{"text":"I want to emphasize on the data.","start":4047.37,"end":4050.17,"topics":[],"words":[{"text":"I","start":4047.37,"end":4047.45},{"text":"want","start":4047.45,"end":4047.73},{"text":"to","start":4047.73,"end":4047.93},{"text":"emphasize","start":4047.93,"end":4048.65},{"text":"on","start":4048.65,"end":4049.13},{"text":"the","start":4049.13,"end":4049.61},{"text":"data.","start":4049.61,"end":4050.17}]},{"text":"Data must be leaded, but dignity must guide.","start":4050.65,"end":4054.25,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Data","start":4050.65,"end":4050.89},{"text":"must","start":4050.89,"end":4051.17},{"text":"be","start":4051.17,"end":4051.37},{"text":"leaded,","start":4051.37,"end":4051.93},{"text":"but","start":4052.33,"end":4052.49},{"text":"dignity","start":4052.49,"end":4053.45},{"text":"must","start":4053.45,"end":4053.85},{"text":"guide.","start":4053.85,"end":4054.25}]},{"text":"Evidence-based tools are powerful, but they must serve people, not just systems.","start":4055.61,"end":4060.73,"topics":[],"words":[{"text":"Evidence-based","start":4055.61,"end":4056.41},{"text":"tools","start":4056.41,"end":4056.73},{"text":"are","start":4056.73,"end":4056.89},{"text":"powerful,","start":4056.89,"end":4057.53},{"text":"but","start":4057.85,"end":4058.05},{"text":"they","start":4058.05,"end":4058.17},{"text":"must","start":4058.17,"end":4058.45},{"text":"serve","start":4058.45,"end":4058.73},{"text":"people,","start":4058.73,"end":4059.21},{"text":"not","start":4059.61,"end":4059.81},{"text":"just","start":4059.81,"end":4060.05},{"text":"systems.","start":4060.05,"end":4060.73}]},{"text":"We know that data must be protected, responsibly used, and never be exploited at the expense of those who represented it.","start":4061.13,"end":4069.05,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"We","start":4061.13,"end":4061.29},{"text":"know","start":4061.29,"end":4061.45},{"text":"that","start":4061.45,"end":4061.93},{"text":"data","start":4061.93,"end":4062.21},{"text":"must","start":4062.21,"end":4062.41},{"text":"be","start":4062.41,"end":4062.53},{"text":"protected,","start":4062.53,"end":4063.21},{"text":"responsibly","start":4063.37,"end":4064.73},{"text":"used,","start":4064.73,"end":4065.13},{"text":"and","start":4065.13,"end":4065.33},{"text":"never","start":4065.33,"end":4065.53},{"text":"be","start":4065.53,"end":4065.69},{"text":"exploited","start":4065.69,"end":4066.49},{"text":"at","start":4066.49,"end":4066.57},{"text":"the","start":4066.57,"end":4066.73},{"text":"expense","start":4066.73,"end":4067.29},{"text":"of","start":4067.29,"end":4067.45},{"text":"those","start":4067.45,"end":4067.77},{"text":"who","start":4067.77,"end":4068.17},{"text":"represented","start":4068.33,"end":4068.89},{"text":"it.","start":4068.89,"end":4069.05}]},{"text":"It must be shaped by community needs and paired with a political will to turn evidence into actions.","start":4069.69,"end":4075.53,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"It","start":4069.69,"end":4069.77},{"text":"must","start":4069.77,"end":4070.09},{"text":"be","start":4070.09,"end":4070.33},{"text":"shaped","start":4070.33,"end":4070.65},{"text":"by","start":4070.65,"end":4070.81},{"text":"community","start":4070.81,"end":4071.25},{"text":"needs","start":4071.25,"end":4071.69},{"text":"and","start":4071.93,"end":4072.17},{"text":"paired","start":4072.17,"end":4072.41},{"text":"with","start":4072.41,"end":4072.61},{"text":"a","start":4072.61,"end":4072.65},{"text":"political","start":4072.65,"end":4073.13},{"text":"will","start":4073.13,"end":4073.45},{"text":"to","start":4073.45,"end":4073.57},{"text":"turn","start":4073.61,"end":4074.01},{"text":"evidence","start":4074.01,"end":4074.49},{"text":"into","start":4074.49,"end":4074.77},{"text":"actions.","start":4074.77,"end":4075.53}]},{"text":"I also want to emphasize on inclusion must be real and not symbolic.","start":4076.09,"end":4080.09,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"I","start":4076.09,"end":4076.25},{"text":"also","start":4076.25,"end":4076.49},{"text":"want","start":4076.49,"end":4076.77},{"text":"to","start":4076.77,"end":4076.89},{"text":"emphasize","start":4076.89,"end":4077.45},{"text":"on","start":4077.45,"end":4077.77},{"text":"inclusion","start":4077.77,"end":4078.33},{"text":"must","start":4078.33,"end":4078.57},{"text":"be","start":4078.57,"end":4078.73},{"text":"real","start":4078.73,"end":4079.05},{"text":"and","start":4079.13,"end":4079.33},{"text":"not","start":4079.33,"end":4079.49},{"text":"symbolic.","start":4079.49,"end":4080.09}]},{"text":"Youth, indigenous people, women, and marginalized communities are often being included in name only.","start":4080.81,"end":4087.05,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."}],"words":[{"text":"Youth,","start":4080.81,"end":4081.13},{"text":"indigenous","start":4081.21,"end":4081.85},{"text":"people,","start":4081.85,"end":4082.33},{"text":"women,","start":4082.57,"end":4083.13},{"text":"and","start":4083.37,"end":4083.53},{"text":"marginalized","start":4083.53,"end":4084.09},{"text":"communities","start":4084.09,"end":4084.65},{"text":"are","start":4084.65,"end":4084.81},{"text":"often","start":4084.81,"end":4085.05},{"text":"being","start":4085.05,"end":4085.25},{"text":"included","start":4085.25,"end":4085.85},{"text":"in","start":4086.01,"end":4086.29},{"text":"name","start":4086.29,"end":4086.57},{"text":"only.","start":4086.57,"end":4087.05}]},{"text":"True inclusion means shifting power.","start":4087.45,"end":4089.53,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"True","start":4087.45,"end":4087.61},{"text":"inclusion","start":4087.61,"end":4088.17},{"text":"means","start":4088.17,"end":4088.49},{"text":"shifting","start":4088.49,"end":4088.97},{"text":"power.","start":4088.97,"end":4089.53}]},{"text":"As mentioned, decolonized approach, funding community-led harm reduction efforts, and dismantling the barriers that keep us out of the room where policy are made.","start":4090.05,"end":4100.89,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"As","start":4090.05,"end":4090.17},{"text":"mentioned,","start":4090.17,"end":4090.81},{"text":"decolonized","start":4091.05,"end":4091.69},{"text":"approach,","start":4091.69,"end":4092.33},{"text":"funding","start":4092.65,"end":4093.13},{"text":"community-led","start":4093.13,"end":4094.09},{"text":"harm","start":4094.09,"end":4094.41},{"text":"reduction","start":4094.41,"end":4094.97},{"text":"efforts,","start":4094.97,"end":4095.61},{"text":"and","start":4095.93,"end":4096.37},{"text":"dismantling","start":4096.37,"end":4096.97},{"text":"the","start":4096.97,"end":4097.13},{"text":"barriers","start":4097.13,"end":4097.77},{"text":"that","start":4097.93,"end":4098.13},{"text":"keep","start":4098.13,"end":4098.41},{"text":"us","start":4098.49,"end":4098.73},{"text":"out","start":4098.81,"end":4099.21},{"text":"of","start":4099.21,"end":4099.37},{"text":"the","start":4099.37,"end":4099.45},{"text":"room","start":4099.45,"end":4099.81},{"text":"where","start":4099.81,"end":4100.01},{"text":"policy","start":4100.01,"end":4100.45},{"text":"are","start":4100.45,"end":4100.57},{"text":"made.","start":4100.57,"end":4100.89}]},{"text":"Thank you again.","start":4101.37,"end":4102.17,"topics":[],"words":[{"text":"Thank","start":4101.37,"end":4101.61},{"text":"you","start":4101.61,"end":4101.73},{"text":"again.","start":4101.73,"end":4102.17}]},{"text":"Thank you for the panelists.","start":4102.17,"end":4103.37,"topics":[],"words":[{"text":"Thank","start":4102.17,"end":4102.37},{"text":"you","start":4102.37,"end":4102.45},{"text":"for","start":4102.45,"end":4102.57},{"text":"the","start":4102.57,"end":4102.65},{"text":"panelists.","start":4102.65,"end":4103.37}]},{"text":"And let us to move on the stigma to science, from punishment to prevention, from exclusion to healing.","start":4103.61,"end":4110.73,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"And","start":4103.61,"end":4103.77},{"text":"let","start":4103.77,"end":4104.09},{"text":"us","start":4104.09,"end":4104.41},{"text":"to","start":4104.41,"end":4104.57},{"text":"move","start":4104.57,"end":4104.81},{"text":"on","start":4104.81,"end":4104.89},{"text":"the","start":4104.89,"end":4104.97},{"text":"stigma","start":4104.97,"end":4105.53},{"text":"to","start":4105.61,"end":4105.73},{"text":"science,","start":4105.77,"end":4106.41},{"text":"from","start":4106.65,"end":4106.89},{"text":"punishment","start":4106.89,"end":4107.69},{"text":"to","start":4107.85,"end":4108.01},{"text":"prevention,","start":4108.01,"end":4108.73},{"text":"from","start":4108.97,"end":4109.17},{"text":"exclusion","start":4109.17,"end":4109.93},{"text":"to","start":4110.01,"end":4110.17},{"text":"healing.","start":4110.17,"end":4110.73}]},{"text":"Thank you.","start":4111.05,"end":4111.29,"topics":[],"words":[{"text":"Thank","start":4111.05,"end":4111.21},{"text":"you.","start":4111.21,"end":4111.29}]}]}],"speaker":{"affiliation":null,"group":null,"function":"Youth delegate","affiliation_full":null}},{"statement_number":27,"start":4111.29,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:08:32","paragraphs":[{"sentences":[{"text":"Thank you very much.","start":4111.29,"end":4112.17,"topics":[],"words":[{"text":"Thank","start":4111.29,"end":4111.45},{"text":"you","start":4111.45,"end":4111.53},{"text":"very","start":4111.53,"end":4111.69},{"text":"much.","start":4111.85,"end":4112.17}]},{"text":"The next, let's save time on clapping, folks, please.","start":4113.05,"end":4116.01,"topics":[],"words":[{"text":"The","start":4113.05,"end":4113.13},{"text":"next,","start":4113.13,"end":4113.57},{"text":"let's","start":4113.61,"end":4113.97},{"text":"save","start":4113.97,"end":4114.17},{"text":"time","start":4114.17,"end":4114.41},{"text":"on","start":4114.41,"end":4114.57},{"text":"clapping,","start":4114.57,"end":4114.97},{"text":"folks,","start":4114.97,"end":4115.37},{"text":"please.","start":4115.53,"end":4116.01}]}]}],"speaker":{"affiliation":"UNDP","group":null,"function":null,"affiliation_full":"UNDP"}},{"statement_number":28,"start":4120.97,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:08:41","paragraphs":[{"sentences":[{"text":"Thank you, Chair.","start":4120.97,"end":4121.85,"topics":[],"words":[{"text":"Thank","start":4120.97,"end":4121.21},{"text":"you,","start":4121.21,"end":4121.37},{"text":"Chair.","start":4121.37,"end":4121.85}]},{"text":"Excellencies, distinguished panelists and colleagues, I want to thank you for prioritizing the role of science and data in shaping global drug policy.","start":4122.93,"end":4132.53,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Excellencies,","start":4122.93,"end":4123.97},{"text":"distinguished","start":4123.97,"end":4124.61},{"text":"panelists","start":4124.61,"end":4125.41},{"text":"and","start":4125.41,"end":4125.57},{"text":"colleagues,","start":4125.57,"end":4126.29},{"text":"I","start":4126.45,"end":4126.53},{"text":"want","start":4126.53,"end":4126.73},{"text":"to","start":4126.73,"end":4126.81},{"text":"thank","start":4126.81,"end":4127.17},{"text":"you","start":4127.17,"end":4127.41},{"text":"for","start":4127.41,"end":4127.73},{"text":"prioritizing","start":4127.73,"end":4128.65},{"text":"the","start":4128.65,"end":4128.77},{"text":"role","start":4128.77,"end":4129.05},{"text":"of","start":4129.05,"end":4129.17},{"text":"science","start":4129.17,"end":4129.81},{"text":"and","start":4129.81,"end":4130.09},{"text":"data","start":4130.09,"end":4130.53},{"text":"in","start":4130.61,"end":4130.85},{"text":"shaping","start":4130.85,"end":4131.33},{"text":"global","start":4131.33,"end":4131.65},{"text":"drug","start":4131.65,"end":4131.89},{"text":"policy.","start":4131.89,"end":4132.53}]},{"text":"My name is Jackson Rund, and I'm honored to join as a youth delegate representing Students for Sensible Drug Policy, which is a global student-led movement advocating for drug policies rooted in health, human rights, and scientific inquiry.","start":4133.17,"end":4147.41,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"My","start":4133.17,"end":4133.29},{"text":"name","start":4133.29,"end":4133.49},{"text":"is","start":4133.49,"end":4133.65},{"text":"Jackson","start":4133.65,"end":4134.21},{"text":"Rund,","start":4134.21,"end":4134.41},{"text":"and","start":4134.41,"end":4134.61},{"text":"I'm","start":4134.61,"end":4134.93},{"text":"honored","start":4134.93,"end":4135.29},{"text":"to","start":4135.29,"end":4135.37},{"text":"join","start":4135.37,"end":4135.81},{"text":"as","start":4135.81,"end":4136.05},{"text":"a","start":4136.05,"end":4136.09},{"text":"youth","start":4136.09,"end":4136.45},{"text":"delegate","start":4136.45,"end":4136.93},{"text":"representing","start":4136.93,"end":4137.57},{"text":"Students","start":4137.57,"end":4138.05},{"text":"for","start":4138.05,"end":4138.17},{"text":"Sensible","start":4138.17,"end":4138.61},{"text":"Drug","start":4138.61,"end":4138.85},{"text":"Policy,","start":4138.85,"end":4139.49},{"text":"which","start":4139.93,"end":4140.17},{"text":"is","start":4140.17,"end":4140.29},{"text":"a","start":4140.29,"end":4140.37},{"text":"global","start":4140.37,"end":4140.93},{"text":"student-led","start":4140.93,"end":4141.57},{"text":"movement","start":4141.57,"end":4142.13},{"text":"advocating","start":4142.13,"end":4142.69},{"text":"for","start":4142.69,"end":4142.85},{"text":"drug","start":4142.85,"end":4143.17},{"text":"policies","start":4143.17,"end":4143.97},{"text":"rooted","start":4143.97,"end":4144.37},{"text":"in","start":4144.37,"end":4144.69},{"text":"health,","start":4144.69,"end":4145.17},{"text":"human","start":4145.25,"end":4145.57},{"text":"rights,","start":4145.57,"end":4146.05},{"text":"and","start":4146.05,"end":4146.25},{"text":"scientific","start":4146.25,"end":4146.85},{"text":"inquiry.","start":4146.85,"end":4147.41}]},{"text":"We welcome the growing agreement that drug policy must be grounded in evidence, but there's a serious gap between principle and practice.","start":4148.21,"end":4155.89,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"We","start":4148.21,"end":4148.33},{"text":"welcome","start":4148.33,"end":4148.69},{"text":"the","start":4148.69,"end":4148.77},{"text":"growing","start":4148.77,"end":4149.05},{"text":"agreement","start":4149.05,"end":4149.53},{"text":"that","start":4149.53,"end":4149.65},{"text":"drug","start":4149.65,"end":4149.97},{"text":"policy","start":4149.97,"end":4150.37},{"text":"must","start":4150.37,"end":4150.61},{"text":"be","start":4150.61,"end":4150.77},{"text":"grounded","start":4150.77,"end":4151.17},{"text":"in","start":4151.17,"end":4151.33},{"text":"evidence,","start":4151.33,"end":4152.05},{"text":"but","start":4152.13,"end":4152.45},{"text":"there's","start":4152.61,"end":4153.01},{"text":"a","start":4153.01,"end":4153.09},{"text":"serious","start":4153.09,"end":4153.57},{"text":"gap","start":4153.57,"end":4153.85},{"text":"between","start":4153.85,"end":4154.29},{"text":"principle","start":4154.29,"end":4154.93},{"text":"and","start":4154.93,"end":4155.17},{"text":"practice.","start":4155.17,"end":4155.89}]},{"text":"The global drug control system still obstructs scientific progress.","start":4156.37,"end":4160.69,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"The","start":4156.37,"end":4156.53},{"text":"global","start":4156.53,"end":4156.85},{"text":"drug","start":4156.85,"end":4157.17},{"text":"control","start":4157.17,"end":4157.65},{"text":"system","start":4157.65,"end":4158.21},{"text":"still","start":4158.21,"end":4158.69},{"text":"obstructs","start":4158.69,"end":4159.33},{"text":"scientific","start":4159.33,"end":4159.97},{"text":"progress.","start":4159.97,"end":4160.69}]},{"text":"Until we address that contradiction, the sustainable development goals remain out of reach.","start":4161.13,"end":4165.89,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"Until","start":4161.13,"end":4161.41},{"text":"we","start":4161.41,"end":4161.57},{"text":"address","start":4161.57,"end":4161.97},{"text":"that","start":4161.97,"end":4162.17},{"text":"contradiction,","start":4162.17,"end":4163.09},{"text":"the","start":4163.17,"end":4163.33},{"text":"sustainable","start":4163.33,"end":4163.89},{"text":"development","start":4163.89,"end":4164.45},{"text":"goals","start":4164.45,"end":4164.77},{"text":"remain","start":4164.77,"end":4165.09},{"text":"out","start":4165.09,"end":4165.29},{"text":"of","start":4165.29,"end":4165.41},{"text":"reach.","start":4165.41,"end":4165.89}]},{"text":"This isn't just procedural.","start":4166.29,"end":4167.77,"topics":[],"words":[{"text":"This","start":4166.29,"end":4166.45},{"text":"isn't","start":4166.45,"end":4166.81},{"text":"just","start":4166.81,"end":4166.97},{"text":"procedural.","start":4166.97,"end":4167.77}]},{"text":"It's a structural failure that harms the most vulnerable.","start":4168.09,"end":4171.09,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"It's","start":4168.09,"end":4168.33},{"text":"a","start":4168.33,"end":4168.37},{"text":"structural","start":4168.37,"end":4168.93},{"text":"failure","start":4168.93,"end":4169.45},{"text":"that","start":4169.45,"end":4169.65},{"text":"harms","start":4169.65,"end":4170.05},{"text":"the","start":4170.05,"end":4170.13},{"text":"most","start":4170.13,"end":4170.45},{"text":"vulnerable.","start":4170.45,"end":4171.09}]},{"text":"Children with severe conditions like Dravet syndrome, for example, could benefit from medical cannabis.","start":4171.49,"end":4177.01,"topics":[],"words":[{"text":"Children","start":4171.49,"end":4171.97},{"text":"with","start":4171.97,"end":4172.13},{"text":"severe","start":4172.13,"end":4172.53},{"text":"conditions","start":4172.53,"end":4173.25},{"text":"like","start":4173.25,"end":4173.41},{"text":"Dravet","start":4173.41,"end":4173.81},{"text":"syndrome,","start":4173.81,"end":4174.33},{"text":"for","start":4174.33,"end":4174.45},{"text":"example,","start":4174.45,"end":4175.09},{"text":"could","start":4175.17,"end":4175.41},{"text":"benefit","start":4175.41,"end":4175.81},{"text":"from","start":4175.81,"end":4176.01},{"text":"medical","start":4176.01,"end":4176.37},{"text":"cannabis.","start":4176.37,"end":4177.01}]},{"text":"The WHO has recognized the value of CBD for treatment-resistant epilepsy, yet in so many jurisdictions, cannabis remains criminalized, creating systems of access shaped by wealth, race, or geography, which undermine SDGs 3, 10, and 16.","start":4177.57,"end":4195.73,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"The","start":4177.57,"end":4177.81},{"text":"WHO","start":4177.85,"end":4178.45},{"text":"has","start":4178.45,"end":4178.61},{"text":"recognized","start":4178.61,"end":4179.29},{"text":"the","start":4179.29,"end":4179.37},{"text":"value","start":4179.37,"end":4179.93},{"text":"of","start":4179.93,"end":4180.05},{"text":"CBD","start":4180.05,"end":4180.69},{"text":"for","start":4180.69,"end":4180.93},{"text":"treatment-resistant","start":4180.93,"end":4182.01},{"text":"epilepsy,","start":4182.01,"end":4182.77},{"text":"yet","start":4183.25,"end":4183.57},{"text":"in","start":4183.57,"end":4183.81},{"text":"so","start":4183.81,"end":4183.97},{"text":"many","start":4183.97,"end":4184.21},{"text":"jurisdictions,","start":4184.21,"end":4185.25},{"text":"cannabis","start":4185.49,"end":4185.97},{"text":"remains","start":4185.97,"end":4186.45},{"text":"criminalized,","start":4186.45,"end":4187.21},{"text":"creating","start":4187.49,"end":4187.89},{"text":"systems","start":4187.89,"end":4188.61},{"text":"of","start":4188.65,"end":4188.77},{"text":"access","start":4188.77,"end":4189.41},{"text":"shaped","start":4189.41,"end":4189.77},{"text":"by","start":4189.77,"end":4189.97},{"text":"wealth,","start":4189.97,"end":4190.53},{"text":"race,","start":4190.61,"end":4191.09},{"text":"or","start":4191.09,"end":4191.33},{"text":"geography,","start":4191.33,"end":4192.13},{"text":"which","start":4192.41,"end":4192.69},{"text":"undermine","start":4192.69,"end":4193.17},{"text":"SDGs","start":4193.17,"end":4193.89},{"text":"3,","start":4193.89,"end":4194.29},{"text":"10,","start":4194.29,"end":4194.57},{"text":"and","start":4194.57,"end":4195.01},{"text":"16.","start":4195.01,"end":4195.73}]},{"text":"This failure extends to research.","start":4196.29,"end":4198.29,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"This","start":4196.29,"end":4196.45},{"text":"failure","start":4196.45,"end":4196.89},{"text":"extends","start":4196.89,"end":4197.49},{"text":"to","start":4197.49,"end":4197.61},{"text":"research.","start":4197.61,"end":4198.29}]},{"text":"What we call research harms are the delays, costs, and barriers that prevent scientists from studying scheduled substances.","start":4198.41,"end":4205.17,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"What","start":4198.41,"end":4198.69},{"text":"we","start":4198.69,"end":4198.77},{"text":"call","start":4198.77,"end":4199.09},{"text":"research","start":4199.09,"end":4199.57},{"text":"harms","start":4199.57,"end":4200.09},{"text":"are","start":4200.09,"end":4200.29},{"text":"the","start":4200.29,"end":4200.37},{"text":"delays,","start":4200.37,"end":4200.85},{"text":"costs,","start":4200.85,"end":4201.33},{"text":"and","start":4201.37,"end":4201.57},{"text":"barriers","start":4201.57,"end":4202.05},{"text":"that","start":4202.05,"end":4202.17},{"text":"prevent","start":4202.17,"end":4202.61},{"text":"scientists","start":4202.61,"end":4203.09},{"text":"from","start":4203.09,"end":4203.33},{"text":"studying","start":4203.33,"end":4203.81},{"text":"scheduled","start":4203.81,"end":4204.37},{"text":"substances.","start":4204.37,"end":4205.17}]},{"text":"These obstacles suppress innovation, limit education, and restrict access to scientific work, which also undermines SDGs 9, 4, and 8.","start":4205.77,"end":4215.21,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"These","start":4205.77,"end":4206.01},{"text":"obstacles","start":4206.01,"end":4206.61},{"text":"suppress","start":4206.61,"end":4207.09},{"text":"innovation,","start":4207.09,"end":4207.85},{"text":"limit","start":4207.85,"end":4208.21},{"text":"education,","start":4208.21,"end":4209.05},{"text":"and","start":4209.05,"end":4209.29},{"text":"restrict","start":4209.29,"end":4209.77},{"text":"access","start":4209.77,"end":4210.25},{"text":"to","start":4210.25,"end":4210.37},{"text":"scientific","start":4210.37,"end":4211.05},{"text":"work,","start":4211.05,"end":4211.45},{"text":"which","start":4211.45,"end":4211.77},{"text":"also","start":4211.93,"end":4212.25},{"text":"undermines","start":4212.25,"end":4212.97},{"text":"SDGs","start":4212.97,"end":4213.61},{"text":"9,","start":4213.61,"end":4214.09},{"text":"4,","start":4214.09,"end":4214.57},{"text":"and","start":4214.57,"end":4214.89},{"text":"8.","start":4214.89,"end":4215.21}]},{"text":"At the root is a regulatory model that equates all non-medical use with abuse, ignoring evidence, context, and lived experiences.","start":4215.93,"end":4224.65,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"At","start":4215.93,"end":4216.05},{"text":"the","start":4216.05,"end":4216.17},{"text":"root","start":4216.17,"end":4216.57},{"text":"is","start":4216.57,"end":4216.73},{"text":"a","start":4216.73,"end":4216.81},{"text":"regulatory","start":4216.81,"end":4217.45},{"text":"model","start":4217.45,"end":4217.85},{"text":"that","start":4217.85,"end":4218.25},{"text":"equates","start":4218.25,"end":4218.81},{"text":"all","start":4218.81,"end":4219.13},{"text":"non-medical","start":4219.13,"end":4219.85},{"text":"use","start":4219.85,"end":4220.25},{"text":"with","start":4220.25,"end":4220.41},{"text":"abuse,","start":4220.41,"end":4221.05},{"text":"ignoring","start":4221.29,"end":4221.77},{"text":"evidence,","start":4221.77,"end":4222.33},{"text":"context,","start":4222.33,"end":4223.13},{"text":"and","start":4223.13,"end":4223.33},{"text":"lived","start":4223.33,"end":4223.61},{"text":"experiences.","start":4223.61,"end":4224.65}]},{"text":"To build drug policy grounded in science, not stigma, SSDP urges member states to adopt reforms aligned with our official UN submissions.","start":4225.29,"end":4234.57,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"To","start":4225.29,"end":4225.41},{"text":"build","start":4225.41,"end":4225.65},{"text":"drug","start":4225.65,"end":4225.93},{"text":"policy","start":4225.93,"end":4226.41},{"text":"grounded","start":4226.41,"end":4226.81},{"text":"in","start":4226.81,"end":4226.97},{"text":"science,","start":4226.97,"end":4227.61},{"text":"not","start":4227.61,"end":4227.85},{"text":"stigma,","start":4227.85,"end":4228.41},{"text":"SSDP","start":4228.89,"end":4229.69},{"text":"urges","start":4229.69,"end":4230.09},{"text":"member","start":4230.09,"end":4230.41},{"text":"states","start":4230.41,"end":4230.81},{"text":"to","start":4230.81,"end":4231.05},{"text":"adopt","start":4231.05,"end":4231.37},{"text":"reforms","start":4231.37,"end":4232.09},{"text":"aligned","start":4232.17,"end":4232.57},{"text":"with","start":4232.57,"end":4232.81},{"text":"our","start":4232.81,"end":4232.97},{"text":"official","start":4232.97,"end":4233.45},{"text":"UN","start":4233.45,"end":4233.69},{"text":"submissions.","start":4233.69,"end":4234.57}]},{"text":"First, revise risk assessments to weigh the harms of scheduling against the harms of restricting research.","start":4235.01,"end":4241.49,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"First,","start":4235.01,"end":4235.57},{"text":"revise","start":4235.73,"end":4236.21},{"text":"risk","start":4236.21,"end":4236.57},{"text":"assessments","start":4236.57,"end":4237.25},{"text":"to","start":4237.25,"end":4237.41},{"text":"weigh","start":4237.41,"end":4237.65},{"text":"the","start":4237.65,"end":4237.73},{"text":"harms","start":4237.73,"end":4238.21},{"text":"of","start":4238.25,"end":4238.37},{"text":"scheduling","start":4238.37,"end":4238.93},{"text":"against","start":4238.93,"end":4239.49},{"text":"the","start":4239.57,"end":4239.73},{"text":"harms","start":4239.73,"end":4240.13},{"text":"of","start":4240.13,"end":4240.21},{"text":"restricting","start":4240.21,"end":4240.85},{"text":"research.","start":4240.85,"end":4241.49}]},{"text":"What public health knowledge are we losing by locking substances out of the lab?","start":4241.81,"end":4246.45,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"What","start":4241.81,"end":4242.13},{"text":"public","start":4242.13,"end":4242.53},{"text":"health","start":4242.53,"end":4242.85},{"text":"knowledge","start":4242.85,"end":4243.33},{"text":"are","start":4243.33,"end":4243.45},{"text":"we","start":4243.45,"end":4243.57},{"text":"losing","start":4243.57,"end":4244.05},{"text":"by","start":4244.05,"end":4244.21},{"text":"locking","start":4244.21,"end":4244.77},{"text":"substances","start":4244.77,"end":4245.65},{"text":"out","start":4245.65,"end":4245.77},{"text":"of","start":4245.77,"end":4245.97},{"text":"the","start":4245.97,"end":4246.05},{"text":"lab?","start":4246.05,"end":4246.45}]},{"text":"Second, align Schedule I research access with Schedule II standards, as recommended by the UK Advisory Council of the Misuse of Drugs.","start":4247.17,"end":4255.65,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Second,","start":4247.17,"end":4247.49},{"text":"align","start":4247.49,"end":4248.13},{"text":"Schedule","start":4248.13,"end":4248.61},{"text":"I","start":4248.61,"end":4248.69},{"text":"research","start":4248.77,"end":4249.17},{"text":"access","start":4249.17,"end":4249.69},{"text":"with","start":4249.69,"end":4249.85},{"text":"Schedule","start":4249.85,"end":4250.29},{"text":"II","start":4250.29,"end":4250.53},{"text":"standards,","start":4250.53,"end":4251.25},{"text":"as","start":4251.25,"end":4251.57},{"text":"recommended","start":4251.57,"end":4252.13},{"text":"by","start":4252.13,"end":4252.37},{"text":"the","start":4252.37,"end":4252.45},{"text":"UK","start":4252.45,"end":4252.93},{"text":"Advisory","start":4252.93,"end":4253.57},{"text":"Council","start":4253.57,"end":4254.21},{"text":"of","start":4254.21,"end":4254.37},{"text":"the","start":4254.37,"end":4254.49},{"text":"Misuse","start":4254.49,"end":4255.01},{"text":"of","start":4255.01,"end":4255.09},{"text":"Drugs.","start":4255.09,"end":4255.65}]},{"text":"Third, allow class-based research approvals so that scientists can study related compounds like hallucinogens or cannabinoids without filing redundant applications supporting SDG 17 on inclusive partnerships.","start":4256.37,"end":4272.13,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Third,","start":4256.37,"end":4256.77},{"text":"allow","start":4257.05,"end":4257.41},{"text":"class-based","start":4257.41,"end":4258.21},{"text":"research","start":4258.21,"end":4258.61},{"text":"approvals","start":4258.61,"end":4259.41},{"text":"so","start":4259.41,"end":4259.65},{"text":"that","start":4259.65,"end":4259.81},{"text":"scientists","start":4259.81,"end":4260.45},{"text":"can","start":4260.45,"end":4260.61},{"text":"study","start":4260.61,"end":4260.97},{"text":"related","start":4260.97,"end":4261.37},{"text":"compounds","start":4261.37,"end":4262.21},{"text":"like","start":4262.21,"end":4262.45},{"text":"hallucinogens","start":4262.45,"end":4263.25},{"text":"or","start":4263.25,"end":4263.41},{"text":"cannabinoids","start":4263.41,"end":4264.21},{"text":"without","start":4264.45,"end":4264.93},{"text":"filing","start":4265.41,"end":4265.81},{"text":"redundant","start":4265.81,"end":4266.45},{"text":"applications","start":4266.45,"end":4267.33},{"text":"supporting","start":4267.33,"end":4268.05},{"text":"SDG","start":4268.05,"end":4268.77},{"text":"17","start":4270.13,"end":4270.69},{"text":"on","start":4270.69,"end":4270.77},{"text":"inclusive","start":4270.77,"end":4271.33},{"text":"partnerships.","start":4271.33,"end":4272.13}]},{"text":"And finally, integrate medical cannabis into national public health systems and essential medicine lists.","start":4272.61,"end":4278.61,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"And","start":4272.61,"end":4272.77},{"text":"finally,","start":4272.77,"end":4273.17},{"text":"integrate","start":4273.17,"end":4273.73},{"text":"medical","start":4273.73,"end":4274.05},{"text":"cannabis","start":4274.05,"end":4274.53},{"text":"into","start":4274.53,"end":4274.77},{"text":"national","start":4274.77,"end":4275.25},{"text":"public","start":4275.25,"end":4275.65},{"text":"health","start":4275.65,"end":4275.89},{"text":"systems","start":4275.89,"end":4276.85},{"text":"and","start":4276.85,"end":4277.25},{"text":"essential","start":4277.25,"end":4277.73},{"text":"medicine","start":4277.73,"end":4278.21},{"text":"lists.","start":4278.21,"end":4278.61}]},{"text":"This includes equitable insurance coverage, removing discriminatory taxes, and ensuring access is a right, not a privilege, advancing SDGs 1 and 5.","start":4278.97,"end":4288.49,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"This","start":4278.97,"end":4279.21},{"text":"includes","start":4279.21,"end":4279.61},{"text":"equitable","start":4279.61,"end":4280.09},{"text":"insurance","start":4280.09,"end":4280.61},{"text":"coverage,","start":4280.61,"end":4281.21},{"text":"removing","start":4281.53,"end":4281.93},{"text":"discriminatory","start":4281.93,"end":4282.81},{"text":"taxes,","start":4282.81,"end":4283.53},{"text":"and","start":4283.53,"end":4283.69},{"text":"ensuring","start":4283.69,"end":4284.09},{"text":"access","start":4284.09,"end":4284.57},{"text":"is","start":4284.57,"end":4284.69},{"text":"a","start":4284.69,"end":4284.73},{"text":"right,","start":4284.73,"end":4285.13},{"text":"not","start":4285.13,"end":4285.45},{"text":"a","start":4285.45,"end":4285.49},{"text":"privilege,","start":4285.49,"end":4286.09},{"text":"advancing","start":4286.41,"end":4286.97},{"text":"SDGs","start":4286.97,"end":4287.49},{"text":"1","start":4287.49,"end":4287.85},{"text":"and","start":4287.85,"end":4288.01},{"text":"5.","start":4288.01,"end":4288.49}]},{"text":"If we want drug policy rooted in evidence, we must allow the evidence to exist.","start":4289.05,"end":4293.37,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"If","start":4289.05,"end":4289.21},{"text":"we","start":4289.21,"end":4289.29},{"text":"want","start":4289.29,"end":4289.49},{"text":"drug","start":4289.49,"end":4289.69},{"text":"policy","start":4289.69,"end":4290.09},{"text":"rooted","start":4290.09,"end":4290.49},{"text":"in","start":4290.49,"end":4290.65},{"text":"evidence,","start":4290.65,"end":4291.21},{"text":"we","start":4291.29,"end":4291.41},{"text":"must","start":4291.41,"end":4291.77},{"text":"allow","start":4291.77,"end":4292.01},{"text":"the","start":4292.01,"end":4292.17},{"text":"evidence","start":4292.17,"end":4292.57},{"text":"to","start":4292.57,"end":4292.73},{"text":"exist.","start":4292.73,"end":4293.37}]},{"text":"And if we truly mean to leave no one behind, we must listen to scientists, to youth, and to the communities that the policy has too long ignored.","start":4293.73,"end":4302.37,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"And","start":4293.73,"end":4293.89},{"text":"if","start":4293.89,"end":4293.97},{"text":"we","start":4293.97,"end":4294.05},{"text":"truly","start":4294.05,"end":4294.45},{"text":"mean","start":4294.45,"end":4294.69},{"text":"to","start":4294.69,"end":4294.85},{"text":"leave","start":4294.85,"end":4295.05},{"text":"no","start":4295.05,"end":4295.21},{"text":"one","start":4295.21,"end":4295.37},{"text":"behind,","start":4295.37,"end":4295.97},{"text":"we","start":4296.13,"end":4296.29},{"text":"must","start":4296.29,"end":4296.57},{"text":"listen","start":4296.57,"end":4297.17},{"text":"to","start":4297.41,"end":4297.53},{"text":"scientists,","start":4297.53,"end":4298.45},{"text":"to","start":4298.53,"end":4298.69},{"text":"youth,","start":4298.69,"end":4299.05},{"text":"and","start":4299.33,"end":4299.57},{"text":"to","start":4299.57,"end":4299.65},{"text":"the","start":4299.65,"end":4299.73},{"text":"communities","start":4299.73,"end":4300.37},{"text":"that","start":4300.37,"end":4300.57},{"text":"the","start":4300.57,"end":4300.69},{"text":"policy","start":4300.69,"end":4301.17},{"text":"has","start":4301.17,"end":4301.41},{"text":"too","start":4301.41,"end":4301.57},{"text":"long","start":4301.57,"end":4301.89},{"text":"ignored.","start":4301.89,"end":4302.37}]},{"text":"I thank you.","start":4302.85,"end":4303.25,"topics":[],"words":[{"text":"I","start":4302.85,"end":4302.89},{"text":"thank","start":4302.89,"end":4303.09},{"text":"you.","start":4303.09,"end":4303.25}]}]}],"speaker":{"affiliation":"SSDP","group":null,"function":"Youth delegate","affiliation_full":"SSDP"}},{"statement_number":29,"start":4303.77,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:11:44","paragraphs":[{"sentences":[{"text":"Thank you very much.","start":4303.77,"end":4304.85,"topics":[],"words":[{"text":"Thank","start":4303.77,"end":4303.97},{"text":"you","start":4303.97,"end":4304.05},{"text":"very","start":4304.05,"end":4304.37},{"text":"much.","start":4304.37,"end":4304.85}]},{"text":"And let's go over here.","start":4304.93,"end":4306.13,"topics":[],"words":[{"text":"And","start":4304.93,"end":4305.09},{"text":"let's","start":4305.09,"end":4305.37},{"text":"go","start":4305.37,"end":4305.57},{"text":"over","start":4305.57,"end":4305.81},{"text":"here.","start":4305.81,"end":4306.13}]},{"text":"I had a bit of a blind spot.","start":4306.13,"end":4307.25,"topics":[],"words":[{"text":"I","start":4306.13,"end":4306.21},{"text":"had","start":4306.21,"end":4306.33},{"text":"a","start":4306.33,"end":4306.37},{"text":"bit","start":4306.41,"end":4306.53},{"text":"of","start":4306.53,"end":4306.61},{"text":"a","start":4306.61,"end":4306.69},{"text":"blind","start":4306.69,"end":4306.97},{"text":"spot.","start":4306.97,"end":4307.25}]},{"text":"I wasn't looking this way.","start":4307.25,"end":4308.37,"topics":[],"words":[{"text":"I","start":4307.25,"end":4307.33},{"text":"wasn't","start":4307.37,"end":4307.69},{"text":"looking","start":4307.69,"end":4307.97},{"text":"this","start":4307.97,"end":4308.13},{"text":"way.","start":4308.13,"end":4308.37}]},{"text":"Please.","start":4308.61,"end":4308.81,"topics":[],"words":[{"text":"Please.","start":4308.61,"end":4308.81}]},{"text":"And this will be the last intervention before we go to the UN family.","start":4308.81,"end":4312.45,"topics":[],"words":[{"text":"And","start":4308.81,"end":4308.93},{"text":"this","start":4308.93,"end":4309.09},{"text":"will","start":4309.09,"end":4309.21},{"text":"be","start":4309.21,"end":4309.33},{"text":"the","start":4309.33,"end":4309.41},{"text":"last","start":4309.41,"end":4309.73},{"text":"intervention","start":4309.73,"end":4310.45},{"text":"before","start":4310.73,"end":4311.05},{"text":"we","start":4311.05,"end":4311.17},{"text":"go","start":4311.17,"end":4311.33},{"text":"to","start":4311.33,"end":4311.49},{"text":"the","start":4311.49,"end":4311.61},{"text":"UN","start":4311.61,"end":4311.97},{"text":"family.","start":4311.97,"end":4312.45}]},{"text":"Thank you.","start":4312.61,"end":4313.01,"topics":[],"words":[{"text":"Thank","start":4312.61,"end":4312.85},{"text":"you.","start":4312.85,"end":4313.01}]}]}],"speaker":{"affiliation":"UNDP","group":null,"function":null,"affiliation_full":"UNDP"}},{"statement_number":30,"start":4314.37,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:11:55","paragraphs":[{"sentences":[{"text":"Excellencies and dear colleagues, my name is Deanna Laughlin, and I speak today on behalf of the International Pharmaceutical Students Federation, representing over 500,000 pharmacy students and young pharmacists from more than 100 countries.","start":4314.37,"end":4326.05,"topics":[],"words":[{"text":"Excellencies","start":4314.37,"end":4314.97},{"text":"and","start":4314.97,"end":4315.13},{"text":"dear","start":4315.13,"end":4315.25},{"text":"colleagues,","start":4315.25,"end":4315.65},{"text":"my","start":4315.65,"end":4315.81},{"text":"name","start":4315.81,"end":4315.97},{"text":"is","start":4315.97,"end":4316.09},{"text":"Deanna","start":4316.09,"end":4316.41},{"text":"Laughlin,","start":4316.41,"end":4317.01},{"text":"and","start":4317.01,"end":4317.17},{"text":"I","start":4317.17,"end":4317.25},{"text":"speak","start":4317.25,"end":4317.57},{"text":"today","start":4317.57,"end":4317.81},{"text":"on","start":4317.81,"end":4317.97},{"text":"behalf","start":4317.97,"end":4318.25},{"text":"of","start":4318.25,"end":4318.37},{"text":"the","start":4318.37,"end":4318.49},{"text":"International","start":4318.49,"end":4319.05},{"text":"Pharmaceutical","start":4319.05,"end":4319.61},{"text":"Students","start":4319.61,"end":4319.97},{"text":"Federation,","start":4319.97,"end":4320.61},{"text":"representing","start":4320.85,"end":4321.41},{"text":"over","start":4321.41,"end":4321.65},{"text":"500,000","start":4321.65,"end":4322.53},{"text":"pharmacy","start":4322.53,"end":4322.93},{"text":"students","start":4322.93,"end":4323.25},{"text":"and","start":4323.25,"end":4323.41},{"text":"young","start":4323.41,"end":4323.65},{"text":"pharmacists","start":4323.65,"end":4324.21},{"text":"from","start":4324.21,"end":4324.37},{"text":"more","start":4324.45,"end":4324.61},{"text":"than","start":4324.61,"end":4324.73},{"text":"100","start":4324.73,"end":4325.29},{"text":"countries.","start":4325.29,"end":4326.05}]},{"text":"We are proud to be a part of the most accessible health care profession in the world, standing with communities on the front lines of HIV prevention, testing, and treatment.","start":4326.29,"end":4335.17,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"We","start":4326.29,"end":4326.49},{"text":"are","start":4326.49,"end":4326.61},{"text":"proud","start":4326.61,"end":4326.97},{"text":"to","start":4326.97,"end":4327.05},{"text":"be","start":4327.05,"end":4327.13},{"text":"a","start":4327.13,"end":4327.17},{"text":"part","start":4327.17,"end":4327.41},{"text":"of","start":4327.41,"end":4327.49},{"text":"the","start":4327.49,"end":4327.57},{"text":"most","start":4327.57,"end":4327.81},{"text":"accessible","start":4327.81,"end":4328.29},{"text":"health","start":4328.29,"end":4328.53},{"text":"care","start":4328.53,"end":4328.69},{"text":"profession","start":4328.69,"end":4329.33},{"text":"in","start":4329.33,"end":4329.61},{"text":"the","start":4329.61,"end":4329.73},{"text":"world,","start":4329.73,"end":4330.13},{"text":"standing","start":4330.37,"end":4330.69},{"text":"with","start":4330.69,"end":4330.85},{"text":"communities","start":4330.85,"end":4331.49},{"text":"on","start":4331.49,"end":4331.73},{"text":"the","start":4331.73,"end":4331.89},{"text":"front","start":4331.89,"end":4332.13},{"text":"lines","start":4332.13,"end":4332.61},{"text":"of","start":4332.61,"end":4332.77},{"text":"HIV","start":4332.77,"end":4333.09},{"text":"prevention,","start":4333.09,"end":4333.73},{"text":"testing,","start":4333.89,"end":4334.45},{"text":"and","start":4334.45,"end":4334.65},{"text":"treatment.","start":4334.65,"end":4335.17}]},{"text":"But let's be clear, progress is not enough.","start":4335.33,"end":4337.97,"topics":[],"words":[{"text":"But","start":4335.33,"end":4335.45},{"text":"let's","start":4335.53,"end":4335.81},{"text":"be","start":4335.81,"end":4335.89},{"text":"clear,","start":4335.89,"end":4336.29},{"text":"progress","start":4336.29,"end":4336.77},{"text":"is","start":4336.77,"end":4337.01},{"text":"not","start":4337.01,"end":4337.33},{"text":"enough.","start":4337.33,"end":4337.97}]},{"text":"While ART now reaches 77% of people living with HIV, over 5 million are left behind.","start":4338.17,"end":4345.01,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"While","start":4338.17,"end":4338.49},{"text":"ART","start":4338.85,"end":4339.49},{"text":"now","start":4339.89,"end":4340.13},{"text":"reaches","start":4340.13,"end":4340.53},{"text":"77%","start":4340.53,"end":4340.57},{"text":"of","start":4340.61,"end":4340.85},{"text":"people","start":4340.85,"end":4341.77},{"text":"living","start":4341.77,"end":4342.13},{"text":"with","start":4342.13,"end":4342.41},{"text":"HIV,","start":4342.41,"end":4342.93},{"text":"over","start":4342.93,"end":4343.25},{"text":"5","start":4343.25,"end":4343.57},{"text":"million","start":4343.57,"end":4343.97},{"text":"are","start":4343.97,"end":4344.13},{"text":"left","start":4344.33,"end":4344.45},{"text":"behind.","start":4344.45,"end":4345.01}]},{"text":"Every day, communities face the crushing weight of stigma, discrimination, and punitive drug policies that drive people away from the care they need.","start":4345.09,"end":4352.77,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Every","start":4345.09,"end":4345.41},{"text":"day,","start":4345.41,"end":4345.73},{"text":"communities","start":4345.73,"end":4346.29},{"text":"face","start":4346.29,"end":4346.61},{"text":"the","start":4346.61,"end":4346.77},{"text":"crushing","start":4346.77,"end":4347.17},{"text":"weight","start":4347.17,"end":4347.45},{"text":"of","start":4347.45,"end":4347.53},{"text":"stigma,","start":4347.53,"end":4347.97},{"text":"discrimination,","start":4348.21,"end":4349.01},{"text":"and","start":4349.01,"end":4349.29},{"text":"punitive","start":4349.29,"end":4349.65},{"text":"drug","start":4349.65,"end":4349.89},{"text":"policies","start":4349.89,"end":4350.41},{"text":"that","start":4350.41,"end":4350.61},{"text":"drive","start":4350.61,"end":4351.01},{"text":"people","start":4351.01,"end":4351.45},{"text":"away","start":4351.45,"end":4351.73},{"text":"from","start":4351.73,"end":4351.93},{"text":"the","start":4351.93,"end":4352.01},{"text":"care","start":4352.01,"end":4352.21},{"text":"they","start":4352.21,"end":4352.29},{"text":"need.","start":4352.29,"end":4352.77}]},{"text":"This is a human rights crisis, not just a health challenge.","start":4353.09,"end":4356.13,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"This","start":4353.09,"end":4353.21},{"text":"is","start":4353.21,"end":4353.33},{"text":"a","start":4353.33,"end":4353.37},{"text":"human","start":4353.37,"end":4353.81},{"text":"rights","start":4353.81,"end":4354.05},{"text":"crisis,","start":4354.05,"end":4354.49},{"text":"not","start":4354.49,"end":4354.77},{"text":"just","start":4354.77,"end":4354.97},{"text":"a","start":4354.97,"end":4355.01},{"text":"health","start":4355.01,"end":4355.37},{"text":"challenge.","start":4355.41,"end":4356.13}]},{"text":"As student pharmacists, we demand action, expand access and affordability of HIV treatment by integrating services into universal healthcare coverage and tackling the intersection burdens of NCDs and substance use.","start":4356.81,"end":4370.01,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"As","start":4356.81,"end":4356.85},{"text":"student","start":4356.85,"end":4357.17},{"text":"pharmacists,","start":4357.17,"end":4357.61},{"text":"we","start":4357.61,"end":4357.73},{"text":"demand","start":4357.73,"end":4358.05},{"text":"action,","start":4358.05,"end":4358.65},{"text":"expand","start":4358.97,"end":4359.45},{"text":"access","start":4359.45,"end":4359.85},{"text":"and","start":4359.85,"end":4360.01},{"text":"affordability","start":4360.01,"end":4360.81},{"text":"of","start":4360.81,"end":4360.97},{"text":"HIV","start":4360.97,"end":4361.37},{"text":"treatment","start":4361.37,"end":4361.85},{"text":"by","start":4361.85,"end":4362.01},{"text":"integrating","start":4362.01,"end":4362.81},{"text":"services","start":4362.81,"end":4363.29},{"text":"into","start":4363.29,"end":4363.57},{"text":"universal","start":4363.57,"end":4364.01},{"text":"healthcare","start":4364.01,"end":4364.49},{"text":"coverage","start":4364.49,"end":4365.05},{"text":"and","start":4365.37,"end":4365.57},{"text":"tackling","start":4365.57,"end":4366.01},{"text":"the","start":4366.01,"end":4366.09},{"text":"intersection","start":4366.09,"end":4367.13},{"text":"burdens","start":4367.45,"end":4368.01},{"text":"of","start":4368.01,"end":4368.17},{"text":"NCDs","start":4368.17,"end":4368.81},{"text":"and","start":4368.81,"end":4368.97},{"text":"substance","start":4368.97,"end":4369.37},{"text":"use.","start":4369.53,"end":4370.01}]},{"text":"As pharmacists, we are the most accessible healthcare professions in the world and can bridge this gap.","start":4370.17,"end":4375.77,"topics":[],"words":[{"text":"As","start":4370.17,"end":4370.37},{"text":"pharmacists,","start":4370.37,"end":4370.89},{"text":"we","start":4370.89,"end":4371.05},{"text":"are","start":4371.05,"end":4371.29},{"text":"the","start":4371.29,"end":4371.41},{"text":"most","start":4371.41,"end":4371.69},{"text":"accessible","start":4371.69,"end":4372.17},{"text":"healthcare","start":4372.17,"end":4372.89},{"text":"professions","start":4372.89,"end":4373.61},{"text":"in","start":4373.61,"end":4373.89},{"text":"the","start":4373.89,"end":4374.01},{"text":"world","start":4374.01,"end":4374.41},{"text":"and","start":4374.41,"end":4374.57},{"text":"can","start":4374.57,"end":4374.73},{"text":"bridge","start":4374.73,"end":4375.09},{"text":"this","start":4375.09,"end":4375.29},{"text":"gap.","start":4375.29,"end":4375.77}]},{"text":"Invest in harm reduction, not punishment.","start":4376.25,"end":4378.49,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"Invest","start":4376.25,"end":4376.73},{"text":"in","start":4376.73,"end":4376.81},{"text":"harm","start":4376.81,"end":4377.13},{"text":"reduction,","start":4377.13,"end":4377.73},{"text":"not","start":4377.73,"end":4377.85},{"text":"punishment.","start":4377.85,"end":4378.49}]},{"text":"Needle and syringe programs, opioid agonist therapy, and decriminalization saves lives, the evidence is clear.","start":4378.49,"end":4384.57,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"Needle","start":4378.49,"end":4378.97},{"text":"and","start":4378.97,"end":4379.21},{"text":"syringe","start":4379.21,"end":4379.61},{"text":"programs,","start":4379.61,"end":4380.17},{"text":"opioid","start":4380.17,"end":4380.65},{"text":"agonist","start":4380.65,"end":4381.17},{"text":"therapy,","start":4381.17,"end":4381.61},{"text":"and","start":4381.61,"end":4381.81},{"text":"decriminalization","start":4381.81,"end":4382.65},{"text":"saves","start":4382.65,"end":4382.97},{"text":"lives,","start":4382.97,"end":4383.33},{"text":"the","start":4383.33,"end":4383.41},{"text":"evidence","start":4383.41,"end":4383.77},{"text":"is","start":4383.77,"end":4384.01},{"text":"clear.","start":4384.01,"end":4384.57}]},{"text":"Center the voices of affected communities, including people who use drugs, adolescents, and young women.","start":4385.09,"end":4390.53,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."}],"words":[{"text":"Center","start":4385.09,"end":4385.57},{"text":"the","start":4385.57,"end":4385.69},{"text":"voices","start":4385.69,"end":4386.13},{"text":"of","start":4386.13,"end":4386.21},{"text":"affected","start":4386.21,"end":4386.61},{"text":"communities,","start":4386.61,"end":4387.25},{"text":"including","start":4387.25,"end":4387.65},{"text":"people","start":4387.65,"end":4388.01},{"text":"who","start":4388.01,"end":4388.21},{"text":"use","start":4388.21,"end":4388.45},{"text":"drugs,","start":4388.45,"end":4388.93},{"text":"adolescents,","start":4388.93,"end":4389.65},{"text":"and","start":4389.65,"end":4389.89},{"text":"young","start":4389.89,"end":4390.13},{"text":"women.","start":4390.13,"end":4390.53}]},{"text":"Nothing for us or without us.","start":4390.69,"end":4392.93,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Nothing","start":4390.69,"end":4391.01},{"text":"for","start":4391.01,"end":4391.29},{"text":"us","start":4391.29,"end":4391.49},{"text":"or","start":4391.97,"end":4392.13},{"text":"without","start":4392.13,"end":4392.53},{"text":"us.","start":4392.61,"end":4392.93}]},{"text":"Young people are not leaders of tomorrow.","start":4393.33,"end":4395.65,"topics":[],"words":[{"text":"Young","start":4393.33,"end":4393.61},{"text":"people","start":4393.61,"end":4393.89},{"text":"are","start":4393.89,"end":4394.01},{"text":"not","start":4394.01,"end":4394.37},{"text":"leaders","start":4394.37,"end":4394.93},{"text":"of","start":4394.93,"end":4395.01},{"text":"tomorrow.","start":4395.01,"end":4395.65}]},{"text":"We are leaders of today.","start":4395.65,"end":4396.85,"topics":[],"words":[{"text":"We","start":4395.65,"end":4395.89},{"text":"are","start":4395.89,"end":4395.97},{"text":"leaders","start":4395.97,"end":4396.29},{"text":"of","start":4396.29,"end":4396.37},{"text":"today.","start":4396.37,"end":4396.85}]},{"text":"We are raising awareness, fighting stigma, advocating for sexual and reproductive health, and demanding governments deliver on these promises.","start":4396.85,"end":4404.77,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."}],"words":[{"text":"We","start":4396.85,"end":4397.09},{"text":"are","start":4397.09,"end":4397.37},{"text":"raising","start":4397.37,"end":4397.69},{"text":"awareness,","start":4397.69,"end":4398.29},{"text":"fighting","start":4398.37,"end":4398.77},{"text":"stigma,","start":4398.77,"end":4399.25},{"text":"advocating","start":4399.57,"end":4400.13},{"text":"for","start":4400.13,"end":4400.29},{"text":"sexual","start":4400.29,"end":4400.61},{"text":"and","start":4400.61,"end":4400.73},{"text":"reproductive","start":4400.73,"end":4401.17},{"text":"health,","start":4401.17,"end":4401.49},{"text":"and","start":4401.49,"end":4401.69},{"text":"demanding","start":4401.69,"end":4402.09},{"text":"governments","start":4402.09,"end":4402.53},{"text":"deliver","start":4402.53,"end":4403.25},{"text":"on","start":4403.25,"end":4403.57},{"text":"these","start":4403.57,"end":4403.81},{"text":"promises.","start":4403.97,"end":4404.77}]},{"text":"We have the science, we have the strategies, but science without solidarity is not enough.","start":4405.37,"end":4410.33,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"We","start":4405.37,"end":4405.53},{"text":"have","start":4405.53,"end":4406.01},{"text":"the","start":4406.17,"end":4406.33},{"text":"science,","start":4406.33,"end":4406.81},{"text":"we","start":4406.81,"end":4406.89},{"text":"have","start":4406.89,"end":4407.13},{"text":"the","start":4407.13,"end":4407.21},{"text":"strategies,","start":4407.21,"end":4407.77},{"text":"but","start":4407.77,"end":4407.93},{"text":"science","start":4407.93,"end":4408.41},{"text":"without","start":4408.41,"end":4408.69},{"text":"solidarity","start":4408.69,"end":4409.37},{"text":"is","start":4409.37,"end":4409.61},{"text":"not","start":4409.61,"end":4409.81},{"text":"enough.","start":4409.81,"end":4410.33}]},{"text":"We need courage, political will, and urgent action to end AIDS as a public health threat.","start":4410.65,"end":4416.09,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"We","start":4410.65,"end":4410.89},{"text":"need","start":4410.89,"end":4411.05},{"text":"courage,","start":4411.05,"end":4411.61},{"text":"political","start":4411.61,"end":4412.01},{"text":"will,","start":4412.01,"end":4412.33},{"text":"and","start":4412.33,"end":4412.49},{"text":"urgent","start":4412.49,"end":4413.45},{"text":"action","start":4413.45,"end":4414.01},{"text":"to","start":4414.17,"end":4414.29},{"text":"end","start":4414.33,"end":4414.53},{"text":"AIDS","start":4414.53,"end":4414.89},{"text":"as","start":4414.89,"end":4415.05},{"text":"a","start":4415.05,"end":4415.13},{"text":"public","start":4415.13,"end":4415.45},{"text":"health","start":4415.45,"end":4415.73},{"text":"threat.","start":4415.73,"end":4416.09}]},{"text":"We are all resources in this room to combat the HIV epidemic globally.","start":4416.41,"end":4420.81,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"We","start":4416.41,"end":4416.73},{"text":"are","start":4416.73,"end":4416.97},{"text":"all","start":4416.97,"end":4417.13},{"text":"resources","start":4417.13,"end":4417.61},{"text":"in","start":4417.61,"end":4417.69},{"text":"this","start":4417.69,"end":4417.85},{"text":"room","start":4417.85,"end":4418.33},{"text":"to","start":4418.57,"end":4418.81},{"text":"combat","start":4418.81,"end":4419.29},{"text":"the","start":4419.29,"end":4419.41},{"text":"HIV","start":4419.41,"end":4419.85},{"text":"epidemic","start":4419.85,"end":4420.33},{"text":"globally.","start":4420.33,"end":4420.81}]},{"text":"How can we embrace global collaboration to enhance this fight?","start":4420.81,"end":4423.85,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"How","start":4420.81,"end":4421.13},{"text":"can","start":4421.13,"end":4421.29},{"text":"we","start":4421.29,"end":4421.45},{"text":"embrace","start":4421.45,"end":4421.85},{"text":"global","start":4421.85,"end":4422.13},{"text":"collaboration","start":4422.13,"end":4422.73},{"text":"to","start":4422.73,"end":4422.81},{"text":"enhance","start":4422.81,"end":4423.25},{"text":"this","start":4423.25,"end":4423.53},{"text":"fight?","start":4423.53,"end":4423.85}]},{"text":"We shall refuse to wait.","start":4424.25,"end":4425.45,"topics":[],"words":[{"text":"We","start":4424.25,"end":4424.41},{"text":"shall","start":4424.41,"end":4424.61},{"text":"refuse","start":4424.61,"end":4424.97},{"text":"to","start":4424.97,"end":4425.05},{"text":"wait.","start":4425.05,"end":4425.45}]},{"text":"Lives depend on this.","start":4425.53,"end":4426.81,"topics":[],"words":[{"text":"Lives","start":4425.53,"end":4425.89},{"text":"depend","start":4425.89,"end":4426.25},{"text":"on","start":4426.25,"end":4426.49},{"text":"this.","start":4426.49,"end":4426.81}]},{"text":"Thank you.","start":4426.97,"end":4427.41,"topics":[],"words":[{"text":"Thank","start":4426.97,"end":4427.29},{"text":"you.","start":4427.29,"end":4427.41}]}]}],"speaker":{"affiliation":"IPSF","group":null,"function":null,"affiliation_full":"IPSF"}},{"statement_number":31,"start":4427.73,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:13:48","paragraphs":[{"sentences":[{"text":"Thank you very much.","start":4427.73,"end":4428.73,"topics":[],"words":[{"text":"Thank","start":4427.73,"end":4427.93},{"text":"you","start":4427.93,"end":4428.01},{"text":"very","start":4428.01,"end":4428.25},{"text":"much.","start":4428.25,"end":4428.73}]},{"text":"Okay, let's move quickly now across the UN family because we still have We want to hear from the Deputy Minister from Colombia, as well as our colleague from Open Societies Foundation.","start":4429.05,"end":4441.89,"topics":[],"words":[{"text":"Okay,","start":4429.05,"end":4429.29},{"text":"let's","start":4429.29,"end":4429.69},{"text":"move","start":4429.69,"end":4429.93},{"text":"quickly","start":4429.93,"end":4430.33},{"text":"now","start":4430.33,"end":4430.73},{"text":"across","start":4431.61,"end":4431.93},{"text":"the","start":4431.93,"end":4432.01},{"text":"UN","start":4432.01,"end":4432.17},{"text":"family","start":4432.17,"end":4432.57},{"text":"because","start":4432.57,"end":4432.81},{"text":"we","start":4432.81,"end":4432.97},{"text":"still","start":4432.97,"end":4433.29},{"text":"have","start":4433.29,"end":4433.49},{"text":"We","start":4434.21,"end":4434.45},{"text":"want","start":4434.45,"end":4434.73},{"text":"to","start":4434.73,"end":4434.81},{"text":"hear","start":4434.81,"end":4435.09},{"text":"from","start":4435.09,"end":4435.49},{"text":"the","start":4435.73,"end":4435.89},{"text":"Deputy","start":4435.89,"end":4436.29},{"text":"Minister","start":4436.29,"end":4436.73},{"text":"from","start":4436.73,"end":4436.93},{"text":"Colombia,","start":4436.93,"end":4437.49},{"text":"as","start":4437.73,"end":4437.97},{"text":"well","start":4437.97,"end":4438.29},{"text":"as","start":4438.29,"end":4438.53},{"text":"our","start":4438.53,"end":4438.77},{"text":"colleague","start":4438.77,"end":4439.17},{"text":"from","start":4439.17,"end":4439.57},{"text":"Open","start":4440.45,"end":4440.69},{"text":"Societies","start":4440.69,"end":4441.21},{"text":"Foundation.","start":4441.21,"end":4441.89}]},{"text":"So over to you, Nainan.","start":4442.21,"end":4444.45,"topics":[],"words":[{"text":"So","start":4442.21,"end":4442.69},{"text":"over","start":4443.49,"end":4443.73},{"text":"to","start":4443.73,"end":4443.89},{"text":"you,","start":4443.89,"end":4444.05},{"text":"Nainan.","start":4444.05,"end":4444.45}]},{"text":"Nainan is the Senior Advisor to the Secretariat of the Joint Programme on AIDS.","start":4444.45,"end":4449.25,"topics":[],"words":[{"text":"Nainan","start":4444.45,"end":4444.85},{"text":"is","start":4444.85,"end":4444.97},{"text":"the","start":4444.97,"end":4445.05},{"text":"Senior","start":4445.05,"end":4445.49},{"text":"Advisor","start":4445.49,"end":4446.13},{"text":"to","start":4446.13,"end":4446.29},{"text":"the","start":4446.29,"end":4446.41},{"text":"Secretariat","start":4446.41,"end":4447.33},{"text":"of","start":4447.37,"end":4447.49},{"text":"the","start":4447.49,"end":4447.65},{"text":"Joint","start":4447.65,"end":4447.97},{"text":"Programme","start":4447.97,"end":4448.61},{"text":"on","start":4448.61,"end":4448.85},{"text":"AIDS.","start":4448.85,"end":4449.25}]},{"text":"Over to you, Nainan.","start":4449.49,"end":4450.45,"topics":[],"words":[{"text":"Over","start":4449.49,"end":4449.73},{"text":"to","start":4449.73,"end":4449.85},{"text":"you,","start":4449.85,"end":4449.97},{"text":"Nainan.","start":4449.97,"end":4450.45}]}]}],"speaker":{"affiliation":"UNDP","group":null,"function":null,"affiliation_full":"UNDP"}},{"statement_number":32,"start":4451.25,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:14:12","paragraphs":[{"sentences":[{"text":"Thank you very much, Madam Chair, Mandeep.","start":4451.25,"end":4454.37,"topics":[],"words":[{"text":"Thank","start":4451.25,"end":4451.49},{"text":"you","start":4451.49,"end":4451.57},{"text":"very","start":4451.57,"end":4451.77},{"text":"much,","start":4451.77,"end":4452.13},{"text":"Madam","start":4452.69,"end":4453.17},{"text":"Chair,","start":4453.41,"end":4453.89},{"text":"Mandeep.","start":4453.89,"end":4454.37}]},{"text":"Excellencies, civil society partners, colleagues, UNAIDS is happy to support this event and it's wonderful to see so many friends and drug policy warriors in this room today.","start":4455.01,"end":4465.21,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Excellencies,","start":4455.01,"end":4455.57},{"text":"civil","start":4455.57,"end":4455.85},{"text":"society","start":4455.85,"end":4456.21},{"text":"partners,","start":4456.21,"end":4456.69},{"text":"colleagues,","start":4456.69,"end":4457.25},{"text":"UNAIDS","start":4457.29,"end":4458.13},{"text":"is","start":4458.13,"end":4458.29},{"text":"happy","start":4458.29,"end":4458.61},{"text":"to","start":4458.61,"end":4458.69},{"text":"support","start":4458.69,"end":4459.05},{"text":"this","start":4459.05,"end":4459.17},{"text":"event","start":4459.17,"end":4459.45},{"text":"and","start":4459.45,"end":4459.57},{"text":"it's","start":4459.57,"end":4459.81},{"text":"wonderful","start":4459.81,"end":4460.25},{"text":"to","start":4460.25,"end":4460.37},{"text":"see","start":4460.37,"end":4460.61},{"text":"so","start":4460.61,"end":4460.81},{"text":"many","start":4460.81,"end":4461.01},{"text":"friends","start":4461.01,"end":4461.57},{"text":"and","start":4462.17,"end":4462.49},{"text":"drug","start":4462.57,"end":4462.89},{"text":"policy","start":4462.89,"end":4463.37},{"text":"warriors","start":4463.37,"end":4464.01},{"text":"in","start":4464.17,"end":4464.41},{"text":"this","start":4464.41,"end":4464.65},{"text":"room","start":4464.65,"end":4464.81},{"text":"today.","start":4464.81,"end":4465.21}]},{"text":"People who use drugs are at high risk of acquiring HIV but face major barriers to accessing health and social services due to stigma, discrimination, and punitive drug laws.","start":4465.77,"end":4476.17,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"People","start":4465.77,"end":4466.13},{"text":"who","start":4466.13,"end":4466.21},{"text":"use","start":4466.21,"end":4466.33},{"text":"drugs","start":4466.33,"end":4466.65},{"text":"are","start":4466.69,"end":4466.77},{"text":"at","start":4466.77,"end":4466.89},{"text":"high","start":4466.89,"end":4467.13},{"text":"risk","start":4467.13,"end":4467.45},{"text":"of","start":4467.45,"end":4467.53},{"text":"acquiring","start":4467.53,"end":4468.01},{"text":"HIV","start":4468.01,"end":4468.49},{"text":"but","start":4468.49,"end":4468.73},{"text":"face","start":4468.73,"end":4469.21},{"text":"major","start":4469.21,"end":4469.61},{"text":"barriers","start":4469.61,"end":4470.09},{"text":"to","start":4470.09,"end":4470.25},{"text":"accessing","start":4470.25,"end":4470.81},{"text":"health","start":4470.81,"end":4471.09},{"text":"and","start":4471.45,"end":4471.61},{"text":"social","start":4471.61,"end":4472.01},{"text":"services","start":4472.01,"end":4472.49},{"text":"due","start":4472.49,"end":4472.65},{"text":"to","start":4472.65,"end":4472.73},{"text":"stigma,","start":4472.73,"end":4473.29},{"text":"discrimination,","start":4473.45,"end":4474.41},{"text":"and","start":4474.65,"end":4474.89},{"text":"punitive","start":4474.89,"end":4475.45},{"text":"drug","start":4475.45,"end":4475.77},{"text":"laws.","start":4475.77,"end":4476.17}]},{"text":"Despite global commitments such as the Global AIDS Strategy 2126 and the 2023 UN Human Rights Council resolution, progress at the national level remains limited.","start":4476.41,"end":4487.77,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Despite","start":4476.41,"end":4476.93},{"text":"global","start":4476.93,"end":4477.29},{"text":"commitments","start":4477.29,"end":4477.97},{"text":"such","start":4477.97,"end":4478.09},{"text":"as","start":4478.13,"end":4478.25},{"text":"the","start":4478.25,"end":4478.37},{"text":"Global","start":4478.37,"end":4478.73},{"text":"AIDS","start":4478.73,"end":4478.93},{"text":"Strategy","start":4478.93,"end":4479.45},{"text":"2126","start":4479.45,"end":4480.73},{"text":"and","start":4481.05,"end":4481.21},{"text":"the","start":4481.21,"end":4481.29},{"text":"2023","start":4481.29,"end":4482.25},{"text":"UN","start":4482.25,"end":4482.73},{"text":"Human","start":4483.05,"end":4483.45},{"text":"Rights","start":4483.45,"end":4483.69},{"text":"Council","start":4483.69,"end":4484.13},{"text":"resolution,","start":4484.13,"end":4484.89},{"text":"progress","start":4485.13,"end":4485.53},{"text":"at","start":4485.53,"end":4485.61},{"text":"the","start":4485.61,"end":4485.77},{"text":"national","start":4485.77,"end":4486.17},{"text":"level","start":4486.17,"end":4486.57},{"text":"remains","start":4486.81,"end":4487.29},{"text":"limited.","start":4487.29,"end":4487.77}]},{"text":"While criminalization of drug possession for personal use persists, And as long as harm reduction services remain unavailable and underfunded, as Catherine mentioned, it will not be possible to end AIDS as a public health threat.","start":4488.05,"end":4501.37,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"While","start":4488.05,"end":4488.33},{"text":"criminalization","start":4488.33,"end":4489.21},{"text":"of","start":4489.29,"end":4489.45},{"text":"drug","start":4489.45,"end":4489.69},{"text":"possession","start":4489.69,"end":4490.25},{"text":"for","start":4490.25,"end":4490.41},{"text":"personal","start":4490.41,"end":4490.89},{"text":"use","start":4490.89,"end":4491.13},{"text":"persists,","start":4491.13,"end":4491.77},{"text":"And","start":4492.13,"end":4492.25},{"text":"as","start":4492.25,"end":4492.41},{"text":"long","start":4492.41,"end":4492.73},{"text":"as","start":4492.73,"end":4492.89},{"text":"harm","start":4492.89,"end":4493.13},{"text":"reduction","start":4493.13,"end":4493.61},{"text":"services","start":4493.61,"end":4494.25},{"text":"remain","start":4494.25,"end":4494.65},{"text":"unavailable","start":4494.69,"end":4495.45},{"text":"and","start":4495.61,"end":4495.85},{"text":"underfunded,","start":4495.85,"end":4496.65},{"text":"as","start":4497.13,"end":4497.37},{"text":"Catherine","start":4497.37,"end":4497.73},{"text":"mentioned,","start":4497.73,"end":4498.25},{"text":"it","start":4498.41,"end":4498.53},{"text":"will","start":4498.53,"end":4498.65},{"text":"not","start":4498.65,"end":4498.93},{"text":"be","start":4498.93,"end":4499.05},{"text":"possible","start":4499.05,"end":4499.61},{"text":"to","start":4499.61,"end":4499.69},{"text":"end","start":4499.69,"end":4499.93},{"text":"AIDS","start":4499.93,"end":4500.21},{"text":"as","start":4500.21,"end":4500.33},{"text":"a","start":4500.33,"end":4500.41},{"text":"public","start":4500.41,"end":4500.77},{"text":"health","start":4500.77,"end":4501.01},{"text":"threat.","start":4501.01,"end":4501.37}]},{"text":"Despite an abundance of evidence on the critical importance of a health-based approach, punitive and coercive policies and practices continue to dominate global drug policy.","start":4501.61,"end":4511.85,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Despite","start":4501.61,"end":4502.17},{"text":"an","start":4502.17,"end":4502.25},{"text":"abundance","start":4502.25,"end":4502.93},{"text":"of","start":4502.93,"end":4503.05},{"text":"evidence","start":4503.13,"end":4503.69},{"text":"on","start":4503.69,"end":4503.85},{"text":"the","start":4503.85,"end":4503.93},{"text":"critical","start":4503.93,"end":4504.53},{"text":"importance","start":4504.53,"end":4505.21},{"text":"of","start":4505.37,"end":4505.57},{"text":"a","start":4505.57,"end":4505.61},{"text":"health-based","start":4505.61,"end":4506.21},{"text":"approach,","start":4506.21,"end":4506.73},{"text":"punitive","start":4506.97,"end":4507.61},{"text":"and","start":4507.61,"end":4507.77},{"text":"coercive","start":4507.77,"end":4508.25},{"text":"policies","start":4508.25,"end":4508.73},{"text":"and","start":4508.73,"end":4508.85},{"text":"practices","start":4508.85,"end":4509.45},{"text":"continue","start":4509.69,"end":4510.17},{"text":"to","start":4510.17,"end":4510.25},{"text":"dominate","start":4510.25,"end":4510.73},{"text":"global","start":4510.73,"end":4511.13},{"text":"drug","start":4511.13,"end":4511.29},{"text":"policy.","start":4511.29,"end":4511.85}]},{"text":"In some countries, governments are working with organizations led by people who use drugs to expand health-focused drug policies, demonstrating that positive change both possible and achievable.","start":4512.17,"end":4524.33,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"In","start":4512.17,"end":4512.33},{"text":"some","start":4512.33,"end":4512.57},{"text":"countries,","start":4512.57,"end":4513.21},{"text":"governments","start":4513.37,"end":4513.89},{"text":"are","start":4513.89,"end":4513.97},{"text":"working","start":4513.97,"end":4514.33},{"text":"with","start":4514.33,"end":4514.49},{"text":"organizations","start":4514.49,"end":4515.21},{"text":"led","start":4515.21,"end":4515.37},{"text":"by","start":4515.37,"end":4515.61},{"text":"people","start":4515.61,"end":4516.01},{"text":"who","start":4516.01,"end":4516.09},{"text":"use","start":4516.09,"end":4516.49},{"text":"drugs","start":4516.49,"end":4516.89},{"text":"to","start":4517.13,"end":4517.25},{"text":"expand","start":4517.25,"end":4517.73},{"text":"health-focused","start":4517.73,"end":4518.49},{"text":"drug","start":4518.65,"end":4518.89},{"text":"policies,","start":4518.89,"end":4519.45},{"text":"demonstrating","start":4519.69,"end":4520.49},{"text":"that","start":4520.49,"end":4520.65},{"text":"positive","start":4520.65,"end":4521.13},{"text":"change","start":4521.13,"end":4521.61},{"text":"both","start":4522.17,"end":4522.33},{"text":"possible","start":4522.33,"end":4523.05},{"text":"and","start":4523.21,"end":4523.61},{"text":"achievable.","start":4523.69,"end":4524.33}]},{"text":"Allow me to leave you with a few recommendations for effecting change.","start":4524.57,"end":4527.69,"topics":[],"words":[{"text":"Allow","start":4524.57,"end":4524.77},{"text":"me","start":4524.77,"end":4524.97},{"text":"to","start":4524.97,"end":4525.05},{"text":"leave","start":4525.05,"end":4525.29},{"text":"you","start":4525.29,"end":4525.41},{"text":"with","start":4525.41,"end":4525.77},{"text":"a","start":4525.77,"end":4525.81},{"text":"few","start":4525.81,"end":4526.01},{"text":"recommendations","start":4526.01,"end":4526.73},{"text":"for","start":4526.73,"end":4526.85},{"text":"effecting","start":4526.85,"end":4527.29},{"text":"change.","start":4527.29,"end":4527.69}]},{"text":"One, scaling up harm reduction and HIV services that are accessible to all, including those in prisons and closed settings.","start":4527.77,"end":4534.65,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"One,","start":4527.77,"end":4528.25},{"text":"scaling","start":4528.41,"end":4528.89},{"text":"up","start":4528.93,"end":4529.05},{"text":"harm","start":4529.05,"end":4529.21},{"text":"reduction","start":4529.21,"end":4530.17},{"text":"and","start":4530.49,"end":4530.77},{"text":"HIV","start":4530.77,"end":4531.05},{"text":"services","start":4531.05,"end":4531.65},{"text":"that","start":4531.65,"end":4531.81},{"text":"are","start":4531.81,"end":4531.89},{"text":"accessible","start":4531.89,"end":4532.41},{"text":"to","start":4532.41,"end":4532.57},{"text":"all,","start":4532.57,"end":4532.73},{"text":"including","start":4532.73,"end":4533.21},{"text":"those","start":4533.21,"end":4533.37},{"text":"in","start":4533.37,"end":4533.49},{"text":"prisons","start":4533.49,"end":4533.89},{"text":"and","start":4533.89,"end":4534.05},{"text":"closed","start":4534.05,"end":4534.25},{"text":"settings.","start":4534.25,"end":4534.65}]},{"text":"And as Helen Clark mentioned, harm reduction works.","start":4535.01,"end":4538.41,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"And","start":4535.01,"end":4535.13},{"text":"as","start":4535.13,"end":4535.37},{"text":"Helen","start":4536.17,"end":4536.49},{"text":"Clark","start":4536.49,"end":4536.73},{"text":"mentioned,","start":4536.73,"end":4537.21},{"text":"harm","start":4537.37,"end":4537.61},{"text":"reduction","start":4537.61,"end":4538.01},{"text":"works.","start":4538.01,"end":4538.41}]},{"text":"Harm reduction saves lives.","start":4538.73,"end":4540.49,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"Harm","start":4538.73,"end":4539.05},{"text":"reduction","start":4539.05,"end":4539.53},{"text":"saves","start":4539.53,"end":4539.93},{"text":"lives.","start":4539.93,"end":4540.49}]},{"text":"Decriminalizing drug use and promoting the human rights of people who use drugs through equal treatment and access to services.","start":4540.89,"end":4546.73,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Decriminalizing","start":4540.89,"end":4541.93},{"text":"drug","start":4542.09,"end":4542.37},{"text":"use","start":4542.37,"end":4542.69},{"text":"and","start":4542.69,"end":4542.81},{"text":"promoting","start":4542.81,"end":4543.21},{"text":"the","start":4543.21,"end":4543.29},{"text":"human","start":4543.29,"end":4543.57},{"text":"rights","start":4543.57,"end":4543.81},{"text":"of","start":4543.81,"end":4543.89},{"text":"people","start":4543.89,"end":4544.25},{"text":"who","start":4544.25,"end":4544.33},{"text":"use","start":4544.33,"end":4544.49},{"text":"drugs","start":4544.49,"end":4544.81},{"text":"through","start":4544.81,"end":4544.97},{"text":"equal","start":4544.97,"end":4545.25},{"text":"treatment","start":4545.25,"end":4545.61},{"text":"and","start":4545.61,"end":4545.73},{"text":"access","start":4545.73,"end":4545.93},{"text":"to","start":4545.93,"end":4546.05},{"text":"services.","start":4546.05,"end":4546.73}]},{"text":"Eliminating stigma and discrimination, especially in healthcare, legal, and social systems.","start":4547.29,"end":4551.29,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Eliminating","start":4547.29,"end":4547.93},{"text":"stigma","start":4547.93,"end":4548.21},{"text":"and","start":4548.21,"end":4548.33},{"text":"discrimination,","start":4548.33,"end":4549.05},{"text":"especially","start":4549.05,"end":4549.45},{"text":"in","start":4549.45,"end":4549.53},{"text":"healthcare,","start":4549.53,"end":4549.93},{"text":"legal,","start":4549.93,"end":4550.25},{"text":"and","start":4550.25,"end":4550.37},{"text":"social","start":4550.37,"end":4550.73},{"text":"systems.","start":4550.73,"end":4551.29}]},{"text":"Redirecting investment from punitive control to health and right-based services, and including supporting and funding and empowering community-led organizations, especially those led by people who use drugs in shaping and delivering policies and programs.","start":4551.77,"end":4565.45,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Redirecting","start":4551.77,"end":4552.33},{"text":"investment","start":4552.33,"end":4552.85},{"text":"from","start":4552.85,"end":4553.01},{"text":"punitive","start":4553.01,"end":4553.45},{"text":"control","start":4553.45,"end":4553.85},{"text":"to","start":4553.85,"end":4553.97},{"text":"health","start":4553.97,"end":4554.21},{"text":"and","start":4554.21,"end":4554.37},{"text":"right-based","start":4554.37,"end":4554.85},{"text":"services,","start":4554.85,"end":4555.45},{"text":"and","start":4555.77,"end":4555.93},{"text":"including","start":4555.93,"end":4556.49},{"text":"supporting","start":4556.49,"end":4557.01},{"text":"and","start":4557.01,"end":4557.13},{"text":"funding","start":4557.13,"end":4557.57},{"text":"and","start":4557.57,"end":4557.69},{"text":"empowering","start":4557.69,"end":4558.25},{"text":"community-led","start":4558.25,"end":4558.89},{"text":"organizations,","start":4558.89,"end":4559.77},{"text":"especially","start":4559.89,"end":4560.41},{"text":"those","start":4560.41,"end":4560.73},{"text":"led","start":4560.89,"end":4561.09},{"text":"by","start":4561.09,"end":4561.21},{"text":"people","start":4561.29,"end":4561.57},{"text":"who","start":4561.61,"end":4561.69},{"text":"use","start":4561.69,"end":4561.81},{"text":"drugs","start":4561.89,"end":4562.21},{"text":"in","start":4562.49,"end":4562.65},{"text":"shaping","start":4562.65,"end":4563.21},{"text":"and","start":4563.21,"end":4563.41},{"text":"delivering","start":4563.41,"end":4563.85},{"text":"policies","start":4563.85,"end":4564.41},{"text":"and","start":4564.49,"end":4564.81},{"text":"programs.","start":4564.81,"end":4565.45}]},{"text":"Reducing inequalities that drive HIV and the engagement of key populations.","start":4565.77,"end":4569.77,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"Reducing","start":4565.77,"end":4566.21},{"text":"inequalities","start":4566.21,"end":4566.85},{"text":"that","start":4566.85,"end":4567.01},{"text":"drive","start":4567.01,"end":4567.29},{"text":"HIV","start":4567.29,"end":4567.85},{"text":"and","start":4568.01,"end":4568.21},{"text":"the","start":4568.21,"end":4568.29},{"text":"engagement","start":4568.29,"end":4568.73},{"text":"of","start":4568.73,"end":4568.81},{"text":"key","start":4568.81,"end":4568.97},{"text":"populations.","start":4568.97,"end":4569.77}]},{"text":"are key to the epidemic and key to the response and our global goal of ending AIDS by 2030.","start":4570.29,"end":4575.49,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"are","start":4570.29,"end":4570.41},{"text":"key","start":4570.41,"end":4570.77},{"text":"to","start":4570.77,"end":4570.85},{"text":"the","start":4570.85,"end":4570.97},{"text":"epidemic","start":4570.97,"end":4571.49},{"text":"and","start":4571.49,"end":4571.61},{"text":"key","start":4571.61,"end":4571.73},{"text":"to","start":4571.73,"end":4571.85},{"text":"the","start":4571.85,"end":4571.93},{"text":"response","start":4571.93,"end":4572.53},{"text":"and","start":4572.73,"end":4572.89},{"text":"our","start":4572.89,"end":4572.97},{"text":"global","start":4572.97,"end":4573.41},{"text":"goal","start":4573.57,"end":4573.81},{"text":"of","start":4573.81,"end":4573.93},{"text":"ending","start":4573.93,"end":4574.29},{"text":"AIDS","start":4574.29,"end":4574.53},{"text":"by","start":4574.53,"end":4574.69},{"text":"2030.","start":4574.69,"end":4575.49}]},{"text":"I thank you very much.","start":4575.49,"end":4576.45,"topics":[],"words":[{"text":"I","start":4575.49,"end":4575.57},{"text":"thank","start":4575.57,"end":4575.81},{"text":"you","start":4575.81,"end":4575.89},{"text":"very","start":4575.89,"end":4576.09},{"text":"much.","start":4576.09,"end":4576.45}]}]}],"speaker":{"affiliation":"UNAIDS","group":null,"function":"Senior Advisor","affiliation_full":"UNAIDS"}},{"statement_number":33,"start":4576.77,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:16:17","paragraphs":[{"sentences":[{"text":"Thanks.","start":4576.77,"end":4577.09,"topics":[],"words":[{"text":"Thanks.","start":4576.77,"end":4577.09}]},{"text":"I'm going to ask our UN colleagues to be even briefer than that.","start":4577.09,"end":4580.77,"topics":[],"words":[{"text":"I'm","start":4577.09,"end":4577.29},{"text":"going","start":4577.29,"end":4577.45},{"text":"to","start":4577.45,"end":4577.53},{"text":"ask","start":4577.53,"end":4578.05},{"text":"our","start":4578.45,"end":4578.69},{"text":"UN","start":4578.69,"end":4578.93},{"text":"colleagues","start":4578.93,"end":4579.33},{"text":"to","start":4579.33,"end":4579.45},{"text":"be","start":4579.45,"end":4579.69},{"text":"even","start":4579.69,"end":4579.89},{"text":"briefer","start":4579.89,"end":4580.21},{"text":"than","start":4580.21,"end":4580.45},{"text":"that.","start":4580.45,"end":4580.77}]},{"text":"Thanks.","start":4580.77,"end":4581.25,"topics":[],"words":[{"text":"Thanks.","start":4580.77,"end":4581.25}]},{"text":"Could we go to Dr. Werner Obermeyer, who is the director of the WHO office at the UN?","start":4581.81,"end":4587.25,"topics":[],"words":[{"text":"Could","start":4581.81,"end":4581.97},{"text":"we","start":4581.97,"end":4582.13},{"text":"go","start":4582.13,"end":4582.29},{"text":"to","start":4582.29,"end":4582.41},{"text":"Dr.","start":4582.41,"end":4582.97},{"text":"Werner","start":4582.97,"end":4583.41},{"text":"Obermeyer,","start":4583.41,"end":4584.09},{"text":"who","start":4584.09,"end":4584.17},{"text":"is","start":4584.17,"end":4584.25},{"text":"the","start":4584.25,"end":4584.37},{"text":"director","start":4584.37,"end":4584.77},{"text":"of","start":4584.77,"end":4584.85},{"text":"the","start":4584.85,"end":4585.09},{"text":"WHO","start":4585.09,"end":4585.41},{"text":"office","start":4585.41,"end":4586.21},{"text":"at","start":4586.53,"end":4586.65},{"text":"the","start":4586.65,"end":4586.73},{"text":"UN?","start":4586.77,"end":4587.25}]},{"text":"Please, Werner.","start":4587.49,"end":4588.29,"topics":[],"words":[{"text":"Please,","start":4587.49,"end":4587.89},{"text":"Werner.","start":4587.93,"end":4588.29}]}]}],"speaker":{"affiliation":"UNDP","group":null,"function":null,"affiliation_full":"UNDP"}},{"statement_number":34,"start":4589.37,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:16:30","paragraphs":[{"sentences":[{"text":"Thank you, Mandeep. The latest WHO global sector health strategies on HIV, viral hepatitis, and STIs are grounded in a person-centered approach and embedded within the principles of universal health coverage.","start":4589.37,"end":4604.53,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"Thank","start":4589.37,"end":4589.57},{"text":"you,","start":4589.57,"end":4589.65},{"text":"Mandeep.","start":4589.65,"end":4590.21},{"text":"The","start":4590.53,"end":4590.73},{"text":"latest","start":4591.25,"end":4592.21},{"text":"WHO","start":4592.21,"end":4592.37},{"text":"global","start":4592.37,"end":4592.93},{"text":"sector","start":4592.93,"end":4593.49},{"text":"health","start":4593.49,"end":4593.77},{"text":"strategies","start":4593.77,"end":4594.61},{"text":"on","start":4595.21,"end":4595.33},{"text":"HIV,","start":4595.37,"end":4595.89},{"text":"viral","start":4595.89,"end":4596.21},{"text":"hepatitis,","start":4596.21,"end":4597.01},{"text":"and","start":4597.13,"end":4597.41},{"text":"STIs","start":4597.49,"end":4598.45},{"text":"are","start":4598.85,"end":4599.01},{"text":"grounded","start":4599.01,"end":4599.49},{"text":"in","start":4599.49,"end":4599.65},{"text":"a","start":4599.65,"end":4599.73},{"text":"person-centered","start":4599.73,"end":4600.53},{"text":"approach","start":4600.53,"end":4601.01},{"text":"and","start":4601.05,"end":4601.21},{"text":"embedded","start":4601.21,"end":4601.73},{"text":"within","start":4601.73,"end":4602.05},{"text":"the","start":4602.05,"end":4602.13},{"text":"principles","start":4602.13,"end":4602.85},{"text":"of","start":4602.85,"end":4603.05},{"text":"universal","start":4603.05,"end":4603.57},{"text":"health","start":4603.57,"end":4603.81},{"text":"coverage.","start":4603.81,"end":4604.53}]},{"text":"People who inject drugs bear a disproportionate burden of hepatitis C infections, and injection drug use is estimated to account for up to 40% of their infections.","start":4605.01,"end":4618.21,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"People","start":4605.01,"end":4605.33},{"text":"who","start":4605.33,"end":4605.49},{"text":"inject","start":4605.49,"end":4606.13},{"text":"drugs","start":4606.13,"end":4606.77},{"text":"bear","start":4607.17,"end":4607.45},{"text":"a","start":4607.45,"end":4607.49},{"text":"disproportionate","start":4607.49,"end":4608.37},{"text":"burden","start":4608.37,"end":4608.85},{"text":"of","start":4608.93,"end":4609.09},{"text":"hepatitis","start":4609.09,"end":4609.85},{"text":"C","start":4609.85,"end":4610.29},{"text":"infections,","start":4611.41,"end":4612.21},{"text":"and","start":4612.69,"end":4612.89},{"text":"injection","start":4612.89,"end":4613.49},{"text":"drug","start":4613.49,"end":4613.81},{"text":"use","start":4613.81,"end":4614.01},{"text":"is","start":4614.01,"end":4614.29},{"text":"estimated","start":4614.29,"end":4614.93},{"text":"to","start":4614.93,"end":4615.05},{"text":"account","start":4615.05,"end":4615.41},{"text":"for","start":4615.41,"end":4616.29},{"text":"up","start":4616.33,"end":4616.45},{"text":"to","start":4616.45,"end":4616.97},{"text":"40%","start":4616.97,"end":4617.01},{"text":"of","start":4617.01,"end":4617.17},{"text":"their","start":4617.17,"end":4617.33},{"text":"infections.","start":4617.33,"end":4618.21}]},{"text":"The WHO key population guideline reaffirms the importance of integrated, person-centered prevention, testing, treatment, and care.","start":4618.93,"end":4628.21,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"The","start":4618.93,"end":4619.17},{"text":"WHO","start":4619.41,"end":4619.65},{"text":"key","start":4619.65,"end":4619.81},{"text":"population","start":4619.81,"end":4620.53},{"text":"guideline","start":4620.53,"end":4621.33},{"text":"reaffirms","start":4621.33,"end":4621.97},{"text":"the","start":4621.97,"end":4622.05},{"text":"importance","start":4622.05,"end":4622.77},{"text":"of","start":4622.77,"end":4623.01},{"text":"integrated,","start":4623.01,"end":4623.81},{"text":"person-centered","start":4623.81,"end":4624.85},{"text":"prevention,","start":4625.41,"end":4626.05},{"text":"testing,","start":4626.05,"end":4626.53},{"text":"treatment,","start":4626.53,"end":4627.25},{"text":"and","start":4627.25,"end":4627.65},{"text":"care.","start":4627.65,"end":4628.21}]}]},{"sentences":[{"text":"Since 2014, our guidelines have underscored the value of considering the decriminalization of drug use and possession of small quantities.","start":4628.89,"end":4637.49,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"Since","start":4628.89,"end":4629.05},{"text":"2014,","start":4629.05,"end":4630.45},{"text":"our","start":4630.45,"end":4630.69},{"text":"guidelines","start":4630.69,"end":4631.33},{"text":"have","start":4631.33,"end":4631.49},{"text":"underscored","start":4631.49,"end":4632.13},{"text":"the","start":4632.13,"end":4632.21},{"text":"value","start":4632.21,"end":4632.57},{"text":"of","start":4632.57,"end":4632.77},{"text":"considering","start":4632.77,"end":4633.41},{"text":"the","start":4633.41,"end":4633.61},{"text":"decriminalization","start":4633.61,"end":4634.73},{"text":"of","start":4634.73,"end":4634.85},{"text":"drug","start":4634.85,"end":4635.21},{"text":"use","start":4635.21,"end":4635.49},{"text":"and","start":4635.49,"end":4635.61},{"text":"possession","start":4635.61,"end":4636.17},{"text":"of","start":4636.17,"end":4636.25},{"text":"small","start":4636.25,"end":4636.61},{"text":"quantities.","start":4636.61,"end":4637.49}]},{"text":"We are now updating both our operational guide for needle and syringe programs and our clinical guidelines for the treatment of opioid dependency and overdose.","start":4638.13,"end":4648.37,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"We","start":4638.13,"end":4638.37},{"text":"are","start":4638.37,"end":4638.45},{"text":"now","start":4638.45,"end":4638.85},{"text":"updating","start":4638.85,"end":4639.57},{"text":"both","start":4639.57,"end":4639.89},{"text":"our","start":4639.89,"end":4640.05},{"text":"operational","start":4640.09,"end":4640.69},{"text":"guide","start":4640.69,"end":4641.09},{"text":"for","start":4641.09,"end":4641.25},{"text":"needle","start":4641.25,"end":4641.57},{"text":"and","start":4641.57,"end":4641.73},{"text":"syringe","start":4641.73,"end":4642.17},{"text":"programs","start":4642.21,"end":4643.01},{"text":"and","start":4643.53,"end":4643.65},{"text":"our","start":4643.65,"end":4643.81},{"text":"clinical","start":4643.81,"end":4644.33},{"text":"guidelines","start":4644.33,"end":4644.97},{"text":"for","start":4644.97,"end":4645.09},{"text":"the","start":4645.09,"end":4645.21},{"text":"treatment","start":4645.25,"end":4645.69},{"text":"of","start":4645.69,"end":4645.81},{"text":"opioid","start":4645.89,"end":4646.33},{"text":"dependency","start":4646.33,"end":4647.17},{"text":"and","start":4647.49,"end":4647.73},{"text":"overdose.","start":4647.73,"end":4648.37}]},{"text":"Thank you.","start":4648.37,"end":4648.77,"topics":[],"words":[{"text":"Thank","start":4648.37,"end":4648.61},{"text":"you.","start":4648.61,"end":4648.77}]}]}],"speaker":{"affiliation":"WHO","group":null,"function":"Director","affiliation_full":"WHO"}},{"statement_number":35,"start":4650.33,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:17:31","paragraphs":[{"sentences":[{"text":"Thank you, Werner. Yves Boukpeti from Office of the High Commissioner for Human Rights, you're welcome.","start":4650.33,"end":4656.81,"topics":[],"words":[{"text":"Thank","start":4650.33,"end":4650.53},{"text":"you,","start":4650.53,"end":4650.65},{"text":"Werner.","start":4650.65,"end":4651.17},{"text":"Yves","start":4651.89,"end":4652.29},{"text":"Boukpeti","start":4652.37,"end":4653.17},{"text":"from","start":4653.17,"end":4653.65},{"text":"Office","start":4653.97,"end":4654.53},{"text":"of","start":4654.53,"end":4654.69},{"text":"the","start":4654.69,"end":4654.77},{"text":"High","start":4654.77,"end":4655.09},{"text":"Commissioner","start":4655.09,"end":4655.61},{"text":"for","start":4655.61,"end":4655.73},{"text":"Human","start":4655.73,"end":4656.05},{"text":"Rights,","start":4656.05,"end":4656.29},{"text":"you're","start":4656.29,"end":4656.45},{"text":"welcome.","start":4656.45,"end":4656.81}]}]}],"speaker":{"affiliation":"UNDP","group":null,"function":null,"affiliation_full":"UNDP"}},{"statement_number":36,"start":4659.37,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:17:40","paragraphs":[{"sentences":[{"text":"Excellencies, distinguished participants, civil society partners, colleagues, let me start with a sentence that the High Commissioner Volker Türk stated on many occasions, that is, war on drugs has failed.","start":4659.37,"end":4676.25,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Excellencies,","start":4659.37,"end":4660.33},{"text":"distinguished","start":4660.93,"end":4661.61},{"text":"participants,","start":4661.61,"end":4662.41},{"text":"civil","start":4662.41,"end":4662.77},{"text":"society","start":4662.77,"end":4663.13},{"text":"partners,","start":4663.13,"end":4663.61},{"text":"colleagues,","start":4663.61,"end":4664.33},{"text":"let","start":4665.77,"end":4666.01},{"text":"me","start":4666.01,"end":4666.17},{"text":"start","start":4666.17,"end":4666.57},{"text":"with","start":4666.57,"end":4666.73},{"text":"a","start":4667.29,"end":4667.33},{"text":"sentence","start":4667.33,"end":4667.93},{"text":"that","start":4667.93,"end":4668.17},{"text":"the","start":4668.17,"end":4668.29},{"text":"High","start":4668.29,"end":4668.49},{"text":"Commissioner","start":4668.49,"end":4669.21},{"text":"Volker","start":4669.37,"end":4669.77},{"text":"Türk","start":4669.77,"end":4670.09},{"text":"stated","start":4670.49,"end":4671.21},{"text":"on","start":4671.21,"end":4671.53},{"text":"many","start":4671.53,"end":4671.93},{"text":"occasions,","start":4671.93,"end":4672.65},{"text":"that","start":4673.13,"end":4673.45},{"text":"is,","start":4673.45,"end":4673.85},{"text":"war","start":4674.17,"end":4674.65},{"text":"on","start":4674.65,"end":4674.89},{"text":"drugs","start":4674.89,"end":4675.37},{"text":"has","start":4675.37,"end":4675.77},{"text":"failed.","start":4675.77,"end":4676.25}]},{"text":"The recently published World Drug Report 2025 once again shows that drug use continues to hit record highs.","start":4677.13,"end":4685.29,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"The","start":4677.13,"end":4677.29},{"text":"recently","start":4677.29,"end":4678.01},{"text":"published","start":4678.01,"end":4678.65},{"text":"World","start":4678.65,"end":4678.93},{"text":"Drug","start":4678.93,"end":4679.21},{"text":"Report","start":4679.21,"end":4679.69},{"text":"2025","start":4679.69,"end":4680.73},{"text":"once","start":4680.73,"end":4681.13},{"text":"again","start":4681.13,"end":4681.45},{"text":"shows","start":4681.45,"end":4681.85},{"text":"that","start":4681.85,"end":4682.09},{"text":"drug","start":4682.09,"end":4682.49},{"text":"use","start":4682.49,"end":4682.89},{"text":"continues","start":4683.13,"end":4683.73},{"text":"to","start":4683.73,"end":4683.89},{"text":"hit","start":4683.89,"end":4684.33},{"text":"record","start":4684.41,"end":4684.85},{"text":"highs.","start":4684.85,"end":4685.29}]},{"text":"Most of the harm caused by drugs are preventable and can be mitigated by acting on different modifiers.","start":4686.13,"end":4693.17,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"Most","start":4686.13,"end":4686.41},{"text":"of","start":4686.41,"end":4686.61},{"text":"the","start":4686.61,"end":4686.69},{"text":"harm","start":4686.69,"end":4687.09},{"text":"caused","start":4687.09,"end":4687.45},{"text":"by","start":4687.45,"end":4687.57},{"text":"drugs","start":4687.57,"end":4688.13},{"text":"are","start":4688.13,"end":4688.29},{"text":"preventable","start":4688.29,"end":4689.25},{"text":"and","start":4689.57,"end":4689.73},{"text":"can","start":4689.73,"end":4689.97},{"text":"be","start":4689.97,"end":4690.29},{"text":"mitigated","start":4690.29,"end":4691.09},{"text":"by","start":4691.09,"end":4691.33},{"text":"acting","start":4691.33,"end":4691.77},{"text":"on","start":4691.77,"end":4691.93},{"text":"different","start":4691.93,"end":4692.45},{"text":"modifiers.","start":4692.45,"end":4693.17}]},{"text":"We must focus on preventing harms of drug.","start":4693.65,"end":4696.61,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"We","start":4693.65,"end":4693.81},{"text":"must","start":4693.81,"end":4694.05},{"text":"focus","start":4694.05,"end":4694.45},{"text":"on","start":4694.45,"end":4694.69},{"text":"preventing","start":4694.69,"end":4695.25},{"text":"harms","start":4695.25,"end":4695.73},{"text":"of","start":4696.05,"end":4696.29},{"text":"drug.","start":4696.29,"end":4696.61}]},{"text":"Evidence clearly show that it is human connection, human rights, and evidence-based approach that can transform and uplift the lives of people affected by drug.","start":4697.25,"end":4708.81,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Evidence","start":4697.25,"end":4697.81},{"text":"clearly","start":4697.81,"end":4698.21},{"text":"show","start":4698.21,"end":4698.69},{"text":"that","start":4699.01,"end":4699.41},{"text":"it","start":4699.41,"end":4699.57},{"text":"is","start":4699.57,"end":4699.73},{"text":"human","start":4699.73,"end":4700.05},{"text":"connection,","start":4700.05,"end":4700.69},{"text":"human","start":4700.69,"end":4701.01},{"text":"rights,","start":4701.01,"end":4701.41},{"text":"and","start":4701.49,"end":4701.73},{"text":"evidence-based","start":4701.73,"end":4702.53},{"text":"approach","start":4702.53,"end":4703.01},{"text":"that","start":4703.25,"end":4703.57},{"text":"can","start":4703.57,"end":4704.05},{"text":"transform","start":4704.69,"end":4705.33},{"text":"and","start":4705.33,"end":4705.53},{"text":"uplift","start":4705.53,"end":4706.05},{"text":"the","start":4706.29,"end":4706.41},{"text":"lives","start":4706.45,"end":4707.01},{"text":"of","start":4707.01,"end":4707.17},{"text":"people","start":4707.17,"end":4707.65},{"text":"affected","start":4707.65,"end":4708.21},{"text":"by","start":4708.21,"end":4708.45},{"text":"drug.","start":4708.45,"end":4708.81}]},{"text":"In 2023, OSHR submitted a report to the Human Rights Council calling for transformative change in drug policies.","start":4709.17,"end":4716.85,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"In","start":4709.17,"end":4709.33},{"text":"2023,","start":4709.33,"end":4710.37},{"text":"OSHR","start":4710.37,"end":4711.09},{"text":"submitted","start":4711.09,"end":4711.57},{"text":"a","start":4711.57,"end":4711.61},{"text":"report","start":4711.61,"end":4712.01},{"text":"to","start":4712.05,"end":4712.13},{"text":"the","start":4712.13,"end":4712.21},{"text":"Human","start":4712.21,"end":4712.45},{"text":"Rights","start":4712.45,"end":4712.69},{"text":"Council","start":4712.69,"end":4713.17},{"text":"calling","start":4713.65,"end":4713.97},{"text":"for","start":4713.97,"end":4714.29},{"text":"transformative","start":4714.29,"end":4715.17},{"text":"change","start":4715.17,"end":4715.65},{"text":"in","start":4715.73,"end":4715.89},{"text":"drug","start":4715.89,"end":4716.13},{"text":"policies.","start":4716.13,"end":4716.85}]},{"text":"Both Human Rights Council in 2023 and the Commission on Narcotic Drugs in 2024 recognized harm reduction an effective measure to prevent harm.","start":4717.33,"end":4730.37,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Both","start":4717.33,"end":4717.73},{"text":"Human","start":4717.73,"end":4718.01},{"text":"Rights","start":4718.01,"end":4718.37},{"text":"Council","start":4718.37,"end":4718.93},{"text":"in","start":4719.09,"end":4719.25},{"text":"2023","start":4719.25,"end":4720.45},{"text":"and","start":4720.69,"end":4720.89},{"text":"the","start":4720.89,"end":4720.97},{"text":"Commission","start":4720.97,"end":4721.49},{"text":"on","start":4721.49,"end":4721.81},{"text":"Narcotic","start":4722.21,"end":4722.85},{"text":"Drugs","start":4722.85,"end":4723.33},{"text":"in","start":4723.49,"end":4723.65},{"text":"2024","start":4723.65,"end":4724.65},{"text":"recognized","start":4724.65,"end":4725.33},{"text":"harm","start":4726.69,"end":4727.25},{"text":"reduction","start":4727.25,"end":4727.97},{"text":"an","start":4728.21,"end":4728.37},{"text":"effective","start":4728.37,"end":4729.01},{"text":"measure","start":4729.01,"end":4729.41},{"text":"to","start":4729.41,"end":4729.57},{"text":"prevent","start":4729.57,"end":4730.05},{"text":"harm.","start":4730.05,"end":4730.37}]},{"text":"Let me quickly highlight some points.","start":4730.77,"end":4733.73,"topics":[],"words":[{"text":"Let","start":4730.77,"end":4731.05},{"text":"me","start":4731.05,"end":4731.49},{"text":"quickly","start":4731.65,"end":4732.29},{"text":"highlight","start":4732.61,"end":4733.09},{"text":"some","start":4733.09,"end":4733.33},{"text":"points.","start":4733.33,"end":4733.73}]},{"text":"One, evidence is clear, harm reduction measure save lives.","start":4733.89,"end":4738.77,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"One,","start":4733.89,"end":4734.45},{"text":"evidence","start":4734.53,"end":4735.13},{"text":"is","start":4735.13,"end":4735.33},{"text":"clear,","start":4735.33,"end":4735.81},{"text":"harm","start":4736.05,"end":4736.37},{"text":"reduction","start":4736.37,"end":4737.09},{"text":"measure","start":4737.33,"end":4737.97},{"text":"save","start":4737.97,"end":4738.29},{"text":"lives.","start":4738.29,"end":4738.77}]},{"text":"Two, harm reduction will not work without clear supportive of legal framework criminalizing of people who use drugs creates stigma and fear three in human reduction In harm reduction and other efforts to address the drug situation, civil society, organizations, and the community of people who use drugs must be included.","start":4739.17,"end":4763.49,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Two,","start":4739.17,"end":4739.65},{"text":"harm","start":4740.93,"end":4741.25},{"text":"reduction","start":4741.25,"end":4741.89},{"text":"will","start":4741.89,"end":4742.21},{"text":"not","start":4742.21,"end":4742.37},{"text":"work","start":4742.37,"end":4742.61},{"text":"without","start":4742.61,"end":4743.05},{"text":"clear","start":4743.05,"end":4743.49},{"text":"supportive","start":4743.49,"end":4744.17},{"text":"of","start":4744.61,"end":4744.77},{"text":"legal","start":4744.77,"end":4745.17},{"text":"framework","start":4745.25,"end":4745.93},{"text":"criminalizing","start":4745.93,"end":4746.77},{"text":"of","start":4746.77,"end":4746.89},{"text":"people","start":4746.93,"end":4747.49},{"text":"who","start":4747.65,"end":4747.89},{"text":"use","start":4747.89,"end":4748.13},{"text":"drugs","start":4748.17,"end":4748.45},{"text":"creates","start":4748.93,"end":4749.49},{"text":"stigma","start":4749.57,"end":4750.25},{"text":"and","start":4750.25,"end":4750.45},{"text":"fear","start":4750.45,"end":4750.85},{"text":"three","start":4751.25,"end":4751.57},{"text":"in","start":4751.97,"end":4752.17},{"text":"human","start":4752.17,"end":4752.45},{"text":"reduction","start":4752.45,"end":4753.33},{"text":"In","start":4754.29,"end":4754.45},{"text":"harm","start":4754.45,"end":4754.77},{"text":"reduction","start":4754.77,"end":4755.41},{"text":"and","start":4755.41,"end":4755.57},{"text":"other","start":4755.57,"end":4756.01},{"text":"efforts","start":4756.01,"end":4756.33},{"text":"to","start":4756.33,"end":4756.45},{"text":"address","start":4756.45,"end":4756.85},{"text":"the","start":4756.85,"end":4757.01},{"text":"drug","start":4757.01,"end":4757.25},{"text":"situation,","start":4757.25,"end":4757.89},{"text":"civil","start":4758.13,"end":4758.45},{"text":"society,","start":4758.45,"end":4759.25},{"text":"organizations,","start":4759.41,"end":4760.29},{"text":"and","start":4760.29,"end":4760.45},{"text":"the","start":4760.45,"end":4760.53},{"text":"community","start":4760.53,"end":4761.05},{"text":"of","start":4761.05,"end":4761.17},{"text":"people","start":4761.17,"end":4761.53},{"text":"who","start":4761.53,"end":4761.65},{"text":"use","start":4761.65,"end":4761.89},{"text":"drugs","start":4761.89,"end":4762.17},{"text":"must","start":4762.37,"end":4762.69},{"text":"be","start":4762.69,"end":4762.85},{"text":"included.","start":4762.85,"end":4763.49}]},{"text":"Four, OSHI is very concerned about the decrease in funds for international aid, including for the health sector.","start":4763.81,"end":4772.29,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"Four,","start":4763.81,"end":4764.29},{"text":"OSHI","start":4764.53,"end":4765.25},{"text":"is","start":4765.29,"end":4765.41},{"text":"very","start":4765.41,"end":4765.73},{"text":"concerned","start":4765.73,"end":4766.29},{"text":"about","start":4766.29,"end":4766.77},{"text":"the","start":4767.01,"end":4767.13},{"text":"decrease","start":4767.17,"end":4767.65},{"text":"in","start":4767.65,"end":4767.89},{"text":"funds","start":4767.89,"end":4768.37},{"text":"for","start":4768.61,"end":4768.81},{"text":"international","start":4768.81,"end":4769.57},{"text":"aid,","start":4769.57,"end":4769.89},{"text":"including","start":4770.05,"end":4770.65},{"text":"for","start":4770.65,"end":4770.97},{"text":"the","start":4770.97,"end":4771.09},{"text":"health","start":4771.09,"end":4771.45},{"text":"sector.","start":4771.57,"end":4772.29}]},{"text":"Five, harm reduction education must be included in the prevention toolbox.","start":4772.53,"end":4778.77,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"Five,","start":4772.53,"end":4773.01},{"text":"harm","start":4774.21,"end":4774.53},{"text":"reduction","start":4774.53,"end":4775.17},{"text":"education","start":4775.25,"end":4775.81},{"text":"must","start":4775.81,"end":4776.05},{"text":"be","start":4776.05,"end":4776.21},{"text":"included","start":4776.21,"end":4776.77},{"text":"in","start":4776.77,"end":4777.01},{"text":"the","start":4777.01,"end":4777.09},{"text":"prevention","start":4777.09,"end":4777.81},{"text":"toolbox.","start":4777.97,"end":4778.77}]},{"text":"This measure should be human rights compliant.","start":4779.17,"end":4781.65,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"This","start":4779.17,"end":4779.49},{"text":"measure","start":4779.49,"end":4779.93},{"text":"should","start":4779.93,"end":4780.17},{"text":"be","start":4780.17,"end":4780.45},{"text":"human","start":4780.45,"end":4780.77},{"text":"rights","start":4780.77,"end":4781.01},{"text":"compliant.","start":4781.01,"end":4781.65}]},{"text":"excellence, participants, and dear colleagues, in conclusion, I would like to emphasize that as we work to ensure no one left behind, we must keep human rights at the center of the global drug policy discussion.","start":4782.41,"end":4794.49,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"excellence,","start":4782.41,"end":4782.89},{"text":"participants,","start":4782.89,"end":4783.61},{"text":"and","start":4783.69,"end":4783.97},{"text":"dear","start":4783.97,"end":4784.13},{"text":"colleagues,","start":4784.13,"end":4784.57},{"text":"in","start":4784.65,"end":4784.77},{"text":"conclusion,","start":4784.77,"end":4785.45},{"text":"I","start":4785.85,"end":4786.01},{"text":"would","start":4786.01,"end":4786.21},{"text":"like","start":4786.21,"end":4786.49},{"text":"to","start":4786.49,"end":4786.61},{"text":"emphasize","start":4786.65,"end":4787.21},{"text":"that","start":4787.21,"end":4787.53},{"text":"as","start":4787.93,"end":4788.25},{"text":"we","start":4788.25,"end":4788.41},{"text":"work","start":4788.41,"end":4788.73},{"text":"to","start":4788.73,"end":4788.89},{"text":"ensure","start":4788.89,"end":4789.29},{"text":"no","start":4789.29,"end":4789.45},{"text":"one","start":4789.45,"end":4789.61},{"text":"left","start":4789.61,"end":4789.93},{"text":"behind,","start":4789.93,"end":4790.41},{"text":"we","start":4790.65,"end":4790.81},{"text":"must","start":4790.81,"end":4791.09},{"text":"keep","start":4791.09,"end":4791.25},{"text":"human","start":4791.25,"end":4791.53},{"text":"rights","start":4791.53,"end":4791.89},{"text":"at","start":4791.89,"end":4791.97},{"text":"the","start":4791.97,"end":4792.05},{"text":"center","start":4792.05,"end":4792.45},{"text":"of","start":4792.45,"end":4792.65},{"text":"the","start":4792.65,"end":4792.77},{"text":"global","start":4792.77,"end":4793.13},{"text":"drug","start":4793.13,"end":4793.37},{"text":"policy","start":4793.37,"end":4793.85},{"text":"discussion.","start":4793.85,"end":4794.49}]},{"text":"In this endeavor, OSHR is committed to support states, civil society, and other stakeholders in line with the UN system, common position on drugs, and the international guidelines on human rights and drug policy.","start":4794.81,"end":4808.09,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"In","start":4794.81,"end":4794.97},{"text":"this","start":4794.97,"end":4795.29},{"text":"endeavor,","start":4795.29,"end":4795.97},{"text":"OSHR","start":4795.97,"end":4796.81},{"text":"is","start":4796.81,"end":4797.01},{"text":"committed","start":4797.01,"end":4797.49},{"text":"to","start":4797.49,"end":4797.57},{"text":"support","start":4797.61,"end":4798.01},{"text":"states,","start":4798.01,"end":4798.45},{"text":"civil","start":4798.45,"end":4798.65},{"text":"society,","start":4798.65,"end":4799.29},{"text":"and","start":4799.53,"end":4799.77},{"text":"other","start":4799.77,"end":4800.01},{"text":"stakeholders","start":4800.01,"end":4800.89},{"text":"in","start":4800.89,"end":4801.09},{"text":"line","start":4801.09,"end":4801.45},{"text":"with","start":4801.45,"end":4801.65},{"text":"the","start":4801.65,"end":4801.73},{"text":"UN","start":4801.73,"end":4802.01},{"text":"system,","start":4802.01,"end":4802.41},{"text":"common","start":4802.65,"end":4802.97},{"text":"position","start":4802.97,"end":4803.61},{"text":"on","start":4803.61,"end":4803.77},{"text":"drugs,","start":4803.77,"end":4804.25},{"text":"and","start":4804.49,"end":4804.69},{"text":"the","start":4804.69,"end":4804.77},{"text":"international","start":4804.77,"end":4805.45},{"text":"guidelines","start":4805.45,"end":4806.09},{"text":"on","start":4806.25,"end":4806.41},{"text":"human","start":4806.41,"end":4806.73},{"text":"rights","start":4806.73,"end":4807.09},{"text":"and","start":4807.13,"end":4807.49},{"text":"drug","start":4807.49,"end":4807.69},{"text":"policy.","start":4807.69,"end":4808.09}]},{"text":"Thank you.","start":4808.09,"end":4808.49,"topics":[],"words":[{"text":"Thank","start":4808.09,"end":4808.41},{"text":"you.","start":4808.41,"end":4808.49}]}]}],"speaker":{"affiliation":"OHCHR","group":null,"function":null,"affiliation_full":"OHCHR"}},{"statement_number":37,"start":4809.53,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:20:10","paragraphs":[{"sentences":[{"text":"you so much.","start":4809.53,"end":4810.41,"topics":[],"words":[{"text":"you","start":4809.53,"end":4809.73},{"text":"so","start":4809.73,"end":4809.93},{"text":"much.","start":4809.93,"end":4810.41}]},{"text":"Could I go next to UN Women and our colleague Elena, please?","start":4810.89,"end":4814.09,"topics":[],"words":[{"text":"Could","start":4810.89,"end":4811.13},{"text":"I","start":4811.13,"end":4811.21},{"text":"go","start":4811.21,"end":4811.37},{"text":"next","start":4811.37,"end":4811.73},{"text":"to","start":4811.73,"end":4811.81},{"text":"UN","start":4811.81,"end":4812.33},{"text":"Women","start":4812.33,"end":4812.65},{"text":"and","start":4812.65,"end":4812.77},{"text":"our","start":4812.77,"end":4812.89},{"text":"colleague","start":4812.89,"end":4813.25},{"text":"Elena,","start":4813.25,"end":4813.57},{"text":"please?","start":4813.57,"end":4814.09}]}]}],"speaker":{"affiliation":"UNDP","group":null,"function":null,"affiliation_full":"UNDP"}},{"statement_number":38,"start":4817.17,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:20:18","paragraphs":[{"sentences":[{"text":"Thank you so much.","start":4817.17,"end":4817.93,"topics":[],"words":[{"text":"Thank","start":4817.17,"end":4817.37},{"text":"you","start":4817.37,"end":4817.45},{"text":"so","start":4817.45,"end":4817.53},{"text":"much.","start":4817.53,"end":4817.93}]},{"text":"Thank you so much, Chair.","start":4818.17,"end":4819.29,"topics":[],"words":[{"text":"Thank","start":4818.17,"end":4818.33},{"text":"you","start":4818.33,"end":4818.41},{"text":"so","start":4818.41,"end":4818.57},{"text":"much,","start":4818.57,"end":4818.97},{"text":"Chair.","start":4818.97,"end":4819.29}]},{"text":"Excellencies, distinguished colleagues, for the sake of time, I'm going to zero in on the recommendations based on UN Women programming and evidence.","start":4819.53,"end":4826.09,"topics":[],"words":[{"text":"Excellencies,","start":4819.53,"end":4820.17},{"text":"distinguished","start":4820.17,"end":4820.69},{"text":"colleagues,","start":4820.69,"end":4821.05},{"text":"for","start":4821.05,"end":4821.21},{"text":"the","start":4821.21,"end":4821.29},{"text":"sake","start":4821.29,"end":4821.49},{"text":"of","start":4821.49,"end":4821.57},{"text":"time,","start":4821.57,"end":4821.69},{"text":"I'm","start":4821.69,"end":4821.89},{"text":"going","start":4821.89,"end":4822.05},{"text":"to","start":4822.05,"end":4822.13},{"text":"zero","start":4822.13,"end":4822.41},{"text":"in","start":4822.41,"end":4822.65},{"text":"on","start":4822.65,"end":4822.81},{"text":"the","start":4822.81,"end":4822.89},{"text":"recommendations","start":4822.89,"end":4823.85},{"text":"based","start":4824.01,"end":4824.41},{"text":"on","start":4824.41,"end":4824.57},{"text":"UN","start":4824.57,"end":4824.77},{"text":"Women","start":4824.77,"end":4825.05},{"text":"programming","start":4825.05,"end":4825.45},{"text":"and","start":4825.45,"end":4825.61},{"text":"evidence.","start":4825.61,"end":4826.09}]},{"text":"First and foremost, policy responses must be women-centered.","start":4826.41,"end":4829.29,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."}],"words":[{"text":"First","start":4826.41,"end":4826.69},{"text":"and","start":4826.69,"end":4826.81},{"text":"foremost,","start":4826.81,"end":4827.41},{"text":"policy","start":4827.41,"end":4827.73},{"text":"responses","start":4827.73,"end":4828.25},{"text":"must","start":4828.25,"end":4828.49},{"text":"be","start":4828.49,"end":4828.57},{"text":"women-centered.","start":4828.57,"end":4829.29}]},{"text":"It means they must reflect the realities women face, from women living with HIV and using drugs, to sex workers and women in prison, to young women and transgender people.","start":4829.53,"end":4838.25,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"It","start":4829.53,"end":4829.69},{"text":"means","start":4829.69,"end":4829.93},{"text":"they","start":4829.93,"end":4830.01},{"text":"must","start":4830.01,"end":4830.25},{"text":"reflect","start":4830.25,"end":4830.57},{"text":"the","start":4830.57,"end":4830.65},{"text":"realities","start":4830.65,"end":4831.29},{"text":"women","start":4831.29,"end":4831.61},{"text":"face,","start":4831.61,"end":4832.09},{"text":"from","start":4832.25,"end":4832.57},{"text":"women","start":4832.57,"end":4832.85},{"text":"living","start":4832.85,"end":4833.05},{"text":"with","start":4833.05,"end":4833.21},{"text":"HIV","start":4833.21,"end":4833.69},{"text":"and","start":4833.69,"end":4833.85},{"text":"using","start":4833.85,"end":4834.09},{"text":"drugs,","start":4834.09,"end":4834.49},{"text":"to","start":4834.49,"end":4834.57},{"text":"sex","start":4834.57,"end":4834.81},{"text":"workers","start":4834.81,"end":4835.21},{"text":"and","start":4835.21,"end":4835.33},{"text":"women","start":4835.33,"end":4835.53},{"text":"in","start":4835.53,"end":4835.61},{"text":"prison,","start":4835.61,"end":4836.17},{"text":"to","start":4836.49,"end":4836.61},{"text":"young","start":4836.61,"end":4836.77},{"text":"women","start":4836.81,"end":4837.21},{"text":"and","start":4837.21,"end":4837.41},{"text":"transgender","start":4837.41,"end":4837.85},{"text":"people.","start":4837.85,"end":4838.25}]},{"text":"We need better and and more consistent data.","start":4838.65,"end":4840.65,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."}],"words":[{"text":"We","start":4838.65,"end":4838.77},{"text":"need","start":4838.77,"end":4838.97},{"text":"better","start":4838.97,"end":4839.29},{"text":"and","start":4839.29,"end":4839.41},{"text":"and","start":4839.49,"end":4839.61},{"text":"more","start":4839.61,"end":4839.73},{"text":"consistent","start":4839.73,"end":4840.29},{"text":"data.","start":4840.29,"end":4840.65}]},{"text":"Without basic and sex and age segregated data and gender analysis, we cannot understand or respond to the specific barriers women face.","start":4840.81,"end":4847.93,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."}],"words":[{"text":"Without","start":4840.81,"end":4841.21},{"text":"basic","start":4841.21,"end":4841.57},{"text":"and","start":4841.57,"end":4841.69},{"text":"sex","start":4841.69,"end":4841.93},{"text":"and","start":4842.09,"end":4842.33},{"text":"age","start":4842.49,"end":4842.81},{"text":"segregated","start":4842.81,"end":4843.41},{"text":"data","start":4843.41,"end":4843.65},{"text":"and","start":4843.65,"end":4843.77},{"text":"gender","start":4843.77,"end":4844.01},{"text":"analysis,","start":4844.01,"end":4844.49},{"text":"we","start":4844.49,"end":4844.61},{"text":"cannot","start":4844.61,"end":4844.89},{"text":"understand","start":4844.89,"end":4845.45},{"text":"or","start":4845.45,"end":4845.57},{"text":"respond","start":4845.57,"end":4846.09},{"text":"to","start":4846.09,"end":4846.21},{"text":"the","start":4846.21,"end":4846.29},{"text":"specific","start":4846.29,"end":4846.69},{"text":"barriers","start":4846.69,"end":4847.21},{"text":"women","start":4847.21,"end":4847.53},{"text":"face.","start":4847.53,"end":4847.93}]},{"text":"Services must be integrated and comprehensive.","start":4848.33,"end":4850.65,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."}],"words":[{"text":"Services","start":4848.33,"end":4848.89},{"text":"must","start":4848.89,"end":4849.13},{"text":"be","start":4849.13,"end":4849.29},{"text":"integrated","start":4849.29,"end":4849.85},{"text":"and","start":4849.89,"end":4850.01},{"text":"comprehensive.","start":4850.01,"end":4850.65}]},{"text":"This includes linking harm reduction and HIV services with interventions addressing and responding to gender-based violence and sexual and reproductive health.","start":4850.73,"end":4857.93,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"This","start":4850.73,"end":4850.93},{"text":"includes","start":4850.93,"end":4851.45},{"text":"linking","start":4851.45,"end":4851.77},{"text":"harm","start":4851.77,"end":4852.01},{"text":"reduction","start":4852.01,"end":4852.49},{"text":"and","start":4852.49,"end":4852.69},{"text":"HIV","start":4852.69,"end":4852.97},{"text":"services","start":4852.97,"end":4853.45},{"text":"with","start":4853.45,"end":4853.57},{"text":"interventions","start":4853.57,"end":4854.17},{"text":"addressing","start":4854.17,"end":4854.73},{"text":"and","start":4854.89,"end":4855.05},{"text":"responding","start":4855.05,"end":4855.53},{"text":"to","start":4855.53,"end":4855.61},{"text":"gender-based","start":4855.61,"end":4856.17},{"text":"violence","start":4856.17,"end":4856.61},{"text":"and","start":4856.61,"end":4856.73},{"text":"sexual","start":4856.73,"end":4857.09},{"text":"and","start":4857.09,"end":4857.21},{"text":"reproductive","start":4857.21,"end":4857.69},{"text":"health.","start":4857.69,"end":4857.93}]},{"text":"Fourth, legal and policy environments must be reformed.","start":4859.09,"end":4861.57,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"Fourth,","start":4859.09,"end":4859.45},{"text":"legal","start":4859.65,"end":4859.93},{"text":"and","start":4859.93,"end":4860.05},{"text":"policy","start":4860.05,"end":4860.37},{"text":"environments","start":4860.37,"end":4860.85},{"text":"must","start":4860.85,"end":4861.05},{"text":"be","start":4861.05,"end":4861.21},{"text":"reformed.","start":4861.21,"end":4861.57}]},{"text":"Punitive laws continue to drive women underground, away from services and support.","start":4861.73,"end":4865.57,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Punitive","start":4861.73,"end":4862.17},{"text":"laws","start":4862.17,"end":4862.37},{"text":"continue","start":4862.37,"end":4862.85},{"text":"to","start":4862.85,"end":4862.93},{"text":"drive","start":4862.93,"end":4863.21},{"text":"women","start":4863.21,"end":4863.49},{"text":"underground,","start":4863.49,"end":4864.09},{"text":"away","start":4864.09,"end":4864.37},{"text":"from","start":4864.37,"end":4864.53},{"text":"services","start":4864.53,"end":4865.01},{"text":"and","start":4865.01,"end":4865.13},{"text":"support.","start":4865.13,"end":4865.57}]},{"text":"And finally, we agree with a lot of has been said about women's leadership.","start":4865.81,"end":4869.81,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"And","start":4865.81,"end":4866.05},{"text":"finally,","start":4866.05,"end":4866.69},{"text":"we","start":4866.77,"end":4866.89},{"text":"agree","start":4866.89,"end":4867.09},{"text":"with","start":4867.09,"end":4867.33},{"text":"a","start":4867.41,"end":4867.49},{"text":"lot","start":4867.49,"end":4867.77},{"text":"of","start":4867.77,"end":4867.89},{"text":"has","start":4867.89,"end":4868.13},{"text":"been","start":4868.13,"end":4868.29},{"text":"said","start":4868.29,"end":4868.61},{"text":"about","start":4868.61,"end":4869.01},{"text":"women's","start":4869.01,"end":4869.37},{"text":"leadership.","start":4869.37,"end":4869.81}]},{"text":"We must invest in women's leadership and meaningful engagement in the design, implementation, and monitoring of all policies and programs that affect their lives.","start":4869.89,"end":4877.09,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"We","start":4869.89,"end":4870.09},{"text":"must","start":4870.09,"end":4870.37},{"text":"invest","start":4870.37,"end":4870.77},{"text":"in","start":4870.77,"end":4870.85},{"text":"women's","start":4870.85,"end":4871.21},{"text":"leadership","start":4871.21,"end":4871.61},{"text":"and","start":4871.61,"end":4871.73},{"text":"meaningful","start":4871.73,"end":4872.13},{"text":"engagement","start":4872.13,"end":4872.69},{"text":"in","start":4872.93,"end":4873.09},{"text":"the","start":4873.09,"end":4873.17},{"text":"design,","start":4873.17,"end":4873.61},{"text":"implementation,","start":4873.61,"end":4874.29},{"text":"and","start":4874.29,"end":4874.41},{"text":"monitoring","start":4874.41,"end":4874.85},{"text":"of","start":4874.85,"end":4875.01},{"text":"all","start":4875.01,"end":4875.25},{"text":"policies","start":4875.25,"end":4875.61},{"text":"and","start":4875.61,"end":4875.73},{"text":"programs","start":4875.73,"end":4876.13},{"text":"that","start":4876.13,"end":4876.25},{"text":"affect","start":4876.25,"end":4876.57},{"text":"their","start":4876.57,"end":4876.69},{"text":"lives.","start":4876.69,"end":4877.09}]},{"text":"Thank you so much for the opportunity to feedback.","start":4877.33,"end":4879.25,"topics":[],"words":[{"text":"Thank","start":4877.33,"end":4877.53},{"text":"you","start":4877.53,"end":4877.61},{"text":"so","start":4877.61,"end":4877.73},{"text":"much","start":4877.73,"end":4877.89},{"text":"for","start":4877.89,"end":4878.01},{"text":"the","start":4878.01,"end":4878.09},{"text":"opportunity","start":4878.37,"end":4878.81},{"text":"to","start":4878.81,"end":4878.89},{"text":"feedback.","start":4878.89,"end":4879.25}]}]}],"speaker":{"affiliation":"UN Women","group":null,"function":null,"affiliation_full":"UN Women"}},{"statement_number":39,"start":4879.77,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:21:20","paragraphs":[{"sentences":[{"text":"Thank you, and thank you so much for saving us a little bit of time.","start":4879.77,"end":4882.69,"topics":[],"words":[{"text":"Thank","start":4879.77,"end":4879.97},{"text":"you,","start":4879.97,"end":4880.09},{"text":"and","start":4880.09,"end":4880.25},{"text":"thank","start":4880.25,"end":4880.41},{"text":"you","start":4880.41,"end":4880.49},{"text":"so","start":4880.49,"end":4880.69},{"text":"much","start":4880.69,"end":4880.93},{"text":"for","start":4880.93,"end":4881.25},{"text":"saving","start":4881.25,"end":4881.65},{"text":"us","start":4881.65,"end":4881.77},{"text":"a","start":4881.77,"end":4881.81},{"text":"little","start":4881.81,"end":4882.09},{"text":"bit","start":4882.09,"end":4882.21},{"text":"of","start":4882.21,"end":4882.29},{"text":"time.","start":4882.29,"end":4882.69}]},{"text":"Let me now go to Delphine Shantz, who's the representative of the UN ODC Liaison Office in New York.","start":4882.85,"end":4889.65,"topics":[],"words":[{"text":"Let","start":4882.85,"end":4883.05},{"text":"me","start":4883.05,"end":4883.17},{"text":"now","start":4883.17,"end":4883.57},{"text":"go","start":4883.81,"end":4884.13},{"text":"to","start":4884.13,"end":4884.37},{"text":"Delphine","start":4884.37,"end":4885.09},{"text":"Shantz,","start":4885.09,"end":4885.53},{"text":"who's","start":4885.53,"end":4885.77},{"text":"the","start":4885.77,"end":4885.85},{"text":"representative","start":4885.85,"end":4886.45},{"text":"of","start":4886.45,"end":4886.53},{"text":"the","start":4886.53,"end":4886.69},{"text":"UN","start":4886.69,"end":4887.17},{"text":"ODC","start":4887.17,"end":4887.89},{"text":"Liaison","start":4888.13,"end":4888.69},{"text":"Office","start":4888.69,"end":4889.09},{"text":"in","start":4889.09,"end":4889.17},{"text":"New","start":4889.17,"end":4889.25},{"text":"York.","start":4889.25,"end":4889.65}]},{"text":"Over to you, Delphine.","start":4889.89,"end":4890.85,"topics":[],"words":[{"text":"Over","start":4889.89,"end":4890.13},{"text":"to","start":4890.13,"end":4890.25},{"text":"you,","start":4890.25,"end":4890.37},{"text":"Delphine.","start":4890.37,"end":4890.85}]}]}],"speaker":{"affiliation":"UNDP","group":null,"function":null,"affiliation_full":"UNDP"}},{"statement_number":40,"start":4892.33,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:21:33","paragraphs":[{"sentences":[{"text":"Thank you very much, Eric. Silence, ladies and gentlemen.","start":4892.33,"end":4894.73,"topics":[],"words":[{"text":"Thank","start":4892.33,"end":4892.61},{"text":"you","start":4892.61,"end":4892.69},{"text":"very","start":4892.69,"end":4892.89},{"text":"much,","start":4892.89,"end":4893.13},{"text":"Eric.","start":4893.13,"end":4893.45},{"text":"Silence,","start":4893.45,"end":4893.77},{"text":"ladies","start":4893.77,"end":4894.05},{"text":"and","start":4894.05,"end":4894.21},{"text":"gentlemen.","start":4894.21,"end":4894.73}]},{"text":"On behalf of the United Nations Office on Drugs and Crime, thank you very much for the opportunity to be here today.","start":4894.73,"end":4900.57,"topics":[],"words":[{"text":"On","start":4894.73,"end":4894.81},{"text":"behalf","start":4894.81,"end":4895.13},{"text":"of","start":4895.13,"end":4895.21},{"text":"the","start":4895.21,"end":4895.37},{"text":"United","start":4895.37,"end":4895.89},{"text":"Nations","start":4895.89,"end":4896.25},{"text":"Office","start":4896.25,"end":4896.45},{"text":"on","start":4896.45,"end":4896.53},{"text":"Drugs","start":4896.53,"end":4896.73},{"text":"and","start":4896.73,"end":4896.85},{"text":"Crime,","start":4896.85,"end":4897.21},{"text":"thank","start":4897.21,"end":4897.37},{"text":"you","start":4897.37,"end":4897.45},{"text":"very","start":4897.45,"end":4897.61},{"text":"much","start":4897.61,"end":4897.81},{"text":"for","start":4897.81,"end":4897.93},{"text":"the","start":4897.93,"end":4898.01},{"text":"opportunity","start":4898.01,"end":4899.13},{"text":"to","start":4899.61,"end":4899.77},{"text":"be","start":4899.77,"end":4899.93},{"text":"here","start":4899.93,"end":4900.09},{"text":"today.","start":4900.09,"end":4900.57}]},{"text":"As you know, UNODC issued last year, last month, the World Drug Report, which shed light that the global number of people who use a drug in the past year was estimated 316 million people, 6% of the global population aged between 15 and 64.","start":4900.89,"end":4915.45,"topics":[],"words":[{"text":"As","start":4900.89,"end":4901.05},{"text":"you","start":4901.05,"end":4901.13},{"text":"know,","start":4901.13,"end":4901.25},{"text":"UNODC","start":4901.25,"end":4902.05},{"text":"issued","start":4902.05,"end":4902.25},{"text":"last","start":4902.25,"end":4902.65},{"text":"year,","start":4902.65,"end":4903.13},{"text":"last","start":4903.13,"end":4903.53},{"text":"month,","start":4903.53,"end":4903.93},{"text":"the","start":4904.09,"end":4904.25},{"text":"World","start":4904.25,"end":4904.53},{"text":"Drug","start":4904.53,"end":4904.69},{"text":"Report,","start":4904.69,"end":4905.17},{"text":"which","start":4905.17,"end":4905.33},{"text":"shed","start":4905.33,"end":4905.49},{"text":"light","start":4905.49,"end":4905.73},{"text":"that","start":4905.73,"end":4905.85},{"text":"the","start":4905.85,"end":4905.93},{"text":"global","start":4905.93,"end":4906.21},{"text":"number","start":4906.21,"end":4906.49},{"text":"of","start":4906.49,"end":4906.57},{"text":"people","start":4906.57,"end":4906.97},{"text":"who","start":4906.97,"end":4907.05},{"text":"use","start":4907.05,"end":4907.29},{"text":"a","start":4907.29,"end":4907.37},{"text":"drug","start":4907.37,"end":4907.77},{"text":"in","start":4907.77,"end":4907.93},{"text":"the","start":4907.93,"end":4908.05},{"text":"past","start":4908.05,"end":4908.49},{"text":"year","start":4908.49,"end":4908.65},{"text":"was","start":4908.65,"end":4908.85},{"text":"estimated","start":4908.85,"end":4909.45},{"text":"316","start":4909.45,"end":4910.65},{"text":"million","start":4910.65,"end":4910.97},{"text":"people,","start":4910.97,"end":4911.45},{"text":"6%","start":4911.45,"end":4911.49},{"text":"of","start":4911.53,"end":4911.61},{"text":"the","start":4911.77,"end":4911.93},{"text":"global","start":4911.93,"end":4912.89},{"text":"population","start":4912.89,"end":4913.61},{"text":"aged","start":4913.61,"end":4913.85},{"text":"between","start":4913.85,"end":4914.17},{"text":"15","start":4914.17,"end":4914.57},{"text":"and","start":4914.57,"end":4914.69},{"text":"64.","start":4914.69,"end":4915.45}]},{"text":"An estimated 14 million people, or 0.27% of the global population aged 14 to 64, injected drugs in 2023.","start":4916.01,"end":4927.17,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"An","start":4916.01,"end":4916.17},{"text":"estimated","start":4916.17,"end":4916.69},{"text":"14","start":4916.69,"end":4917.09},{"text":"million","start":4917.09,"end":4917.41},{"text":"people,","start":4917.41,"end":4917.97},{"text":"or","start":4918.05,"end":4918.45},{"text":"0.27%","start":4918.61,"end":4918.65},{"text":"of","start":4918.69,"end":4918.89},{"text":"the","start":4919.05,"end":4919.13},{"text":"global","start":4919.13,"end":4921.25},{"text":"population","start":4921.25,"end":4921.89},{"text":"aged","start":4921.89,"end":4922.29},{"text":"14","start":4922.45,"end":4922.77},{"text":"to","start":4922.77,"end":4922.89},{"text":"64,","start":4922.89,"end":4923.73},{"text":"injected","start":4923.97,"end":4924.41},{"text":"drugs","start":4924.41,"end":4924.77},{"text":"in","start":4924.77,"end":4925.73},{"text":"2023.","start":4926.29,"end":4927.17}]},{"text":"So injecting drugs continues to be a significant driver to some infections, particularly global hepatitis and HIV.","start":4927.41,"end":4937.65,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"So","start":4927.41,"end":4927.53},{"text":"injecting","start":4927.53,"end":4927.89},{"text":"drugs","start":4927.89,"end":4928.21},{"text":"continues","start":4928.21,"end":4928.85},{"text":"to","start":4928.85,"end":4928.97},{"text":"be","start":4929.01,"end":4929.29},{"text":"a","start":4929.29,"end":4929.33},{"text":"significant","start":4929.33,"end":4929.89},{"text":"driver","start":4929.89,"end":4930.37},{"text":"to","start":4930.37,"end":4930.77},{"text":"some","start":4931.17,"end":4931.73},{"text":"infections,","start":4932.45,"end":4933.01},{"text":"particularly","start":4933.01,"end":4933.65},{"text":"global","start":4933.65,"end":4934.17},{"text":"hepatitis","start":4934.17,"end":4934.97},{"text":"and","start":4934.97,"end":4935.81},{"text":"HIV.","start":4937.01,"end":4937.65}]},{"text":"So most harm of the health could actually be preventable by making services that address opioid use disorder available and accessible, reducing the risk of opioid overdoses, providing services that reduce the transmission impact of communicable diseases among people who use drugs.","start":4939.01,"end":4955.09,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"So","start":4939.01,"end":4939.33},{"text":"most","start":4939.57,"end":4939.89},{"text":"harm","start":4939.89,"end":4940.37},{"text":"of","start":4940.37,"end":4940.61},{"text":"the","start":4940.61,"end":4940.69},{"text":"health","start":4940.69,"end":4940.97},{"text":"could","start":4940.97,"end":4941.21},{"text":"actually","start":4941.21,"end":4941.49},{"text":"be","start":4941.49,"end":4941.57},{"text":"preventable","start":4941.57,"end":4942.17},{"text":"by","start":4942.17,"end":4942.29},{"text":"making","start":4942.29,"end":4942.61},{"text":"services","start":4942.61,"end":4943.33},{"text":"that","start":4943.33,"end":4943.81},{"text":"address","start":4944.05,"end":4944.45},{"text":"opioid","start":4944.45,"end":4944.77},{"text":"use","start":4944.77,"end":4945.01},{"text":"disorder","start":4945.01,"end":4945.41},{"text":"available","start":4945.41,"end":4946.05},{"text":"and","start":4946.05,"end":4946.17},{"text":"accessible,","start":4946.17,"end":4946.85},{"text":"reducing","start":4947.09,"end":4947.57},{"text":"the","start":4947.57,"end":4947.69},{"text":"risk","start":4947.69,"end":4947.97},{"text":"of","start":4947.97,"end":4948.05},{"text":"opioid","start":4948.05,"end":4948.37},{"text":"overdoses,","start":4948.37,"end":4949.17},{"text":"providing","start":4949.17,"end":4949.65},{"text":"services","start":4949.65,"end":4950.29},{"text":"that","start":4950.29,"end":4950.45},{"text":"reduce","start":4950.45,"end":4950.93},{"text":"the","start":4950.93,"end":4951.01},{"text":"transmission","start":4951.01,"end":4951.65},{"text":"impact","start":4951.65,"end":4952.21},{"text":"of","start":4952.21,"end":4952.37},{"text":"communicable","start":4952.37,"end":4953.09},{"text":"diseases","start":4953.09,"end":4953.65},{"text":"among","start":4953.65,"end":4953.97},{"text":"people","start":4953.97,"end":4954.29},{"text":"who","start":4954.29,"end":4954.45},{"text":"use","start":4954.45,"end":4954.65},{"text":"drugs.","start":4954.65,"end":4955.09}]},{"text":"All such interventions have indeed proved to be effective in reducing HIV and hepatitis C infections, improving quality of life and preventing overdoses.","start":4955.73,"end":4964.29,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"All","start":4955.73,"end":4955.97},{"text":"such","start":4955.97,"end":4956.21},{"text":"interventions","start":4956.21,"end":4957.01},{"text":"have","start":4957.01,"end":4957.17},{"text":"indeed","start":4957.17,"end":4957.49},{"text":"proved","start":4957.49,"end":4957.81},{"text":"to","start":4957.81,"end":4957.89},{"text":"be","start":4957.89,"end":4958.01},{"text":"effective","start":4958.01,"end":4958.53},{"text":"in","start":4958.53,"end":4958.69},{"text":"reducing","start":4958.69,"end":4959.17},{"text":"HIV","start":4959.17,"end":4959.81},{"text":"and","start":4959.81,"end":4960.05},{"text":"hepatitis","start":4960.05,"end":4960.65},{"text":"C","start":4960.65,"end":4960.85},{"text":"infections,","start":4960.85,"end":4961.53},{"text":"improving","start":4961.53,"end":4961.97},{"text":"quality","start":4961.97,"end":4962.41},{"text":"of","start":4962.41,"end":4962.53},{"text":"life","start":4962.53,"end":4962.81},{"text":"and","start":4962.81,"end":4962.93},{"text":"preventing","start":4962.93,"end":4963.49},{"text":"overdoses.","start":4963.49,"end":4964.29}]},{"text":"UNODC is committed to supporting Member States implementing such policy as part of a broader, comprehensive drug control.","start":4965.09,"end":4970.65,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"UNODC","start":4965.09,"end":4965.81},{"text":"is","start":4965.81,"end":4965.89},{"text":"committed","start":4965.89,"end":4966.17},{"text":"to","start":4966.17,"end":4966.25},{"text":"supporting","start":4966.25,"end":4966.57},{"text":"Member","start":4966.57,"end":4966.81},{"text":"States","start":4966.81,"end":4967.01},{"text":"implementing","start":4967.01,"end":4967.53},{"text":"such","start":4967.53,"end":4967.77},{"text":"policy","start":4967.77,"end":4968.13},{"text":"as","start":4968.13,"end":4968.25},{"text":"part","start":4968.25,"end":4968.57},{"text":"of","start":4968.57,"end":4968.65},{"text":"a","start":4968.65,"end":4968.73},{"text":"broader,","start":4968.73,"end":4969.13},{"text":"comprehensive","start":4969.13,"end":4969.85},{"text":"drug","start":4969.85,"end":4970.09},{"text":"control.","start":4970.09,"end":4970.65}]},{"text":"Health systems must be supplied with the resources and tools needed to provide scientific-based evidence, quality interventions, and such intervention must be age and gender appropriate and include efforts to prevent drug use and provide treatment and care for those with drug use disorders, as well as measures that support their long-term recovery.","start":4971.05,"end":4989.85,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"Health","start":4971.05,"end":4971.33},{"text":"systems","start":4971.33,"end":4971.93},{"text":"must","start":4971.93,"end":4972.25},{"text":"be","start":4972.25,"end":4972.37},{"text":"supplied","start":4972.37,"end":4972.77},{"text":"with","start":4972.77,"end":4972.93},{"text":"the","start":4972.93,"end":4973.01},{"text":"resources","start":4973.01,"end":4973.45},{"text":"and","start":4973.45,"end":4973.65},{"text":"tools","start":4973.65,"end":4974.01},{"text":"needed","start":4974.01,"end":4974.29},{"text":"to","start":4974.29,"end":4974.45},{"text":"provide","start":4974.45,"end":4974.81},{"text":"scientific-based","start":4974.81,"end":4975.77},{"text":"evidence,","start":4975.77,"end":4976.33},{"text":"quality","start":4976.57,"end":4976.97},{"text":"interventions,","start":4976.97,"end":4977.85},{"text":"and","start":4977.89,"end":4978.09},{"text":"such","start":4978.09,"end":4978.33},{"text":"intervention","start":4978.33,"end":4978.97},{"text":"must","start":4978.97,"end":4979.21},{"text":"be","start":4979.21,"end":4979.53},{"text":"age","start":4979.61,"end":4979.93},{"text":"and","start":4979.93,"end":4980.13},{"text":"gender","start":4980.13,"end":4980.69},{"text":"appropriate","start":4980.69,"end":4981.17},{"text":"and","start":4981.17,"end":4981.29},{"text":"include","start":4981.29,"end":4981.69},{"text":"efforts","start":4981.69,"end":4982.17},{"text":"to","start":4982.33,"end":4982.45},{"text":"prevent","start":4982.45,"end":4982.85},{"text":"drug","start":4982.85,"end":4983.05},{"text":"use","start":4983.05,"end":4983.33},{"text":"and","start":4983.33,"end":4983.45},{"text":"provide","start":4983.45,"end":4983.73},{"text":"treatment","start":4983.73,"end":4984.25},{"text":"and","start":4984.25,"end":4984.37},{"text":"care","start":4984.37,"end":4984.73},{"text":"for","start":4984.89,"end":4985.09},{"text":"those","start":4985.09,"end":4985.53},{"text":"with","start":4985.69,"end":4985.93},{"text":"drug","start":4985.93,"end":4986.25},{"text":"use","start":4986.33,"end":4986.61},{"text":"disorders,","start":4986.61,"end":4987.21},{"text":"as","start":4987.21,"end":4987.29},{"text":"well","start":4987.29,"end":4987.41},{"text":"as","start":4987.41,"end":4987.53},{"text":"measures","start":4987.53,"end":4987.97},{"text":"that","start":4987.97,"end":4988.09},{"text":"support","start":4988.09,"end":4988.57},{"text":"their","start":4988.65,"end":4988.85},{"text":"long-term","start":4988.85,"end":4989.29},{"text":"recovery.","start":4989.29,"end":4989.85}]},{"text":"The limited availability of evidence-based services remains a barrier to the provision of effective treatment.","start":4990.69,"end":4996.77,"topics":[],"words":[{"text":"The","start":4990.69,"end":4990.73},{"text":"limited","start":4990.73,"end":4991.13},{"text":"availability","start":4991.13,"end":4991.97},{"text":"of","start":4991.97,"end":4992.13},{"text":"evidence-based","start":4992.13,"end":4993.33},{"text":"services","start":4993.65,"end":4994.13},{"text":"remains","start":4994.13,"end":4994.57},{"text":"a","start":4994.57,"end":4994.61},{"text":"barrier","start":4994.61,"end":4994.85},{"text":"to","start":4994.85,"end":4994.97},{"text":"the","start":4994.97,"end":4995.05},{"text":"provision","start":4995.05,"end":4995.49},{"text":"of","start":4995.49,"end":4995.57},{"text":"effective","start":4995.57,"end":4996.05},{"text":"treatment.","start":4996.05,"end":4996.77}]},{"text":"Some people are still unwilling to seek treatment owing to the fear of stigma and discrimination.","start":4996.93,"end":5001.81,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Some","start":4996.93,"end":4997.25},{"text":"people","start":4997.25,"end":4997.73},{"text":"are","start":4997.73,"end":4997.97},{"text":"still","start":4997.97,"end":4998.33},{"text":"unwilling","start":4998.33,"end":4998.85},{"text":"to","start":4998.85,"end":4998.97},{"text":"seek","start":4998.97,"end":4999.25},{"text":"treatment","start":4999.25,"end":4999.77},{"text":"owing","start":4999.77,"end":4999.97},{"text":"to","start":4999.97,"end":5000.05},{"text":"the","start":5000.05,"end":5000.13},{"text":"fear","start":5000.13,"end":5000.41},{"text":"of","start":5000.41,"end":5000.49},{"text":"stigma","start":5000.49,"end":5000.81},{"text":"and","start":5000.81,"end":5000.97},{"text":"discrimination.","start":5000.97,"end":5001.81}]},{"text":"Women face additional barriers, such as the double stigma, expectations about their social roles and responsibilities, fear of legal sanctions, and lack of childcare support.","start":5002.05,"end":5011.25,"topics":[{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"Women","start":5002.05,"end":5002.45},{"text":"face","start":5002.45,"end":5002.93},{"text":"additional","start":5003.57,"end":5004.01},{"text":"barriers,","start":5004.01,"end":5004.37},{"text":"such","start":5004.37,"end":5004.57},{"text":"as","start":5004.57,"end":5004.73},{"text":"the","start":5004.73,"end":5004.81},{"text":"double","start":5004.81,"end":5005.09},{"text":"stigma,","start":5005.09,"end":5005.45},{"text":"expectations","start":5005.45,"end":5006.37},{"text":"about","start":5006.37,"end":5006.61},{"text":"their","start":5006.61,"end":5006.77},{"text":"social","start":5006.77,"end":5007.09},{"text":"roles","start":5007.09,"end":5007.41},{"text":"and","start":5007.41,"end":5007.57},{"text":"responsibilities,","start":5007.57,"end":5008.53},{"text":"fear","start":5008.69,"end":5008.93},{"text":"of","start":5008.93,"end":5009.01},{"text":"legal","start":5009.01,"end":5009.29},{"text":"sanctions,","start":5009.29,"end":5009.69},{"text":"and","start":5009.69,"end":5009.85},{"text":"lack","start":5009.85,"end":5010.13},{"text":"of","start":5010.13,"end":5010.21},{"text":"childcare","start":5010.21,"end":5010.65},{"text":"support.","start":5010.65,"end":5011.25}]},{"text":"Better policy, the strengthening of health and social systems and services, and education and outreach are needed to tackle these issues.","start":5011.73,"end":5017.81,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"Better","start":5011.73,"end":5012.05},{"text":"policy,","start":5012.05,"end":5012.53},{"text":"the","start":5012.53,"end":5012.61},{"text":"strengthening","start":5012.61,"end":5013.25},{"text":"of","start":5013.25,"end":5013.41},{"text":"health","start":5013.41,"end":5013.73},{"text":"and","start":5013.73,"end":5013.93},{"text":"social","start":5013.93,"end":5014.21},{"text":"systems","start":5014.21,"end":5014.65},{"text":"and","start":5014.65,"end":5014.77},{"text":"services,","start":5014.77,"end":5015.17},{"text":"and","start":5015.17,"end":5015.29},{"text":"education","start":5015.29,"end":5015.81},{"text":"and","start":5015.81,"end":5015.93},{"text":"outreach","start":5015.93,"end":5016.33},{"text":"are","start":5016.33,"end":5016.41},{"text":"needed","start":5016.41,"end":5016.73},{"text":"to","start":5016.73,"end":5016.81},{"text":"tackle","start":5016.81,"end":5017.09},{"text":"these","start":5017.09,"end":5017.25},{"text":"issues.","start":5017.25,"end":5017.81}]},{"text":"So we remain committed to supporting member states with legislative policy and technical assistance, promoting balanced, evidence-based responses to world drug problem in line with international law and the UN common position on drugs.","start":5018.41,"end":5031.29,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"So","start":5018.41,"end":5018.49},{"text":"we","start":5018.49,"end":5018.61},{"text":"remain","start":5018.61,"end":5018.97},{"text":"committed","start":5018.97,"end":5019.53},{"text":"to","start":5020.01,"end":5020.21},{"text":"supporting","start":5020.21,"end":5020.65},{"text":"member","start":5020.65,"end":5020.89},{"text":"states","start":5020.89,"end":5021.13},{"text":"with","start":5021.13,"end":5021.25},{"text":"legislative","start":5021.25,"end":5021.81},{"text":"policy","start":5021.81,"end":5022.37},{"text":"and","start":5022.37,"end":5022.49},{"text":"technical","start":5022.49,"end":5023.13},{"text":"assistance,","start":5023.13,"end":5023.97},{"text":"promoting","start":5023.97,"end":5024.41},{"text":"balanced,","start":5024.41,"end":5024.97},{"text":"evidence-based","start":5024.97,"end":5025.65},{"text":"responses","start":5025.65,"end":5026.25},{"text":"to","start":5026.25,"end":5026.33},{"text":"world","start":5026.33,"end":5026.61},{"text":"drug","start":5026.61,"end":5026.77},{"text":"problem","start":5026.77,"end":5027.29},{"text":"in","start":5027.61,"end":5027.77},{"text":"line","start":5027.77,"end":5027.97},{"text":"with","start":5027.97,"end":5028.09},{"text":"international","start":5028.09,"end":5028.97},{"text":"law","start":5029.01,"end":5029.09},{"text":"and","start":5029.13,"end":5029.45},{"text":"the","start":5029.45,"end":5029.53},{"text":"UN","start":5029.53,"end":5029.85},{"text":"common","start":5029.85,"end":5030.25},{"text":"position","start":5030.25,"end":5030.81},{"text":"on","start":5030.81,"end":5030.89},{"text":"drugs.","start":5030.89,"end":5031.29}]},{"text":"Thank you.","start":5031.29,"end":5031.61,"topics":[],"words":[{"text":"Thank","start":5031.29,"end":5031.53},{"text":"you.","start":5031.53,"end":5031.61}]}]}],"speaker":{"affiliation":"UNODC","group":null,"function":null,"affiliation_full":"UNODC"}},{"statement_number":41,"start":5031.93,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:23:52","paragraphs":[{"sentences":[{"text":"Thank you so much.","start":5031.93,"end":5032.81,"topics":[],"words":[{"text":"Thank","start":5031.93,"end":5032.13},{"text":"you","start":5032.13,"end":5032.25},{"text":"so","start":5032.25,"end":5032.41},{"text":"much.","start":5032.41,"end":5032.81}]},{"text":"And it's now my pleasure to hand back over to the ambassador to close us out with two very, very important interventions.","start":5032.89,"end":5039.85,"topics":[],"words":[{"text":"And","start":5032.89,"end":5033.17},{"text":"it's","start":5033.17,"end":5033.45},{"text":"now","start":5033.45,"end":5033.61},{"text":"my","start":5033.61,"end":5033.77},{"text":"pleasure","start":5033.77,"end":5034.41},{"text":"to","start":5034.73,"end":5034.85},{"text":"hand","start":5034.85,"end":5035.13},{"text":"back","start":5035.13,"end":5035.49},{"text":"over","start":5035.49,"end":5035.69},{"text":"to","start":5035.69,"end":5035.81},{"text":"the","start":5035.81,"end":5035.89},{"text":"ambassador","start":5035.89,"end":5036.41},{"text":"to","start":5036.41,"end":5036.53},{"text":"close","start":5036.53,"end":5037.05},{"text":"us","start":5037.05,"end":5037.13},{"text":"out","start":5037.13,"end":5037.29},{"text":"with","start":5037.29,"end":5037.53},{"text":"two","start":5037.85,"end":5038.09},{"text":"very,","start":5038.09,"end":5038.37},{"text":"very","start":5038.37,"end":5038.65},{"text":"important","start":5038.65,"end":5039.05},{"text":"interventions.","start":5039.05,"end":5039.85}]},{"text":"And let me just before that, just to pay tribute to the young people who were clearly very well organized in their interventions, and we certainly need and more of that spirit.","start":5040.17,"end":5049.85,"topics":[],"words":[{"text":"And","start":5040.17,"end":5040.41},{"text":"let","start":5040.41,"end":5040.53},{"text":"me","start":5040.53,"end":5040.65},{"text":"just","start":5040.65,"end":5040.93},{"text":"before","start":5040.93,"end":5041.29},{"text":"that,","start":5041.29,"end":5041.57},{"text":"just","start":5041.57,"end":5041.81},{"text":"to","start":5041.81,"end":5041.93},{"text":"pay","start":5042.01,"end":5042.25},{"text":"tribute","start":5042.25,"end":5042.73},{"text":"to","start":5042.73,"end":5042.81},{"text":"the","start":5042.81,"end":5042.93},{"text":"young","start":5042.93,"end":5043.13},{"text":"people","start":5043.13,"end":5043.61},{"text":"who","start":5043.77,"end":5043.93},{"text":"were","start":5043.93,"end":5044.13},{"text":"clearly","start":5044.13,"end":5044.57},{"text":"very","start":5044.57,"end":5044.89},{"text":"well","start":5044.89,"end":5045.13},{"text":"organized","start":5045.13,"end":5045.81},{"text":"in","start":5045.81,"end":5045.89},{"text":"their","start":5045.89,"end":5046.09},{"text":"interventions,","start":5046.09,"end":5046.97},{"text":"and","start":5047.13,"end":5047.37},{"text":"we","start":5047.37,"end":5047.53},{"text":"certainly","start":5047.53,"end":5048.01},{"text":"need","start":5048.01,"end":5048.25},{"text":"and","start":5048.45,"end":5048.65},{"text":"more","start":5048.69,"end":5049.05},{"text":"of","start":5049.05,"end":5049.17},{"text":"that","start":5049.17,"end":5049.37},{"text":"spirit.","start":5049.37,"end":5049.85}]},{"text":"And as a fellow Canadian, I was very proud to hear from all of our Canadian colleagues and young people.","start":5049.85,"end":5055.93,"topics":[],"words":[{"text":"And","start":5049.85,"end":5050.05},{"text":"as","start":5050.05,"end":5050.17},{"text":"a","start":5050.17,"end":5050.25},{"text":"fellow","start":5050.25,"end":5050.57},{"text":"Canadian,","start":5050.57,"end":5051.13},{"text":"I","start":5051.37,"end":5051.53},{"text":"was","start":5051.53,"end":5051.69},{"text":"very","start":5051.69,"end":5052.09},{"text":"proud","start":5052.09,"end":5052.33},{"text":"to","start":5052.33,"end":5052.65},{"text":"hear","start":5052.81,"end":5053.13},{"text":"from","start":5053.13,"end":5053.37},{"text":"all","start":5053.37,"end":5053.53},{"text":"of","start":5053.53,"end":5053.61},{"text":"our","start":5053.61,"end":5053.69},{"text":"Canadian","start":5053.69,"end":5054.41},{"text":"colleagues","start":5054.65,"end":5055.21},{"text":"and","start":5055.21,"end":5055.37},{"text":"young","start":5055.37,"end":5055.53},{"text":"people.","start":5055.53,"end":5055.93}]},{"text":"So keep up the energy and the engagement with the UN system.","start":5055.93,"end":5059.69,"topics":[],"words":[{"text":"So","start":5055.93,"end":5056.41},{"text":"keep","start":5056.97,"end":5057.29},{"text":"up","start":5057.29,"end":5057.45},{"text":"the","start":5057.45,"end":5057.57},{"text":"energy","start":5057.57,"end":5057.97},{"text":"and","start":5057.97,"end":5058.09},{"text":"the","start":5058.09,"end":5058.21},{"text":"engagement","start":5058.21,"end":5058.73},{"text":"with","start":5058.73,"end":5058.89},{"text":"the","start":5058.89,"end":5058.97},{"text":"UN","start":5058.97,"end":5059.29},{"text":"system.","start":5059.29,"end":5059.69}]},{"text":"We need you.","start":5059.69,"end":5060.33,"topics":[],"words":[{"text":"We","start":5059.69,"end":5059.85},{"text":"need","start":5059.85,"end":5060.17},{"text":"you.","start":5060.17,"end":5060.33}]},{"text":"Madam Ambassador.","start":5061.37,"end":5062.25,"topics":[],"words":[{"text":"Madam","start":5061.37,"end":5061.65},{"text":"Ambassador.","start":5061.65,"end":5062.25}]}]}],"speaker":{"affiliation":"UNDP","group":null,"function":null,"affiliation_full":"UNDP"}},{"statement_number":42,"start":5068.49,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:24:29","paragraphs":[{"sentences":[{"text":"Thank you very much.","start":5068.49,"end":5069.49,"topics":[],"words":[{"text":"Thank","start":5068.49,"end":5068.69},{"text":"you","start":5068.69,"end":5068.77},{"text":"very","start":5068.77,"end":5068.93},{"text":"much.","start":5068.93,"end":5069.49}]},{"text":"And I want to thank all our speakers, partners, and participants for your contributions.","start":5069.49,"end":5075.09,"topics":[],"words":[{"text":"And","start":5069.49,"end":5069.89},{"text":"I","start":5069.89,"end":5069.97},{"text":"want","start":5069.97,"end":5070.25},{"text":"to","start":5070.25,"end":5070.33},{"text":"thank","start":5070.33,"end":5070.69},{"text":"all","start":5070.85,"end":5071.13},{"text":"our","start":5071.13,"end":5071.33},{"text":"speakers,","start":5071.33,"end":5071.97},{"text":"partners,","start":5072.05,"end":5072.65},{"text":"and","start":5072.65,"end":5072.77},{"text":"participants","start":5072.77,"end":5073.57},{"text":"for","start":5073.57,"end":5073.89},{"text":"your","start":5073.89,"end":5074.21},{"text":"contributions.","start":5074.21,"end":5075.09}]},{"text":"So to close our session, it is my pleasure to introduce Mr. Mauricio Jaramillo Yacir, Deputy Minister of Multilateral Affairs of the Ministry of Foreign Affairs of Colombia, who will be followed by Mr. Quisito Bienkia, Advocacy Advisor for Multilateral Engagement at the Open Society Foundation.","start":5075.33,"end":5096.05,"topics":[],"words":[{"text":"So","start":5075.33,"end":5075.65},{"text":"to","start":5075.65,"end":5075.81},{"text":"close","start":5075.81,"end":5076.17},{"text":"our","start":5076.17,"end":5076.37},{"text":"session,","start":5076.37,"end":5077.01},{"text":"it","start":5077.01,"end":5077.17},{"text":"is","start":5077.17,"end":5077.33},{"text":"my","start":5077.33,"end":5077.49},{"text":"pleasure","start":5077.49,"end":5077.89},{"text":"to","start":5077.89,"end":5078.05},{"text":"introduce","start":5078.05,"end":5078.61},{"text":"Mr.","start":5078.61,"end":5078.93},{"text":"Mauricio","start":5078.93,"end":5079.73},{"text":"Jaramillo","start":5080.09,"end":5080.69},{"text":"Yacir,","start":5081.09,"end":5081.41},{"text":"Deputy","start":5081.89,"end":5082.53},{"text":"Minister","start":5082.53,"end":5083.25},{"text":"of","start":5083.57,"end":5083.89},{"text":"Multilateral","start":5083.89,"end":5084.73},{"text":"Affairs","start":5084.73,"end":5085.01},{"text":"of","start":5085.01,"end":5085.17},{"text":"the","start":5085.17,"end":5085.25},{"text":"Ministry","start":5085.25,"end":5085.61},{"text":"of","start":5085.61,"end":5085.69},{"text":"Foreign","start":5085.69,"end":5086.05},{"text":"Affairs","start":5086.05,"end":5086.41},{"text":"of","start":5086.41,"end":5086.53},{"text":"Colombia,","start":5086.53,"end":5087.17},{"text":"who","start":5087.41,"end":5087.57},{"text":"will","start":5087.57,"end":5087.77},{"text":"be","start":5087.77,"end":5087.97},{"text":"followed","start":5087.97,"end":5088.33},{"text":"by","start":5088.33,"end":5088.61},{"text":"Mr.","start":5088.77,"end":5089.41},{"text":"Quisito","start":5089.41,"end":5090.21},{"text":"Bienkia,","start":5090.21,"end":5090.89},{"text":"Advocacy","start":5090.89,"end":5091.61},{"text":"Advisor","start":5091.61,"end":5092.29},{"text":"for","start":5092.53,"end":5092.77},{"text":"Multilateral","start":5092.77,"end":5093.53},{"text":"Engagement","start":5093.53,"end":5094.29},{"text":"at","start":5094.29,"end":5094.45},{"text":"the","start":5094.45,"end":5094.61},{"text":"Open","start":5094.61,"end":5094.93},{"text":"Society","start":5094.93,"end":5095.41},{"text":"Foundation.","start":5095.41,"end":5096.05}]},{"text":"Deputy Minister Jaramillo, you have the.","start":5096.53,"end":5098.37,"topics":[],"words":[{"text":"Deputy","start":5096.53,"end":5096.85},{"text":"Minister","start":5096.85,"end":5097.25},{"text":"Jaramillo,","start":5097.25,"end":5097.65},{"text":"you","start":5097.65,"end":5097.97},{"text":"have","start":5097.97,"end":5098.21},{"text":"the.","start":5098.21,"end":5098.37}]}]}],"speaker":{"affiliation":"MEX","group":null,"function":"Deputy Permanent Representative","affiliation_full":"Mexico"}},{"statement_number":43,"start":5101.25,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:25:02","paragraphs":[{"sentences":[{"text":"Thank you, Ambassador, for giving me the floor.","start":5101.25,"end":5102.93,"topics":[],"words":[{"text":"Thank","start":5101.25,"end":5101.49},{"text":"you,","start":5101.49,"end":5101.61},{"text":"Ambassador,","start":5101.61,"end":5102.05},{"text":"for","start":5102.05,"end":5102.17},{"text":"giving","start":5102.17,"end":5102.37},{"text":"me","start":5102.37,"end":5102.53},{"text":"the","start":5102.53,"end":5102.65},{"text":"floor.","start":5102.65,"end":5102.93}]},{"text":"Hello, everyone.","start":5102.93,"end":5104.13,"topics":[],"words":[{"text":"Hello,","start":5102.93,"end":5103.33},{"text":"everyone.","start":5103.53,"end":5104.13}]},{"text":"I would like to start by thanking our longstanding partners and friends from Mexico, Switzerland, Czechia, the Office of the High Commissioner for Human Rights, WHO, UNDP, UNAIDS, Open Society, and the Global Commission for organizing this timely event.","start":5105.73,"end":5121.77,"topics":[],"words":[{"text":"I","start":5105.73,"end":5105.77},{"text":"would","start":5105.77,"end":5105.89},{"text":"like","start":5105.89,"end":5106.17},{"text":"to","start":5106.17,"end":5106.25},{"text":"start","start":5106.25,"end":5106.53},{"text":"by","start":5106.53,"end":5106.69},{"text":"thanking","start":5106.69,"end":5107.21},{"text":"our","start":5107.21,"end":5107.41},{"text":"longstanding","start":5107.57,"end":5108.29},{"text":"partners","start":5108.29,"end":5108.69},{"text":"and","start":5108.69,"end":5109.01},{"text":"friends","start":5109.01,"end":5109.57},{"text":"from","start":5109.57,"end":5109.93},{"text":"Mexico,","start":5109.93,"end":5110.41},{"text":"Switzerland,","start":5110.41,"end":5111.01},{"text":"Czechia,","start":5111.01,"end":5111.49},{"text":"the","start":5112.45,"end":5112.73},{"text":"Office","start":5112.73,"end":5113.09},{"text":"of","start":5113.09,"end":5113.25},{"text":"the","start":5113.25,"end":5113.37},{"text":"High","start":5113.37,"end":5113.57},{"text":"Commissioner","start":5113.57,"end":5114.05},{"text":"for","start":5114.05,"end":5114.17},{"text":"Human","start":5114.17,"end":5114.41},{"text":"Rights,","start":5114.41,"end":5114.93},{"text":"WHO,","start":5115.17,"end":5115.49},{"text":"UNDP,","start":5115.73,"end":5116.77},{"text":"UNAIDS,","start":5116.77,"end":5117.61},{"text":"Open","start":5117.61,"end":5117.77},{"text":"Society,","start":5117.77,"end":5118.05},{"text":"and","start":5118.05,"end":5118.17},{"text":"the","start":5118.17,"end":5118.25},{"text":"Global","start":5118.25,"end":5118.53},{"text":"Commission","start":5118.53,"end":5119.09},{"text":"for","start":5119.65,"end":5119.81},{"text":"organizing","start":5119.81,"end":5120.49},{"text":"this","start":5120.49,"end":5120.85},{"text":"timely","start":5120.85,"end":5121.45},{"text":"event.","start":5121.45,"end":5121.77}]},{"text":"It is an honor for me to be here with all of you.","start":5121.81,"end":5125.09,"topics":[],"words":[{"text":"It","start":5121.81,"end":5122.21},{"text":"is","start":5122.21,"end":5122.41},{"text":"an","start":5122.41,"end":5122.61},{"text":"honor","start":5122.61,"end":5122.77},{"text":"for","start":5122.77,"end":5123.01},{"text":"me","start":5123.01,"end":5123.13},{"text":"to","start":5123.13,"end":5123.25},{"text":"be","start":5123.25,"end":5123.65},{"text":"here","start":5123.65,"end":5124.05},{"text":"with","start":5124.05,"end":5124.29},{"text":"all","start":5124.41,"end":5124.61},{"text":"of","start":5124.65,"end":5124.85},{"text":"you.","start":5124.85,"end":5125.09}]},{"text":"Our discussions today are rooted in one element that has been crucial in our past and ongoing discussions on drug policy and health evidence.","start":5125.97,"end":5135.33,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Our","start":5125.97,"end":5126.13},{"text":"discussions","start":5126.13,"end":5126.93},{"text":"today","start":5126.93,"end":5127.33},{"text":"are","start":5127.33,"end":5127.57},{"text":"rooted","start":5127.57,"end":5127.97},{"text":"in","start":5127.97,"end":5128.09},{"text":"one","start":5128.09,"end":5128.29},{"text":"element","start":5128.29,"end":5128.65},{"text":"that","start":5128.65,"end":5128.77},{"text":"has","start":5128.77,"end":5128.93},{"text":"been","start":5128.93,"end":5129.25},{"text":"crucial","start":5129.25,"end":5130.37},{"text":"in","start":5130.37,"end":5130.57},{"text":"our","start":5130.57,"end":5130.77},{"text":"past","start":5130.77,"end":5131.09},{"text":"and","start":5131.09,"end":5131.25},{"text":"ongoing","start":5131.25,"end":5131.65},{"text":"discussions","start":5131.65,"end":5132.45},{"text":"on","start":5132.73,"end":5132.81},{"text":"drug","start":5132.81,"end":5133.01},{"text":"policy","start":5133.01,"end":5133.57},{"text":"and","start":5133.57,"end":5133.81},{"text":"health","start":5133.81,"end":5134.21},{"text":"evidence.","start":5134.69,"end":5135.33}]},{"text":"As all of you are aware, for some years now, the centrality of science and evidence as an indispensable tool for informing drug policy has been one of Colombia's major interests at the national and international levels.","start":5135.89,"end":5149.17,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"As","start":5135.89,"end":5136.21},{"text":"all","start":5136.29,"end":5136.45},{"text":"of","start":5136.45,"end":5136.61},{"text":"you","start":5136.61,"end":5136.85},{"text":"are","start":5136.85,"end":5137.17},{"text":"aware,","start":5137.17,"end":5137.65},{"text":"for","start":5137.65,"end":5137.85},{"text":"some","start":5137.85,"end":5138.05},{"text":"years","start":5138.05,"end":5138.29},{"text":"now,","start":5138.29,"end":5138.45},{"text":"the","start":5138.45,"end":5138.61},{"text":"centrality","start":5138.61,"end":5139.17},{"text":"of","start":5139.17,"end":5139.25},{"text":"science","start":5139.25,"end":5139.81},{"text":"and","start":5139.81,"end":5140.01},{"text":"evidence","start":5140.01,"end":5140.69},{"text":"as","start":5141.21,"end":5141.41},{"text":"an","start":5141.45,"end":5141.65},{"text":"indispensable","start":5141.65,"end":5142.37},{"text":"tool","start":5142.37,"end":5142.61},{"text":"for","start":5142.61,"end":5142.77},{"text":"informing","start":5142.77,"end":5143.37},{"text":"drug","start":5143.37,"end":5143.57},{"text":"policy","start":5143.57,"end":5143.93},{"text":"has","start":5143.93,"end":5144.09},{"text":"been","start":5144.09,"end":5144.29},{"text":"one","start":5144.29,"end":5144.45},{"text":"of","start":5144.45,"end":5144.61},{"text":"Colombia's","start":5144.69,"end":5145.29},{"text":"major","start":5145.29,"end":5145.65},{"text":"interests","start":5145.73,"end":5146.45},{"text":"at","start":5146.93,"end":5147.17},{"text":"the","start":5147.17,"end":5147.29},{"text":"national","start":5147.29,"end":5147.85},{"text":"and","start":5147.89,"end":5148.13},{"text":"international","start":5148.13,"end":5148.73},{"text":"levels.","start":5148.73,"end":5149.17}]},{"text":"For us, it is clear facts, data, and scientific rigor are necessary drivers for public policy, particularly when addressing intersecting issues like drugs, health, and human rights.","start":5150.09,"end":5161.69,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"For","start":5150.09,"end":5150.33},{"text":"us,","start":5150.33,"end":5150.57},{"text":"it","start":5150.65,"end":5150.89},{"text":"is","start":5150.89,"end":5151.05},{"text":"clear","start":5151.05,"end":5151.69},{"text":"facts,","start":5151.77,"end":5152.33},{"text":"data,","start":5152.33,"end":5152.77},{"text":"and","start":5152.77,"end":5152.93},{"text":"scientific","start":5152.93,"end":5153.45},{"text":"rigor","start":5153.45,"end":5153.81},{"text":"are","start":5153.81,"end":5154.09},{"text":"necessary","start":5154.09,"end":5154.65},{"text":"drivers","start":5154.65,"end":5155.09},{"text":"for","start":5155.09,"end":5155.21},{"text":"public","start":5155.21,"end":5155.61},{"text":"policy,","start":5155.61,"end":5156.17},{"text":"particularly","start":5156.17,"end":5156.97},{"text":"when","start":5157.37,"end":5157.61},{"text":"addressing","start":5157.61,"end":5158.25},{"text":"intersecting","start":5158.25,"end":5158.97},{"text":"issues","start":5158.97,"end":5159.53},{"text":"like","start":5159.61,"end":5159.85},{"text":"drugs,","start":5159.85,"end":5160.29},{"text":"health,","start":5160.33,"end":5160.73},{"text":"and","start":5160.73,"end":5160.89},{"text":"human","start":5160.89,"end":5161.21},{"text":"rights.","start":5161.21,"end":5161.69}]},{"text":"In this context, we always must keep in mind that the original aim of the international drug control system is to protect the health and welfare of humankind.","start":5162.49,"end":5172.49,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"In","start":5162.49,"end":5162.65},{"text":"this","start":5162.65,"end":5162.89},{"text":"context,","start":5162.89,"end":5163.45},{"text":"we","start":5163.85,"end":5164.09},{"text":"always","start":5164.09,"end":5164.73},{"text":"must","start":5164.81,"end":5165.13},{"text":"keep","start":5165.13,"end":5165.37},{"text":"in","start":5165.37,"end":5165.53},{"text":"mind","start":5165.53,"end":5165.81},{"text":"that","start":5165.81,"end":5165.93},{"text":"the","start":5165.93,"end":5166.05},{"text":"original","start":5166.05,"end":5166.57},{"text":"aim","start":5166.57,"end":5166.97},{"text":"of","start":5167.05,"end":5167.21},{"text":"the","start":5167.21,"end":5167.33},{"text":"international","start":5167.33,"end":5167.85},{"text":"drug","start":5167.85,"end":5168.13},{"text":"control","start":5168.13,"end":5168.49},{"text":"system","start":5168.49,"end":5168.97},{"text":"is","start":5169.41,"end":5169.49},{"text":"to","start":5169.49,"end":5169.61},{"text":"protect","start":5169.61,"end":5170.09},{"text":"the","start":5170.09,"end":5170.21},{"text":"health","start":5170.21,"end":5170.65},{"text":"and","start":5170.69,"end":5170.81},{"text":"welfare","start":5170.81,"end":5171.37},{"text":"of","start":5171.37,"end":5171.53},{"text":"humankind.","start":5171.77,"end":5172.49}]},{"text":"Therefore, we have to instrumentalize evidence as a tool for obtaining those goals.","start":5173.09,"end":5178.97,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Therefore,","start":5173.09,"end":5173.65},{"text":"we","start":5173.89,"end":5174.05},{"text":"have","start":5174.05,"end":5174.21},{"text":"to","start":5174.21,"end":5174.37},{"text":"instrumentalize","start":5174.37,"end":5175.33},{"text":"evidence","start":5175.33,"end":5176.05},{"text":"as","start":5176.05,"end":5176.29},{"text":"a","start":5176.29,"end":5176.37},{"text":"tool","start":5176.37,"end":5176.77},{"text":"for","start":5176.85,"end":5177.25},{"text":"obtaining","start":5177.25,"end":5178.05},{"text":"those","start":5178.05,"end":5178.53},{"text":"goals.","start":5178.53,"end":5178.97}]},{"text":"In other words, the main objectives of the international drug system can only be achieved if we adopt evidence and science-based policies.","start":5178.97,"end":5188.61,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"In","start":5178.97,"end":5179.09},{"text":"other","start":5179.09,"end":5179.25},{"text":"words,","start":5179.25,"end":5179.81},{"text":"the","start":5180.13,"end":5180.25},{"text":"main","start":5180.25,"end":5180.45},{"text":"objectives","start":5181.25,"end":5182.05},{"text":"of","start":5182.25,"end":5182.37},{"text":"the","start":5182.37,"end":5182.49},{"text":"international","start":5182.49,"end":5183.09},{"text":"drug","start":5183.09,"end":5183.25},{"text":"system","start":5183.25,"end":5183.73},{"text":"can","start":5184.13,"end":5184.37},{"text":"only","start":5184.37,"end":5184.61},{"text":"be","start":5184.61,"end":5184.77},{"text":"achieved","start":5184.77,"end":5185.33},{"text":"if","start":5185.33,"end":5185.53},{"text":"we","start":5185.53,"end":5185.81},{"text":"adopt","start":5185.81,"end":5186.29},{"text":"evidence","start":5186.29,"end":5186.93},{"text":"and","start":5186.93,"end":5187.13},{"text":"science-based","start":5187.13,"end":5187.97},{"text":"policies.","start":5188.05,"end":5188.61}]},{"text":"There is a plethora of reports, analysis, and statistics that show that decriminalizing consumption and possession of small amounts of drugs for personal use and adopting and implementing harm reduction measures are effective tools for materializing human rights and for attaining health objectives.","start":5189.33,"end":5209.49,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"There","start":5189.33,"end":5189.49},{"text":"is","start":5189.49,"end":5189.65},{"text":"a","start":5189.65,"end":5189.73},{"text":"plethora","start":5189.73,"end":5190.09},{"text":"of","start":5190.09,"end":5190.21},{"text":"reports,","start":5190.21,"end":5190.77},{"text":"analysis,","start":5190.77,"end":5191.25},{"text":"and","start":5191.25,"end":5191.41},{"text":"statistics","start":5191.41,"end":5192.05},{"text":"that","start":5192.05,"end":5192.93},{"text":"show","start":5192.93,"end":5193.25},{"text":"that","start":5193.25,"end":5193.57},{"text":"decriminalizing","start":5193.57,"end":5194.61},{"text":"consumption","start":5194.61,"end":5195.41},{"text":"and","start":5195.49,"end":5195.81},{"text":"possession","start":5195.81,"end":5196.33},{"text":"of","start":5196.33,"end":5196.53},{"text":"small","start":5196.53,"end":5196.93},{"text":"amounts","start":5196.93,"end":5197.29},{"text":"of","start":5197.29,"end":5197.37},{"text":"drugs","start":5197.37,"end":5197.73},{"text":"for","start":5197.81,"end":5198.05},{"text":"personal","start":5198.05,"end":5198.45},{"text":"use","start":5198.45,"end":5198.77},{"text":"and","start":5199.33,"end":5199.45},{"text":"adopting","start":5199.45,"end":5200.29},{"text":"and","start":5200.29,"end":5200.45},{"text":"implementing","start":5200.45,"end":5201.41},{"text":"harm","start":5201.49,"end":5201.89},{"text":"reduction","start":5201.89,"end":5202.61},{"text":"measures","start":5202.61,"end":5203.17},{"text":"are","start":5203.49,"end":5203.73},{"text":"effective","start":5203.73,"end":5204.37},{"text":"tools","start":5204.45,"end":5204.93},{"text":"for","start":5204.93,"end":5205.17},{"text":"materializing","start":5205.17,"end":5205.89},{"text":"human","start":5205.89,"end":5206.21},{"text":"rights","start":5206.21,"end":5206.69},{"text":"and","start":5207.09,"end":5207.33},{"text":"for","start":5207.33,"end":5207.57},{"text":"attaining","start":5207.57,"end":5208.13},{"text":"health","start":5208.13,"end":5208.53},{"text":"objectives.","start":5208.77,"end":5209.49}]},{"text":"In this regard, please allow me to recall two authoritative reports.","start":5210.21,"end":5215.09,"topics":[],"words":[{"text":"In","start":5210.21,"end":5210.29},{"text":"this","start":5210.29,"end":5210.53},{"text":"regard,","start":5210.53,"end":5211.09},{"text":"please","start":5211.21,"end":5211.65},{"text":"allow","start":5211.73,"end":5211.93},{"text":"me","start":5211.93,"end":5212.13},{"text":"to","start":5212.13,"end":5212.25},{"text":"recall","start":5212.25,"end":5212.77},{"text":"two","start":5212.77,"end":5213.09},{"text":"authoritative","start":5213.33,"end":5214.13},{"text":"reports.","start":5214.21,"end":5215.09}]},{"text":"First, the High Commissioner for Human Rights showed that as a result of lack of services in 2021, 10% of all new HIV infections globally were among people who inject drugs, and people who inject drugs face a 35 times higher risk of acquiring HIV than the rest of the adult population.","start":5216.13,"end":5237.97,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"First,","start":5216.13,"end":5216.61},{"text":"the","start":5216.61,"end":5216.81},{"text":"High","start":5216.81,"end":5216.93},{"text":"Commissioner","start":5216.93,"end":5217.41},{"text":"for","start":5217.41,"end":5217.53},{"text":"Human","start":5217.53,"end":5217.81},{"text":"Rights","start":5217.81,"end":5218.37},{"text":"showed","start":5218.37,"end":5218.85},{"text":"that","start":5219.25,"end":5219.57},{"text":"as","start":5219.57,"end":5219.73},{"text":"a","start":5219.89,"end":5219.97},{"text":"result","start":5219.97,"end":5220.77},{"text":"of","start":5220.93,"end":5221.17},{"text":"lack","start":5221.17,"end":5221.57},{"text":"of","start":5221.85,"end":5221.97},{"text":"services","start":5221.97,"end":5222.49},{"text":"in","start":5222.49,"end":5222.61},{"text":"2021,","start":5222.61,"end":5223.81},{"text":"10%","start":5224.77,"end":5224.81},{"text":"of","start":5224.85,"end":5225.37},{"text":"all","start":5225.37,"end":5225.57},{"text":"new","start":5225.57,"end":5225.97},{"text":"HIV","start":5226.13,"end":5226.85},{"text":"infections","start":5226.85,"end":5227.49},{"text":"globally","start":5227.49,"end":5227.93},{"text":"were","start":5227.93,"end":5228.13},{"text":"among","start":5228.13,"end":5228.53},{"text":"people","start":5228.53,"end":5228.97},{"text":"who","start":5228.97,"end":5229.17},{"text":"inject","start":5229.17,"end":5229.73},{"text":"drugs,","start":5229.89,"end":5230.37},{"text":"and","start":5230.37,"end":5230.49},{"text":"people","start":5230.49,"end":5230.77},{"text":"who","start":5230.77,"end":5230.89},{"text":"inject","start":5230.89,"end":5231.25},{"text":"drugs","start":5231.25,"end":5231.57},{"text":"face","start":5231.57,"end":5232.05},{"text":"a","start":5232.61,"end":5232.65},{"text":"35","start":5232.65,"end":5233.33},{"text":"times","start":5233.49,"end":5233.89},{"text":"higher","start":5233.89,"end":5234.33},{"text":"risk","start":5234.33,"end":5234.65},{"text":"of","start":5234.65,"end":5234.77},{"text":"acquiring","start":5234.77,"end":5235.33},{"text":"HIV","start":5235.41,"end":5236.05},{"text":"than","start":5236.05,"end":5236.21},{"text":"the","start":5236.21,"end":5236.33},{"text":"rest","start":5236.33,"end":5236.57},{"text":"of","start":5236.57,"end":5236.77},{"text":"the","start":5236.77,"end":5236.97},{"text":"adult","start":5236.97,"end":5237.29},{"text":"population.","start":5237.29,"end":5237.97}]},{"text":"Secondly, the Special Rapporteur on the right to health said that criminal laws relating to HIV and drug use impede access to HIV prevention and treatment.","start":5239.49,"end":5248.33,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"Secondly,","start":5239.49,"end":5240.05},{"text":"the","start":5240.05,"end":5240.13},{"text":"Special","start":5240.13,"end":5240.49},{"text":"Rapporteur","start":5240.49,"end":5241.17},{"text":"on","start":5241.29,"end":5241.41},{"text":"the","start":5241.41,"end":5241.53},{"text":"right","start":5241.53,"end":5241.77},{"text":"to","start":5241.77,"end":5241.89},{"text":"health","start":5241.89,"end":5242.21},{"text":"said","start":5242.21,"end":5242.49},{"text":"that","start":5242.49,"end":5242.69},{"text":"criminal","start":5242.69,"end":5243.13},{"text":"laws","start":5243.13,"end":5243.33},{"text":"relating","start":5243.33,"end":5243.81},{"text":"to","start":5243.81,"end":5243.97},{"text":"HIV","start":5243.97,"end":5244.57},{"text":"and","start":5244.57,"end":5244.73},{"text":"drug","start":5244.73,"end":5244.89},{"text":"use","start":5244.89,"end":5245.13},{"text":"impede","start":5245.13,"end":5245.65},{"text":"access","start":5245.65,"end":5246.13},{"text":"to","start":5246.13,"end":5246.29},{"text":"HIV","start":5246.29,"end":5247.09},{"text":"prevention","start":5247.17,"end":5247.69},{"text":"and","start":5247.69,"end":5247.85},{"text":"treatment.","start":5247.85,"end":5248.33}]},{"text":"Thus, it is no surprise that people living with HIV and using drugs are driving away from the appropriate and evidence-based health care that they might need.","start":5248.33,"end":5257.49,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"Thus,","start":5248.33,"end":5248.69},{"text":"it","start":5249.17,"end":5249.29},{"text":"is","start":5249.29,"end":5249.41},{"text":"no","start":5249.41,"end":5249.57},{"text":"surprise","start":5249.57,"end":5249.97},{"text":"that","start":5249.97,"end":5250.13},{"text":"people","start":5250.13,"end":5250.41},{"text":"living","start":5250.41,"end":5250.69},{"text":"with","start":5250.69,"end":5250.89},{"text":"HIV","start":5251.57,"end":5252.21},{"text":"and","start":5252.21,"end":5252.37},{"text":"using","start":5252.37,"end":5252.65},{"text":"drugs","start":5252.65,"end":5252.89},{"text":"are","start":5252.89,"end":5253.01},{"text":"driving","start":5253.01,"end":5253.33},{"text":"away","start":5253.33,"end":5253.73},{"text":"from","start":5253.73,"end":5253.97},{"text":"the","start":5253.97,"end":5254.09},{"text":"appropriate","start":5254.09,"end":5254.73},{"text":"and","start":5254.73,"end":5254.85},{"text":"evidence-based","start":5254.85,"end":5255.53},{"text":"health","start":5255.53,"end":5255.73},{"text":"care","start":5255.73,"end":5256.05},{"text":"that","start":5256.45,"end":5256.65},{"text":"they","start":5256.65,"end":5256.93},{"text":"might","start":5256.93,"end":5257.21},{"text":"need.","start":5257.25,"end":5257.49}]},{"text":"This shows a clear link between criminalization of drug use and health outcomes, particularly when it comes to HIV, viral hepatitis, and other blood-borne infection diseases.","start":5258.45,"end":5268.85,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"This","start":5258.45,"end":5258.69},{"text":"shows","start":5258.69,"end":5259.01},{"text":"a","start":5259.01,"end":5259.05},{"text":"clear","start":5259.05,"end":5259.25},{"text":"link","start":5259.25,"end":5259.57},{"text":"between","start":5259.57,"end":5259.89},{"text":"criminalization","start":5259.89,"end":5260.61},{"text":"of","start":5260.61,"end":5260.69},{"text":"drug","start":5260.69,"end":5260.85},{"text":"use","start":5260.85,"end":5261.25},{"text":"and","start":5261.25,"end":5261.41},{"text":"health","start":5261.41,"end":5261.73},{"text":"outcomes,","start":5261.81,"end":5262.45},{"text":"particularly","start":5262.61,"end":5263.29},{"text":"when","start":5263.29,"end":5263.45},{"text":"it","start":5263.45,"end":5263.57},{"text":"comes","start":5263.57,"end":5263.81},{"text":"to","start":5263.81,"end":5263.97},{"text":"HIV,","start":5263.97,"end":5264.93},{"text":"viral","start":5265.01,"end":5265.41},{"text":"hepatitis,","start":5265.41,"end":5266.13},{"text":"and","start":5266.13,"end":5266.29},{"text":"other","start":5266.29,"end":5266.45},{"text":"blood-borne","start":5266.45,"end":5267.73},{"text":"infection","start":5267.81,"end":5268.29},{"text":"diseases.","start":5268.29,"end":5268.85}]},{"text":"To overcome the situation, we can adopt human, practical, and cost-effective measures, as some of the participants have highlighted.","start":5269.41,"end":5277.57,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"To","start":5269.41,"end":5269.53},{"text":"overcome","start":5269.53,"end":5269.97},{"text":"the","start":5269.97,"end":5270.09},{"text":"situation,","start":5270.09,"end":5271.21},{"text":"we","start":5271.25,"end":5271.49},{"text":"can","start":5271.49,"end":5271.81},{"text":"adopt","start":5271.81,"end":5272.37},{"text":"human,","start":5273.09,"end":5273.49},{"text":"practical,","start":5273.49,"end":5274.01},{"text":"and","start":5274.01,"end":5274.13},{"text":"cost-effective","start":5274.13,"end":5274.85},{"text":"measures,","start":5274.85,"end":5275.33},{"text":"as","start":5275.33,"end":5275.41},{"text":"some","start":5275.41,"end":5275.65},{"text":"of","start":5275.65,"end":5275.73},{"text":"the","start":5275.73,"end":5275.89},{"text":"participants","start":5275.89,"end":5276.57},{"text":"have","start":5276.57,"end":5276.77},{"text":"highlighted.","start":5276.77,"end":5277.57}]},{"text":"Now, allow me to share with you key developments coming from our national policy that have enabled us to adopt such measures.","start":5277.65,"end":5287.25,"topics":[],"words":[{"text":"Now,","start":5277.65,"end":5278.05},{"text":"allow","start":5278.85,"end":5279.05},{"text":"me","start":5279.05,"end":5279.25},{"text":"to","start":5279.25,"end":5279.33},{"text":"share","start":5279.33,"end":5279.65},{"text":"with","start":5279.65,"end":5279.89},{"text":"you","start":5279.89,"end":5280.21},{"text":"key","start":5281.09,"end":5281.17},{"text":"developments","start":5281.17,"end":5282.05},{"text":"coming","start":5282.05,"end":5282.45},{"text":"from","start":5282.45,"end":5282.73},{"text":"our","start":5282.73,"end":5282.93},{"text":"national","start":5282.93,"end":5283.33},{"text":"policy","start":5283.33,"end":5283.73},{"text":"that","start":5283.73,"end":5283.89},{"text":"have","start":5283.89,"end":5284.13},{"text":"enabled","start":5284.13,"end":5284.65},{"text":"us","start":5284.65,"end":5285.01},{"text":"to","start":5285.57,"end":5285.81},{"text":"adopt","start":5285.81,"end":5286.17},{"text":"such","start":5286.17,"end":5286.53},{"text":"measures.","start":5286.53,"end":5287.25}]},{"text":"In our case, the Constitutional Court established that more than 30 years ago that personal consumption cannot be a criminal offense and instead call on all institutions to adopt a public health approach.","start":5287.81,"end":5299.81,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"In","start":5287.81,"end":5287.97},{"text":"our","start":5287.97,"end":5288.21},{"text":"case,","start":5288.21,"end":5288.45},{"text":"the","start":5288.45,"end":5288.57},{"text":"Constitutional","start":5288.57,"end":5289.09},{"text":"Court","start":5289.09,"end":5289.65},{"text":"established","start":5289.81,"end":5290.41},{"text":"that","start":5290.41,"end":5290.61},{"text":"more","start":5290.61,"end":5290.93},{"text":"than","start":5290.93,"end":5291.17},{"text":"30","start":5291.25,"end":5291.73},{"text":"years","start":5291.73,"end":5291.97},{"text":"ago","start":5291.97,"end":5292.29},{"text":"that","start":5292.29,"end":5292.53},{"text":"personal","start":5293.01,"end":5293.41},{"text":"consumption","start":5293.41,"end":5294.21},{"text":"cannot","start":5294.21,"end":5294.53},{"text":"be","start":5294.53,"end":5294.73},{"text":"a","start":5294.73,"end":5294.77},{"text":"criminal","start":5294.77,"end":5295.21},{"text":"offense","start":5295.21,"end":5295.73},{"text":"and","start":5295.73,"end":5295.93},{"text":"instead","start":5295.93,"end":5296.45},{"text":"call","start":5296.93,"end":5297.17},{"text":"on","start":5297.17,"end":5297.41},{"text":"all","start":5297.41,"end":5297.57},{"text":"institutions","start":5297.57,"end":5298.21},{"text":"to","start":5298.21,"end":5298.37},{"text":"adopt","start":5298.37,"end":5298.61},{"text":"a","start":5298.61,"end":5298.69},{"text":"public","start":5298.69,"end":5299.05},{"text":"health","start":5299.05,"end":5299.25},{"text":"approach.","start":5299.25,"end":5299.81}]},{"text":"That historic decision led us also to implement different measures, in particular harm reduction aimed at guaranteeing access to comprehensive health care services for people who use drugs.","start":5300.77,"end":5312.69,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"That","start":5300.77,"end":5301.01},{"text":"historic","start":5301.01,"end":5301.45},{"text":"decision","start":5301.45,"end":5301.89},{"text":"led","start":5301.89,"end":5302.13},{"text":"us","start":5302.13,"end":5302.45},{"text":"also","start":5302.45,"end":5302.77},{"text":"to","start":5302.77,"end":5302.89},{"text":"implement","start":5302.89,"end":5303.37},{"text":"different","start":5303.37,"end":5303.73},{"text":"measures,","start":5303.73,"end":5304.21},{"text":"in","start":5304.53,"end":5304.69},{"text":"particular","start":5304.69,"end":5305.33},{"text":"harm","start":5305.41,"end":5305.81},{"text":"reduction","start":5305.81,"end":5306.81},{"text":"aimed","start":5306.81,"end":5307.01},{"text":"at","start":5307.57,"end":5307.65},{"text":"guaranteeing","start":5307.65,"end":5308.45},{"text":"access","start":5308.53,"end":5308.93},{"text":"to","start":5308.93,"end":5309.05},{"text":"comprehensive","start":5309.05,"end":5309.73},{"text":"health","start":5309.73,"end":5310.05},{"text":"care","start":5310.05,"end":5310.29},{"text":"services","start":5310.29,"end":5310.93},{"text":"for","start":5311.49,"end":5311.73},{"text":"people","start":5311.73,"end":5312.05},{"text":"who","start":5312.05,"end":5312.21},{"text":"use","start":5312.21,"end":5312.41},{"text":"drugs.","start":5312.41,"end":5312.69}]},{"text":"In 2024, a total of 33 mobile assistance centers, also known as CAMAT, projects were approved with an effective investment of 18.4 Colombian pesos billion.","start":5312.69,"end":5327.57,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."}],"words":[{"text":"In","start":5312.69,"end":5312.77},{"text":"2024,","start":5312.77,"end":5313.89},{"text":"a","start":5313.89,"end":5313.97},{"text":"total","start":5313.97,"end":5314.41},{"text":"of","start":5314.41,"end":5314.61},{"text":"33","start":5314.61,"end":5315.49},{"text":"mobile","start":5315.49,"end":5315.97},{"text":"assistance","start":5315.97,"end":5316.65},{"text":"centers,","start":5316.65,"end":5317.17},{"text":"also","start":5317.33,"end":5317.61},{"text":"known","start":5317.61,"end":5318.05},{"text":"as","start":5318.13,"end":5318.21},{"text":"CAMAT,","start":5318.25,"end":5319.01},{"text":"projects","start":5319.89,"end":5320.45},{"text":"were","start":5320.77,"end":5321.17},{"text":"approved","start":5321.17,"end":5321.69},{"text":"with","start":5321.69,"end":5321.81},{"text":"an","start":5321.81,"end":5321.93},{"text":"effective","start":5321.93,"end":5322.45},{"text":"investment","start":5322.45,"end":5323.13},{"text":"of","start":5323.13,"end":5323.41},{"text":"18.4","start":5323.89,"end":5325.33},{"text":"Colombian","start":5325.73,"end":5326.37},{"text":"pesos","start":5326.45,"end":5326.93},{"text":"billion.","start":5326.93,"end":5327.57}]},{"text":"In 2024, 24 CAMAT projects have been approved in prioritized municipalities with a total allocation of 14.4 billion of Colombian pesos, particularly on harm reduction between 2022 and 2024, Colombia tripled public investment in related projects, increasing from 1.8 Colombian pesos billion in 2022 to 6.4 billion in 2024.","start":5327.97,"end":5357.41,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"In","start":5327.97,"end":5328.13},{"text":"2024,","start":5328.13,"end":5328.77},{"text":"24","start":5328.77,"end":5329.33},{"text":"CAMAT","start":5329.89,"end":5330.65},{"text":"projects","start":5330.65,"end":5331.17},{"text":"have","start":5331.25,"end":5331.49},{"text":"been","start":5331.49,"end":5331.89},{"text":"approved","start":5331.89,"end":5332.37},{"text":"in","start":5332.37,"end":5332.53},{"text":"prioritized","start":5332.53,"end":5334.29},{"text":"municipalities","start":5334.29,"end":5335.17},{"text":"with","start":5335.41,"end":5335.65},{"text":"a","start":5335.65,"end":5335.69},{"text":"total","start":5335.69,"end":5336.01},{"text":"allocation","start":5336.01,"end":5336.61},{"text":"of","start":5336.61,"end":5336.85},{"text":"14.4","start":5337.57,"end":5339.25},{"text":"billion","start":5339.49,"end":5339.97},{"text":"of","start":5339.97,"end":5340.13},{"text":"Colombian","start":5340.13,"end":5340.53},{"text":"pesos,","start":5340.53,"end":5341.01},{"text":"particularly","start":5341.01,"end":5341.81},{"text":"on","start":5341.93,"end":5342.05},{"text":"harm","start":5342.05,"end":5342.25},{"text":"reduction","start":5342.25,"end":5342.77},{"text":"between","start":5342.77,"end":5343.09},{"text":"2022","start":5343.09,"end":5343.65},{"text":"and","start":5343.65,"end":5343.77},{"text":"2024,","start":5343.77,"end":5345.01},{"text":"Colombia","start":5345.61,"end":5346.01},{"text":"tripled","start":5346.01,"end":5346.41},{"text":"public","start":5346.41,"end":5346.77},{"text":"investment","start":5346.77,"end":5347.33},{"text":"in","start":5347.33,"end":5347.49},{"text":"related","start":5347.49,"end":5347.97},{"text":"projects,","start":5347.97,"end":5348.41},{"text":"increasing","start":5348.41,"end":5348.89},{"text":"from","start":5349.33,"end":5349.81},{"text":"1.8","start":5349.81,"end":5350.69},{"text":"Colombian","start":5351.09,"end":5351.53},{"text":"pesos","start":5351.53,"end":5351.73},{"text":"billion","start":5351.73,"end":5352.21},{"text":"in","start":5352.21,"end":5352.57},{"text":"2022","start":5352.57,"end":5353.65},{"text":"to","start":5353.65,"end":5353.73},{"text":"6.4","start":5353.97,"end":5355.01},{"text":"billion","start":5355.01,"end":5355.57},{"text":"in","start":5355.65,"end":5355.81},{"text":"2024.","start":5356.45,"end":5357.41}]},{"text":"A total of 22 projects have been implemented across the country.","start":5357.41,"end":5361.49,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"A","start":5357.41,"end":5357.45},{"text":"total","start":5357.45,"end":5358.01},{"text":"of","start":5358.01,"end":5358.21},{"text":"22","start":5358.21,"end":5359.21},{"text":"projects","start":5359.21,"end":5359.81},{"text":"have","start":5359.81,"end":5359.93},{"text":"been","start":5359.93,"end":5360.09},{"text":"implemented","start":5360.09,"end":5360.69},{"text":"across","start":5360.69,"end":5360.97},{"text":"the","start":5360.97,"end":5361.09},{"text":"country.","start":5361.09,"end":5361.49}]},{"text":"But there is also an international dimension to these discussions, and that is why Colombia has been so vocal in international fora on harm reduction.","start":5362.49,"end":5370.01,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"But","start":5362.49,"end":5362.65},{"text":"there","start":5362.65,"end":5362.81},{"text":"is","start":5362.81,"end":5362.97},{"text":"also","start":5362.97,"end":5363.25},{"text":"an","start":5363.25,"end":5363.33},{"text":"international","start":5363.33,"end":5363.97},{"text":"dimension","start":5363.97,"end":5364.41},{"text":"to","start":5364.41,"end":5364.57},{"text":"these","start":5364.57,"end":5364.77},{"text":"discussions,","start":5364.77,"end":5365.45},{"text":"and","start":5365.45,"end":5365.57},{"text":"that","start":5365.57,"end":5365.85},{"text":"is","start":5365.85,"end":5366.09},{"text":"why","start":5366.09,"end":5366.37},{"text":"Colombia","start":5366.37,"end":5366.81},{"text":"has","start":5366.81,"end":5366.93},{"text":"been","start":5366.93,"end":5367.09},{"text":"so","start":5367.09,"end":5367.29},{"text":"vocal","start":5367.29,"end":5367.65},{"text":"in","start":5367.65,"end":5367.73},{"text":"international","start":5367.73,"end":5368.33},{"text":"fora","start":5368.33,"end":5368.85},{"text":"on","start":5368.85,"end":5368.97},{"text":"harm","start":5368.97,"end":5369.29},{"text":"reduction.","start":5369.29,"end":5370.01}]},{"text":"We are convinced that this is the way to move forward.","start":5370.57,"end":5373.37,"topics":[],"words":[{"text":"We","start":5370.57,"end":5370.73},{"text":"are","start":5370.73,"end":5370.81},{"text":"convinced","start":5370.81,"end":5371.53},{"text":"that","start":5371.53,"end":5371.85},{"text":"this","start":5371.85,"end":5372.09},{"text":"is","start":5372.09,"end":5372.25},{"text":"the","start":5372.25,"end":5372.37},{"text":"way","start":5372.37,"end":5372.57},{"text":"to","start":5372.57,"end":5372.69},{"text":"move","start":5372.69,"end":5372.89},{"text":"forward.","start":5372.89,"end":5373.37}]},{"text":"International action has been taken with resistance, but we are moving forward.","start":5373.37,"end":5378.41,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"International","start":5373.37,"end":5374.01},{"text":"action","start":5374.01,"end":5374.33},{"text":"has","start":5374.33,"end":5374.49},{"text":"been","start":5374.49,"end":5374.89},{"text":"taken","start":5374.89,"end":5375.33},{"text":"with","start":5375.33,"end":5375.61},{"text":"resistance,","start":5375.61,"end":5376.41},{"text":"but","start":5376.97,"end":5377.21},{"text":"we","start":5377.21,"end":5377.37},{"text":"are","start":5377.37,"end":5377.61},{"text":"moving","start":5377.61,"end":5377.93},{"text":"forward.","start":5377.93,"end":5378.41}]},{"text":"For example, the international guidelines on human rights and drug policy have been critical for guiding states to harmonize drug policies with international human rights obligations.","start":5378.89,"end":5390.57,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"For","start":5378.89,"end":5379.09},{"text":"example,","start":5379.09,"end":5379.49},{"text":"the","start":5379.49,"end":5379.57},{"text":"international","start":5379.57,"end":5380.73},{"text":"guidelines","start":5381.13,"end":5382.09},{"text":"on","start":5382.09,"end":5382.17},{"text":"human","start":5382.17,"end":5382.49},{"text":"rights","start":5382.49,"end":5382.85},{"text":"and","start":5382.85,"end":5383.01},{"text":"drug","start":5383.01,"end":5383.17},{"text":"policy","start":5383.17,"end":5383.53},{"text":"have","start":5383.53,"end":5383.69},{"text":"been","start":5383.69,"end":5384.01},{"text":"critical","start":5384.41,"end":5384.89},{"text":"for","start":5384.89,"end":5385.13},{"text":"guiding","start":5385.13,"end":5385.53},{"text":"states","start":5385.61,"end":5386.25},{"text":"to","start":5386.25,"end":5386.37},{"text":"harmonize","start":5386.41,"end":5387.13},{"text":"drug","start":5387.13,"end":5387.37},{"text":"policies","start":5387.37,"end":5387.93},{"text":"with","start":5387.93,"end":5388.21},{"text":"international","start":5388.21,"end":5388.85},{"text":"human","start":5388.85,"end":5389.13},{"text":"rights","start":5389.13,"end":5389.53},{"text":"obligations.","start":5389.65,"end":5390.57}]},{"text":"The guidelines are and will continue to be pivotal for building momentum on harm reduction and decriminalization.","start":5391.57,"end":5399.05,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"The","start":5391.57,"end":5391.61},{"text":"guidelines","start":5391.61,"end":5392.53},{"text":"are","start":5393.09,"end":5393.33},{"text":"and","start":5393.45,"end":5393.65},{"text":"will","start":5393.65,"end":5393.89},{"text":"continue","start":5393.89,"end":5394.37},{"text":"to","start":5394.37,"end":5394.49},{"text":"be","start":5394.49,"end":5394.69},{"text":"pivotal","start":5394.97,"end":5395.57},{"text":"for","start":5395.57,"end":5395.81},{"text":"building","start":5395.81,"end":5396.13},{"text":"momentum","start":5396.13,"end":5396.77},{"text":"on","start":5396.77,"end":5396.93},{"text":"harm","start":5396.93,"end":5397.21},{"text":"reduction","start":5397.25,"end":5397.89},{"text":"and","start":5397.89,"end":5398.05},{"text":"decriminalization.","start":5398.05,"end":5399.05}]},{"text":"Also, Colombia pushed for the inclusion of harm reduction strategies and policies in the Commission on Narcotic Drugs Resolution 67/4 on overdose care.","start":5399.05,"end":5408.61,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"Also,","start":5399.05,"end":5399.41},{"text":"Colombia","start":5399.65,"end":5400.01},{"text":"pushed","start":5400.01,"end":5400.45},{"text":"for","start":5400.45,"end":5400.65},{"text":"the","start":5400.65,"end":5400.73},{"text":"inclusion","start":5400.73,"end":5401.21},{"text":"of","start":5401.21,"end":5401.29},{"text":"harm","start":5401.29,"end":5401.57},{"text":"reduction","start":5401.57,"end":5401.97},{"text":"strategies","start":5401.97,"end":5402.45},{"text":"and","start":5402.45,"end":5402.57},{"text":"policies","start":5402.57,"end":5403.17},{"text":"in","start":5403.57,"end":5403.73},{"text":"the","start":5403.73,"end":5403.81},{"text":"Commission","start":5403.81,"end":5404.29},{"text":"on","start":5404.29,"end":5404.37},{"text":"Narcotic","start":5404.37,"end":5404.89},{"text":"Drugs","start":5404.89,"end":5405.21},{"text":"Resolution","start":5405.21,"end":5405.81},{"text":"67/4","start":5406.37,"end":5407.49},{"text":"on","start":5407.49,"end":5407.65},{"text":"overdose","start":5407.65,"end":5408.21},{"text":"care.","start":5408.21,"end":5408.61}]},{"text":"That was the first time the term harm reduction was adopted by the CND and was a step towards its recognition as an effective public health response to drug use, particularly for the benefit of those most vulnerable.","start":5409.09,"end":5423.13,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"That","start":5409.09,"end":5409.29},{"text":"was","start":5409.29,"end":5409.45},{"text":"the","start":5409.45,"end":5409.57},{"text":"first","start":5409.57,"end":5409.85},{"text":"time","start":5409.85,"end":5410.21},{"text":"the","start":5410.21,"end":5410.45},{"text":"term","start":5410.45,"end":5410.77},{"text":"harm","start":5410.85,"end":5411.13},{"text":"reduction","start":5411.13,"end":5411.65},{"text":"was","start":5411.65,"end":5411.81},{"text":"adopted","start":5411.81,"end":5412.21},{"text":"by","start":5412.21,"end":5412.37},{"text":"the","start":5412.37,"end":5412.45},{"text":"CND","start":5412.45,"end":5413.09},{"text":"and","start":5413.09,"end":5413.21},{"text":"was","start":5413.21,"end":5413.41},{"text":"a","start":5413.41,"end":5413.45},{"text":"step","start":5413.45,"end":5413.73},{"text":"towards","start":5413.73,"end":5414.29},{"text":"its","start":5414.29,"end":5414.57},{"text":"recognition","start":5414.57,"end":5415.33},{"text":"as","start":5415.65,"end":5415.89},{"text":"an","start":5415.89,"end":5416.05},{"text":"effective","start":5416.05,"end":5416.53},{"text":"public","start":5416.53,"end":5416.93},{"text":"health","start":5416.93,"end":5417.25},{"text":"response","start":5417.25,"end":5417.97},{"text":"to","start":5418.57,"end":5418.61},{"text":"drug","start":5418.61,"end":5419.17},{"text":"use,","start":5419.17,"end":5419.69},{"text":"particularly","start":5419.69,"end":5420.49},{"text":"for","start":5420.73,"end":5420.97},{"text":"the","start":5420.97,"end":5421.05},{"text":"benefit","start":5421.05,"end":5421.61},{"text":"of","start":5421.65,"end":5421.77},{"text":"those","start":5421.77,"end":5422.17},{"text":"most","start":5422.17,"end":5422.57},{"text":"vulnerable.","start":5422.57,"end":5423.13}]},{"text":"Colombia, together with many other states, including our fellow organizers of this event, have been actively promoting harm reduction in the national fora.","start":5424.25,"end":5433.05,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Colombia,","start":5424.25,"end":5424.81},{"text":"together","start":5424.89,"end":5425.29},{"text":"with","start":5425.29,"end":5425.45},{"text":"many","start":5425.45,"end":5425.77},{"text":"other","start":5425.77,"end":5425.97},{"text":"states,","start":5425.97,"end":5426.57},{"text":"including","start":5426.57,"end":5427.01},{"text":"our","start":5427.01,"end":5427.21},{"text":"fellow","start":5427.21,"end":5427.53},{"text":"organizers","start":5427.53,"end":5428.33},{"text":"of","start":5428.37,"end":5428.49},{"text":"this","start":5428.49,"end":5428.81},{"text":"event,","start":5428.81,"end":5429.29},{"text":"have","start":5429.85,"end":5430.09},{"text":"been","start":5430.09,"end":5430.33},{"text":"actively","start":5430.33,"end":5430.89},{"text":"promoting","start":5430.89,"end":5431.45},{"text":"harm","start":5431.45,"end":5431.69},{"text":"reduction","start":5431.69,"end":5432.13},{"text":"in","start":5432.13,"end":5432.25},{"text":"the","start":5432.25,"end":5432.37},{"text":"national","start":5432.37,"end":5432.73},{"text":"fora.","start":5432.73,"end":5433.05}]},{"text":"For example, we have delivered joint statements in the General Assembly, the Human Rights Council, in the CND, and the World Health Assembly.","start":5433.05,"end":5442.25,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"For","start":5433.05,"end":5433.21},{"text":"example,","start":5433.21,"end":5433.61},{"text":"we","start":5433.61,"end":5433.77},{"text":"have","start":5433.77,"end":5434.01},{"text":"delivered","start":5434.01,"end":5434.53},{"text":"joint","start":5435.45,"end":5436.01},{"text":"statements","start":5436.41,"end":5437.05},{"text":"in","start":5437.05,"end":5437.21},{"text":"the","start":5437.21,"end":5437.33},{"text":"General","start":5437.33,"end":5437.77},{"text":"Assembly,","start":5437.77,"end":5438.25},{"text":"the","start":5438.25,"end":5438.37},{"text":"Human","start":5438.37,"end":5438.65},{"text":"Rights","start":5438.65,"end":5438.97},{"text":"Council,","start":5438.97,"end":5439.37},{"text":"in","start":5439.37,"end":5439.53},{"text":"the","start":5439.53,"end":5439.65},{"text":"CND,","start":5439.65,"end":5440.17},{"text":"and","start":5440.17,"end":5440.49},{"text":"the","start":5440.73,"end":5440.85},{"text":"World","start":5440.85,"end":5441.13},{"text":"Health","start":5441.13,"end":5441.45},{"text":"Assembly.","start":5441.61,"end":5442.25}]},{"text":"But to make reality the benefits of harm reduction, we need to engage all sectors of society.","start":5443.21,"end":5448.53,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"But","start":5443.21,"end":5443.29},{"text":"to","start":5443.29,"end":5443.41},{"text":"make","start":5443.41,"end":5443.61},{"text":"reality","start":5443.61,"end":5444.05},{"text":"the","start":5444.05,"end":5444.17},{"text":"benefits","start":5444.17,"end":5444.85},{"text":"of","start":5444.89,"end":5445.01},{"text":"harm","start":5445.01,"end":5445.33},{"text":"reduction,","start":5445.33,"end":5445.81},{"text":"we","start":5445.81,"end":5445.89},{"text":"need","start":5445.89,"end":5446.09},{"text":"to","start":5446.09,"end":5446.29},{"text":"engage","start":5446.29,"end":5446.85},{"text":"all","start":5446.85,"end":5447.17},{"text":"sectors","start":5447.17,"end":5447.65},{"text":"of","start":5447.65,"end":5447.81},{"text":"society.","start":5447.81,"end":5448.53}]},{"text":"We have encountered committed and responsive partners in civil society and jointly with harm reduction international and local civil society organizations.","start":5449.09,"end":5457.17,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"We","start":5449.09,"end":5449.29},{"text":"have","start":5449.29,"end":5449.45},{"text":"encountered","start":5449.45,"end":5449.93},{"text":"committed","start":5449.93,"end":5450.33},{"text":"and","start":5450.33,"end":5450.45},{"text":"responsive","start":5450.45,"end":5450.93},{"text":"partners","start":5450.93,"end":5451.33},{"text":"in","start":5451.33,"end":5451.45},{"text":"civil","start":5451.45,"end":5451.69},{"text":"society","start":5451.69,"end":5452.25},{"text":"and","start":5452.25,"end":5452.45},{"text":"jointly","start":5452.45,"end":5453.01},{"text":"with","start":5453.01,"end":5453.25},{"text":"harm","start":5453.41,"end":5453.73},{"text":"reduction","start":5453.73,"end":5454.21},{"text":"international","start":5454.21,"end":5454.97},{"text":"and","start":5454.97,"end":5455.09},{"text":"local","start":5455.09,"end":5455.41},{"text":"civil","start":5455.41,"end":5455.65},{"text":"society","start":5455.65,"end":5456.21},{"text":"organizations.","start":5456.21,"end":5457.17}]},{"text":"In April 2025, we hosted the Harm Reduction International Conference.","start":5457.25,"end":5462.93,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"In","start":5457.25,"end":5457.41},{"text":"April","start":5457.41,"end":5457.77},{"text":"2025,","start":5457.77,"end":5458.93},{"text":"we","start":5459.65,"end":5459.89},{"text":"hosted","start":5459.89,"end":5460.45},{"text":"the","start":5460.53,"end":5460.73},{"text":"Harm","start":5460.73,"end":5461.09},{"text":"Reduction","start":5461.09,"end":5461.61},{"text":"International","start":5461.61,"end":5462.21},{"text":"Conference.","start":5462.21,"end":5462.93}]},{"text":"This is one of the most important global events on harm reduction, human rights, and drug policy.","start":5463.57,"end":5467.89,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"This","start":5463.57,"end":5463.73},{"text":"is","start":5463.73,"end":5463.81},{"text":"one","start":5463.81,"end":5464.01},{"text":"of","start":5464.01,"end":5464.13},{"text":"the","start":5464.13,"end":5464.21},{"text":"most","start":5464.21,"end":5464.41},{"text":"important","start":5464.41,"end":5464.81},{"text":"global","start":5464.81,"end":5465.09},{"text":"events","start":5465.13,"end":5465.65},{"text":"on","start":5465.69,"end":5465.81},{"text":"harm","start":5465.81,"end":5466.09},{"text":"reduction,","start":5466.09,"end":5466.57},{"text":"human","start":5466.57,"end":5466.85},{"text":"rights,","start":5466.85,"end":5467.13},{"text":"and","start":5467.13,"end":5467.25},{"text":"drug","start":5467.25,"end":5467.41},{"text":"policy.","start":5467.41,"end":5467.89}]},{"text":"The event brought together more than 1,000 participants, including frontline health workers, academics, researchers, decision makers, United Nations representatives, and stakeholders in the criminal justice system.","start":5468.61,"end":5480.93,"topics":[],"words":[{"text":"The","start":5468.61,"end":5468.65},{"text":"event","start":5469.09,"end":5469.49},{"text":"brought","start":5469.49,"end":5469.77},{"text":"together","start":5469.81,"end":5470.29},{"text":"more","start":5470.29,"end":5470.45},{"text":"than","start":5470.45,"end":5470.77},{"text":"1,000","start":5471.09,"end":5471.77},{"text":"participants,","start":5471.77,"end":5472.61},{"text":"including","start":5472.61,"end":5473.09},{"text":"frontline","start":5473.09,"end":5473.57},{"text":"health","start":5473.65,"end":5473.97},{"text":"workers,","start":5473.97,"end":5474.53},{"text":"academics,","start":5474.53,"end":5475.17},{"text":"researchers,","start":5475.17,"end":5475.77},{"text":"decision","start":5475.77,"end":5476.17},{"text":"makers,","start":5476.17,"end":5476.57},{"text":"United","start":5476.57,"end":5476.93},{"text":"Nations","start":5476.93,"end":5477.25},{"text":"representatives,","start":5477.25,"end":5478.13},{"text":"and","start":5478.45,"end":5478.69},{"text":"stakeholders","start":5478.69,"end":5479.49},{"text":"in","start":5479.49,"end":5479.65},{"text":"the","start":5479.65,"end":5479.73},{"text":"criminal","start":5479.73,"end":5480.13},{"text":"justice","start":5480.13,"end":5480.49},{"text":"system.","start":5480.49,"end":5480.93}]},{"text":"Through presentation, workshops, and exchange activities, the conference fostered discussions on best practices, progress, and challenges in the implementation of these measures.","start":5481.49,"end":5490.69,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"Through","start":5481.49,"end":5481.65},{"text":"presentation,","start":5481.65,"end":5482.37},{"text":"workshops,","start":5482.37,"end":5482.97},{"text":"and","start":5482.97,"end":5483.13},{"text":"exchange","start":5483.13,"end":5483.61},{"text":"activities,","start":5483.61,"end":5484.17},{"text":"the","start":5484.17,"end":5484.25},{"text":"conference","start":5484.25,"end":5484.85},{"text":"fostered","start":5484.85,"end":5485.37},{"text":"discussions","start":5485.37,"end":5486.09},{"text":"on","start":5486.41,"end":5486.57},{"text":"best","start":5486.57,"end":5486.77},{"text":"practices,","start":5486.77,"end":5487.49},{"text":"progress,","start":5487.89,"end":5488.33},{"text":"and","start":5488.33,"end":5488.49},{"text":"challenges","start":5488.49,"end":5488.93},{"text":"in","start":5488.93,"end":5489.05},{"text":"the","start":5489.05,"end":5489.13},{"text":"implementation","start":5489.13,"end":5489.85},{"text":"of","start":5489.85,"end":5489.97},{"text":"these","start":5489.97,"end":5490.21},{"text":"measures.","start":5490.21,"end":5490.69}]},{"text":"I want to highlight the progress made by all of us when we act together, but our achievements are The risk, the abrupt reduction of international funding, the persistence of discriminatory laws, stigma, and structural barriers continue to be there, and in some cases, they are getting reinforced.","start":5491.49,"end":5509.69,"topics":[{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"I","start":5491.49,"end":5491.57},{"text":"want","start":5491.57,"end":5491.93},{"text":"to","start":5491.93,"end":5492.01},{"text":"highlight","start":5492.01,"end":5492.69},{"text":"the","start":5492.69,"end":5492.77},{"text":"progress","start":5492.77,"end":5493.17},{"text":"made","start":5493.17,"end":5493.41},{"text":"by","start":5493.41,"end":5493.57},{"text":"all","start":5493.65,"end":5493.89},{"text":"of","start":5493.89,"end":5494.13},{"text":"us","start":5494.13,"end":5494.29},{"text":"when","start":5494.29,"end":5494.45},{"text":"we","start":5494.45,"end":5494.61},{"text":"act","start":5494.61,"end":5494.81},{"text":"together,","start":5494.81,"end":5495.33},{"text":"but","start":5495.33,"end":5495.65},{"text":"our","start":5495.65,"end":5495.89},{"text":"achievements","start":5495.89,"end":5496.69},{"text":"are","start":5496.93,"end":5497.25},{"text":"The","start":5498.01,"end":5498.05},{"text":"risk,","start":5498.05,"end":5498.65},{"text":"the","start":5499.77,"end":5499.89},{"text":"abrupt","start":5499.89,"end":5500.33},{"text":"reduction","start":5500.33,"end":5500.81},{"text":"of","start":5500.81,"end":5500.89},{"text":"international","start":5500.89,"end":5501.45},{"text":"funding,","start":5501.45,"end":5501.85},{"text":"the","start":5501.85,"end":5501.97},{"text":"persistence","start":5501.97,"end":5502.85},{"text":"of","start":5502.85,"end":5503.13},{"text":"discriminatory","start":5503.13,"end":5503.93},{"text":"laws,","start":5503.93,"end":5504.21},{"text":"stigma,","start":5504.21,"end":5504.93},{"text":"and","start":5504.93,"end":5505.17},{"text":"structural","start":5505.17,"end":5505.69},{"text":"barriers","start":5505.69,"end":5506.25},{"text":"continue","start":5506.25,"end":5506.65},{"text":"to","start":5506.65,"end":5506.73},{"text":"be","start":5506.73,"end":5506.89},{"text":"there,","start":5506.89,"end":5507.17},{"text":"and","start":5507.17,"end":5507.33},{"text":"in","start":5507.33,"end":5507.45},{"text":"some","start":5507.45,"end":5507.69},{"text":"cases,","start":5507.69,"end":5508.09},{"text":"they","start":5508.09,"end":5508.17},{"text":"are","start":5508.17,"end":5508.25},{"text":"getting","start":5508.25,"end":5508.69},{"text":"reinforced.","start":5508.89,"end":5509.69}]},{"text":"This is one of the main reasons we have been supporters of the request and look forward to the outcome in October of the critical review of the coca leaf being conducted by the expert committee on drug dependence of the WHO.","start":5509.77,"end":5520.81,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"This","start":5509.77,"end":5509.93},{"text":"is","start":5509.93,"end":5510.01},{"text":"one","start":5510.01,"end":5510.25},{"text":"of","start":5510.25,"end":5510.33},{"text":"the","start":5510.33,"end":5510.45},{"text":"main","start":5510.45,"end":5510.65},{"text":"reasons","start":5510.65,"end":5511.13},{"text":"we","start":5511.53,"end":5511.65},{"text":"have","start":5511.65,"end":5511.77},{"text":"been","start":5511.77,"end":5511.97},{"text":"supporters","start":5511.97,"end":5512.57},{"text":"of","start":5512.57,"end":5512.65},{"text":"the","start":5512.65,"end":5512.77},{"text":"request","start":5512.77,"end":5513.17},{"text":"and","start":5513.17,"end":5513.29},{"text":"look","start":5513.29,"end":5513.45},{"text":"forward","start":5513.45,"end":5513.89},{"text":"to","start":5513.89,"end":5514.01},{"text":"the","start":5514.33,"end":5514.53},{"text":"outcome","start":5514.57,"end":5514.97},{"text":"in","start":5514.97,"end":5515.09},{"text":"October","start":5515.09,"end":5515.49},{"text":"of","start":5515.49,"end":5515.61},{"text":"the","start":5515.61,"end":5515.73},{"text":"critical","start":5515.77,"end":5516.25},{"text":"review","start":5516.25,"end":5516.73},{"text":"of","start":5516.81,"end":5516.93},{"text":"the","start":5516.93,"end":5517.05},{"text":"coca","start":5517.05,"end":5517.29},{"text":"leaf","start":5517.29,"end":5517.61},{"text":"being","start":5517.61,"end":5517.85},{"text":"conducted","start":5517.85,"end":5518.33},{"text":"by","start":5518.33,"end":5518.41},{"text":"the","start":5518.49,"end":5518.57},{"text":"expert","start":5518.57,"end":5519.01},{"text":"committee","start":5519.01,"end":5519.37},{"text":"on","start":5519.37,"end":5519.49},{"text":"drug","start":5519.49,"end":5519.69},{"text":"dependence","start":5519.69,"end":5520.17},{"text":"of","start":5520.17,"end":5520.33},{"text":"the","start":5520.33,"end":5520.65},{"text":"WHO.","start":5520.69,"end":5520.81}]},{"text":"Therefore, we need to strengthen our collective actions and our political and financial commitment to multilateral, evidence-based, and people-centered responses.","start":5522.25,"end":5531.13,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Therefore,","start":5522.25,"end":5522.49},{"text":"we","start":5522.49,"end":5522.65},{"text":"need","start":5522.65,"end":5522.85},{"text":"to","start":5522.85,"end":5522.93},{"text":"strengthen","start":5522.93,"end":5523.45},{"text":"our","start":5523.45,"end":5523.77},{"text":"collective","start":5523.77,"end":5524.25},{"text":"actions","start":5524.25,"end":5524.69},{"text":"and","start":5524.69,"end":5524.89},{"text":"our","start":5524.89,"end":5525.13},{"text":"political","start":5525.13,"end":5525.61},{"text":"and","start":5525.61,"end":5525.77},{"text":"financial","start":5525.77,"end":5526.37},{"text":"commitment","start":5526.37,"end":5526.89},{"text":"to","start":5526.89,"end":5526.97},{"text":"multilateral,","start":5526.97,"end":5527.69},{"text":"evidence-based,","start":5527.81,"end":5529.41},{"text":"and","start":5529.41,"end":5529.53},{"text":"people-centered","start":5529.53,"end":5530.41},{"text":"responses.","start":5530.41,"end":5531.13}]},{"text":"Only through the strengthening of public health systems, active community participation, and respect of human rights will it be possible to ensure the policies that are responsive to the health and well-being of all.","start":5531.13,"end":5544.25,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Only","start":5531.13,"end":5531.53},{"text":"through","start":5532.25,"end":5532.45},{"text":"the","start":5532.45,"end":5532.57},{"text":"strengthening","start":5532.57,"end":5533.37},{"text":"of","start":5533.41,"end":5533.53},{"text":"public","start":5533.61,"end":5534.01},{"text":"health","start":5534.01,"end":5534.25},{"text":"systems,","start":5534.25,"end":5534.81},{"text":"active","start":5534.81,"end":5535.13},{"text":"community","start":5535.13,"end":5535.85},{"text":"participation,","start":5535.97,"end":5536.73},{"text":"and","start":5536.73,"end":5536.85},{"text":"respect","start":5536.85,"end":5537.25},{"text":"of","start":5537.25,"end":5537.33},{"text":"human","start":5537.33,"end":5537.61},{"text":"rights","start":5537.61,"end":5538.09},{"text":"will","start":5538.73,"end":5538.97},{"text":"it","start":5539.05,"end":5539.21},{"text":"be","start":5539.21,"end":5539.37},{"text":"possible","start":5539.37,"end":5539.93},{"text":"to","start":5539.93,"end":5540.01},{"text":"ensure","start":5540.01,"end":5540.33},{"text":"the","start":5540.33,"end":5540.49},{"text":"policies","start":5540.49,"end":5540.97},{"text":"that","start":5540.97,"end":5541.21},{"text":"are","start":5541.21,"end":5541.41},{"text":"responsive","start":5541.41,"end":5542.01},{"text":"to","start":5542.01,"end":5542.13},{"text":"the","start":5542.13,"end":5542.25},{"text":"health","start":5542.25,"end":5542.65},{"text":"and","start":5542.65,"end":5542.81},{"text":"well-being","start":5542.81,"end":5543.37},{"text":"of","start":5543.37,"end":5543.69},{"text":"all.","start":5543.93,"end":5544.25}]},{"text":"I want to finalize highlighting the importance of the support and joint commitment of all actors in this endeavor.","start":5545.05,"end":5550.17,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"I","start":5545.05,"end":5545.13},{"text":"want","start":5545.13,"end":5545.37},{"text":"to","start":5545.37,"end":5545.45},{"text":"finalize","start":5545.45,"end":5545.93},{"text":"highlighting","start":5545.93,"end":5546.41},{"text":"the","start":5546.41,"end":5546.49},{"text":"importance","start":5546.49,"end":5547.05},{"text":"of","start":5547.05,"end":5547.13},{"text":"the","start":5547.13,"end":5547.29},{"text":"support","start":5547.29,"end":5547.73},{"text":"and","start":5547.73,"end":5547.89},{"text":"joint","start":5547.89,"end":5548.09},{"text":"commitment","start":5548.09,"end":5548.53},{"text":"of","start":5548.53,"end":5548.65},{"text":"all","start":5548.65,"end":5548.81},{"text":"actors","start":5548.81,"end":5549.29},{"text":"in","start":5549.29,"end":5549.37},{"text":"this","start":5549.37,"end":5549.61},{"text":"endeavor.","start":5549.61,"end":5550.17}]},{"text":"including many of the agencies and members of the UN system co-sponsoring this event, which we appreciate very much.","start":5550.81,"end":5557.69,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"including","start":5550.81,"end":5551.37},{"text":"many","start":5551.37,"end":5551.73},{"text":"of","start":5551.73,"end":5551.93},{"text":"the","start":5551.93,"end":5552.05},{"text":"agencies","start":5552.05,"end":5552.69},{"text":"and","start":5552.69,"end":5552.81},{"text":"members","start":5552.81,"end":5553.21},{"text":"of","start":5553.21,"end":5553.29},{"text":"the","start":5553.29,"end":5553.37},{"text":"UN","start":5553.37,"end":5553.61},{"text":"system","start":5553.61,"end":5554.09},{"text":"co-sponsoring","start":5554.33,"end":5555.29},{"text":"this","start":5555.29,"end":5555.57},{"text":"event,","start":5555.57,"end":5556.01},{"text":"which","start":5556.01,"end":5556.33},{"text":"we","start":5556.33,"end":5556.65},{"text":"appreciate","start":5556.65,"end":5557.05},{"text":"very","start":5557.05,"end":5557.37},{"text":"much.","start":5557.37,"end":5557.69}]},{"text":"We will continue to actively pursue partnerships and cooperation with and amongst them.","start":5558.25,"end":5563.53,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"We","start":5558.25,"end":5558.37},{"text":"will","start":5558.37,"end":5558.57},{"text":"continue","start":5558.57,"end":5558.97},{"text":"to","start":5558.97,"end":5559.09},{"text":"actively","start":5559.13,"end":5559.53},{"text":"pursue","start":5559.53,"end":5560.49},{"text":"partnerships","start":5560.49,"end":5561.21},{"text":"and","start":5561.21,"end":5561.37},{"text":"cooperation","start":5561.37,"end":5562.17},{"text":"with","start":5562.17,"end":5562.57},{"text":"and","start":5562.57,"end":5562.81},{"text":"amongst","start":5562.81,"end":5563.21},{"text":"them.","start":5563.21,"end":5563.53}]},{"text":"As an example, we have met recently at ministerial level with the Director General of the WHO in the framework of FFD4 in Sevilla to manifest our support and positive interest to strengthen cooperation between these agendas.","start":5564.33,"end":5580.65,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"As","start":5564.33,"end":5564.57},{"text":"an","start":5564.61,"end":5564.73},{"text":"example,","start":5564.73,"end":5565.37},{"text":"we","start":5565.37,"end":5565.53},{"text":"have","start":5565.53,"end":5565.77},{"text":"met","start":5566.17,"end":5566.41},{"text":"recently","start":5566.41,"end":5566.97},{"text":"at","start":5566.97,"end":5567.09},{"text":"ministerial","start":5567.09,"end":5567.65},{"text":"level","start":5567.65,"end":5567.93},{"text":"with","start":5567.93,"end":5568.17},{"text":"the","start":5568.17,"end":5568.25},{"text":"Director","start":5568.25,"end":5568.65},{"text":"General","start":5568.65,"end":5569.01},{"text":"of","start":5569.01,"end":5569.09},{"text":"the","start":5569.09,"end":5569.49},{"text":"WHO","start":5569.61,"end":5570.49},{"text":"in","start":5570.57,"end":5570.73},{"text":"the","start":5570.73,"end":5570.81},{"text":"framework","start":5570.81,"end":5571.45},{"text":"of","start":5571.45,"end":5571.69},{"text":"FFD4","start":5571.69,"end":5572.97},{"text":"in","start":5572.97,"end":5573.13},{"text":"Sevilla","start":5573.13,"end":5573.61},{"text":"to","start":5574.33,"end":5574.37},{"text":"manifest","start":5574.41,"end":5574.97},{"text":"our","start":5574.97,"end":5575.21},{"text":"support","start":5575.21,"end":5575.93},{"text":"and","start":5576.21,"end":5576.33},{"text":"positive","start":5576.33,"end":5576.81},{"text":"interest","start":5576.81,"end":5577.33},{"text":"to","start":5577.33,"end":5577.45},{"text":"strengthen","start":5577.45,"end":5577.93},{"text":"cooperation","start":5577.93,"end":5578.73},{"text":"between","start":5579.13,"end":5579.61},{"text":"these","start":5579.61,"end":5580.01},{"text":"agendas.","start":5580.01,"end":5580.65}]},{"text":"So we believe there are many lessons and opportunities if we keep momentum and political commitment high in our priorities, and we invite you to take part in this effort.","start":5581.77,"end":5592.17,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"So","start":5581.77,"end":5582.25},{"text":"we","start":5582.65,"end":5582.81},{"text":"believe","start":5582.81,"end":5583.21},{"text":"there","start":5583.21,"end":5583.33},{"text":"are","start":5583.33,"end":5583.45},{"text":"many","start":5583.45,"end":5583.69},{"text":"lessons","start":5583.69,"end":5584.09},{"text":"and","start":5584.13,"end":5584.25},{"text":"opportunities","start":5584.25,"end":5585.13},{"text":"if","start":5585.13,"end":5585.21},{"text":"we","start":5585.21,"end":5585.37},{"text":"keep","start":5585.37,"end":5585.69},{"text":"momentum","start":5585.77,"end":5586.37},{"text":"and","start":5586.37,"end":5586.49},{"text":"political","start":5586.49,"end":5586.97},{"text":"commitment","start":5586.97,"end":5587.69},{"text":"high","start":5587.69,"end":5588.09},{"text":"in","start":5588.09,"end":5588.33},{"text":"our","start":5588.33,"end":5588.57},{"text":"priorities,","start":5588.57,"end":5589.21},{"text":"and","start":5589.21,"end":5589.33},{"text":"we","start":5589.33,"end":5589.53},{"text":"invite","start":5589.69,"end":5590.17},{"text":"you","start":5590.17,"end":5590.49},{"text":"to","start":5590.49,"end":5590.57},{"text":"take","start":5590.57,"end":5590.89},{"text":"part","start":5590.89,"end":5591.13},{"text":"in","start":5591.13,"end":5591.25},{"text":"this","start":5591.25,"end":5591.61},{"text":"effort.","start":5591.81,"end":5592.17}]},{"text":"Thank you.","start":5592.25,"end":5592.65,"topics":[],"words":[{"text":"Thank","start":5592.25,"end":5592.49},{"text":"you.","start":5592.49,"end":5592.65}]}]}],"speaker":{"affiliation":"COL","group":null,"function":"Deputy Minister of Multilateral Affairs","affiliation_full":"Colombia"}},{"statement_number":44,"start":5593.49,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:33:14","paragraphs":[{"sentences":[{"text":"Deputy Minister Jaramillo, thank you very much.","start":5593.49,"end":5595.89,"topics":[],"words":[{"text":"Deputy","start":5593.49,"end":5593.93},{"text":"Minister","start":5593.93,"end":5594.37},{"text":"Jaramillo,","start":5594.37,"end":5594.89},{"text":"thank","start":5594.89,"end":5595.25},{"text":"you","start":5595.25,"end":5595.37},{"text":"very","start":5595.37,"end":5595.57},{"text":"much.","start":5595.57,"end":5595.89}]},{"text":"And I'll pass the floor to our last speaker, and this is Mr. Bienkier.","start":5595.89,"end":5600.97,"topics":[],"words":[{"text":"And","start":5595.89,"end":5596.01},{"text":"I'll","start":5596.01,"end":5596.21},{"text":"pass","start":5596.21,"end":5596.49},{"text":"the","start":5596.49,"end":5596.57},{"text":"floor","start":5596.57,"end":5596.89},{"text":"to","start":5596.89,"end":5597.05},{"text":"our","start":5597.05,"end":5597.29},{"text":"last","start":5597.29,"end":5597.53},{"text":"speaker,","start":5597.53,"end":5598.49},{"text":"and","start":5598.89,"end":5599.29},{"text":"this","start":5599.37,"end":5599.77},{"text":"is","start":5599.77,"end":5600.01},{"text":"Mr.","start":5600.01,"end":5600.53},{"text":"Bienkier.","start":5600.53,"end":5600.97}]},{"text":"You have the floor.","start":5600.97,"end":5601.77,"topics":[],"words":[{"text":"You","start":5600.97,"end":5601.13},{"text":"have","start":5601.13,"end":5601.33},{"text":"the","start":5601.33,"end":5601.45},{"text":"floor.","start":5601.45,"end":5601.77}]}]}],"speaker":{"affiliation":"MEX","group":null,"function":"Deputy Permanent Representative","affiliation_full":"Mexico"}},{"statement_number":45,"start":5603.41,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:33:24","paragraphs":[{"sentences":[{"text":"Thank you, Chair. Thank you, Excellencies and distinguished guests.","start":5603.41,"end":5606.61,"topics":[],"words":[{"text":"Thank","start":5603.41,"end":5603.61},{"text":"you,","start":5603.61,"end":5603.73},{"text":"Chair.","start":5603.73,"end":5604.05},{"text":"Thank","start":5604.05,"end":5604.25},{"text":"you,","start":5604.25,"end":5604.37},{"text":"Excellencies","start":5604.37,"end":5605.17},{"text":"and","start":5605.33,"end":5605.53},{"text":"distinguished","start":5605.53,"end":5606.05},{"text":"guests.","start":5606.05,"end":5606.61}]},{"text":"A lot of thanks as well to Colombia, Czech Republic, Mexico, Switzerland, UNDP, OHCHR, UNAIDS, WHO, and the Global Commission on Drug Policy.","start":5607.01,"end":5617.25,"topics":[],"words":[{"text":"A","start":5607.01,"end":5607.09},{"text":"lot","start":5607.17,"end":5607.37},{"text":"of","start":5607.37,"end":5607.45},{"text":"thanks","start":5607.45,"end":5607.77},{"text":"as","start":5607.77,"end":5607.89},{"text":"well","start":5607.89,"end":5608.05},{"text":"to","start":5608.05,"end":5608.13},{"text":"Colombia,","start":5608.13,"end":5608.85},{"text":"Czech","start":5608.93,"end":5609.25},{"text":"Republic,","start":5609.25,"end":5609.81},{"text":"Mexico,","start":5609.81,"end":5610.37},{"text":"Switzerland,","start":5610.37,"end":5611.17},{"text":"UNDP,","start":5611.41,"end":5612.13},{"text":"OHCHR,","start":5612.29,"end":5613.33},{"text":"UNAIDS,","start":5613.57,"end":5614.61},{"text":"WHO,","start":5614.61,"end":5614.69},{"text":"and","start":5615.17,"end":5615.49},{"text":"the","start":5615.49,"end":5615.61},{"text":"Global","start":5615.61,"end":5615.93},{"text":"Commission","start":5615.93,"end":5616.29},{"text":"on","start":5616.29,"end":5616.37},{"text":"Drug","start":5616.37,"end":5616.61},{"text":"Policy.","start":5616.61,"end":5617.25}]},{"text":"We stand at a pivotal moment in history.","start":5617.89,"end":5620.45,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"We","start":5617.89,"end":5618.13},{"text":"stand","start":5618.13,"end":5618.69},{"text":"at","start":5618.69,"end":5618.89},{"text":"a","start":5618.89,"end":5618.93},{"text":"pivotal","start":5618.93,"end":5619.41},{"text":"moment","start":5619.41,"end":5619.81},{"text":"in","start":5619.81,"end":5619.93},{"text":"history.","start":5619.93,"end":5620.45}]},{"text":"There are good opportunities that have all been raised with the global drug control system.","start":5621.01,"end":5626.61,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"There","start":5621.01,"end":5621.33},{"text":"are","start":5621.33,"end":5621.41},{"text":"good","start":5621.41,"end":5621.77},{"text":"opportunities","start":5621.77,"end":5622.69},{"text":"that","start":5622.69,"end":5622.93},{"text":"have","start":5622.93,"end":5623.09},{"text":"all","start":5623.09,"end":5623.17},{"text":"been","start":5623.17,"end":5623.41},{"text":"raised","start":5623.41,"end":5623.85},{"text":"with","start":5624.05,"end":5624.41},{"text":"the","start":5624.41,"end":5624.53},{"text":"global","start":5624.53,"end":5625.49},{"text":"drug","start":5625.49,"end":5625.73},{"text":"control","start":5625.73,"end":5626.13},{"text":"system.","start":5626.13,"end":5626.61}]},{"text":"With strategic support, We can help transform these opportunities into pathways towards justice, health, and dignity.","start":5627.17,"end":5634.57,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"With","start":5627.17,"end":5627.33},{"text":"strategic","start":5627.33,"end":5627.81},{"text":"support,","start":5627.81,"end":5628.45},{"text":"We","start":5628.89,"end":5628.97},{"text":"can","start":5628.97,"end":5629.29},{"text":"help","start":5629.45,"end":5629.77},{"text":"transform","start":5629.77,"end":5630.33},{"text":"these","start":5630.33,"end":5630.49},{"text":"opportunities","start":5630.49,"end":5631.17},{"text":"into","start":5631.17,"end":5631.37},{"text":"pathways","start":5631.37,"end":5632.09},{"text":"towards","start":5632.09,"end":5632.41},{"text":"justice,","start":5632.41,"end":5633.13},{"text":"health,","start":5633.29,"end":5633.69},{"text":"and","start":5633.69,"end":5633.89},{"text":"dignity.","start":5633.89,"end":5634.57}]},{"text":"This is a time and a moment of construction, not critique, exemplified by the good interventions we have heard today.","start":5635.05,"end":5641.61,"topics":[],"words":[{"text":"This","start":5635.05,"end":5635.41},{"text":"is","start":5635.41,"end":5635.49},{"text":"a","start":5635.49,"end":5635.53},{"text":"time","start":5635.53,"end":5635.93},{"text":"and","start":5636.13,"end":5636.29},{"text":"a","start":5636.29,"end":5636.33},{"text":"moment","start":5636.33,"end":5636.73},{"text":"of","start":5636.73,"end":5636.89},{"text":"construction,","start":5636.89,"end":5637.81},{"text":"not","start":5637.81,"end":5637.97},{"text":"critique,","start":5637.97,"end":5638.57},{"text":"exemplified","start":5639.05,"end":5639.69},{"text":"by","start":5639.69,"end":5639.81},{"text":"the","start":5639.81,"end":5639.93},{"text":"good","start":5639.93,"end":5640.13},{"text":"interventions","start":5640.13,"end":5640.81},{"text":"we","start":5640.81,"end":5640.89},{"text":"have","start":5640.89,"end":5641.05},{"text":"heard","start":5641.05,"end":5641.21},{"text":"today.","start":5641.21,"end":5641.61}]},{"text":"We can build a new drug policy paradigm, one that will reduce criminalization, scale lifesaving services, and center human rights.","start":5642.01,"end":5651.13,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"We","start":5642.01,"end":5642.17},{"text":"can","start":5642.17,"end":5642.33},{"text":"build","start":5642.33,"end":5642.61},{"text":"a","start":5642.61,"end":5642.65},{"text":"new","start":5642.65,"end":5643.05},{"text":"drug","start":5643.37,"end":5643.69},{"text":"policy","start":5643.69,"end":5644.17},{"text":"paradigm,","start":5644.17,"end":5644.81},{"text":"one","start":5645.13,"end":5645.45},{"text":"that","start":5645.45,"end":5645.61},{"text":"will","start":5645.61,"end":5645.77},{"text":"reduce","start":5645.77,"end":5646.17},{"text":"criminalization,","start":5646.17,"end":5647.13},{"text":"scale","start":5647.85,"end":5648.29},{"text":"lifesaving","start":5648.29,"end":5648.73},{"text":"services,","start":5648.73,"end":5649.45},{"text":"and","start":5649.61,"end":5649.77},{"text":"center","start":5649.77,"end":5650.25},{"text":"human","start":5650.25,"end":5650.61},{"text":"rights.","start":5650.61,"end":5651.13}]},{"text":"As we do so, there are great lessons that we can learn from the HIV epidemic to inform our approach.","start":5651.93,"end":5657.45,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"As","start":5651.93,"end":5652.17},{"text":"we","start":5652.17,"end":5652.25},{"text":"do","start":5652.25,"end":5652.49},{"text":"so,","start":5652.49,"end":5652.81},{"text":"there","start":5652.81,"end":5652.97},{"text":"are","start":5652.97,"end":5653.05},{"text":"great","start":5653.05,"end":5653.29},{"text":"lessons","start":5653.29,"end":5653.65},{"text":"that","start":5653.65,"end":5653.77},{"text":"we","start":5653.77,"end":5653.89},{"text":"can","start":5653.89,"end":5654.05},{"text":"learn","start":5654.05,"end":5654.49},{"text":"from","start":5654.49,"end":5654.73},{"text":"the","start":5654.73,"end":5654.81},{"text":"HIV","start":5654.81,"end":5655.45},{"text":"epidemic","start":5655.53,"end":5656.17},{"text":"to","start":5656.17,"end":5656.33},{"text":"inform","start":5656.33,"end":5656.73},{"text":"our","start":5656.73,"end":5656.85},{"text":"approach.","start":5656.85,"end":5657.45}]},{"text":"And one of those critical lessons is that when transmission is rapid, the response must be immediate.","start":5658.01,"end":5663.73,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"And","start":5658.01,"end":5658.13},{"text":"one","start":5658.13,"end":5658.33},{"text":"of","start":5658.33,"end":5658.41},{"text":"those","start":5658.41,"end":5658.61},{"text":"critical","start":5658.61,"end":5658.97},{"text":"lessons","start":5658.97,"end":5659.65},{"text":"is","start":5659.89,"end":5660.05},{"text":"that","start":5660.05,"end":5660.17},{"text":"when","start":5660.17,"end":5660.45},{"text":"transmission","start":5660.45,"end":5661.17},{"text":"is","start":5661.17,"end":5661.33},{"text":"rapid,","start":5661.33,"end":5661.81},{"text":"the","start":5661.97,"end":5662.13},{"text":"response","start":5662.13,"end":5662.69},{"text":"must","start":5662.69,"end":5662.89},{"text":"be","start":5662.89,"end":5663.09},{"text":"immediate.","start":5663.09,"end":5663.73}]},{"text":"For example, countries that acted swiftly and prioritized harm reduction all were able to flatten the curve.","start":5664.37,"end":5670.61,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"For","start":5664.37,"end":5664.53},{"text":"example,","start":5664.53,"end":5665.09},{"text":"countries","start":5665.41,"end":5665.81},{"text":"that","start":5665.81,"end":5665.97},{"text":"acted","start":5665.97,"end":5666.25},{"text":"swiftly","start":5666.25,"end":5666.77},{"text":"and","start":5666.77,"end":5666.89},{"text":"prioritized","start":5666.89,"end":5667.49},{"text":"harm","start":5667.49,"end":5667.81},{"text":"reduction","start":5667.81,"end":5668.37},{"text":"all","start":5668.69,"end":5668.93},{"text":"were","start":5668.93,"end":5669.09},{"text":"able","start":5669.09,"end":5669.41},{"text":"to","start":5669.41,"end":5669.49},{"text":"flatten","start":5669.49,"end":5670.05},{"text":"the","start":5670.05,"end":5670.13},{"text":"curve.","start":5670.13,"end":5670.61}]},{"text":"This underlines the need and importance of timely, evidence-based interventions in the face of fast-moving public health threats.","start":5671.41,"end":5679.57,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"This","start":5671.41,"end":5671.65},{"text":"underlines","start":5671.65,"end":5672.13},{"text":"the","start":5672.13,"end":5672.21},{"text":"need","start":5672.21,"end":5672.69},{"text":"and","start":5672.69,"end":5672.93},{"text":"importance","start":5672.93,"end":5673.53},{"text":"of","start":5673.53,"end":5673.65},{"text":"timely,","start":5673.65,"end":5674.21},{"text":"evidence-based","start":5674.69,"end":5675.57},{"text":"interventions","start":5675.89,"end":5676.69},{"text":"in","start":5676.69,"end":5676.77},{"text":"the","start":5676.77,"end":5676.85},{"text":"face","start":5676.85,"end":5677.13},{"text":"of","start":5677.13,"end":5677.21},{"text":"fast-moving","start":5677.21,"end":5677.97},{"text":"public","start":5678.29,"end":5678.69},{"text":"health","start":5678.69,"end":5678.97},{"text":"threats.","start":5678.97,"end":5679.57}]},{"text":"For example, the introduction that we're seeing now of fentanyl is mirroring much of the early days of HIV.","start":5680.21,"end":5686.61,"topics":[{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."}],"words":[{"text":"For","start":5680.21,"end":5680.37},{"text":"example,","start":5680.37,"end":5680.85},{"text":"the","start":5680.85,"end":5681.05},{"text":"introduction","start":5681.05,"end":5682.13},{"text":"that","start":5682.13,"end":5682.25},{"text":"we're","start":5682.25,"end":5682.41},{"text":"seeing","start":5682.41,"end":5682.65},{"text":"now","start":5682.65,"end":5682.93},{"text":"of","start":5682.93,"end":5683.09},{"text":"fentanyl","start":5683.09,"end":5683.81},{"text":"is","start":5683.97,"end":5684.13},{"text":"mirroring","start":5684.13,"end":5684.53},{"text":"much","start":5684.53,"end":5684.85},{"text":"of","start":5684.85,"end":5685.01},{"text":"the","start":5685.01,"end":5685.13},{"text":"early","start":5685.13,"end":5685.41},{"text":"days","start":5685.41,"end":5685.81},{"text":"of","start":5685.81,"end":5686.05},{"text":"HIV.","start":5686.05,"end":5686.61}]},{"text":"We need to be proactive, policy grounded in harm reduction, decriminalization, and community engagement.","start":5687.77,"end":5693.69,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"We","start":5687.77,"end":5687.81},{"text":"need","start":5687.81,"end":5687.97},{"text":"to","start":5687.97,"end":5688.05},{"text":"be","start":5688.05,"end":5688.17},{"text":"proactive,","start":5688.17,"end":5688.89},{"text":"policy","start":5689.21,"end":5689.69},{"text":"grounded","start":5689.69,"end":5690.09},{"text":"in","start":5690.09,"end":5690.17},{"text":"harm","start":5690.17,"end":5690.41},{"text":"reduction,","start":5690.41,"end":5691.05},{"text":"decriminalization,","start":5691.45,"end":5692.33},{"text":"and","start":5692.33,"end":5692.57},{"text":"community","start":5692.57,"end":5693.01},{"text":"engagement.","start":5693.01,"end":5693.69}]},{"text":"Like we have heard well from colleagues, Catherine Cook, as well as Anton Basenko.","start":5694.49,"end":5700.25,"topics":[],"words":[{"text":"Like","start":5694.49,"end":5694.65},{"text":"we","start":5694.65,"end":5694.77},{"text":"have","start":5694.77,"end":5694.89},{"text":"heard","start":5694.89,"end":5695.13},{"text":"well","start":5695.13,"end":5695.61},{"text":"from","start":5695.61,"end":5696.01},{"text":"colleagues,","start":5696.09,"end":5696.89},{"text":"Catherine","start":5697.29,"end":5697.81},{"text":"Cook,","start":5697.81,"end":5698.17},{"text":"as","start":5698.41,"end":5698.57},{"text":"well","start":5698.57,"end":5698.81},{"text":"as","start":5698.81,"end":5699.13},{"text":"Anton","start":5699.37,"end":5699.69},{"text":"Basenko.","start":5699.69,"end":5700.25}]},{"text":"At the Open Society Foundations, we aim to support non-punitive drug policy that recognizes people's dignity, protects human rights, and advances public health.","start":5701.13,"end":5711.13,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"At","start":5701.13,"end":5701.37},{"text":"the","start":5701.37,"end":5701.49},{"text":"Open","start":5701.49,"end":5701.69},{"text":"Society","start":5701.69,"end":5702.17},{"text":"Foundations,","start":5702.17,"end":5702.97},{"text":"we","start":5703.05,"end":5703.37},{"text":"aim","start":5703.37,"end":5703.53},{"text":"to","start":5703.53,"end":5703.65},{"text":"support","start":5703.65,"end":5704.09},{"text":"non-punitive","start":5704.09,"end":5705.13},{"text":"drug","start":5705.13,"end":5705.49},{"text":"policy","start":5705.49,"end":5706.09},{"text":"that","start":5706.33,"end":5706.49},{"text":"recognizes","start":5706.49,"end":5707.13},{"text":"people's","start":5707.13,"end":5707.61},{"text":"dignity,","start":5707.61,"end":5708.09},{"text":"protects","start":5708.61,"end":5709.01},{"text":"human","start":5709.01,"end":5709.25},{"text":"rights,","start":5709.25,"end":5709.77},{"text":"and","start":5709.77,"end":5709.93},{"text":"advances","start":5709.93,"end":5710.41},{"text":"public","start":5710.41,"end":5710.81},{"text":"health.","start":5710.81,"end":5711.13}]},{"text":"For economically disadvantaged communities to benefit from a sustainable, and regulatory framework, and for people who use drugs to have access to harm reduction.","start":5711.61,"end":5721.33,"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."}],"words":[{"text":"For","start":5711.61,"end":5711.77},{"text":"economically","start":5711.77,"end":5712.33},{"text":"disadvantaged","start":5712.33,"end":5712.97},{"text":"communities","start":5712.97,"end":5713.53},{"text":"to","start":5713.53,"end":5713.65},{"text":"benefit","start":5713.65,"end":5714.25},{"text":"from","start":5714.25,"end":5714.49},{"text":"a","start":5714.49,"end":5714.53},{"text":"sustainable,","start":5714.53,"end":5715.37},{"text":"and","start":5716.13,"end":5716.21},{"text":"regulatory","start":5716.21,"end":5716.77},{"text":"framework,","start":5716.77,"end":5717.41},{"text":"and","start":5717.65,"end":5717.85},{"text":"for","start":5717.85,"end":5717.97},{"text":"people","start":5717.97,"end":5718.45},{"text":"who","start":5718.93,"end":5719.09},{"text":"use","start":5719.09,"end":5719.33},{"text":"drugs","start":5719.33,"end":5719.69},{"text":"to","start":5719.69,"end":5719.81},{"text":"have","start":5719.81,"end":5719.97},{"text":"access","start":5719.97,"end":5720.37},{"text":"to","start":5720.37,"end":5720.53},{"text":"harm","start":5720.53,"end":5720.73},{"text":"reduction.","start":5720.73,"end":5721.33}]},{"text":"Current policies that focus on punishment and enforcement oversimplify the problem by ignoring the broader economic and political context in which drug production and sales occur.","start":5721.89,"end":5733.01,"topics":[{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"Current","start":5721.89,"end":5722.17},{"text":"policies","start":5722.17,"end":5722.61},{"text":"that","start":5722.61,"end":5722.77},{"text":"focus","start":5722.77,"end":5723.21},{"text":"on","start":5723.21,"end":5723.33},{"text":"punishment","start":5723.33,"end":5723.97},{"text":"and","start":5723.97,"end":5724.17},{"text":"enforcement","start":5724.17,"end":5725.01},{"text":"oversimplify","start":5725.17,"end":5726.13},{"text":"the","start":5726.13,"end":5726.29},{"text":"problem","start":5726.29,"end":5726.77},{"text":"by","start":5727.25,"end":5727.53},{"text":"ignoring","start":5727.53,"end":5727.93},{"text":"the","start":5727.93,"end":5728.05},{"text":"broader","start":5728.05,"end":5728.45},{"text":"economic","start":5728.49,"end":5729.17},{"text":"and","start":5729.17,"end":5729.37},{"text":"political","start":5729.49,"end":5729.93},{"text":"context","start":5729.93,"end":5730.41},{"text":"in","start":5730.41,"end":5730.53},{"text":"which","start":5730.53,"end":5730.69},{"text":"drug","start":5730.69,"end":5731.01},{"text":"production","start":5731.01,"end":5731.73},{"text":"and","start":5731.81,"end":5732.05},{"text":"sales","start":5732.05,"end":5732.53},{"text":"occur.","start":5732.53,"end":5733.01}]},{"text":"Looking ahead, the future of drug policy must include those who are most impacted.","start":5734.29,"end":5738.93,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Looking","start":5734.29,"end":5734.69},{"text":"ahead,","start":5734.69,"end":5735.17},{"text":"the","start":5735.17,"end":5735.41},{"text":"future","start":5735.41,"end":5735.69},{"text":"of","start":5735.69,"end":5735.81},{"text":"drug","start":5735.81,"end":5736.05},{"text":"policy","start":5736.05,"end":5736.61},{"text":"must","start":5736.61,"end":5736.93},{"text":"include","start":5736.93,"end":5737.41},{"text":"those","start":5737.41,"end":5737.73},{"text":"who","start":5737.73,"end":5737.81},{"text":"are","start":5737.81,"end":5737.89},{"text":"most","start":5737.89,"end":5738.21},{"text":"impacted.","start":5738.21,"end":5738.93}]},{"text":"It's also important to include future generations, as we've heard from the great interventions by youth today.","start":5739.81,"end":5745.17,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"It's","start":5739.81,"end":5740.05},{"text":"also","start":5740.05,"end":5740.45},{"text":"important","start":5740.77,"end":5741.37},{"text":"to","start":5741.37,"end":5741.45},{"text":"include","start":5741.45,"end":5741.77},{"text":"future","start":5741.77,"end":5742.05},{"text":"generations,","start":5742.05,"end":5742.69},{"text":"as","start":5742.69,"end":5742.81},{"text":"we've","start":5742.81,"end":5742.97},{"text":"heard","start":5742.97,"end":5743.13},{"text":"from","start":5743.13,"end":5743.29},{"text":"the","start":5743.29,"end":5743.37},{"text":"great","start":5743.37,"end":5743.61},{"text":"interventions","start":5743.61,"end":5744.29},{"text":"by","start":5744.29,"end":5744.45},{"text":"youth","start":5744.45,"end":5744.77},{"text":"today.","start":5744.77,"end":5745.17}]},{"text":"It's also a time to shift leadership to communities in the global south and institutions grounded in health, rights, and justice.","start":5746.09,"end":5753.57,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"It's","start":5746.09,"end":5746.29},{"text":"also","start":5746.29,"end":5746.45},{"text":"a","start":5746.45,"end":5746.49},{"text":"time","start":5746.49,"end":5746.85},{"text":"to","start":5746.85,"end":5746.97},{"text":"shift","start":5746.97,"end":5747.25},{"text":"leadership","start":5747.25,"end":5747.89},{"text":"to","start":5748.13,"end":5748.29},{"text":"communities","start":5748.29,"end":5748.85},{"text":"in","start":5748.85,"end":5749.01},{"text":"the","start":5749.01,"end":5749.09},{"text":"global","start":5749.09,"end":5749.41},{"text":"south","start":5749.41,"end":5749.89},{"text":"and","start":5750.37,"end":5750.61},{"text":"institutions","start":5750.61,"end":5751.25},{"text":"grounded","start":5751.25,"end":5751.65},{"text":"in","start":5751.65,"end":5751.73},{"text":"health,","start":5751.73,"end":5752.13},{"text":"rights,","start":5752.13,"end":5752.61},{"text":"and","start":5752.61,"end":5752.81},{"text":"justice.","start":5752.81,"end":5753.57}]},{"text":"Today, a new vision is emerging, one that is rooted in evidence, rights, and compassion, importantly, compassion.","start":5754.01,"end":5761.33,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"Today,","start":5754.01,"end":5754.41},{"text":"a","start":5754.41,"end":5754.45},{"text":"new","start":5754.45,"end":5754.85},{"text":"vision","start":5754.85,"end":5755.17},{"text":"is","start":5755.17,"end":5755.33},{"text":"emerging,","start":5755.33,"end":5756.21},{"text":"one","start":5756.69,"end":5756.93},{"text":"that","start":5756.93,"end":5757.09},{"text":"is","start":5757.09,"end":5757.21},{"text":"rooted","start":5757.21,"end":5757.53},{"text":"in","start":5757.53,"end":5757.65},{"text":"evidence,","start":5757.65,"end":5758.37},{"text":"rights,","start":5758.37,"end":5759.01},{"text":"and","start":5759.01,"end":5759.25},{"text":"compassion,","start":5759.25,"end":5760.05},{"text":"importantly,","start":5760.05,"end":5760.61},{"text":"compassion.","start":5760.61,"end":5761.33}]},{"text":"It's also time to seize this moment and move away from the decades of punitive drug policy that have caused much harm.","start":5761.69,"end":5767.89,"topics":[{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."}],"words":[{"text":"It's","start":5761.69,"end":5761.93},{"text":"also","start":5761.93,"end":5762.13},{"text":"time","start":5762.13,"end":5762.53},{"text":"to","start":5762.53,"end":5762.65},{"text":"seize","start":5762.65,"end":5762.89},{"text":"this","start":5762.89,"end":5763.09},{"text":"moment","start":5763.09,"end":5763.37},{"text":"and","start":5763.37,"end":5763.49},{"text":"move","start":5763.49,"end":5763.69},{"text":"away","start":5763.69,"end":5763.89},{"text":"from","start":5763.89,"end":5764.09},{"text":"the","start":5764.09,"end":5764.21},{"text":"decades","start":5764.21,"end":5764.77},{"text":"of","start":5764.77,"end":5764.85},{"text":"punitive","start":5764.85,"end":5765.33},{"text":"drug","start":5765.33,"end":5765.65},{"text":"policy","start":5765.65,"end":5766.21},{"text":"that","start":5766.61,"end":5766.77},{"text":"have","start":5766.77,"end":5766.89},{"text":"caused","start":5766.89,"end":5767.25},{"text":"much","start":5767.25,"end":5767.49},{"text":"harm.","start":5767.49,"end":5767.89}]},{"text":"Thank you.","start":5768.13,"end":5768.53,"topics":[],"words":[{"text":"Thank","start":5768.13,"end":5768.45},{"text":"you.","start":5768.45,"end":5768.53}]}]}],"speaker":{"affiliation":"OSF","group":null,"function":"Advocacy Advisor for Multilateral Engagement","affiliation_full":"OSF"}},{"statement_number":46,"start":5770.21,"pageUrl":"/en/asset/k1j/k1jrujg19l?t=1:36:11","paragraphs":[{"sentences":[{"text":"Thank you very, very much, and thank you for the time you gave us.","start":5770.21,"end":5775.09,"topics":[],"words":[{"text":"Thank","start":5770.21,"end":5770.45},{"text":"you","start":5770.45,"end":5770.69},{"text":"very,","start":5770.77,"end":5771.17},{"text":"very","start":5771.17,"end":5771.41},{"text":"much,","start":5771.41,"end":5771.97},{"text":"and","start":5771.97,"end":5772.37},{"text":"thank","start":5772.77,"end":5773.01},{"text":"you","start":5773.01,"end":5773.09},{"text":"for","start":5773.09,"end":5773.49},{"text":"the","start":5773.65,"end":5773.81},{"text":"time","start":5773.81,"end":5774.29},{"text":"you","start":5774.29,"end":5774.45},{"text":"gave","start":5774.45,"end":5774.77},{"text":"us.","start":5774.77,"end":5775.09}]},{"text":"And thank you again to all participants, co-organizers, and attendants.","start":5775.49,"end":5779.89,"topics":[],"words":[{"text":"And","start":5775.49,"end":5775.89},{"text":"thank","start":5776.13,"end":5776.37},{"text":"you","start":5776.37,"end":5776.49},{"text":"again","start":5776.49,"end":5776.77},{"text":"to","start":5776.77,"end":5776.93},{"text":"all","start":5776.93,"end":5777.01},{"text":"participants,","start":5777.01,"end":5777.89},{"text":"co-organizers,","start":5777.89,"end":5779.01},{"text":"and","start":5779.01,"end":5779.17},{"text":"attendants.","start":5779.17,"end":5779.89}]},{"text":"It was a pleasure to moderate today's discussion, which has shown us that the shift toward evidence-based, rights-affirming drug policy is not only necessary, it is happening.","start":5780.13,"end":5792.13,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."}],"words":[{"text":"It","start":5780.13,"end":5780.33},{"text":"was","start":5780.33,"end":5780.53},{"text":"a","start":5780.53,"end":5780.61},{"text":"pleasure","start":5780.61,"end":5781.09},{"text":"to","start":5781.09,"end":5781.21},{"text":"moderate","start":5781.21,"end":5781.77},{"text":"today's","start":5781.77,"end":5782.17},{"text":"discussion,","start":5782.17,"end":5782.93},{"text":"which","start":5782.93,"end":5783.21},{"text":"has","start":5783.21,"end":5783.49},{"text":"shown","start":5783.49,"end":5784.05},{"text":"us","start":5784.61,"end":5784.85},{"text":"that","start":5784.85,"end":5785.01},{"text":"the","start":5785.01,"end":5785.13},{"text":"shift","start":5785.13,"end":5785.53},{"text":"toward","start":5785.53,"end":5785.97},{"text":"evidence-based,","start":5785.97,"end":5787.05},{"text":"rights-affirming","start":5787.41,"end":5788.61},{"text":"drug","start":5788.61,"end":5788.85},{"text":"policy","start":5788.85,"end":5789.57},{"text":"is","start":5789.57,"end":5789.73},{"text":"not","start":5789.73,"end":5789.97},{"text":"only","start":5789.97,"end":5790.21},{"text":"necessary,","start":5790.21,"end":5791.01},{"text":"it","start":5791.17,"end":5791.37},{"text":"is","start":5791.41,"end":5791.61},{"text":"happening.","start":5791.61,"end":5792.13}]},{"text":"Let us continue to stand with communities, amplify good practices, and work together across sectors and borders.","start":5792.45,"end":5799.17,"topics":[{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."}],"words":[{"text":"Let","start":5792.45,"end":5792.69},{"text":"us","start":5792.69,"end":5792.77},{"text":"continue","start":5792.77,"end":5793.25},{"text":"to","start":5793.25,"end":5793.37},{"text":"stand","start":5793.41,"end":5793.73},{"text":"with","start":5793.73,"end":5793.89},{"text":"communities,","start":5793.89,"end":5794.77},{"text":"amplify","start":5794.93,"end":5795.57},{"text":"good","start":5795.57,"end":5795.77},{"text":"practices,","start":5795.77,"end":5796.49},{"text":"and","start":5796.49,"end":5796.65},{"text":"work","start":5796.65,"end":5796.89},{"text":"together","start":5796.89,"end":5797.37},{"text":"across","start":5797.37,"end":5797.77},{"text":"sectors","start":5797.77,"end":5798.33},{"text":"and","start":5798.33,"end":5798.53},{"text":"borders.","start":5798.53,"end":5799.17}]},{"text":"Let's also continue to use multilateralism to advance towards more effective, more humane drug policies.","start":5799.73,"end":5806.77,"topics":[{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}],"words":[{"text":"Let's","start":5799.73,"end":5800.05},{"text":"also","start":5800.05,"end":5800.33},{"text":"continue","start":5800.33,"end":5800.85},{"text":"to","start":5800.85,"end":5800.97},{"text":"use","start":5800.97,"end":5801.41},{"text":"multilateralism","start":5801.41,"end":5802.69},{"text":"to","start":5802.69,"end":5802.85},{"text":"advance","start":5802.85,"end":5803.37},{"text":"towards","start":5803.37,"end":5803.81},{"text":"more","start":5804.05,"end":5804.37},{"text":"effective,","start":5804.37,"end":5805.01},{"text":"more","start":5805.01,"end":5805.33},{"text":"humane","start":5805.33,"end":5805.81},{"text":"drug","start":5805.81,"end":5806.09},{"text":"policies.","start":5806.09,"end":5806.77}]},{"text":"This side event is now closed, so I thank you.","start":5807.01,"end":5809.97,"topics":[],"words":[{"text":"This","start":5807.01,"end":5807.29},{"text":"side","start":5807.29,"end":5807.57},{"text":"event","start":5807.61,"end":5808.01},{"text":"is","start":5808.05,"end":5808.29},{"text":"now","start":5808.29,"end":5808.53},{"text":"closed,","start":5808.53,"end":5808.93},{"text":"so","start":5808.93,"end":5809.41},{"text":"I","start":5809.41,"end":5809.57},{"text":"thank","start":5809.57,"end":5809.89},{"text":"you.","start":5809.89,"end":5809.97}]}]}],"speaker":{"affiliation":"MEX","group":null,"function":"Deputy Permanent Representative","affiliation_full":"Mexico"}}],"topics":[{"key":"harm-reduction","label":"Harm Reduction","description":"Speakers repeatedly discussed harm reduction measures such as needle and syringe programs, safer consumption spaces, naloxone, drug checking, and opioid agonist therapy. These interventions were presented as evidence-based tools that save lives, reduce overdose, and lower HIV and hepatitis transmission."},{"key":"decriminalization","label":"Decriminalization","description":"A major topic was the decriminalization of drug use and possession for personal use as an alternative to punitive approaches. Multiple speakers argued that criminalization drives people away from health services, increases stigma, and worsens both public health and human rights outcomes."},{"key":"social-determinants","label":"Social Determinants and Development","description":"Another recurring topic was the need to address the social and economic conditions that shape problematic drug use, including poverty, exclusion, lack of opportunity, and weak support systems. Speakers linked drug policy to broader development goals and argued for prevention and recovery strategies grounded in social justice and inclusion."},{"key":"hiv-hepatitis-overdose","label":"HIV, Hepatitis, and Overdose","description":"Many interventions focused on the high burden of HIV, hepatitis C, and overdose among people who use drugs, especially people who inject drugs. Speakers emphasized that drug policy must be linked to prevention, treatment, and integrated health services to avoid preventable deaths and infections."},{"key":"human-rights-inclusion","label":"Human Rights and Community Inclusion","description":"The discussion repeatedly framed drug policy as a human rights issue, including the rights to health, dignity, and equal treatment. Speakers also stressed meaningful participation of people who use drugs, civil society, and affected communities in designing and implementing policy."},{"key":"gender-responsive-policy","label":"Gender-Responsive Policy","description":"Gender was discussed as a key dimension of drug and HIV policy, with emphasis on the specific barriers faced by women who use drugs. Speakers called for women-centered services, better sex- and age-disaggregated data, and policies that address gender inequality, violence, and stigma."},{"key":"harm-reduction-financing","label":"Financing for Harm Reduction","description":"Several speakers highlighted severe underfunding of harm reduction services and the risks created by donor cuts and uncertain international financing. They called for stronger domestic investment, protection of community-led services, and shifting resources away from punitive enforcement toward health responses."},{"key":"international-drug-policy","label":"International Drug Policy Reform","description":"Speakers discussed ongoing efforts to reform global drug policy through the UN system, including CND resolutions, human rights guidelines, and the review of international drug control approaches. The debate centered on moving multilateral policy away from narrow control models toward health-, evidence-, and rights-based frameworks."}]}}